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8Preface
Preface
On the 26th of October 2010, I took the 8:00 AM Green Line subway (nicknamed ‘the turtle’) 
from Hynes Convention Center to Longwood Avenue, to continue on foot past Brigham and 
Women’s Hospital and Harvard Medical School towards the adjacent, awe-inspiring Boston 
Children’s Hospital. In town for the AASLD’s 2010 Liver Meeting, I had taken the opportunity to 
arrange a meeting with prof. Richard Grand and Edda Fiebiger with the purpose of determining 
whether we could create a position that would serve as my PhD training in the field of pediatric 
gastrointestinal immunology. 
  The architect of today’s get-together had been prof. Edmond Rings, whom I had met during 
my internship at the Beatrix Children’s Hospital in Groningen, and who himself was an alumnus 
of a longstanding exchange program in pediatric gastroenterology for Dutch medical students 
(spearheaded by prof. Hans Büller and prof. Hugo Heymans) with the laboratory of prof. Grand 
in Boston (the interested reader is referred to the scientific publication in 2008 by Rings et al. in 
the Journal of Pediatric Gastroenterology and Nutrition volume 46, pages 419–422 that delineates 
the career outcomes of former students who partook in this program). During the previous 
months, Edmond and I had sat down a number of times in his office to discuss the options and 
the obstacles of doing PhD work in the United States, and from the first time we had talked about 
this I had grown determined to explore all those options and overcome all those obstacles. And 
this determination turned out to be needed. We soon found out that the ‘canonical’ pathway – a 
job in the lab of dr. Stephen Krasinsky who had taken over the reigns in the former Grand lab – 
was unavailable for at least two more years due to the fact that my colleague (and future friend) 
Boaz Aronson had recently started his PhD work with Steve’s group. Fortunately, Boaz’s efforts 
and dedication had not gone unnoticed, and dr. Edda Fiebiger, a colleague of Steve Krasinsky 
within the GI Division who was already involved in supervising short-stay Dutch MD students in her 
lab via an exchange program of her own, had indicated to dr. Grand that she would be interested 
to meet with me as a potential PhD candidate from The Netherlands.
  The meeting went well enough. Dick Grand almost immediately displayed the boundless 
enthusiasm that, as I would come to learn, so exemplifies his attitude and mentorship, and 
started drafting a preliminary budget (based on a grossly underestimated monthly expenditure 
of $1200!). Edda seemed more hesitant; I would be the first PhD student she had ever taken on 
(would I have what it takes?) and although the financial position of the lab was currently strong 
it was unclear – as it always is – how long this would remain to be the case. And thus the offer 
on the table was as follows: I could come for a trial period of one year, with my own funding, 
and if to mutual satisfaction, I could stay for the length of the PhD and we would then talk about 
getting my name on the lab’s payroll. 
  I did get to meet Boaz as well that first day at Children’s, who at the local Starbucks clearly 
delineated the contrast between a custom-made PhD program like the one he found himself 
in (and that I had similarly started plotting for myself that very morning), and the seemingly 
9smooth, all-expenses-paid-for, experience we believed PhD students in The Netherlands 
would have. “Basically it is a self-financed endeavor, where you live from grant-to-grant until 
your PI (‘maybe, fingers crossed!’) one day has sufficient funding to take on your salary”, only 
to be followed by a vivid recital of the frustrating procedure of procuring the appropriate 
research visa. However at the end of our talk he also gave me a heartfelt recommendation: 
“you should do it… it will be a lot of stress and effort, but you should do it”.
  And I did, obviously. On the 5th of April 2011 I began working in Edda’s lab in Boston. Not 
having procured a single grant yet from applications I had written in Holland over the months 
before, I started those first weeks with writing a research proposal directed at the Ter Meulen 
Fund of the Royal Netherlands Academy of Arts and Sciences (KNAW), which about a month 
later generously agreed to pay all my expenses for the first year of my studies in Boston. 
Furthermore, an application I had sent to the Banning de Jong Fund (part of the Prins Bernhard 
Cultural Fund) in The Netherlands also got approved, extending my funding period to well over 
1.5 years: more than enough to hold my end of the bargain. 
  The significance of the early support from these two institutions for the work described in 
this thesis cannot be overstated. During the first years, in which I was still looking for an overarching 
topic for this project, the privately acquired funding enabled me to pursue a variety of avenues 
of research that I considered interesting and to collaborate with a great number of people. I was 
fortunate that Edda has continued to wholeheartedly and generously support this attitude during 
my entire time in Boston. In search of the research question that would ultimately form the core of 
my thesis, I was thus allowed to work on several topics. Some of these make up the first part of this 
thesis; others remain in a drawer, deemed too inconclusive or complicated to continue, and others 
still eventually did or will get published but fall so far outside the scope of the already broad topic 
of Th2-type intestinal inflammation that they could not be reasonably included in this thesis. 
  Two years into my time in Boston, on Friday the 10th of May 2013 to be exact, dr. Jeremy 
Goettel (collaborator, friend, paranimf) and I had an idea that would herald the work described 
in the second part of this thesis and that I consider to be the core of my scholarly endeavors 
at the Children’s Hospital. The preliminary data that rapidly accumulated within this line of 
investigation, through a strike of serendipitous luck, gathered the interest of Dr. Dirk de Hond 
and Dr. Ric van Tol from the Mead Johnson Company, who had very recently started to get 
involved with the GI Division at the Children’s Hospital Boston. Their incredible enthusiasm 
and generous financial support in the form of a tailor-made post-doctoral fellowship has 
made possible the research delineated in Chapters 7, 8 and 9, and provided the means for me 
to prolong my stay in Boston up to the 4.5 years that it ultimately took to generate the data 
described in the thesis as it now lies before you. 
  I sincerely hope that by reading this work you will experience a fraction of the joy I have 
gotten out of working on it. 
Willem S. Lexmond, June 2017
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Introduction, outline, and rationale of this thesis
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These are incredibly exciting times to become involved in the field of mucosal immunology. 
The mucosal surfaces of our body form our most direct and intimate connection to the outside 
world, and are therefore at the center stage of the interplay between our rapidly changing 
environment and our evolutionary (genetic) heritage. We have evolved under circumstances 
that differed in many ways from our current, affluent living conditions. Any rapid changes in 
external (environmental) factors1 have the potential to disrupt the balance that has followed 
from hundreds of thousands of years of evolution. Such instability between external and 
internal factors puts us at risk for what are sometimes referred to as evolutionary mismatch 
diseases. They are complex, multifactorial disorders that are driven by gene-environment 
interactions and that are only beginning to be understood at the molecular level. 
  Aberrant type 2 inflammation in the intestinal tract, the topic of this thesis, affects the 
largest and arguably most complex mucosal surface of our body, and is a prime example of 
a highly complicated disease state that is directly related to changes in our environment. 
It underlies several immune-mediated disorders such as food allergy and eosinophilic 
gastrointestinal diseases that are characterized by rapidly increasing incidence and 
prevalence in children (and adults) in Westernized societies. The overarching goal of this 
thesis is to improve our understanding of the pathophysiology of type 2 intestinal 
inflammation. To this end, two complimentary approaches have been applied, and they 
are described in detail in the two parts that make up this work. In Part 1, we have aimed to 
obtain novel insights into the pathogenesis of allergic intestinal inflammation from 
a cohort of patients with established eosinophilic esophagitis, a type 2 inflammatory 
disorder of the upper GI tract. Using clinical data in combination with tissue biopsies of 
these children, we demonstrate considerable immunological heterogeneity, suggesting that 
distinct mechanisms may underlie a final common pathway of disease. In Part 2, we have 
approached the problem of aberrant type 2 intestinal inflammation by characterizing 
a novel experimental mouse model of food allergy that allows for the interrogation 
of the critical pathways involved in its pathogenesis. In both these approaches, we have 
strived towards translational value of our experiments. Multifactorial, immune-mediated 
diseases at the mucosal surface are defined in humans, but commonly studied in mice. 
Therefore, in the parts of the thesis where we rely on data from animal models, we have 
actively investigated the degree of overlap with the human situation and these comparisons 
form an essential aspect of the experimental work presented in this thesis (Part 1 Chapter 
5, Part 2 Chapters 6-9). In this introductory chapter, we will first present a brief overview 
of type 2 inflammation, after which the outline, sub aims, and rationale of both parts of the 
thesis are sequentially discussed. 
1  Environmental factors in this context include physical, biological and behavioral factors, for example diet, 
family-size and organization, living conditions, birthing habits, availability of therapeutic modalities (antibiotics, 
immunosuppressants, or anti-inflammatory agents), quality of water, air and soil, etc. 
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More than a hundred years ago, the Frenchman Charles Richet was awarded the Nobel Prize 
in physiology for the first description of anaphylaxis. In his acceptance speech, he marveled 
at the “extraordinary phenomenon that so insignificant a quantity of poison can modify 
the organism to the extent that the succeeding days down long years can not eradicate this 
indelible modification” (Richet, 1913). Based on transfusion experiments between sensitized 
and non-sensitized dogs, Richet already concluded that “the anaphylactogen poison is 
therefore a chemical substance contained in the blood”, but it would take an additional fifty 
years for immunoglobulin E (IgE) to be identified as the mediator of anaphylactic reactions. 
Historically, IgE-mediated anaphylaxis is classified as the archetypal, type I, hypersensitivity 
reaction according to the scheme proposed by Gell and Coombs in 1963 (Male et al., 2006). 
Since the identification of distinct Th1 and Th2 T helper subsets in the 1980s, it has become 
clear that anaphylaxis can be considered the most extreme manifestation of what are 
collectively termed type 2 (or Th2-type) immune responses. 
  Type 2 immunity has evolved to serve a variety of host-defense functions, ranging from 
protection against parasites and support of epithelial barrier integrity, to regulation of wound 
healing and control of metabolic homeostasis (Palm et al., 2012; Pulendran and Artis, 2012; 
Wynn, 2015). Many of these functions are performed by effector cells of the innate immune 
system, including eosinophils, basophils and mast cells, which in turn are orchestrated by 
Th2 lymphocytes of the adaptive immune system through the production of type 2 cytokines 
such as IL-4, IL-5 and IL-13. Th2 help is critical for the production of IgE antibodies from B 
cells, which through binding to the high-affinity IgE surface receptor FcεRI can bestow 
antigen-specific effector functions onto mast cells and basophils. Following antigen-
mediated crosslinking of surface bound IgE, these IgE effector cells respond by releasing pre-
formed inflammatory mediators such as histamine and proteases in the extracellular space, 
which lead to vasodilation, fluid extravasation and pruritus (Burton and Oettgen, 2011; 
Gould and Sutton, 2008; Kraft and Kinet, 2007). Severe IgE-mediated immune responses 
are accompanied by systemic symptoms that can include airway edema and hypotension 
(anaphylactic shock), and will occasionally result in death if left untreated. 
Because of the potency of IgE-mediated immunity, it is no surprise that multiple inhibitory 
pathways have evolved to control the initiation and magnitude of type 2 immune responses 
(Wynn, 2015). Failure in these regulatory mechanisms is increasingly common in Westernized 
societies, and can result in the generation of allergen-specific IgE, type I hypersensitivity 
reactions and allergic tissue inflammation (Palm et al., 2012; Pulendran and Artis, 2012; 
Wynn, 2015). Manifestations of allergic diseases depend on the nature of the allergen to 
which the host has become sensitized: pollen sensitivity will result in hay fever, house dust 
mite is strongly associated with allergic asthma and food allergies are due to IgE-mediated 
reactions after ingestion of regular food antigens. However, it is important to stress that the 
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spectrum of Th2-type atopic disease extends beyond IgE-mediated immune activation. 
IgE-independent forms of atopic diseases have been described (Novak and Bieber, 2003) 
and induction of allergen-specific IgE should probably be considered a symptom of type 2 
immune disorders rather than its pathognomonic feature. One type 2 inflammatory disease 
that illustrates this complex relationship is eosinophilic esophagitis, which forms the subject 
of the first part of this thesis and will therefore be introduced in the following section. 
1.2 Eosinophilic esophagitis: a type 2 inflammatory disorder of the upper 
gastrointestinal tract – an introduction to Part 1
Eosinophilic esophagitis (EoE) belongs to the primary eosinophilic gastrointestinal disorders 
(EGIDs), which additionally include eosinophilic gastritis, eosinophilic gastroenteritis, 
eosinophilic enteritis, and eosinophilic colitis (Gonsalves et al., 2016). The unifying feature of 
all EGIDs is accumulation of an eosinophil-rich inflammatory infiltrate at the mucosal surface. 
The pathogenesis of these disorders involves a complex interplay of genetic predisposition, 
exposure to allergens, and Th2-type activation of the immune system (Masterson et al., 2011; 
Mikhail and Sampson, 2016). EoE is the most frequently diagnosed EGID (Gonsalves et al., 
2016), with an incidence of approximately 1 new case per 10,000 persons per year and a 
prevalence of 0.5-1 cases/1000 persons in Westernized societies (Dellon, 2014; Furuta and 
Katzka, 2015).  
  As is clear from its name, eosinophilic esophagitis is characterized by chronic 
eosinophilic inflammation of the esophagus. It has only been recognized as a distinct clinical 
entity since the early 1990s (Attwood et al., 1993), and the disorder is strongly associated 
with allergies to both inhaled as well as food-derived antigens (Hruz et al., 2011; Mulder and 
Justinich, 2011; Rothenberg, 2009). EoE often manifests in childhood with symptoms that 
become increasingly localized with a later age of onset; affected infants typically present with 
failure to thrive and feeding disorders, whereas abdominal pain, vomiting, dysphagia and 
food impaction are more pronounced in older children and adults (Assa’ad et al., 2007; Brown-
Whitehorn and Liacouras, 2007; Straumann et al., 2012). The differential diagnosis of these 
symptoms is broad, and commonly there is considerable delay between onset of symptoms 
and diagnosis (Hruz et al., 2011; Schoepfer et al., 2011). The diagnostic gold standard of 
EoE remains to be histopathological examination of multiple esophageal biopsies for the 
presence of ≥15 eosinophils per high power field. This finding is, however, not pathognomonic 
(Liacouras et al., 2011; Straumann, 2009) and diagnostic uncertainty often further delays the 
start of appropriate treatment. Esophageal inflammation can be controlled with topical 
corticosteroids, most often in the form of swallowed fluticasone or liquid budesonide, and 
with dietary interventions. The reported response rates to either dietary interventions or 
topical steroids vary from 50% to >90%, and best responses are achieved by treatment with 
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et al., 2013). However, since EoE is a chronic condition, inflammation typically recurs upon 
discontinuation of treatment. Furthermore, tissue-remodeling events may continue despite 
installation of appropriate therapy, which in turn can lead to the long-term complications of 
disease such as strictures of the esophagus (DeBrosse et al., 2011). Dilatation of esophageal 
strictures is used to relieve EoE-associated symptoms, such as dysphagia, but does not 
reduce ongoing inflammation (Dellon and Liacouras, 2014). Altogether, EoE results in a 
reduced quality of life and commonly has persistent symptoms 15 years after presentation 
(DeBrosse et al., 2011).
  The immunologic hallmark of EoE is a Th2-type, allergen-driven immune response 
that leads to chemotaxis and infiltration of eosinophils into the affected esophagus. The 
comorbidity of allergic diseases ranges from 42-93% in pediatric and 28-86% in adult EoE 
patients, which is significantly higher than in patients with reflux esophagitis or in the general 
population (Liacouras et al., 2005; 2014; Roy-Ghanta et al., 2008; Spergel et al., 2005). Food 
antigen-specific IgE can be detected in a large percentage of patients, and cross-reactivity 
between aeroallergens and food antigens has been associated with disease progression 
(Spergel, 2005; van Rhijn et al., 2013). Despite the clear association between EoE and atopic 
disease, serum IgE levels are normal in up to 50% of EoE patients, which has led some authors 
to conclude that eosinophilic inflammation occurs largely independent of IgE (Simon et al., 
2016). In support of this notion, anti-IgE treatment with the monoclonal antibody omalizumab 
does not improve EoE in children or adults (Clayton et al., 2014; Rocha et al., 2011). Instead, 
it has been suggested that esophageal inflammation is mediated by IgG4 antibodies against 
food antigens, which are found in higher titers in serum and esophageal tissue of adult EoE 
patients when compared to controls (Clayton et al., 2014). Importantly, IgG4 and IgE are both 
Th2-type antibodies because B cells require IL-4 to class-switch to either isotype (Aalberse et 
al., 2016). In vivo, allergen-specific IgG4 and IgE are thought to compete for allergen binding, 
and increased titers of allergen-specific IgG4 are associated with acquisition of tolerance 
during oral immunotherapy trials for IgE-mediated food allergies (Akdis and Akdis, 2014b). It is 
interesting to note that a number of cases have been described in which children undergoing 
oral immunotherapy developed EoE (Lucendo et al., 2014). 
  Irrespective of the results of allergenic testing in an individual patient, the type 2 
inflammatory nature of EoE is apparent from the esophageal mRNA pattern (Blanchard 
et al., 2006a; 2006b; Furuta et al., 2007; Noti et al., 2013), the predominant role for IL-13 
in pathogenesis (Blanchard et al., 2010; Davis and Rothenberg, 2016) and esophageal 
infiltration of basophils and mast cells in addition to eosinophils (Abonia et al., 2010; Noti 
et al., 2013). Much remains to be learned about the interplay between allergic comorbidities 
and atopic constitution on the one hand, and the evolution of EoE pathophysiology on the 
other. In Chapter 5, we explore one aspect of this interplay by demonstrating that allergic 
sensitization through an impaired skin barrier promotes the development of EoE via IL-
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33 and basophils. This finding links EoE to eczema in early life and suggests that EoE, like 
asthma, could be regarded another station in what has been termed the atopic march2. 
The large number of clinical and mechanistic reviews that have been published last year 
alone on the subject of eosinophilic esophagitis (EoE) is indicative of the great interest that 
allergists, immunologists, and gastroenterologists have in this relatively new disease entity 
(see for example (Aceves, 2015; Cianferoni and Spergel, 2016; Davis and Rothenberg, 2016; 
Furuta and Katzka, 2015; Oyoshi, 2015; Rothenberg, 2015)). Given the availability of these 
recent publications, no attempt will be made to further review the general characteristics of 
EoE here, since the aim of this chapter is to introduce the specific research questions that are 
the focus in the upcoming chapters.
1.3 Outline and aims of this thesis pertaining to Part 1 
In contrast to asthma, for which analysis of lung biopsies is not part of routine patient care, 
EoE can currently only be diagnosed through demonstration of an eosinophilic infiltrate in the 
affected tissue. It is this diagnostic requirement, together with increasing awareness amongst 
physicians, a relatively high and rising incidence of disease, and technological advances in high-
throughput quantification of tissue mRNA levels that has given rise to large cohorts of pediatric 
and adult patients in whom clinical information can be correlated to histological and functional 
changes at the level of the esophagus. Examples of such cohorts are the ones at the University 
of North Carolina (Dellon et al., 2012; 2013), and Cincinnati Children’s Hospital (Blanchard et al., 
2011; Wen et al., 2015; 2013), as well as the cohort at Boston Children’s Hospital that is featured 
in the following chapters (Chapter 2, 3, 4,  and 5). These translational research projects are 
aimed at (I) reducing the need for (repeated) endoscopy by identifying non-invasive biomarkers 
of disease; (II) further elucidating EoE pathogenesis; and (III) improving the diagnostic yield of 
esophageal biopsies that are endoscopically obtained. 
  With regards to the first aim, in work not included in this thesis, we have explored 
the possibility of using a soluble form of the high-affinity IgE receptor FcεRI as a serum 
biomarker for the presence of EoE (Lexmond et al., 2011). In addition, we have tested whether 
urinary leukotriene E4 (Chapter 3) or the soluble IL-33 receptor in serum (Chapter 5) could 
distinguish EoE patients from controls. Others have tried a combination of blood cytokines 
(Blanchard et al., 2011) or sampling of esophageal luminal contents via a swallowed capsule 
on a string (Furuta et al., 2013). Despite these efforts, there is still no alternative to upper 
endoscopy available in daily practice. 
2   The World Allergy Organization defines the atopic march (also called the ‘allergic march’) as the natural history of 
atopic manifestations, characterized by a typical sequence of immunoglobulin E (IgE) antibody responses and 
clinical symptoms which may appear early in life, persist over years or decades and often remit spontaneously 
with age (see www.worldallergy.org).
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been studied to shed light on the pathogenesis of EoE. In 2006, the EoE transcriptome was 
published (Blanchard et al., 2006b), which revealed that the disease is associated with 
a distinct local gene expression signature, with upregulation of eotaxin-3 and periostin 
as hallmark features. In Chapter 2, we will demonstrate that a mathematical model built 
around the expression of a combination of 10 genes can identify EoE patients from children 
with gastroesophageal reflux disease (GERD) or normal controls with up to 94% sensitivity, 
and can thus provide a diagnosis in a blinded fashion in the absence of evaluation by a 
pathologist. This high sensitivity and significant diagnostic power can be obtained because 
the characteristic changes that constitute the EoE transcriptome reflect a final common 
pathway that appears to be activated in all patients. Indeed, the original description of the EoE 
transcriptome already delineated that it did not distinguish between food allergen-sensitized 
or non-sensitized subjects (Blanchard et al., 2006a; 2007). However, given the heterogeneity 
of the disease in terms of clinical presentation, the age of onset, and association with 
concurrent allergic diatheses, we asked whether this variation would be reflected in perhaps 
more subtle differences in the esophageal transcriptome. This hypothesis forms the basis of 
Chapter 3, in which we identified a subset of pediatric EoE patients that shows increased 
tissue expression levels of leukotriene C4 synthase (LTC4S), an enzyme involved in the 
synthesis of an inflammatory mediator associated with allergic inflammation. Patients with 
increased expression of LTC4S more frequently suffered from co-existing IgE-mediated food 
allergies, and as such form a subcategory of EoE patients that can be defined based on both 
clinical and functional characteristics. Interestingly, treatment with the leukotriene receptor 
antagonist montelukast showed mixed results in patients with EoE, benefitting some but not 
others, which allows the tempting speculation that perhaps only LTC4S-positive EoE patients 
will experience clinical benefit from this treatment strategy. 
  In addition to potentially informing personalized medicine, identification of EoE patient 
subsets might shed further light on the pathogenesis of disease. Like other allergic diseases, 
the incidence of EoE is rapidly rising in Westernized societies, implicating environmental 
factors as critical determinants in disease pathogenesis (Davis and Rothenberg, 2016; 
Furuta and Katzka, 2015). As will also be described in Chapter 7 and Chapter 9, signals 
obtained from commensal microbiota residing in proximity of mucosal tissues have been 
experimentally demonstrated to play a pivotal role in regulating allergic tissue responses 
(Berni Canani et al., 2015; Feehley and Nagler, 2014). Particularly dependent upon microbial 
regulation are invariant chain Natural Killer T (iNKT) cells, which have been shown to 
accumulate in mucosal tissues in germ-free mice and then confer increased susceptibility 
to asthma and colitis (Olszak et al., 2012). In Chapter 4, we provide evidence that invariant 
chain Natural Killer T (iNKT) cells are present in the esophagus of pediatric EoE patients. 
Involvement of the iNKT cell pathway proved most pronounced in patients who developed 
esophageal inflammation early in life and who showed IgE sensitization against food antigens 
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and increased LTC4S expression, which further attests to the existence of different patient 
subsets amongst EoE patients. Following allergen avoidance therapy, iNKT cell infiltration 
and esophageal inflammation resolved, identifying involvement of the iNKT-cell axis as a 
modifiable factor in disease pathogenesis. Furthermore, we found that EoE was associated 
with use of antibiotics in early life, which has been corroborated by others (Jensen et al., 2013; 
Radano et al., 2014), and in combination with beginning efforts to evaluate the esophageal 
microbiome in patients with EoE (Harris et al., 2015), this line of investigation may ultimately 
inform preventative treatment strategies. 
  As stressed before, EoE is a complex, multifactorial disorder, and aberrant microbial 
colonization and iNKT cell homeostasis is unlikely to explain all facets of the disease. For 
example, genetic polymorphisms in a variety of genes including TSLP and IL33 have been 
found to be associated with the disease (Kottyan et al., 2014; Rothenberg et al., 2010; Sherrill 
et al., 2010; Spergel, 2010), and EoE often occurs in the context of other allergic diseases. In 
Chapter 5, we found that allergen sensitization via the skin of mice with dermatitis (induced 
either mechanically through tape-stripping, or genetically by using filaggrin-deficient 
animals) followed by intranasal allergen challenge results in esophageal eosinophilia via 
increased expression of IL-33 and TSLP. Basophils proved critical mediators of increased 
disease susceptibility, as basophil-depleted mice showed attenuated EoE and basophils 
deficient in the IL-33 receptor also failed to mediate esophageal eosinophil accumulation. 
These findings support the notion that atopic dermatitis, which is commonly the first disease 
in the atopic march, can directly promote the development of EoE in later life, establishing 
EoE as a manifestation of an atopic constitution.
In Chapter 5, we have used animal models to interrogate cause and effect in the pathogenesis 
of Th2-mediated intestinal inflammation. The advantages, considerations, and caveats that 
come with the use of such experimental systems are the focus of the second part of this 
thesis and will be introduced in the following section.
1.4 Animal models in the study of type 2 intestinal inflammation – an 
introduction to Part 2
IgE and its effector cells are evolutionarily highly conserved features of the mammalian 
immune system, and many of our advances in understanding allergic responses have 
been achieved through animal experiments. Richet already stated that “anaphylaxis has 
been observed in all animals: the horse, the goat, the ox, the rat, the pigeon, the duck and 
even recently in frogs” (Richet, 1913), but no animal has played a bigger part in allergy 
research than the laboratory mouse. As illustrated in the following sections, IgE mediated 
anaphylactic responses can reliably be induced in mice, rendering them amenable to 
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human and murine IgE systems, which limits the degree to which mechanistic insight can be 
applied across species. One example is the expression of the high-affinity IgE receptor FcεRI, 
which in mice is restricted to basophils and mast cells, but in humans can also be found on 
dendritic cells and eosinophils. The consequences of this disparity have been an important 
research subject in the laboratory where this PhD thesis has been performed. With the use 
of transgenic models, FcεRI has been expressed on the surface of murine dendritic cells, and 
this approach has revealed important functions for dendritic cell-bound IgE in regulating 
Th2-type intestinal inflammation in vivo (Platzer et al., 2015a; 2015b; Sallmann et al., 2011). 
The ingenuity of this system notwithstanding, bridging one known difference between mice 
and men does not resolve other disparities between the species, some of which we may not 
even be aware of as of yet.  
  An alternative approach to bypass this caveat is to study IgE responses in 
immunodeficient mice in which the human immune system has been reconstituted with 
immune cells from human donors. These ‘humanized’ mice thus not only allow for the 
investigation of the effects of IgE-mediated activation on human immune cells, but also 
provide a means to study the regulating mechanism of the entire IgE network on distinct 
immune cell populations. Multiple techniques are employed to reconstitute a functional 
human immune system in immunodeficient mice (Shultz et al., 2012), though the most 
widely studied model in the context of allergy research has been the engraftment of isolated 
human peripheral blood cells (PBMCs) in NOD/SCID mice deficient in the gamma-chain of the 
IL-2 receptor (NSG mice). These mice are characterized by arrested lymphocyte development 
and as such are unable to reject HLA mismatched donor cells. Using this experimental 
approach, it was shown that the transfer of human allergic PBMCs induced Th2 cytokine 
production and colonic inflammation upon intestinal challenge with the relevant allergen 
(Weigmann et al., 2012). Inflammation could be blocked with the anti-human IgE monoclonal 
antibody omalizumab, implying human IgE as a critical mediator in this model. However, 
treatment with anti-murine FcεRI antibody MAR1 also reduced inflammation, showing that 
murine basophils and mast cells may have also contributed to the allergic phenotype. In 
line with these results, a different study showed that transfer of PBMCs from allergic, but not 
healthy donors induced airway hyperresponsiveness in NSG mice that were challenged with 
aeroallergens (Martin et al., 2012).  
  These findings suggest that human allergic disease can be phenocopied to a certain 
degree in immunodeficient mice, and several authors have used this model to assess the 
effect of therapeutic interventions (Bellinghausen et al., 2012; Brightbill et al., 2010). Although 
such studies highlight the potential of humanized mice in advancing IgE and allergy research, 
it is important to recognize that reconstitution of NSG mice with human PBMCs is limited by 
less efficient B cell reconstitution compared to T cells. Furthermore, the immunopathology 
of interest is likely to be confounded by concurrent GVHD reactions that result from HLA-
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mismatch (Shultz et al., 2012). These limitations can be overcome by reconstitution of 
neonatal NSG mice with human hematopoietic stem cells (HSC). In this setting, human 
lymphocytes are educated on murine HLA, which eliminates the potential for GVHD and 
allows for the study of a naïve immune system. Tanaka et al. showed that this strategy gives 
rise to human mast cells and basophils, but did not report on IgE receptor loading or serum 
IgE levels (Tanaka et al., 2012). Furthermore, Ito et al. showed that knock-in of transgenes 
for human IL-3 and GM-CSF in NSG recipients enhanced the populations of FcεRI positive 
mast cells and basophils after CD34+ HSC transfer (Ito et al., 2013). However, as we shall see 
in Chapter 6, because CD4+ T cells are positively selected on murine MHCII in the thymus, 
naturally occurring IgE responses in this setting remain modest. 
  Attempts to humanize mice are relatively recent developments, and the largest 
contribution by far to our detailed knowledge of downstream effects of allergen-IgE-FcεRI 
interactions has been derived from in vitro experiments using cell lines in combination with 
experimental models of allergic sensitization in wild-type mice. The body of knowledge 
generated using these approaches has been instrumental in guiding the development of our 
currently available therapeutic modalities for allergic diseases, and, as a result, we are not 
only able to effectively treat anaphylactic shock following accidental allergen exposure, but 
we can also pharmacologically manage the less dramatic manifestations of IgE–mediated 
immune activation such as hay fever, atopic dermatitis and allergic asthma. Unfortunately, 
the advances in our understanding of allergic immune responses have not translated in a 
reduction of the burden of allergic diseases on our societies. On the contrary, in Western 
countries, IgE-mediated food allergies alone have a current prevalence of 4-10% in children 
(Longo et al., 2013; Osborne et al., 2011; Sicherer and Sampson, 2010), and asthma and atopic 
dermatitis are also among the most frequently occurring chronic diseases in the pediatric 
population. As long as the prevalence of allergic diseases keeps rising and our therapeutic 
options remain limited to drugs that only temporarily control symptoms, these disorders 
will continue to demand an ever-increasing price from public health. Because this allergic 
epidemic has taken place over the course of one or two generations, it cannot be merely 
explained by genetic predisposition. Epidemiological studies have given rise to a multitude 
of hypotheses how environmental factors may contribute to increasing rates of allergic 
sensitization (Platts-Mills, 2015). Yet despite our advanced understanding of IgE-mediated 
immunity, the experimental and mechanistic evidence to prove causality of any of these 
presumed factors has lagged behind. 
  As will be argued in Chapter 8, this discrepancy may at least in part be attributed to the 
lack of animal models that spontaneously develop allergic diseases. To determine a causal 
effect of an environmental influence, an ideal experiment would assess the rate of allergic 
disease between animals exposed or unexposed to that particular factor, with all other 
factors held equal. Of course, such studies are only feasible when the disease of interest does 
in fact occur in the experimental animal in a way that faithfully resembles the pathogenic 
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or inflammatory bowel diseaes (Strober et al., 2002; Wirtz and Neurath, 2007), King:2012bs}, 
there is currently no model that mimics spontaneous sensitization to food antigens as 
it occurs in humans (Oyoshi et al., 2014; Van Gramberg et al., 2013). Wild-type mice have 
proven to be highly resistant to the dysregulation of IgE-mediated immune responses to food 
allergens due to the robustness of ‘oral tolerance’, the collective of cellular mechanisms that is 
responsible for tolerance of ingested foreign antigens. In order to overcome the establishment 
of oral tolerance, murine models of food allergy commonly rely on adjuvant-based strategies 
to induce systemic production of antigen-specific IgE prior to first intestinal exposure. 
Alternatively, the induction of oral tolerance can be disrupted by intestinal co-exposure to 
adjuvants such as cholera toxin or staphylococcal enterotoxin B (Berin and Mayer, 2009). Even 
less physiological is the passive immunization of animals with exogenous antigen-specific 
IgE, administered via injection, prior to challenge with an allergen. It is clear that none of these 
forced sensitization methods resembles the pathogenesis of allergic sensitization in humans. 
Such models, which recapitulate the symptoms and treatment responses of human disease 
but not the underlying cause of disease, are termed ‘isomorphic’. In contrast, a ‘homologous’ 
animal model of food allergy would not only capture the IgE effector phase of disease, but 
also faithfully mimic spontaneous oral sensitization to food antigens (Oyoshi et al., 2014). It 
can be argued that our mechanistic insight increases along the temporal sequence of the 
naturally occurring IgE effector response: we understand the intracellular events following 
IgE-mediated cellular activation at the deepest molecular level, but we cannot yet explain the 
origin of the first antigen-specific IgE molecules that are responsible for allergic responses. 
This difference is reflected in our current treatment strategies for allergic diseases, which 
are aimed at symptomatic control of IgE effector responses. However, in order to reduce 
the burden of allergic diseases, curative and preventative strategies are required, and these 
demand a more thorough understanding of the immunological events that underlie early 
allergic sensitization. We believe that the lack of homologous experimental models is partly 
responsible for the paucity of insight into the early stages of food allergy. This argument is 
summarized in Figure 1.1.
1.5 Outline and aims of this thesis pertaining to Part 2
As mentioned in the previous subsection, transfer of human PBMCs to an immunodeficient 
mouse results in a certain degree of immune reconstitution, which allows the experimental 
manipulation of human immune cells in an in vivo setting. Although IgE-mediated 
immune activation can occur in this system (Weigmann et al., 2012), HLA-mismatch 
will ultimately result in graft-versus-host reactions in the recipient with high risk of 
confounding the interpretation of any spontaneously occurring immune activation. This
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Figure 1.1.
problem is circumvented by reconstitution with CD34+ HSCs, in which education of naïve 
lymphocytes occurs on murine HLA molecules, but this process is ineff icient and adaptive 
immune responses consequently remain weak (Baenziger et al., 2006). Selection of T cells and 
IgE-mediated immunity can be enhanced by concurrently transplanting human bone-marrow, 
liver and thymus-derived tissue as well as autologous CD34+ HSCs, but this approach is limited 
by high-costs and demand for fetal tissues with its inevitable ethical implications (Shultz et al., 
2012). In Chapter 6, we have tested whether immune reconstitution from HSCs and adaptive 
immune responses in immunodeficient NOD.Rag1-/-Il2rg-/- (NSG) mice could be improved by 
replacing murine MHC II with a human MHC II DR1 allele. We show that this system results in 
a richer TCR repertoire and higher B cell maturation and class switch recombination resulting 
in elevated levels of immunoglobulins, including IgE. Furthermore, transfer of human stem 
cells obtained from a donor suff ering from the immune dysregulation, polyendocrinopathy, 
enteropathy, X-linked (IPEX) syndrome that results from loss of regulatory T cells (Tregs) due 
to mutation of the Treg-specific transcription factor FOXP3 led to reconstitution of auto-
inflammatory symptoms in animals that expressed the human DR1 allele, but not in those 
who did not. Based on recently published data, it is tempting to speculate that additional 
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improve mast cell reconstitution in this model as well, which could further augment IgE effector 
responses (Bryce et al., 2016; Ito et al., 2013). Going forward, this new experimental system 
could thus serve as an improved pre-clinical model for the study of human allergic diseases 
and IgE-mediated immunity.  
  In addition to severe autoimmunity, patients with IPEX almost uniformly develop food 
allergies, eczema and increased levels of IgE (Akdis and Akdis, 2009; Lin et al., 2005; Suscovich 
et al., 2012). Similarly, elevated levels of IgE were found in NSG mice reconstituted with IPEX-
HSCs (Figure 6.6, page 135). These symptoms are the result of unrestrained activation 
of Th2 immune responses that occur in the complete absence of FOXP3+ Tregs. However, 
dysregulated Th2 responses, atopy and elevated IgE levels are seen in a variety of primary 
human immunodeficiencies (Liston et al., 2008; Ozcan et al., 2008). In fact, a number of such 
diseases have been phenotypically lumped together under the term ‘hyper IgE syndromes’ 
(formerly known as Job’s syndrome), which share symptoms of extremely elevated serum 
IgE, eczema and recurrent infections (Yong et al., 2012). It is now becoming clear that hyper 
IgE phenotypes can result from alterations in distinct immunological pathways. For example, 
mutations in STAT3, DOCK8, TYK2 and multiple genes involved in TCR signaling such as LAT, 
ZAP70 or RAG are all associated with aberrant IgE responses. In most of these cases, however, 
the underlying mechanisms of increased IgE production or the functional consequences of 
elevated serum IgE have not been studied in detail.  
  One well-known3 primary immunodeficiency with increased IgE titers is the Wiskott-
Aldrich syndrome (WAS) (Datta and Milner, 2011; Ozcan et al., 2008). WAS is caused by 
mutations in the Wiskott-Aldrich syndrome (WAS) gene on the X-chromosome, which 
is expressed in all hematopoietic cells and encodes for the Wiskott-Aldrich Syndrome 
protein (WASP). WASP is the founding member of a family of actin regulators, capable of 
transducing a variety of signals to mediate changes in the actin cytoskeleton, and has been 
implicated in a great variety of cellular functions in both lymphocytes and non-lymphocytes 
(Snapper and Rosen, 1999; Thrasher and Burns, 2010). Over a 100 unique loss-of-function 
WAS mutations have been reported and these give rise to a clinically highly heterogeneous 
group of patients (Thrasher and Burns, 2010). Males that are most severely affected 
present early in life with thrombocytopenia, eczema, autoimmune sequelae and recurrent 
infections, which in the absence of bone-marrow transplantation or gene therapy can be 
fatal. Milder loss-of-function mutations, in contrast, have been identified in patients who 
suffer from an attenuated form of the disease that is termed X-linked thrombocytopenia 
(XLT), which has an excellent long-term survival with medical management alone (Albert 
et al., 2011). Despite the long-known association between WAS mutations and atopy, the 
antigenic specificity of the expanded IgE pool and the consequences of elevated IgE on the 
3   In fact, elevated levels of serum Ig ND (Ig not determined) had been observed in patients with Wiskott-Aldrich 
syndrome even before Ig ND was formally changed to IgE in Lausanne in 1968 (Berglund et al., 1968). 
Chapter 1
24
prevalence of allergic disorders have not been investigated in detail in human patients 
with WAS.
  Since 1998, an animal model has been available in which the murine ortholog Was is 
deleted from the X chromosome (Snapper et al., 1998). Many of the immunological features 
of human WAS are phenocopied in these mice, and they have been extremely informative 
in unraveling the immune pathogenesis of WAS-associated autoimmunity and lymphocyte 
dysfunction. However, aberrant IgE production in WASP-deficient mice had never been 
examined until very recently in a paper dissecting the role of WASP in B cells (Recher et 
al., 2012), and no data has been published on the mechanism and consequences of these 
aberrant IgE responses in mice. 
  In Chapters 7, 8 and 9, we have studied IgE-mediated immune responses in WASP-
deficient mice and in human patients suffering from WAS. These investigations have been 
driven by the overarching hypothesis that elevated levels of serum IgE could potentially have 
specificity for ingested food antigens and, if so, that Was-/- animals could serve as a novel, 
perhaps more homologous experimental model of food allergy. In Chapter 7, we describe 
that food allergy occurs in 20% of patients with mutations in the WAS gene, which is a markedly 
higher prevalence than in the general population. We furthermore demonstrate that elevated 
levels of IgE are found in WASP-deficient mice on a variety of genetic backgrounds, and that 
IgE in these animals does indeed contain specificity for antigens found in mouse chow. 
Importantly, anti-food IgE titers were highest for food antigens commonly associated with 
IgE-mediated food allergy in humans such as wheat and soy. This latter finding suggests that 
the mechanisms that drive the allergenicity of these particular food antigens in human food 
allergy are also operative in Was-/- mice, which would be an argument in favor of homology of 
the model. 
  We dedicated a separate paper to the further characterization of WASP-deficient mice 
as a novel model of food allergy (Chapter 8). Using the model antigen ovalbumin (OVA), 
we demonstrate that spontaneous induction of OVA-specific IgE occurs following oral OVA 
exposure, thus bypassing the need for adjuvant-mediated sensitization. Since a homologous 
model of food allergy should also faithfully recapitulate the IgE effector phase, we assessed 
the response to OVA challenge, and found that the occurrence of allergic diarrhea was similar 
to WT mice subjected to a conventional, adjuvant-based model of food allergy. 
  Having established that WASP-deficient mice can be utilized in the study of food 
allergy, we aimed to further elucidate the pathogenesis of aberrant Th2-mediated intestinal 
inflammation. First, we ruled out that allergic sensitization resulted from dysbiosis in microbial 
commensal populations by demonstrating that sensitization to food allergens occurred 
to a similar degree in WASP-deficient mice raised under germfree conditions (Figure 7.3, 
page 163). Next, using a combination of genetic approaches that allow cell-type-specific 
deletion of WASP, we show that mice that only lack WASP in FOXP3+ Tregs spontaneously 
develop allergic intestinal inflammation and IgE antibodies against food allergens. Loss of 
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whereas Th1 and Th17 subsets remain effectively controlled by WASP-deficient FOXP3+ Tregs. 
Phenotypically, WASP-deficient Tregs showed increased expression of the Th2 transcription 
factor GATA3, both in mice as well as human patients. Although the molecular mechanism 
for this differential transcription factor expression in FOXP3+ Tregs remains speculative, it is 
important to note that GATA3+ Tregs have recently also been observed in children with food 
allergy (Noval Rivas et al., 2015), and this finding thus identifies another point of overlap 
between the pathogenesis of WAS-associated and common food allergy. 
  As illustrated in Figure 7.4 (page 164), Treg-specific deletion of WASP results in an 
exacerbated allergic phenotype compared to Was-/- mice that lack WASP in all hematopoietic 
lineages. In Chapter 9, this observation is discussed in detail, with a comprehensive review 
of the known functions of WASP in different cell types of the innate and adaptive immune 
system. Not limited by journal-specific restrictions to word count or figure numbers, this 
chapter was written as both a synthesis of the data presented in the second part of this 
thesis, as well as a means to incorporate additional results from experiments that had not yet 
been presented in Chapter 7 and Chapter 8. Here we show data that the microbiome and 
maternal factors affect and shape WAS-associated food allergies, and that WASP-deficient 
FOXP3+ Tregs can even cause allergic disease in mice that lack WASP in only half of Tregs. In 
addition, we outline the future directions of this new line of investigation. 

PART 1
Diagnosis and pathophysiology of eosinophilic esophagitis

Chapter 2 
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2.1 Abstract
Background: Quantification of tissue eosinophils remains the golden standard in diagnosing 
eosinophilic esophagitis (EoE), but this approach suffers from poor specificity. It has been 
recognized that histopathological changes that occur in patients with EoE are associated 
with a disease-specific tissue transcriptome. 
Objective: We hypothesized that digital mRNA profiling targeted at a set of EoE-specific and 
Th2 inflammatory genes in esophageal biopsies could help differentiate patients with EoE 
from those with reflux esophagitis (RE) or normal tissue histology (NH). 
Methods: The mRNA expression levels of 79 target genes were defined in both proximal 
and distal biopsies of 196 patients with nCounter® (Nanostring) technology. According to 
clinicopathological diagnosis, these patients were grouped in a training set (35 EoE, 30 RE, 
30 NH) for building of a three-class prediction model using the random forest method, and a 
blinded predictive set (n=47) for model validation. 
Results: A diagnostic model built on ten differentially expressed genes was able to 
differentiate with 100% sensitivity and specificity between conditions in the training set. In 
a blinded predictive set, this model was able to correctly predict EoE in 14 out of 18 patients 
in distal (sensitivity 78%, 95% CI 52%-93%) and 16 out of 18 patients in proximal biopsies 
(sensitivity 89%, 95% CI 64%-98%), without false positive diagnosis of EoE in RE or NH 
patients (specificity 100%, 95% CI 85%-100%). Sensitivity was increased to 94% (95% CI 71%-
100%) when either the best predictive distal or proximal biopsy was used.
Conclusion & Clinical Relevance: We conclude that mRNA profiling of esophageal tissue is 
an accurate diagnostic strategy in detecting EoE. 
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2.2 Introduction
Quantification of tissue eosinophils under proton-pump inhibitor (PPI) therapy in combination 
with appraisal of clinical symptomatology remains the gold standard in diagnosing patients 
with eosinophilic esophagitis (EoE) (Liacouras et al., 2011). Unfortunately, this approach 
suffers from poor specificity since a wide variety of gastrointestinal disorders can give rise 
to esophageal eosinophilia, and EoE-like symptoms such as failure-to-thrive or feeding 
difficulties are generally non-specific, especially in young children (Brown-Whitehorn and 
Liacouras, 2007; Liacouras et al., 2011). In daily practice, the distinction between reflux-
associated eosinophil infiltration and true EoE remains particularly difficult, because these 
disease entities have considerable symptomatic and histologic overlap and are typically 
patchy in nature.(Papadopoulou et al., 2014) Differentiation can furthermore be complicated 
by poor patient compliance with PPI therapy prior to diagnostic endoscopy, as well as the 
recent recognition of PPI-responsive EoE variants (Dellon et al., 2013; Papadopoulou et al., 
2014). These diagnostic difficulties often cause considerable delay between onset of disease 
and diagnosis, hence delaying installment of optimal therapy (Hruz et al., 2011; Schoepfer 
et al., 2011). As such, a need for more refined diagnostic methods to reliably differentiate 
EoE from reflux esophagitis (RE) and other causes of esophageal eosinophilia clearly persists 
(Katzka, 2014).
  It has been recognized that EoE is associated with a tissue-specific transcriptome 
and that increased esophageal mRNA levels of genetic markers such as eotaxin-3 and 
periostin display considerable diagnostic sensitivity and specificity (Blanchard et al., 2008; 
2006b). Additionally, we and others have shown that the EoE-transcriptome can be used to 
identify involvement of specific inflammatory pathways that are operative in subsets of EoE 
patients (Abonia et al., 2010; Lexmond et al., 2013; 2014). Following the identification of an 
EoE-specific transcriptome, it has been hypothesized that an esophageal mRNA expression 
pattern across multiple disease-specific and Th2-inflammatory genes can provide additional 
diagnostic benefit over the current golden standard of histopathological eosinophil count 
(Wen et al., 2013). However, analysis of mRNA expression levels of EoE-markers in esophageal 
biopsies has not yet been introduced into routine clinical practice. This may in part be due 
to the relatively challenging requirements for large-scale mRNA tissue diagnostics, which 
in the case of quantitative RT-PCR requires multi-step processing that is both time and 
manipulation-sensitive. In the current study, we have taken advantage of a digital mRNA 
expression profiling method (Nanostring technology, nCounter® system) that has been 
described to have sensitivity comparable to quantitative RT-PCR, yet does not require tissue 
extraction procedures or generation of cDNA as an intermediate step (Geiss et al., 2008). 
Using this direct, state-of-the-art mRNA profiling methodology, we here aimed to define an 
esophageal mRNA pattern stamp that can distinguish patients with EoE from those with RE 
or normal tissue histology (NH) and lead to improved tissue diagnosis. 
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2.3 Methods
In the reporting of this study, we have adhered to the guidelines put forth by the STARD 
initiative (Bossuyt et al., 2003).
2.3.1 Study population
The patients described in this study were included at Boston Children’s Hospital as part of 
a prospective cohort study that focuses on EoE pathophysiology and diagnostics. Details 
pertaining this study have been previously described (Lexmond et al., 2013). Study inclusion 
was based on clinical presentation. Children (1-18 years of age) who presented with EoE-like 
symptoms (such as failure-to-thrive, food aversion, regurgitation or dysphagia) and who were 
scheduled for diagnostic upper esophagogastroduodenoscopy were invited to participate. In 
all patients, endoscopy was performed after a minimum of four weeks of PPI therapy (mean 
duration 10.8 months, with a range of 1-120 months). Additional patient information was 
collected through a standardized questionnaire at time of enrollment. For each patient, an 
additional study biopsy was obtained from both the proximal and distal esophagus, defined 
as lying either ≥10 cm or 1-2 cm from the gastro-esophageal junction respectively. Biopsies 
were directly stored in RNAlater (Qiagen) for a minimum of 24h and frozen at -80°C. From 
our cohort, we randomly selected patients to undergo digital transcriptional profiling of 
both proximal and distal esophageal biopsies. Approval for this study was obtained from the 
Investigational Review Board of Boston Children’s Hospital (Harvard Medical School, Boston, 
MA, approval number: 07-11-0460). All patients or their legal guardians provided written 
informed consent prior to enrollment. 
2.3.2 Clinicopathological diagnosis (reference standard)
A board-certified pediatric gastroenterologist, who was blinded to the results of pattern 
profiling, reviewed the clinicopathological diagnosis of every patient by taking into account 
all available clinical information, which included symptomatology at presentation, laboratory 
testing, the pathology report of esophageal histology and tissue eosinophil count, as well as 
the clinical course after initial diagnosis, and the results of follow-up endoscopies if performed. 
This review took place after a minimum follow-up of two years after the enrollment endoscopy, 
and was used in our study as the reference standard against which we aimed to validate our 
novel diagnostic approach (Liacouras et al., 2011). Following consensus guidelines (Liacouras 
et al., 2011), we considered patients to have EoE when they met the following criteria: 1. 
treatment with PPI for ≥4 weeks prior to diagnostic endoscopy; 2. tissue eosinophil count 
>15/hpf in at least one biopsy; 3. exclusion of other origins of esophageal eosinophilia. Use 
of corticosteroids was considered an exclusion criteria. Conversely, patients were classified 
as RE when they showed: 1. histological evidence of esophageal tissue inflammation such 
as basal zone hyperplasia and an inflammatory cell infiltrate; 2. eosinophil count 1-15/hpf; 
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3. a clinical history suggestive of reflux-associated symptoms 4. Evidence of pathologic GERD 
either by abnormal pH/impedance studies, or by erosive esophagitis that healed after antacid 
therapy, and 5 no evidence of development of EoE after long term follow up. Lastly, NH patients 
were defined as having: 1. normal tissue histology in all routine biopsies,  and 2. no evidence 
of underlying gastrointestinal disease for at least 3 months after endoscopy in the absence 
of antacid therapy. Patients that did not meet any of these three diagnostic categories were 
excluded from training and predictive patient set.
2.3.3 Sample processing and mRNA profiling with the nCounter® system
Biopsies were homogenized in RLT buffer (Qiagen) and further processed with the nCounter® 
Prep Station and Digital Analyzer, following the manufacturer’s instructions (nCounter® system, 
www.nanostring.com). Samples were analyzed using a customized panel that consisted of five 
housekeeping genes and 79 genes of interest based on previously published microarray data 
(Blanchard et al., 2006b). This code set is summarized in supplemental Table 2.S1. Expression 
data from separate nCounter® runs were normalized through quantile normalization, and 
then log2 transformed prior to downstream analysis. Outlying samples with low readout in the 
internal positive controls were excluded from further analysis
2.3.4 Definition of a training and predictive patient set
A total of 95 unambiguously diagnosed patients were otherwise randomly selected into 
a training set, which was used to identify differentially expressed genes to include in a 
diagnostic prediction model. The remaining unambiguous patients were used for the 
predictive patient test set. For training set patients, both the clinicopathological diagnosis 
from the reference standard and the mRNA pattern profile were provided to the statistician, 
who performed differential gene expression analysis and diagnostic model building. For the 
predictive set, the statistician was blinded to the histopathological diagnosis and only the 
mRNA profile was provided. 
2.3.5 Differential gene expression analysis
Three individual linear statistical models were built (R Bioconductor limma package) to 
compare training set patients (EoE vs. NH, RE vs. NH, and EoE vs. RE, respectively) to identify 
genes that were differentially expressed between all three disease conditions (p-value<0.05). 
2.3.6 Diagnostic model 
A three-class (EoE, RE, and NH) diagnostic model was built with 10-fold cross validation using 
the random forest method. In each round of the cross validation process, the ratio of EoE, 
RE, and NH samples was set to be the same as in the complete training set. Once the model 
for a given biomarker gene set was trained in the training samples, the expression profile 
of the same biomarker gene set from the predictive set samples was fitted on the trained 
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model and the EoE/RE/NH classification diagnostic probability, i.e. the probability of having 
each diagnosis, was calculated for the predictive samples. A predicted probability >50% was 
considered a positive mathematical diagnosis for that particular condition. 
2.3.7 Statistical analysis
Comparison of clinical characteristics and probability scores between diagnostic groups was 
performed with ANOVA or Kruskal-Wallis test for continuous variables or Fisher’s exact test 
for dichotomous predictors. Correlation analysis was performed using Pearson correlation 
coefficient. Values are expressed as mean ± SD unless otherwise indicated. Analyses were 
performed using Stata 12 (StataCorp, TX, USA). 
2.4 Results
2.4.1 Patient inclusion
The 196 patients analyzed in this study were randomly selected from a previously described 
(Dehlink et al., 2011; Lexmond et al., 2013), longitudinal cohort of 429 children who were 
included at our center between April 2008 and May 2012. For every patient, one proximal 
and one distal research biopsy was analyzed with the nCounter® system to obtain a digital 
mRNA expression profile of the esophageal tissue. The collection of two additional research 
biopsies was not associated with adverse events. 
2.4.2 Patient classification
Histological evidence of esophageal inflammation was present in 110 out of 196 patients 
(56%). In 96 (87%) of those, an unambiguous clinicopathological diagnosis of either EoE or 
RE could be made based on comprehensive case review after a follow-up time of a minimum 
of two years. These 96 cases were used to form the basis of a training and a predictive patient 
set. From those unequivocally diagnosed patients, we randomly selected 35 EoE and 30 RE 
patients, together with 30 randomly selected NH cases to give rise to the training set. The 
remaining 31/96 unambiguous patients with esophageal inflammation were combined with 
another 16 NH patients to generate the predictive test set that we used for validation of the 
diagnostic model. In 14/110 patients with esophageal inflammation (13%), no unambiguous 
diagnosis of either RE or EoE could be established with the available clinical and histologic 
information and were excluded from further analysis. These patients either suffered from 
non-RE, non-EoE esophageal inflammation (e.g. candida esophagitis), or had undocumented 
or unclear use of a PPI prior to diagnostic endoscopy. We also excluded patients when a 
diagnosis of EoE was hampered by prior installment of some form of EoE-specific treatment 
before study enrollment if biopsies did not have the established number of eosinophils to 
diagnose them as EoE and 2-year follow-up had not revealed a clear underlying condition. 
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Table 2.1. Clinical details and characteristics of patients used in training and predictive sets. *comparing patients 
from all three diagnostic groups in combined training and predictive sets, calculated using Fisher’s exact test or 
ANOVA. 
PARAMETER TRAINING SET PREDICTIVE SET p-value*
NH EoE RE NH EoE RE
n 30 35 30 16 18 13
Age (years, median, range) 10.3 (1.25-18.0) 10.6 (2-18.5) 10.0 (1.4-18.6) 9.5 (1.6-17.2) 6.8 (2.8-16) 13.5 (4.2-18.5) 0.55
Male gender 10/30 (33%) 20/35 (57%) 20/30 (67%) 5/16 (31%) 11/18 (61%) 9/13 (69%) 0.003
Symptomatology in last year
Dysphagia 10/30 (33%) 16/35 (46%) 6/30 (20%) 4/16 (25%) 9/18 (50%) 4/13 (31%) 0.04
Food impaction 0/30 (0%) 4/35 (11%) 0/30 (0%) 1/16 (6%) 2/18 (11%) 1/13 (8%) 0.12
Chest pain 0/30 (0%) 4/35 (11%) 3/30 (10%) 0/16 (0%) 1/18 (6%) 3/13 (23%) 0.02
Epigastric pain 13/30 (43%) 5/35 (14%) 11/30 (37%) 6/16 (38%) 5/18 (28%) 3/13 (23%) 0.04
Heartburn 2/30 (7%) 7/35 (20%) 6/30 (20%) 2/16 (13%) 2/18 (11%) 4/13 (31%) 0.17
Reflux 2/30 (7%) 14/35 (40%) 16/30 (53%) 3/16 (19%) 2/18 (11%) 7/13 (54%) <0.001
Feeding difficulties 4/30 (13%) 5/35 (14%) 1/30 (3%) 3/16 (19%) 3/18 (17%) 1/13 (8%) 0.22
Vomiting 4/30 (13%) 9/35 (26%) 12/30 (40%) 4/16 (25%) 7/18 (39%) 3/13 (23%) 0.15
Endoscopy
Pallor 0/30 (0%) 12/35 (34%) 4/30 (13%) 1/16 (6%) 0/18 (0%) 0/13 (0%) 0.005
Edema 0/30 (0%) 3/35 (9%) 1/30 (3%) 1/16 (6%) 1/18 (6%) 0/13 (0%) 0.38
Loss of vascularity 0/30 (0%) 13/35 (37%) 4/30 (13%) 2/16 (13%) 5/18 (28%) 1/13 (8%) <0.001
Furrowing 3/30 (10%) 27/35 (77%) 8/30 (27%) 1/16 (6%) 15/18 (83%) 1/13 (8%) <0.001
Exudate 1/30 (3%) 10/35 (29%) 0/30 (0%) 0/16 (0%) 8/18 (44%) 0/13 (0%) <0.001
Allergic diatheses
IgE (median, range) 21 (2-308) 195 (4-1768) 38 (0-1658) 6 (2-99) 136 (28-714) 69 (7-957) <0.001
Eczema 6/29 (21%) 16/35 (46%) 13/29 (44%) 3/16 (19%) 5/18 (28%) 5/13 (38%) 0.046
Asthma 6/30 (20%) 9/35 (26%) 11/29 (38%) 5/16 (31%) 4/18 (22%) 4/13 (31%) 0.39
Seasonal allergies 7/30 (23%) 20/35 (57%) 15/29 (52%) 5/16 (31%) 13/18 (72%) 4/13 (31%) 0.002
Food allergy 4/30 (13%) 18/35 (51%) 6/29 (21%) 3/16 (19%) 11/16 (69%) 4/11 (36%) <0.001
Positive RAST or skin 
prick test against food 
antigens
0/6 (0%) 22/30 (73%) 9/20 (45%) 1/4 (25%) 16/17 (94%) 1/5 (20%) <0.001
Tissue eosinophilia (peak value) 
 Proximal (median, 
range) 0 (0-0) 30 (5-150) 4 (2-10) 0 (0-0) 40 (2-150) 2 (1-5) <0.001
Distal (median, range) 0 (0-0) 40 (20-150) 3 (1-20) 0 (0-0) 50 (2-150) 1.5 (1-2) <0.001
  The flow diagram of patient inclusion and distribution over the training and predictive 
sets is shown in Figure 2.1. The distal biopsy of one RE patient in the predictive set was 
excluded from analysis due to overall low mRNA counts. Clinical, endoscopic and histological 
features of patients in both sets are summarized in Table 2.1. In line with previous reports 
(Lexmond et al., 2013; Liacouras et al., 2011; Rothenberg, 2009), statistically significant 
Part 1 - Chapter 2 
36
differences between diagnostic groups were found in distribution of gender, presenting 
symptoms, allergic comorbidity and findings during diagnostic endoscopy. 
Included at time of 
first endoscopy  
(n=429)
Randomly selected 
for gene expression 
profiling (index test) 
(n=196)
Ambiguous:
n=14
(Excluded)
Unambiguous:
n=96
Reference standard: 
Clinicopathologic diagnosis 
after >2 year follow-up
Training set (95):
RE n=30
EoE n=35
NH n=30
Predictive set (47)
RE n=13
EoE n=18
NH n=16
Esophageal 
inflammation 
(n=110)
Normal esophageal 
histology (n=86)
Randomly selected
n=46
EoE n=53 RE n=43 NH n=46
Figure 2.1. Flow diagram of patient inclusion and composition of training and predictive sets. 
2.4.3 Selection of predictor genes in the training set of patients
To identify which of the 79 genes in our panel were differentially expressed between disease 
conditions, we first performed comparative gene expression analysis in patients with EoE, RE 
or NH that were included in the training set. As expected from previous studies (Blanchard 
et al., 2006b; 2011; Lexmond et al., 2013), this analysis revealed striking differences between 
conditions in both proximally and distally-derived biopsies (Figure 2.2 A, B). Differential 
gene expression analysis for EoE vs. NH, RE vs. NH and EoE vs. RE patients identified 38 genes 
in proximal biopsies and 43 genes in distal biopsies that were differentially 
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Figure 2.2. Heatmap display of differentially regulated genes in either distal (A) or proximal (B) oesophageal 
biopsies by clinicopathological diagnosis. Bubble plots display levels of statistical significance and the direction of 
regulation (color: blue for down and red for up-regulation), and the statistical significance of the effect (size: larger 
bubbles signify smaller p-values). 
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expressed in at least one comparison at α=0.05 (Figure 2.2 A, B). We hypothesized a priori that 
most discriminative power would be attained by a model that only included genes that were 
differentially expressed between all three pathologies. For proximal biopsies, seven genes met 
this criterion, whereas 10 genes were found to be differentially expressed in distal biopsies at a 
p-value <0.05 in all three comparisons (Table 2.2). Because distal biopsies gave rise to a greater 
abundance of significantly regulated genes, we selected those biopsies to build our diagnostic 
model. As such, our strategy resulted in inclusion of the major EoE-specific gene eotaxin-3 (CCL26) 
as well as the mast cell-marker carboxypeptidase A3 (CPA3) and β-chain of the high-affinity IgE 
receptor (FcεR1), but not periostin, which although highly upregulated in both biopsies in EoE 
patients compared to RE or NH patients (t-statistic >5.5, p-value <10-6) was not significantly 
different between NH controls and RE patients in proximal or distal tissue biopsies (p-value >0.05, 
Figure 2.2) Additional upregulated genes were the eotaxin-3 receptor CCR3, which is mainly 
expressed on eosinophils and basophils, and the Th2-cytokine IL-13. EoE-specific downregulation 
of genes was noted for CD4, CCL17, CD207, FcεR1α and LGALS3 (galectin-3). In proximal, but not 
distal, biopsies, statistical significance was reached for CCL22 and CD40 ligand (Figure 2.2 and 
Table 2.2). These results suggested that disease-specific regulation of these ten target genes 
could potentially be used to discriminate between patients with EoE, RE, and NH. 
Table 2.2. Significantly regulated genes between all three conditions. 
Comparison: EoE / NH RE / NH EoE / RE
t-value p-value t-value p-value t-value p-value
Proximal
CD4 -6.61 7.39 x 10-9 -3.65 0.001 -2.43 0.018
CCL22 -4.72 1.22 x 10-5 -2.84 0.006 -2.13 0.037
FCER1A -7.70 7.96 x 10-11 -3.10 0.003 -3.59 0.001
CCL26 10.56 5.96 x 10-16 2.13 0.037 7.38 3.00 x 10-10
FCERIB 7.42 2.51 x 10-10 2.43 0.018 4.73 1.17 x 10-5
IL13 8.05 1.85 x 10-11 2.71 0.009 4.45 3.25 x 10-5
CD40LG -5.29 1.42 x 10-6 -2.54 0.013 -2.45 0.017
Distal
CD4 -7.90 3.92 x 10-11 -3.53 0.001 -2.84 0.006
CCL17 -7.13 9.23 x 10-10 -2.63 0.011 -3.77 3.45 x 10-4
CD207 -6.80 3.68 x 10-9 -2.01 0.049 -3.63 5.41 x 10-4
FCERIB 11.48 2.14 x 10-17 2.66 0.010 6.55 9.37 x 10-9
FCER1A -9.46 6.60 x 10-14 -3.57 0.001 -3.39 0.001
CPA3 11.43 2.60 x 10-17 2.29 0.026 7.38 3.17 x 10-9
CCL26 14.70 1.60 x 10-22 2.87 0.006 8.66 1.51 x 10-12
CCR3 7.54 1.74 x 10-10 2.62 0.011 5.15 2.47 x 10-6
IL13 10.25 2.69 x 10-15 4.28 6.80 x 10-5 4.59 2.02 x 10-5
LGALS3 -5.40 9.73 x 10-7 -3.48 0.001 -2.35 0.022
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Figure 2.3. (A) EoE probability in EoE training set patients correlates positively with the severity of tissue eosinophil 
infiltration. (B) Graphical representation of cumulative disease-specific probability scores in proximal biopsies of 
training set patients, with summary statistics per diagnosis depicted under (C). 
2.4.4 Definition of a predictive diagnostic model
A three-class statistical model was built to predict the diagnosis of patients from the 
expression levels of the ten genes that were identified to be significantly regulated in distal 
biopsies. The primary output of our model was a probability score per patient for each of 
the three diagnostic categories (NH, EoE or RE), which allowed for quantification of the 
confidence of the model in predicting the underlying diagnosis. Aft er 10-fold cross validation 
on distal training set samples, the disease-specific probability scores discriminated perfectly 
between all three diagnostic categories: mean predicted EoE-probability in EoE patients 
0.92±0.09 (range 0.64-1.0); RE-probability in RE patients 0.81±0.08 (range 0.64-0.94) and 
NH-probability in NH patients 0.87±0.07 (range 0.67-0.96). In patients with EoE, a positive 
correlation was observed between distal tissue eosinophil count and the predicted EoE 
probability, which suggests that a more pronounced eosinophilic infiltrate results in better 
performance of the diagnostic model (Figure 2.3A). However, even in patients with a modest 
eosinophilic infiltrate in the distal esophagus (20-25 eosinophils/hpf), a clear prediction of 
EoE over RE or NH etiology could be made with probabilities ranging from 0.74 to 0.97. These 
results indicated that distal mRNA levels of ten diff erentially expressed genes are suff iciently 
dissimilar between disease conditions to allow for clear mathematical diff erentiation. 
  This finding, however, does not necessarily guarantee a similar degree of performance 
on biopsies that do themselves not further shape the algorithmic parameters of the model. 
In assessing how our pre-defined model performed on an independent subset of biopsies, 
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Figure 2.4. Predicted probability of underlying diagnosis from predictive set patients in distal or and proximal
biopsies, with corresponding summary statistics of diagnostic probability per clinicopathological category. Graphs 
in the combined panel display the highest EoE probability in either proximal or distal biopsy.
we first further validated our prediction model on the paired proximal biopsies from the 
patients in the training set. This analysis revealed that application of the distally-defined 
prediction model on proximal biopsies from the same patients resulted in an equally clear 
differentiation between patients from all three conditions (Figure 2.3B-C), and that a 
diagnostic cut-off of >50% EoE probability identified EoE patients from NH or RE patients 
with 100% sensitivity and specificity in our training set. Importantly, these results are also 
indicative of a high degree of test reproducibility as proximal and distal biopsies had been 
independently collected, stored, and processed prior to digital mRNA profiling. 
2.4.5 Performance of diagnostic model in the blinded predictive patient set 
To further assess the power of our model in differentiating EoE from non-EoE patients, we 
next applied it to the patients in the predictive subset (Figure 2.4). In 14 out of 18 patients 
with EoE, the model correctly predicted the presence of EoE with >50% probability in distal 
biopsies (sensitivity 78%, 95% CI 52%-93%). Conversely, in none of the NH or RE control 
patients a diagnosis of EoE was made using the model (specificity 100%, 95% CI 85%-
100%). For proximal biopsies, similar results were obtained, with 16 out of 18 patients with 
EoE correctly identified (sensitivity 89%, 95% CI 64%-98%), again with no false positives 
in the 29 non-EoE control patients. It is well recognized that EoE is a patchy disease and 
histopathological analysis of multiple biopsies is required for a reliable diagnosis.(Liacouras 
et al., 2011; Nielsen et al., 2014) When a cut-off of >50% EoE probability in either proximal or 
distal biopsy was used to identify patients with EoE, sensitivity was increased to 94% (95% 
CI 71%-100%) without compromising specificity, which remained at 100%. These results 
indicate that gene expression analysis of multiple biopsies enhances the diagnostic power of 
this predictive model for EoE. 
  In contrast to the performance of the model on the proximal biopsies in the training set 
patients, differentiation between RE and NH patients in this blinded predictive patient set 
was poor. No significant differences were found in either the NH or RE probabilities between 
patients with a clinicopathological diagnosis of these conditions (Figure 2.4). Our diagnostic 
model therefore failed to identify patients suffering from RE from the controls within the pool 
of non-EoE patients. It is, however, conceivable that a gene set for RE diagnostic could be 
defined with our approach.
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2.5 Discussion
In the current study, we have tested the hypothesis that a diagnosis of EoE can reliably be made 
based on changes in the mRNA expression levels of a limited number of EoE-specific target 
genes. Using a diagnostic panel of merely ten targets, the analysis of a single research biopsy 
could detect EoE with a sensitivity of 78% for distal and 89% for proximal biopsies, which was 
increased further to 94% when results of two investigated biopsies were combined. Importantly, 
no false-positive EoE predictions were made amongst 29 normal or inflammatory controls. 
  The increased sensitivity upon analysis of multiple biopsies is not unexpected given 
the patchy nature of the disease, and is also true in histological assessment of esophageal 
tissue, where it has been shown that sensitivity increases from 73% in a single biopsy, to 
84%, 97%, and 100% with obtaining two, three, and six biopsies respectively (Shah et al., 
2009). Our results thus compare favorably to eosinophil count alone, which suggests that 
the transcriptome signature may be a more sensitive readout of disease involvement than 
histological evaluation. Although we did observe a positive correlation between eosinophil 
count and predicted EoE probability, the model still reliably identified EoE at moderate 
eosinophil counts of 20-25 eosinophils/hpf. One of the main findings of our current study 
is therefore that an objective, observer-independent diagnosis of EoE could be made using 
the esophageal transcriptome within our study population. We think that this technique will 
be a useful adjunct to the clinical evaluation of patients with suspected EoE, and may allow 
establishment of an accurate diagnosis from fewer biopsies and help in equivocal cases. 
  A rather surprising observation that can be made from this work is the seemingly 
paradoxical condition of EoE-specific tissue downregulation of the α-chain of the high 
affinity IgE receptor FcεRI in combination with upregulation of its β-chain. Increased β-chain 
expression can be readily explained by esophageal infiltration of mast cells, as has been well 
documented to occur in EoE (Abonia et al., 2010). Less is known, however, about reduced 
tissue expression of FcεRIα. In addition to its expression on mast cells as part of the tetrameric 
FcεRI complex, the α-chain is also expressed in the GI-tract by Langerhans cells to form part 
of a β-chain-independent, trimeric FcεRI (Bannert et al., 2012). As such, it is conceivable that 
reduced mRNA levels of FcεRIα signify lower numbers of Langerhans cells in the esophagus of 
patients with EoE. In support of this notion, we found significantly lower transcript numbers 
of CD207 (Langerin, Table 2.2) and CD1a (results not shown) in EoE patients compared to 
non-EoE patients. Since CD207+ dendritic cells have been associated with the establishment 
of oral tolerance to ingested antigens (Chang et al., 2010), it could be hypothesized that 
altered numbers of these cells contribute to disease pathogenesis and future experimental 
studies addressing the role of these dendritic cells in EoE are therefore warranted. 
  One strength of our study is that we were able to follow the included patients for a minimum 
follow-up of two years, ensuring that the initial clinicopathological diagnosis that was given 
initially was accurate. Our strategy allowed us to incorporate additional clinical information 
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such as response to treatment, progression of symptoms and follow-up endoscopies. Because 
of this comprehensive follow-up we were able to validate our novel diagnostic approach 
against an optimized gold standard reference. Mutual blinding of the reviewing clinician and 
analyzing statistician eliminated the potential of bias during this process. 
  Our results indicate that the EoE signature is reliably identified in almost all investigated 
patients. Unfortunately, even though the model performed well in separating EoE patients 
from those with RE, the sensitivity and specificity of our model was too low to be considered of 
diagnostic value in differentiating RE patients from NH controls. This distinction is, however, 
not a difficult problem in daily clinical practice. To more reliably make a transcriptome-
based diagnosis of RE-mediated inflammation, it is likely that a broader gene array panel 
needs to be screened, since our combination of 76 genes only yielded two genes that were 
differentially regulated between NH controls and RE but not EoE patients. 
  Our findings are in line with a recently published study that also tested the diagnostic 
potential of esophageal transcriptome changes in adult and pediatric patients with EoE 
(Wen et al., 2013). Using a real-time quantitative PCR approach on a panel of 94 EoE-specific 
genes, of which four (CCL26, CPA3, IL13 and CCR3) are also included in our set of 10 genes, 
this group attained a 96% sensitivity and 98% specificity rate for a diagnosis of EoE over 
non-EoE control patients. The results presented here, showing equivalently high degrees 
of diagnostic accuracy, thus confirm the great diagnostic potential of the esophageal 
transcriptome in detecting EoE, and further validate this approach using a different technical 
platform in another patient cohort. In addition, our data demonstrate that a diagnosis of EoE 
can reliably be made with a greatly reduced number of target genes and that analysis with 
a novel high-throughput mRNA expression system that eliminates the need for intermediary 
sample processing steps is a feasible approach to obtaining a tissue diagnosis of EoE. 
Although restricted availability and costs of this technology limit its current applicability, 
it is possible that with technological advances these costs will decrease in the future. 
Furthermore, transcriptome diagnostics with digital mRNA profiling may prove applicable to 
other disorders as well, which will help further promote distribution of this novel diagnostic 
technique.  
In summary, using a high-throughput digital mRNA expression platform, we show that a 
statistical model built on changes in expression of 10 EoE-specific genes detects EoE patients 
from non-EoE patients with high diagnostic sensitivity and specificity. This novel strategy 
could help stratify patients at time of their first diagnostic endoscopy and lead to rapid 
installment of appropriate EoE-specific therapy. 
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3.1 Abstract
Background: Cysteinyl leukotrienes contribute to Th2-type inflammatory immune 
responses. Their levels in esophageal tissue, however, do not distinguish patients with 
eosinophilic esophagitis (EoE) from controls. 
Objective: We asked whether mRNA levels of leukotriene C4 synthase (LTC4S), a key regulator 
of leukotriene production, could serve as a marker for EoE. 
Methods: Digital mRNA expression profiling (nCounter® Technology) was performed on 
proximal and distal esophageal biopsies of 30 paediatric EoE patients and 40 non-EoE 
controls. Expression data were confirmed with RT-qPCR. LTC4S mRNA levels were quantified 
in whole blood samples. Leukotriene E4 was measured in urine.
Results: LTC4S mRNA levels were elevated in proximal (2.6-fold, p<0.001) and distal (2.9-
fold, p<0.001) esophageal biopsies from EoE patients. Importantly, increased LTC4S mRNA 
transcripts identified a subpopulation of EoE patients (28%). This patient subgroup had 
higher serum IgE levels (669 U/ml vs. 106 U/ml, p=0.01), higher mRNA transcript numbers 
of TSLP (1.6-fold, p=0.009) and CD4 (1.4-fold, p=0.04) but lower IL-23 mRNA levels (0.5-fold, 
p=0.04). In contrast, elevated levels of IL-23 mRNA were found in esophageal biopsies of 
patients with reflux esophagitis. LTC4S mRNA transcripts in whole blood and urinary excretion 
of leukotriene E4 were similar in EoE patient subgroups and non-EoE patients.
Conclusion & Clinical Relevance: Elevated esophageal expression of LTC4S mRNA is found 
in a subgroup of EoE patients, concomitant with higher serum IgE levels and an esophageal 
transcriptome indicative of a more-pronounced allergic phenotype. Together with TSLP and 
IL-23 mRNA levels, esophageal LTC4S mRNA may facilitate diagnosis of an EoE subpopulation 
for personalized therapy. 
Esophageal LTC4S expression in EoE
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3.2 Introduction
Eosinophilic esophagitis (EoE) is commonly considered a Th2-type allergic disease of the 
esophagus (Straumann et al., 2001). As a clinicopathological entity, EoE is characterized 
by eosinophil-rich, chronic inflammation of the esophagus with symptoms of esophageal 
dysfunction (Liacouras et al., 2011). The disorder is strongly allergen-driven(Hruz et al., 2011; 
Mulder and Justinich, 2011; Rothenberg, 2009) and comorbidity with concurrent allergic 
diatheses ranges from 42% to 93% for paediatric and 28% to 86% for adult patients (Liacouras 
et al., 2011). Like other Th2-type allergies, elevated serum levels of IgE are commonly 
encountered in EoE patients and identify allergen-sensitized individuals. However, up to 50% 
of EoE patients have normal serum IgE levels without evidence of prior allergic sensitization 
(Erwin et al., 2010; Liacouras et al., 2011; Mulder and Justinich, 2011; Norvell et al., 2007). The 
extent to which IgE contributes to EoE pathogenesis is therefore not yet fully understood.
  mRNA expression analysis of esophageal tissue demonstrated t hat IgE is produced 
locally in the esophagus of EoE patients, independent of the patient’s allergic status(Vicario 
et al., 2010). Furthermore, the EoE-specific tissue transcriptome fails to distinguish allergic 
from non-allergic EoE, as increased levels of eotaxin-3 and IL-13 mRNA, signifying Th2-
mediated inflammation, are found in all EoE patients(Blanchard et al., 2006b; 2007). Thus, 
our understanding about the difference between allergic and non-allergic EoE at the site of 
local pathology is similarly incomplete and characteristics that identify allergic EoE at the 
tissue level remain to be identified. 
  Leukotrienes are arachidonic acid metabolites and inflammatory mediators of Th2-
type allergies. All leukotrienes are products of the 5-lipoxygenase (5-LO) pathway, which 
generates leukotriene A4 (LTA4) from arachidonic acid by phospholipase A2. LTA4 is rapidly 
converted into either leukotriene B4 (LTB4) by LTA4 hydrolase, or, in the presence of the enzyme 
leukotriene C4 synthase (LTC4S) and glutathione, into leukotriene C4 (LTC4), which opens the 
synthetic pathway for the additional cysteinyl leukotrienes LTD4 and LTE4 (Drazen et al., 1999; 
Murphy and Gijón, 2007; Penrose, 1999). LTC4S thus functions as the gatekeeper of cysteinyl 
leukotriene synthesis, which in turn enhances Th2-type inflammation (Drazen et al., 1999). 
  Despite the contribution of leukotrienes to allergic tissue inflammation, esophageal 
levels of cysteinyl leukotrienes do not differentiate EoE patients from controls (Gupta et 
al., 2006). Nevertheless, a number of case series have ascribed therapeutic benefit to the 
application of leukotriene receptor antagonists in EoE patients (Attwood et al., 2003; Neustrom 
and Friesen, 1999; Stumphy et al., 2011; Vanderhoof et al., 2003). We hypothesized that mRNA 
levels of the regulator enzyme LTC4S, rather than metabolites of the pathway, could serve as 
a marker to identify esophageal biopsies of EoE patients from patients suffering from other 
inflammatory diseases of the esophagus. Here we describe that elevated esophageal LTC4S 
mRNA levels can be used to identify a subpopulation of EoE patients and that this patient 
subgroup shows a more-pronounced allergic phenotype. 
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3.3 Materials and Methods
3.3.1 Patients
Patient material was obtained during an ongoing prospective study on the pathophysiology 
of EoE at Boston Children’s Hospital (Dehlink et al., 2011; 2010; Lexmond et al., 2011; Yen et al., 
2010). All children 1-18 years of age whose clinical presentation raised the suspicion of EoE 
(e.g., dysphagia, feeding intolerance, food aversion, failure to thrive or regurgitation) and who 
were consequently scheduled to undergo diagnostic upper esophagogastroduodenoscopy 
were invited to participate. Serum, two esophageal biopsies, whole blood and urine samples 
were collected at the time of the first diagnostic endoscopy, which was performed after 
patients had received proton pump inhibition (PPI) for a minimum of 4 weeks (10-40 mg 
once or twice a day, depending on body weight and symptoms). Information on the subject’s 
past medical history was obtained through a questionnaire. Total IgE levels were assessed in 
collected serum samples by the hospital laboratory using standardized methods as previously 
described (Dehlink et al., 2011). Standardized allergic testing in the form of RAST, skin prick 
testing or antigen-specific IgE levels was not performed in this study. A majority (72%) of 
EoE patients underwent RAST testing before or after inclusion as part of their diagnostic 
workup and these results were retrieved from chart review. This study was approved by the 
Investigational Review Board of Boston Children’s Hospital (Harvard Medical School, Boston, 
MA). Patients or their legal guardians provided written informed consent. 
  Patients were classified according to routine histopathological analysis of a minimum 
of 2 esophageal biopsies as: (I) EoE, characterized by the presence of esophagitis with >15 
eosinophils per high power field, unresponsive to at least 4 weeks of proton pump inhibitors 
(Liacouras et al., 2011); (II) Reflux esophagitis (RE), characterized by histological evidence of 
basal zone hyperplasia, inflammatory cell infiltrate and <15 eosinophils per high power field; 
or (III) Normal, children with esophageal biopsies without signs of inflammation. The first 
30 EoE, 20 RE and 20 normal patients that had undergone digital tissue mRNA expression 
profiling were selected for this study. None used corticosteroids or leukotriene receptor 
antagonists (LTRAs) at time of inclusion. 
3.3.2 Digital mRNA pattern profiling 
Quantification of mRNA transcripts with reporter probes was performed with the nCounter® 
system (NanoString Technologies) according to the manufacturer’s instructions (Geiss et al., 
2008). Target probes for genes of interest are summarized in supplementary Table 3.S1. 
mRNA counts were collected for all patients, grouped according to anatomical location and 
normalized following the nCounter® Data Analysis Guidelines (http://www.nanostring.com) 
against the geometric mean expression of 6 internal positive controls as well as the following 
5 housekeeping genes: glyceraldehyde 3-phosphate dehydrogenase (GAPDH), hypoxanthine 
phosphoribosyltransferase 1 (HPRT1), beta-actin (ACTB), 60S ribosomal protein L13a 
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(RPL13A) and heat shock protein HSP 90-beta (HSP90AB1). A total of 68 proximal (28 EoE, 40 
non-EoE controls) and 63 distal biopsies (26 EoE, 37 non-EoE controls) met the stringency 
criteria that are recommended by the manufacturer to prevent overcorrection of mRNA 
counts through normalization and were used for further analysis. 
 
3.3.3 Sample preparation
Proximal (≥10 cm above the gastroesophageal junction) and distal (1-2 cm above the 
gastroesophageal junction) biopsies were homogenized in 350 μl RLT Buffer (Qiagen) with 
β-mercaptoethanol (Sigma) in GentleMACS M tubes (Miltenyi Biotec). Homogenates were 
processed according to the nCounter® system manufacturer’s protocol. All further processing 
of samples occurred with the nCounter® Prep Station and nCounter® Digital Analyzer.
  Whole blood samples were collected in EDTA blood tubes (BD) and processed by 
incubation in RBC lysis buffer (eBioscience) and centrifugation at 350 RCF. Pellets were re-
suspended in PBS (Invitrogen) and centrifuged at 200 RCF to separate thrombocytes. Cells 
were counted (CASY, Roche) before a final centrifugation at 400 RCF and storage at –80°C. 
Prior to digital mRNA profiling, total RNA was isolated from pellets with the RNeasy mini kit 
(Qiagen). RNA concentration was assessed (NanoDrop, Thermo Scientific) and 500 ng was 
processed for nCounter® analysis. Urine was centrifuged at 350 RCF and stored at -80°C till 
further analysis. 
3.3.4 Quantitative RT-PCR
After isolation from tissue homogenates with RNeasy Plus kit (Qiagen), 500 ng of total RNA 
was reverse transcribed with iScript (Bio-rad). cDNA was diluted 1:5 in H2O and expression of 
LTC4S, eotaxin-3 and periostin was assessed using TaqMan Gene Expression assays (Applied 
Biosystems) in duplex RT-qPCR reactions with the housekeeping gene GAPDH on a C1000 
Thermal Cycler (Bio-rad). Distal biopsies from 15 EoE patients and 5 controls of which enough 
RNA was available were analyzed; cDNA from the 5 normal controls was pooled and used as 
an inter-run calibrator on every plate. Results were analyzed with CFX Manager version 3.0 
(Bio-rad) by calculating gene expression relative to GAPDH (ΔΔct) (Pfaffl, 2001). 
 
3.3.5 ELISAs
LTE4 was measured with a commercial ELISA following manufacturer’s instructions (Cayman 
Chemical, 520411). For correction for varying levels of dilution, creatinine content was 
measured with a urinary creatinine assay kit (Cayman Chemical, 500701). 
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3.3.6 Statistical Analysis 
Data were analyzed with Stata 12.1 (StataCorp) and Prism 5.0 (GraphPad Software). Nominal 
variables were compared with Fisher’s exact test. Distribution of continuous variables was 
assessed with D’Agostino-Pearson omnibus test and subsequently compared with Student’s 
t test or ANOVA for normally distributed or Mann-Whitney U test for non-parametric variables. 
Correlation analysis was performed by calculating Spearman’s rho for non-parametric 
variables. ROC analysis was based on logistic regression modeling with proximal and 
distal gene expression data as individual predictors of diagnosis. Results were considered 
significant for p-values <0.05 upon two-sided testing. 
3.4 Results
The 70 patients included in this study were enrolled between July 2008 and May 2011 (47 
boys, 23 girls, mean age 10.1±5.0 years). To investigate the value of LTC4S mRNA expression as 
a discriminative marker for EoE at time of diagnosis, our initial analyses focused on a patient 
set representative of clinical practice. The non-EoE control group thus included children with 
normal esophageal histology as well as those with reflux esophagitis (RE). One EoE patient 
was excluded because of low mRNA yield from both esophageal biopsies. EoE patients 
received an average daily PPI dose of 36 mg (±18 mg), which did not differ from those patients 
with RE (35mg ±17 mg). Patient characteristics are depicted in Table 3.1.
  Patient groups did not differ significantly with regards to their GI symptomatology. 
Frequency of self-reported food allergies was significantly higher in EoE patients compared to 
the other groups. Normal appearance of the esophagus during endoscopy was reported in 80% 
of RE patients. In contrast, all EoE patients had a minimum of one macroscopic abnormality, 
which although not pathognomic for EoE (Liacouras et al., 2011) is found in 93% of EoE patients 
(Kim et al., 2012). In line with epidemiological data (Noel et al., 2004; Rothenberg et al., 2010), 
we found a strong male preponderance in the EoE cohort (76%). EoE patients furthermore 
had higher serum IgE levels than non-EoE controls, though IgE levels were also elevated in 
the control group. To account for the age-dependent variation in normal serum IgE range, we 
additionally compared IgE Z-scores expressing IgE levels as the number of standard deviations 
from the age-dependent mean (Kjellman et al., 1976), which yielded comparable results. 
3.4.1 LTC4S mRNA is upregulated in esophageal biopsies of EoE patients
Comparative analysis of mRNA expression levels showed a significant upregulation of 
LTC4S in tissue biopsies of EoE patients when compared to non-EoE controls (2.6-fold in 
proximal and 2.9-fold increase in distal biopsies, Figure 3.1A and 3.1B respectively). Equal 
expression levels of normalized GAPDH mRNA counts confirmed that differences were not 
due to higher mRNA content (Figure 3.1A and 3.1B). To validate the clinicopathological
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diagnosis in our patient cohort, we analyzed the expression of 4 EoE marker genes (Figure 
3.1C and 3.1D): eotaxin-3 was found to be upregulated 21-fold in proximal and 13-fold in distal 
biopsies, as were carboxypeptidase A3 (7-fold proximal, 7-fold distal), periostin (41-fold proximal, 
27-fold distal) and IL-13 (6-fold proximal, 6-fold distal). These results confirm the diagnostic 
potential of the published EoE-specific gene expression profile (Abonia et al., 2010; Blanchard et 
al., 2006b; 2007) in supplementing histopathological EoE diagnosis. To rule out a confounding 
effect of our normalization method, we applied an alternative normalization strategy that directly 
divides LTC4S mRNA counts by GAPDH counts in individual samples, which yielded comparable 
results (2.1-fold increase in proximal and 2.5-fold increase in distal biopsies, Table 3.S2). 
  We next validated the results obtained with digital mRNA expression profiling using RT-
qPCR as an established method to evaluate mRNA expression levels. LTC4S, eotaxin-3, and 
periostin mRNA expression in distal biopsies of EoE patients (N=15) and controls with normal 
distal biopsy (N=5) was compared (Figure 3.S1A). Average LTC4S mRNA levels as determined 
by RT-qPCR were 4.8-fold higher in EoE patients than controls (p=0.001) and correlated well 
with digital LTC4S mRNA counts from nCounter® analysis (Figure 3.S1B, r=0.619). These 
experiments confirm that digital mRNA expression profiling is an alternative to RT-qPCR for 
analysis of mRNA expression in esophageal tissue (Blanchard et al., 2011). Additionally, we 
confirmed with a second method that tissue LTC4S mRNA levels are elevated in EoE patients. 
  To analyze the sensitivity and specificity of elevated LTC4S mRNA transcripts for 
distinguishing EoE from non-EoE controls, we compared the area under the receiver 
operating characteristic (ROC) curve with those of eotaxin-3 and periostin (Figure 3.2). This 
analysis revealed that expression of LTC4S mRNA in esophageal biopsies has sensitivity and 
specificity >80% in predicting EoE (area under the ROC curve 0.89; 95% CI 0.80 – 0.97) but 
as a single diagnostic tool, LTC4S expression did not outperform periostin (area under the 
ROC curve 0.91; 95% 0.84 – 0.99, p=0.56) and was inferior to eotaxin-3 (0.98; 95% CI 0.93 – 
1.0, p=0.02). Furthermore, addition of LTC4S mRNA counts to an EoE prediction model that 
included eotaxin-3 expression did not significantly increase the area under the ROC curve 
(0.976 vs. 0.977, p=0.75). Combined, these results indicate good, but non-superior sensitivity 
and specificity of elevated LTC4S mRNA levels over known EoE marker genes. 
3.4.2 Increased LTC4S mRNA levels differentiate EoE from RE patients
We next compared EoE patients with those who had RE-associated inflammation and asked 
whether LTC4S mRNA levels can specifically differentiate EoE from RE. Comparison of LTC4S 
mRNA levels in EoE and RE patients revealed a 2.8-fold increase in proximal and 3.3-fold 
increase in distal biopsies (Figure 3.3A and 3.3B). This difference was more pronounced 
than was observed between EoE patients and controls with normal tissue biopsies, which 
was 2.4-fold in proximal and 2.6-fold in distal biopsies. Within our non-EoE control group, RE 
patients showed a significantly decreased expression of LTC4S mRNA in distal biopsies (0.8-
fold, p=0.03) compared to normal controls. 
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Figure 3.2. Sensitivity and specificity of elevated LTC4S mRNA levels in distinguishing EoE from non-EoE 
patients. Receiver operator characteristic (ROC) curves were derived from a logistic regression model in which the 
proximal and distal esophageal mRNA expression served as individual predictors. Area under the ROC curve was 
higher for eotaxin-3 than periostin (p=0.09) and LTC4S (p=0.03). Addition of LTC4S mRNA counts to a model that 
already included eotaxin-3 did not significantly increase the area under the ROC curve (p=0.75).
Figure 3.3. Elevated LTC4S mRNA counts diff erentiate EoE from RE. Based on the histology of esophageal 
biopsies, control patients were divided into a group without signs of inflammation (normal, N=20) and inflammation 
most likely associated with gastroesophageal reflux (RE, N=20). LTC4S mRNA levels were compared in (A) proximal and 
(B) distal biopsies. Horizontal bars mark the mean ± standard deviation (SD). Dotted line indicates the mean LTC4S 
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expression + 2 SDs as calculated from all normal and RE control patients. (C) Expression of LTC4S mRNA correlates 
highly between samples from proximal and distal esophagus in the entire cohort (N=62). (D) Subanalysis of LTC4S 
correlation in proximal and distal paired biopsies of EoE patients (N=25). *p<0.05; ***p<0.001; NS: not significant.
3.4.3 Increased LTC4S mRNA levels distinguish a subpopulation of EoE patients
Correlation analysis within the total patient population showed that proximal and distal LTC4S 
expression correlated highly in paired samples (Spearman rho = 0.843, Figure 3.3C). This 
correlation remained when only samples from EoE patients were analyzed (Spearman rho = 
0.575, Figure 3.3D). Of the 6 patients that expressed LTC4S at the highest level in the distal 
biopsies, 5 (83%) were found among the 10 patients with the highest expression in proximal 
biopsies. These findings suggested that the increase in LTC4S mRNA transcripts in individuals is 
part of the disease immune phenotype rather than a result of patchiness of the disease. 
  EoE biopsies were next divided into groups of LTC4S
HIGH and LTC4S
LOW mRNA counts. 
Low expression levels were defined as ≤200 normalized mRNA counts. This cutoff value was 
derived from the control population as follows: mean LTC4S expression in all non-EoE control 
biopsies + 2 standard deviations. Based on this cutoff, we identified 23 biopsies with high and 
31 biopsies with low LTC4S expression. LTC4S
HIGH and LTC4S
LOW groups differed 3.0-fold in mean 
LTC4S mRNA expression but had similar GAPDH mRNA levels (Figure 3.4A). The 23 biopsies 
were derived from a total of 17 patients (59%); biopsies from 8 patients (28%) were exclusive 
to the LTC4S
HIGH group and 9 patients (31%) had LTC4S mRNA counts >200 in only one of the 
biopsies. Table 3.2 shows the characteristics of EoE patients with high LTC4S expression 
in both biopsies versus those with low LTC4S mRNA counts in one or both biopsies. No 
difference in the degree of tissue eosinophilia as established by routine histopathological 
analysis was depicted. Furthermore, neither symptomatology nor comorbidity of allergic 
diatheses differed significantly between the patient groups; only one LTC4S
HIGH patient was 
suffering from asthma. We noticed that 7 out of 8 (88%) LTC4S
HIGH patients had been enrolled 
during the pollen season compared to only 29% of children that classified as LTC4S
LOW 
(p=0.01). Self-reported seasonal allergies also had a high prevalence in our non-EoE control 
population (43%). Interestingly, in 17 control patients with seasonal allergies (10 RE and 7 
normal controls), the average tissue LTC4S mRNA counts obtained from 8 patients enrolled 
during the pollen season was significantly higher than in the 9 patients recruited off-season 
(normalized LTC4S mRNA counts of 85±8 vs. 52±9, p=0.02). Importantly, LTC4S counts were 
on average still lower in controls than in LTC4S
LOW EoE patients. This set of data argues for an 
overall correlation of LTC4S mRNA expression levels with pollen exposure, with an amplified 
effect in EoE patients.
  Because mean serum IgE levels were higher in the 8 patients with the highest LTC4S 
expression, we investigated tissue mRNA levels of the constant region of the IgE heavy chain 
(IGHE). Arguing against a difference in local IgE production by plasma B-cells, no significant 
difference in IGHE transcript levels was found between the EoE subgroups (Figure 3.4B). We 
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next assessed whether the groups differed in the expression of eotaxin-3, periostin and IL-13. 
This comparison did not yield significant differences (Figure 3.4C). In summary, these results 
showed that high LTC4S mRNA counts were only found in a subpopulation of EoE patients 
and that high expression of LTC4S was not merely part of a more active EoE transcriptome.
Table 3.2. Characteristics of LTC4SHIGH and LTC4SLOW EoE patients. *Tissue eosinophilia >100/hpf was not further 
quantified in the pathology reports. **Endoscopy report from 1 LTC4SLOW patient was missing. § Clinical data on 2 
of the 21 (10%) LTC4SLOW EoE patients was missing. §§ Pollen season defined as mid March–June and mid August-
October according to (Fogg et al., 2003).
LTC4SHIGH LTC4SLOW P value
Number of patients 8 21
Male/female 6/2 16/5 1.00
Age in years (mean, range) 11.0 (2 – 17) 10.4 (3 – 17) 0.76
Serum IgE in U/ml (mean, range) 669 (5 – 1900) 106 (4 – 377) 0.01
IgE Z-score (mean, range) 2.38 (-1.2 – 4.5) 0.8 (-0.8 – 2.7) 0.04
IgE Z-score ≥ 2 5/8 (63%) 5/13 (38%) 0.38
≥1 positive RAST (>0.35 U/ml) 5/7 (71%) 8/14 (57%) 0.66
Tissue Eosinophil count* 56 (25 – >100) 45 (15 – >100) 0.35
Macroscopic findings on endoscopy **:
Furrowing 6 (75%) 17 (85%) 0.61
Decreased vascularity 5 (63%) 8 (40%) 0.40
Edema 3 (38%) 2 (10%) 0.12
Reported symptoms in past 6 months §:
Painful swallowing 1 (13%) 5 (26%) 0.63
Food getting stuck 3 (38%) 9 (47%) 0.70
Dysphagia 1 (13%) 7 (37%) 0.36
Abdominal pain 3 (38%) 8 (42%) 1.00
Constipation 1 (13%) 7 (37%) 0.36
Diarrhea 4 (50%) 6 (32%) 0.41
Weight loss 1 (13%) 2 (11%) 1.00
Regurgitation 2 (25%) 5 (26%) 1.00
Reported medical history of:
Eczema 4 (50%) 10 (53%) 1.00
Asthma 1 (13%) 6 (32%) 0.63
Seasonal allergies 6 (75%) 10 (53%) 0.40
Heartburn or chest pain 4 (50%) 5 (26%) 0.37
Food allergies 7 (88%) 9 (47%) 0.09
Endoscopy during pollen season §§ 7 (88%) 6 (29%) 0.01
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Figure 3.4. Elevated LTC4S mRNA levels define a subpopulation of EoE patients with a distinct inflammatory 
transcriptome. (A) A subpopulation of 23 EoE biopsies with high LTC4S mRNA counts was defined (High) using a 
cutoff  of the mean + 2 standard deviations from the LTC4S mRNA expression in all control biopsies. 31 EoE biopsies 
(64%) had expression below the cutoff  and were classified as low LTC4S expression (Low). GAPDH expression was 
similar between LTC4S
HIGH and LTC4S
LOW groups. (B) IGHE mRNA transcripts were similar between LTC4SHIGH and 
LTC4S
LOW groups. (C) LTC4SHIGH and LTC4SLOW samples did not diff er significantly in expression of the EoE marker genes 
eotaxin-3, periostin or IL-13. (D) LTC4SHIGH biopsies had significantly higher mRNA levels of TSLP (p=0.009) and CD4 
(p=0.01). (E) Conversely, mRNA levels of IL-23 were significantly lower (p=0.04) in LTC4SHIGH compared to LTC4SLOW 
biopsies. When compared to control biopsies, IL-23 mRNA was higher in biopsies of patients with RE compared to 
normal controls (p<0.001). IL-23 expression in LTC4S
HIGH was not diff erent from normal controls and LTC4S
LOW biopsies 
had IL-23 expression similar to RE patients. *p<0.05, **p<0.01, ***p<0.001, NS: not significant.
Part 1 – Chapter 3
60
3.4.4 LTC4S
HIGH biopsies show increased expression of TSLP and lower levels of IL-23
Leukotriene synthesis is considered part of the tissue Th2 response, but LTC4S
HIGH and LTC4S
LOW 
biopsies did not differ in their IL-13 mRNA expression levels. We therefore compared LTC4S
HIGH 
and LTC4S
LOW biopsies for mRNA expression of thymic stromal lymphopoietin (TSLP), a known 
local regulator of the Th1-Th2 balance. We found a 1.6-fold higher expression of TSLP in the 
LTC4S
HIGH biopsies and the higher TSLP expression in LTC4S
HIGH biopsies was accompanied by a 
1.4-fold increase in CD4 mRNA counts (Figure 3.4D). Conversely, we identified a 2-fold lower 
expression of IL-23 mRNA in LTC4S
HIGH biopsies (Figure 3.4E). Since IL-23 is an important 
early mediator of Th17-type inflammation, high expression of LTC4S might be the result of 
a distinct inflammatory pattern of EoE. In support of this interpretation, we found that IL-23 
expression was 2.6-fold higher in RE biopsies in comparison to healthy tissue controls (normal 
controls). IL-23 mRNA counts in the LTC4S
HIGH biopsies did not differ from the levels found in 
normal controls. Importantly, IL-23 expression in the LTC4S
LOW group was equivalent to that 
found in RE biopsies. These findings indicate that LTC4S mRNA overexpression characterizes 
esophageal inflammation in allergic EoE while the tissue characteristics of the non-allergic 
EoE group appears to resemble that of RE patients.
3.4.5 Eosinophils and mast cells are both cellular sources of LTC4S mRNA transcripts
Based on the literature, we hypothesized that the most likely cellular sources of LTC4S 
mRNA in esophageal biopsies from EoE patients are eosinophils, mast cells and basophils. 
Histopathological analysis showed equivalent degrees of eosinophil infiltration in LTC4S
HIGH 
and LTC4S
LOW patients (Table 3.2). No significant correlation between tissue eosinophil 
numbers and LTC4S mRNA transcripts numbers was found within the total EoE population 
(Figure 3.5A, r=0.165, p=0.41) or in LTC4SHIGH patients (Figure 3.5B, r= -0.253, p=0.54). 
In contrast, we found a strongly positive correlation between both parameters in tissue 
biopsies of patients with low LTC4S mRNA counts in both tissue biopsies (r=0.665, p=0.01). 
This set of data shows that eosinophils are a likely source of LTC4S transcripts in the LTC4S
LOW 
population, but also indicates that an additional cellular source might exist in the LTC4S
HIGH 
sub-population.
  Therefore, we analyzed mRNA expression levels of the β-chain of the high-affinity 
IgE receptor FcεRI, expression of which is confined to mast cells and basophils. We found 
increased β-chain transcripts in LTC4S
HIGH when compared to LTC4S
LOW biopsies (Figure 3.5C, 
428 vs. 256, p=0.01). Analogous to the correlation analysis of LTC4S expression and eosinophil 
counts, we found a strong correlation in the LTC4S
LOW but not in the LTC4S
HIGH biopsies (Figure 
3.5D, r=0.492, p=0.005 versus r=0.260, p=0.25). Similar results were obtained for the mast cell 
marker carboxypeptidase A3, with higher mRNA levels in LTC4S
HIGH versus LTC4S
LOW patients 
(mRNA counts 2644 vs. 1880, p=0.06) and correlation coefficients of 0.458 (p=0.01) in LTC4S
LOW 
and 0.225 (p=0.30) in LTC4S
HIGH biopsies. 
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 Combined, these results suggest that LTC4S expression levels are not simply a surrogate 
marker for eosinophil infiltration in LTC4S
HIGH patients and that other cell types such as 
mast cells and basophils contribute to local LTC4S mRNA production in this patient group. 
The correlation analysis indicates that another cell type contributes to the elevated mRNA 
levels in the LTC4S
HIGH patient group. An alternative explanation would be that LTC4S mRNA 
production is upregulated in eosinophils or mast cells of this patient subgroup. In summary, 
these findings form an additional argument that LTC4S
HIGH EoE patients have a distinct 
immunologic tissue phenotype.  
Figure 3.6. LTC4S mRNA levels in whole blood samples and urinary LTE4 excretion do not distinguish EoE 
patients from controls. LTC4S mRNA levels in whole blood w assessed in 17 EoE patients and 25 controls. (A) LTC4S 
mRNA expression was similar between EoE patients and controls. (B) Expression of LTC4S mRNA in whole blood did 
not correlate with the average tissue mRNA levels from proximal and distal biopsies. Urinary excretion of leukotriene 
E4 (ULTE4) per mg creatinine was assessed in 10 EoE patients and 13 controls. (C) ULTE4 levels were similar between 
EoE patients and controls. (D) ULTE4 did not correlate with the average tissue LTC4S mRNA levels in 11 available 
paired samples. NS: not significant.
3.4.6 The LTC4S
HIGH EoE subpopulation has to be defined based on esophageal LTC4S mRNA 
transcript levels 
We next asked whether LTC4S
HIGH EoE patients could be identified by less invasive methods 
than tissue biopsy. Therefore, we analyzed mRNA expression in whole blood samples from 
which erythrocytes and thrombocytes had been removed. Here we found similar LTC4S 
mRNA levels between EoE patients (N=17) and non-EoE controls (N=25, Figure 3.6A). No 
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correlation between the average LTC4S mRNA counts from the proximal and distal biopsy 
with the patient’s LTC4S mRNA counts in whole blood samples was depicted (Spearman rho 
= 0.079, Figure 3.6B). 
  Finally, we tested if increased urinary excretion of cysteinyl leukotrienes occurs in EoE 
patients. Leukotriene E4 (LTE4) is excreted in the urine and can be reliably quantified using 
immunoassays (Kumlin et al., 1995; Rabinovitch, 2007). A total of 10 urine samples from EoE 
patients and 13 samples from controls were available for analysis. No significant difference 
in average concentration of urinary leukotriene E4 was found between patient groups 
(Figure 3.6C). Comparable to our results with mRNA analysis in whole blood, we did not 
detect a significant correlation between the average tissue LTC4S expression and urinary 
LTE4 concentration (Spearman rho = 0.246, Figure 3.6D). Combined, these results stress the 
importance of local diagnosis in distinguishing LTC4S
HIGH EoE patients. 
3.5 Discussion
Our study demonstrates that mRNA expression of LTC4S, a key regulator of cysteinyl 
leukotriene synthesis, is elevated in esophageal biopsies of EoE patients. More importantly, 
we found that tissue LTC4S mRNA levels identify a subpopulation of EoE patients. LTC4S
HIGH 
EoE patients were not distinguished from LTC4S
LOW patients by age, sex, tissue eosinophil 
count or expression of known EoE marker genes, but did show elevated mRNA levels of TSLP 
and CD4 and significantly lower levels of IL-23. Serum IgE levels in the LTC4S
HIGH subpopulation 
were significantly higher than in LTC4S
LOW patients. Since IgE levels commonly correlate with 
the severity of an allergic phenotype (Cheng et al., 2010; Novak and Bieber, 2003), this finding 
suggests a higher degree of allergic sensitization in patients that overexpress LTC4S. As such, 
mRNA levels of LTC4S, TSLP and IL-23 could potentially discriminate an EoE subpopulation 
with a more pronounced allergic phenotype at the tissue level. 
  Our study did not include standardized allergen testing and therefore the antigenic 
specificity of the allergic tissue phenotype in LTC4S
HIGH patients remains unknown. However, 
increased secretion of LTC4S protein has been documented in nasopharyngeal secretions of 
ragweed-pollen sensitive children during the pollen season (Figueroa et al., 2003; Volovitz et 
al., 1988) as well as in isolated blood leukocytes after in vitro pollen-stimulation (Kopp et al., 
2007). Accordingly, increased tissue eosinophilia after exposure to pollen has been described 
in EoE (Fogg et al., 2003; Onbasi et al., 2005; Spergel, 2005) and experimental EoE could be 
induced through aeroallergen exposure (Mishra et al., 2001). In line with these published 
data and our findings, it is well conceivable that aeroallergen exposure during the pollen 
season results in increased LTC4S mRNA levels in sensitized EoE patients. Our findings that 
LTC4S mRNA levels were also mildly elevated in sensitized, non-EoE control patients enrolled 
during the pollen season could be used as an argument that upregulation of esophageal 
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LTC4S mRNA expression in response to pollen is not confined to EoE patients. However, 
expression levels were markedly higher in EoE patients, suggesting amplified leukotriene 
production in those patients with ongoing eosinophilic inflammation. 
  How LTC4S mediated inflammation contributes to disease severity in EoE cannot be 
determined by the present study. We did not identify any differences in GI symptomatology 
as reported by LTC4S
HIGH vs. LTC4S
LOW patients at time of enrollment. EoE, however, is a 
relatively new, chronic disorder, in which the clinical course is still impossible to predict at 
time of diagnosis. One potential sequela of EoE is esophageal fibrosis, which is associated 
with local collagen deposits in the esophagus that likely contributes to clinical symptoms 
of food impaction and dysphagia (Aceves and Ackerman, 2009). Recently, LTC4 has been 
described to promote skin collagen deposition and thickening in an atopic dermatitis mouse 
model (Oyoshi et al., 2012). It is thus conceivable that LTC4S
HIGH EoE patients may be prone to 
local collagen deposition and therefore are at increased risk for the development of fibrosis. 
This concept is further supported by a 15-year follow-up study of paediatric-onset EoE which 
showed that allergic rhinitis during childhood was the single factor most strongly associated 
with dysphagia during early adulthood (OR 3.5, p<0.001), closely followed by food allergies 
(OR 2.7, p<0.01) (DeBrosse et al., 2011). Combined, these findings support a model in which 
LTC4S mRNA in esophageal tissue in sensitized EoE patients is increased in response to 
allergen-exposure, resulting in increased collagen deposition and ultimately progression of 
dysphagia and food impaction. 
  The published EoE transcriptome, with upregulation of eotaxin-3, periostin, 
carboxypeptidase A3 and IL-13 as hallmark features, was found not to divert between allergic 
and non-allergic EoE patients (Blanchard et al., 2006b; 2007). This is confirmed by our data 
that show similar mRNA levels of these four target genes in LTC4S
HIGH and LTC4S
LOW biopsies. 
Furthermore, our LTC4S
HIGH samples were not characterized by higher local IgE production, 
which is in line with data by Vicario et al. who showed that local IgE production occurs to the 
same extent in both allergic and non-allergic EoE patients (Vicario et al., 2010). 
  Identification of distinct features of an allergic EoE transcriptome may have important 
consequences for our understanding of individual disease phenotypes. LTC4S mRNA was 
not only found to be upregulated in a subpopulation of EoE patients but also distinguished 
RE patients from those with normal tissue histology. This disease-associated regulation of 
baseline tissue LTC4S expression may reflect two separate pathways of immune activation. 
Since IL-23 was found to be significantly higher expressed in LTC4S
LOW biopsies as well as in RE 
patients, it is conceivable that its induction is part of a distinct inflammatory transcriptome 
that overlaps with the inflammation signature of RE. Within a heterogeneous population of 
EoE patients, this may potentially identify those with PPI-responsive EoE.  
  To our knowledge, this study is the first report on mRNA expression of LTC4S in esophageal 
tissue of EoE patients. Previously, quantification of the cysteinyl leukotrienes LTC4, LTD4 and 
LTE4 in esophageal tissue yielded no differences between 12 EoE patients and 10 controls 
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(Gupta et al., 2006). Only 25% of the EoE patients in this study showed elevated serum IgE 
levels. Since we found elevated LTC4S mRNA levels mostly in the EoE group with classical 
allergic diagnosis, a possible explanation for the equivalent protein levels of LTC4S between 
EoE and control patients in the study by Gupta et al. was a relative underrepresentation of 
allergic EoE patients with elevated serum IgE. Recently, Dellon et al. reported that protein 
levels of LTC4S and LTA4 hydrolase as determined by immunohistochemical staining failed 
to identify EoE patients (Dellon et al., 2012). These enzymes might be highly stable proteins 
and the question of how LTC4S mRNA expression correlates with tissue protein levels in EoE 
requires clinical follow-up studies. Such studies are important because based on our results, 
it is conceivable that patients with high expression of LTC4S mRNA will benefit most from 
pharmacological treatment with the leukotriene receptor antagonist montelukast, which 
thus far has been described to yield mixed clinical results in EoE (Attwood et al., 2003; Daikh 
et al., 2003; Lucendo et al., 2011; Stumphy et al., 2011; Vanderhoof et al., 2003), but showing 
clear improvement in some patients.  Prospective clinical studies to address this hypothesis 
are now of the utmost importance. 
In summary, we here describe the identification of a subpopulation of EoE patients that is 
characterized by elevated mRNA levels of LTC4S and TSLP, combined with lower expression 
of IL-23 in esophageal tissue. Our results stress the importance of local diagnosis of this 
allergic disease. Incorporation of our findings into clinical practice could advance current 
EoE classification and direct personalized treatment strategies.
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Table 3.S2. Alternative normalization strategy for mRNA levels in our patient population confirms the 
upregulation of LTC4S as a distinguishing parameter for EoE. Differential gene expression was verified using 
an alternative normalization strategy in which direct mRNA counts were divided by direct mRNA counts of GAPDH 
in that sample.
Gene nCounter® Normalization Alternative Normalization
Fold Upregulation P-value Fold Upregulation P-value
LTC4S Prox 2.6 <0.0001 2.1 <0.0001
Dist 2.9 <0.0001 2.5 <0.0001
Eotaxin-3 Prox 21 <0.0001 22 <0.0001
Dist 13 <0.0001 12 <0.0001
Periostin Prox 41 <0.0001 26 <0.0001
Dist 27 <0.0001 23 <0.0001
Carboxypeptidase A3 Prox 7 <0.0001 5 <0.0001
Dist 7 <0.0001 7 <0.0001
IL-13 Prox 6 <0.0001 4 <0.0001
Dist 6 <0.0001 4 <0.0001
GAPDH Prox 1.0 0.64
Dist 1.0 0.96
HPRT1 Prox 0.9 0.63
Dist 0.9 0.16
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Chapter 4 
Involvement of the iNKT cell pathway is associated with 
early-onset eosinophilic esophagitis and response to 
allergen avoidance therapy 
Willem S. Lexmond MD, Joana F Neves PhD, Samuel Nurko MD MPH, Torsten Olszak, 
Mark A. Exley PhD, Richard S. Blumberg MD*, Edda Fiebiger PhD*
* These authors were equal contributors
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4.1 Abstract
Objectives: Recent experimental evidence suggests that environmental microbial factors 
early in life determine susceptibility to allergic diseases through inappropriate chemotaxis 
and local activation of CD1d-restricted, invariant chain natural killer T (iNKT) cells. In this 
study, we analyzed the involvement of these pathways in pediatric patients with eosinophilic 
esophagitis (EoE) before and after dietary allergen elimination. 
Methods: mRNA expression levels of components of the CXCL16-iNKT-CD1d axis were 
compared in esophageal biopsies from EoE patients vs. normal or inflammatory controls, 
and before and after treatment. 
Results: CXCL16, iNKT cell associated cell marker Vα24 and CD1d were significantly 
upregulated in esophageal biopsies from EoE patients and correlated with expression of 
inflammatory mediators associated with allergy. Upregulation of each of these factors was 
significantly more pronounced in patients <6 years of age at diagnosis and this early-onset 
EoE subpopulation was characterized by a more prominent food allergic disease phenotype 
in a cohort-wide analysis. Successful, but not unsuccessful, treatment of early-onset EoE 
patients with dietary elimination of instigating allergens led to reduction in infiltrating iNKT 
cells and complete normalization of mRNA expression levels of CXCL16 and CD1d. 
Conclusion: Our observations place iNKT cells at the center of allergic inflammation 
associated with EoE, which could have profound implications for our understanding, 
treatment and prevention of this and other human allergic diseases. 
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4.2 Introduction
A wide variety of allergic and immune-mediated inflammatory disorders are rapidly and 
globally increasing (Eder et al., 2006; Molodecky et al., 2012), suggesting that environmental 
factors are critical mediators of these changes (Garn et al., 2013), Moreover, the increasing 
incidence of these diseases is especially apparent among children (Branum and Lukacs, 
2009; Cherian et al., 2006; Noel et al., 2004), which implicates a role for the environment in the 
processes of education and development of the immune system that follow the acquisition 
of a commensal microbiota along mucosal surfaces early in life (Blumberg and Powrie, 2012; 
Ege et al., 2011). 
  Recently, direct evidence has emerged from animal models of asthma and inflammatory 
bowel disease (IBD) that microbially-derived signals during a critical neonatal time frame 
are important regulators of later-life susceptibility to immune-mediated diseases (Olszak et 
al., 2012). Furthermore, environmentally-induced disruptions of these signals, such as those 
that result from the use of antibiotics, conferred increased susceptibility to experimental 
asthma and IBD (Olszak et al., 2012; Russell et al., 2012). These rodent models have focused 
particular attention on the role played by microbial-induced expression of chemoattractant 
chemokines that promote infiltration of mucosal tissues with invariant natural killer T (iNKT) 
cells. iNKT cells respond to host and microbial lipid antigens when presented by CD1d and 
rapidly express a variety of mediators that regulate downstream immune events and effector 
cells (Brennan et al., 2013; Kronenberg, 2005). In the absence of microbiota during neonatal, 
but not adult life, as in germ-free or antibiotic-treated mice, such tissues express increased 
quantities of CXCL16, a chemokine involved in iNKT cell trafficking (Germanov et al., 2008; 
Olszak et al., 2012). When these early-life microbial signals are not provided, an excessive and 
persistent accumulation of iNKT cells occurs in the colon and lungs. Consequently, these 
mucosal tissues are rendered more susceptible to later-life environmental triggers of iNKT 
cells, which are potent and rapid producers of Th2-type cytokines such as IL-4, IL-5 and IL-13, 
which mediate allergic sensitization and tissue inflammation (Brennan et al., 2013; Olszak 
et al., 2012; Scanlon et al., 2011). These model studies suggest that microbially-regulated 
immune events during early-life, or lack thereof as a consequence of, for example, antibiotic 
administration, are critical determinants of later-life susceptibility to allergic disease. In 
addition, given that components of CD1d-restricted T cell pathways and their regulating 
factors such as CXCL16 serve as mediators of this susceptibility, it is reasonable to expect 
that they have a potential role as markers for disease risk in humans.  
  To test the relevance of the hypothesis that early-life events determine the tone 
of CD1d-restricted T cell pathways and susceptibility to immune-mediated diseases in 
humans, we turned our attention to pediatric patients with eosinophilic esophagitis (EoE). 
EoE is characterized by chronic eosinophilic inflammation of the esophagus and is strongly 
associated with allergies to inhaled and food-derived antigens (Mulder and Justinich, 2011; 
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Rothenberg, 2009). Like other allergic diseases, the disorder often manifests during childhood 
(Assa’ad et al., 2007) and is undergoing a rapid increase in incidence and prevalence 
worldwide (Hruz et al., 2011; Noel et al., 2004; Prasad et al., 2009), suggesting a pathogenic 
role of yet-to-be defined environmental factors (Mulder and Justinich, 2011).
  In addition to their previously established role in asthma and IBD (Fuss et al., 2004; 
Umetsu and DeKruyff, 2010), iNKT cells have recently been implicated in the pathogenesis 
of experimental EoE (Rajavelu et al., 2012). To study the involvement of this pathway in EoE, 
we here analyzed mRNA expression levels of CXCL16, as well as iNKT cells and their markers 
in serum and esophageal biopsies that were obtained before and after treatment with an 
allergen-elimination diet. 
4.3 Materials and Methods
4.3.1 Study population
The patients included in this study are part of an observational longitudinal cohort study at 
Boston Children’s Hospital that aims at understanding the pathophysiology of EoE and is 
approved by the institutional Investigational Review Board (Harvard Medical School, Boston, 
MA) (Dehlink et al., 2011; Lexmond et al., 2013; Yen et al., 2010). Parents of children 0-18 
years of age whose clinical presentation indicated possible EoE (e.g. feeding intolerance, 
food aversion, dysphagia, failure-to-thrive) were invited to participate. Prior to routine 
diagnostic endoscopy, caregivers were asked to fill out a questionnaire regarding the 
child’s past medical history, current and past symptomatology, allergic comorbidity, and 
dietary habits. We only considered children to be food allergic when foods were avoided 
based on the results of RAST, skin prick, or patch testing. Upon written informed consent, 
serum and additional esophageal biopsies were obtained. EoE was diagnosed according to 
current consensus guidelines (Liacouras et al., 2011). After diagnosis, patients were treated 
independently of this study, but were again asked to participate when admitted for follow-up 
endoscopy. Since 2008, 451 children have been included in the cohort, 160 of whom received 
a diagnosis of EoE. The 291 non-EoE patients had either normal esophageal tissue biopsies 
(N=225) or inflammation that was classified by the hospital pathologist as consistent with RE 
(N=66). Within this patient cohort, we focused on 31 biopsies available from patients <6 years 
of age (18 EoE, 5 RE and 8 normal histology) as well as 16 biopsies from patients ≥6 years 
old (10 EoE, 6 normal histology). Twelve follow-up biopsies from EoE patients <6 years were 
available for analysis. 
4.3.2 Sample preparation and assay
Study biopsies from the distal esophagus (approximately 2 cm from the gastro-esophageal 
junction) were collected in RNAlater (Qiagen, Valencia, CA) and stored at -80°C prior to 
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processing. Tissue was homogenized in 350 μl RLT Buffer (Qiagen) with β-mercaptoethanol 
(Sigma, St. Louis, MO) in GentleMACS M tubes (Miltenyi Biotec, Auburn, CA) and RNA was 
extracted using RNeasy plus kit (Qiagen). RT-qPCR was performed using Taqman gene 
expression assays (Applied Biosystems, Foster City, CA) for CXCL16, CD1d, CD1a, CXCR6, 
TRAV10 (Vα24), CD3ε, leukotriene C4 synthase (LTC4S), eotaxin-3 and periostin in duplex 
RT-qPCR reactions with the housekeeping gene GAPDH (C1000 Thermal Cycler, Bio-rad, 
Herculus, CA). Gene expression relative to GAPDH (ΔΔct) was calculated. Pooled cDNA from 
5 control patients was used as an inter-run calibrator. CXCL16 protein levels were measured 
in serum using a commercially available ELISA according to the manufacturer’s instructions 
(R&D Systems, Minneapolis, MN). 
4.3.3 Statistical analysis
Distribution of serum and mRNA expression values was assessed with D’Agostino and 
Pearson omnibus normality test and patient groups were accordingly compared with either 
Student’s t test for normally distributed or Mann-Whitney U test for non-parametric values 
unless otherwise indicated. Correlations were expressed as Pearson’s or Spearman’s rho. 
Epidemiological data retrieved from questionnaires was analyzed with Fisher’s exact test. For 
logistic regression analysis, potential predictors of EoE that were estimated to relate directly 
to the report of early-life antibiotic use were analyzed with univariate logistic regression, and 
subsequently included in a multivariate model, regardless of statistical significance. Analyses 
were performed with Stata 12.1 (StataCorp, College Station, TX) and Prism 5.0 (GraphPad 
Software, La Jolla, CA). Reported values represent mean±SEM. All statistical testing was two-
sided, with an alpha of 0.05.  
4.4 Results
4.4.1 The CXCL16-iNKT-CD1d axis is prominently involved in early-onset EoE patients. 
To investigate the contribution of CXCL16 to local disease in EoE, we analyzed mRNA 
expression levels of CXCL16 in esophageal biopsies at time of diagnosis in 47 children. 
Patients were grouped according to age at diagnosis: (1) patients <6 years (18 EoE vs. 13 non-
EoE, of whom 5 with histologic evidence of reflux esophagitis (RE)) and (2) 6-18 years (10 
EoE vs. 6 non-EoE with normal tissue histology). CXCL16 was expressed in all esophageal 
biopsies analyzed (Cycle threshold range 26.6 – 32.7), but expression was significantly higher 
in EoE patients when compared to controls (3.2±0.3 vs. 1.2±0.2, p<0.001, Figure 4.1A). 
Furthermore, expression levels were higher in early-onset EoE patients, which we defined as 
children diagnosed before 6 years of age, compared to their older EoE counterparts (3.7±0.4 
vs. 2.2±0.2, p<0.05). No age-dependent difference was seen in the non-EoE control patients 
(1.3±0.3 vs. 1.0±0.1, p=0.52, Figure 4.1A). 
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Figure 4.1. Components of the CXCL16-iNKT cell-CD1d pathway are most prominently expressed in early-
onset EoE patients. Gene expression relative to housekeeping gene GAPDH (expressed as ΔΔCt values) is shown in 
early-onset EoE patients (<6 years of age, full circles), EoE patients 6-18 years (open circles), and non-EoE controls 
(patients <6 years shown as full squares and patients 6-18 years as open squares) (A-F and H). mRNA expression 
levels were elevated in EoE patients compared to non-EoE controls for CXCL16 (A), CXCR6 (B), Vα24 TCR (C), CD3ε 
(D), CD1d (F), but not for CD1a (H). Early-onset EoE patients express significantly higher levels of CXCL16 (A), CXCR6 
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(B), and Vα24 TCR (C) when compared to older EoE patients. Ratio of expression is plotted for Vα24/CD3ε and Vα24/
CXCR6 (E). Vα24 TCR mRNA levels correlated significantly with CD1d and CXCL16 (G). Expression values under the 
detection limit or the corresponding expression ratios are plotted under the dotted line when transcripts were not 
detected. Serum CXCL16 levels of early-onset EoE patients were compared with age-matched non-EoE controls (I). 
Serum CXCL16 was correlated to age at diagnosis (J and K). *p<0.05, **p<0.01, ***p<0.001, NS: not significant.
  We analyzed the same biopsies for mRNA expression of CXCR6, the canonical receptor 
for CXCL16 that is expressed on a variety of T cell subsets, including Th1-polarized CD4+ 
and CD8+ T cells(Kim et al., 2001), as well as iNKT cells (Kim et al., 2002). Although higher 
expression levels were seen in EoE patients compared to non-EoE controls (Figure 4.1B), 
the highest expression levels were observed in EoE patients 6-18 years of age. In light of the 
elevated CXCL16 levels observed in EoE patients <6 years old, these results are consistent 
with observations that CXCR6 in T cells is down-regulated upon activation (Koprak et al., 
2003) and suggest that CXCL16 engagement is highly active in early-onset EoE patients. 
  To determine whether CXCL16 overexpression was indeed associated with infiltration of 
iNKT cells, we analyzed gene expression of Vα24, an essential component of the invariant T 
cell antigen receptor (TCR) of iNKT cells (Vijayanand et al., 2007) Vα24 TCR mRNA transcripts 
were detected in 17 out of 18 early-onset EoE patients, all 10 older EoE patients, and in 14 
of 19 control patients. In line with CXCL16 expression results, the highest levels of Vα24 TCR 
mRNA were detected in EoE patients <6 years (Figure 4.1C). Increased Vα24 expression did 
not result from more pronounced overall T cell infiltration, because expression levels of the ε 
chain of the TCR (CD3ε) were equivalent in both young and older EoE patients (Figure 4.1D) 
and normalization of Vα24 expression against CD3ε or CXCR6 did not resolve the difference 
between old and young EoE patients (Figure 4.1E). These results suggest the existence of 
distinct differences in infiltrating T cell subsets between early-onset and older EoE patients. 
  iNKT cells are restricted by recognition of lipid-antigen presented through CD1d on 
antigen-presenting cells (Brennan et al., 2013). We therefore examined CD1d mRNA and 
observed increased expression in EoE patients compared to non-EoE control patients, indicating 
that at the site of inflammation, there is enhanced capacity to activate infiltrating iNKT cells 
(Figure 4.1F). Indeed, we depicted a positive correlation between tissue mRNA expression of 
CD1d and Vα24 in esophageal biopsies (Spearman rho=0.654, p<0.001, Figure 4.1G). Similarly, 
expression of CXCL16 and Vα24 correlated positively (Spearman rho=0.542, p<0.001, Figure 
4.1G). Conversely, expression levels of CD1a, a related glycoprotein on antigen presenting 
cells, did not differ between EoE patients and controls (1.0±0.2 vs. 1.2±0.2, p=0.38), arguing that 
increased CD1d expression in EoE is part of the disease-specific immune phenotype rather than 
the result of overall increase in tissue myeloid or inflammatory cells (Figure 4.1H). Combined, 
these data show local involvement of the CXCL16-iNKT-CD1d axis in EoE patients and that this 
involvement is significantly more prominent in early-onset EoE patients. 
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4.4.2 Serum CXCL16 levels in early-onset EoE patients are consistent with an age-
dependent role in EoE pathogenesis 
CXCL16 is present as a membrane-bound protein on epithelial and myeloid cells, as well as a 
soluble form that can be retrieved from patient serum (Diegelmann et al., 2010). We hypothesized 
that early-onset EoE patients might also be characterized by higher levels of CXCL16 in serum 
when compared to non-EoE control patients, as was observed in tissues (Figure 4.1A). If so, this 
might serve as a convenient biomarker for disease. Serum levels were similar between patient 
groups (2.9±0.2 μg/ml for EoE (N=18) vs. 2.6±0.1 μg/ml for non-EoE (N=24), p=0.19, Figure 4.1I). 
Interestingly, there was a significant negative correlation between serum CXCL16 levels and age 
of diagnosis in EoE (r=-0.65, p=0.004, Figure 4.1J). Conversely, this relationship between age and 
serum CXCL16 levels was absent in the non-EoE patients (r=-0.16, p=0.46, Figure 4.1J) and EoE 
patients 6-18 years of age (N=8, r=0.31, p=0.45). These results further support an age-dependent 
role for CXCL16 in EoE pathophysiology, which is detectable in the serum. 
4.4.3 Involvement of the CXCL16-iNKT-CD1d axis is associated with a more pronounced 
food allergic phenotype 
Since CXCL16 overexpression and iNKT cell infiltration were significantly more pronounced in 
the younger EoE patients, we asked whether early-onset EoE differs from EoE that becomes 
apparent during later childhood. Within our entire cohort of 451 patients, 44 of 160 EoE 
patients (28%) were <6 years at time of diagnosis. In line with data from multiple patient 
populations (Hruz et al., 2011; Noel et al., 2004), we saw a strong male preponderance in 
EoE patients, as well as a higher occurrence of all investigated allergic diatheses compared 
to control patients (Table 4.1). Comparison between EoE patients <6 and ≥6 years of age, 
however, revealed striking differences in the distribution of allergic comorbidity. Whereas 
older patients were more likely to be asthmatic (50% vs. 20%, p=0.003), early-onset EoE 
patients had significantly more often been diagnosed with food allergy against milk (32% vs. 
14%, p=0.02) or any specific food allergen (48% vs. 25%, p=0.008) through skin prick, patch, 
or RAST testing. These epidemiological data are suggestive of a particularly dominant role of 
food allergic sensitization in early-onset EoE. 
  To further test this hypothesis at the tissue level, we again turned to tissue biopsies. We 
have recently demonstrated that elevated mRNA levels of leukotriene C4 synthase (LTC4S) mark 
a subpopulation of EoE patients with a more pronounced local allergic phenotype (Lexmond 
et al., 2013). No difference was found in tissue eosinophil counts between early and later-onset 
EoE patients (Figure 4.2A). However, in line with our epidemiological data, we found that early-
onset EoE patients had significantly higher levels of LTC4S mRNA expression (Figure 4.2B). 
  In addition, we analyzed tissue biopsies for EoE marker genes eotaxin-3, periostin, and 
IL-13, which were among the first genes to be identified as part of an EoE-specific esophageal 
transcriptome (Blanchard et al., 2008; 2006b; 2007). We observed that all were increased 
in patients with EoE relative to the non-EoE subjects (Figure 4.2C-E). Although no age-
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Figure 4.2. CXCL16 correlates with allergic mediators in early-onset EoE. Early-onset EoE patients do not show 
more severe tissue eosinophilia (counts/hpf, A) or increased expression of EoE-specific marker genes eotaxin-3 (C), 
periostin (D) or IL-13 (E) but show a more pronounced allergic tissue phenotype as signified by increased expression 
of leukotriene C4 synthase (LTC4S, B). In EoE patients, CXCL16 expression correlates with IL-13 and disease-specific, 
IL-13-dependent tissue markers eotaxin-3 (C) and periostin (D). **p<0.01, ***p<0.001, NS: not significant. 
dependent diff erences in expression were found, we observed a strongly positive correlation 
between tissue mRNA expression levels of CXCL16 and these marker genes (Figure 4.2C-
E). Eotaxin-3 has been identified as one of the key eosinophil attractant cytokines in EoE 
(Blanchard et al., 2006b) and periostin is described to facilitate eosinophil tissue infiltration 
(Blanchard et al., 2008). Expression of both eff ector molecules has been described to 
occur downstream of IL-13 signaling in EoE (Blanchard et al., 2008; 2007). Although IL-13 is 
produced by iNKT cells (Brennan et al., 2013), we did not observe a significant correlation 
between expression of IL-13 and Vα24 (r=0.13, p=0.50), indicating that iNKT cells are 
unlikely the dominant cellular source of IL-13. These data suggest a link between the local 
expression of CXCL16 and eff ector pathways of EoE at the site of tissue inflammation.
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Figure 4.3. The CXCL16-iNKT cell-CD1d pathway responds to treatment with dietary elimination of allergens 
in early-onset EoE. Tissue eosinophil counts decreased upon successful treatment (Response+, N=7) but remained 
unaltered or increased in non-responders (Response-, N=5, A). CXCL16 mRNA expression levels decreased in all patients 
upon treatment, but remained significantly elevated in non-responders over responders and controls (B). Comparable 
results were obtained for expression levels of CXCR6 and Vα24 (C) and CD1d (D). No decrease in CD1a expression was 
seen upon successful treatment (E). Elimination of dietary allergens led to normalization of tissue LTC4S mRNA levels in 
responding but not in non-responding patients (F). Allergen avoidance does not aff ect serum CXCL16 levels in EoE patients 
(G). Asterisks represent the result of statistical testing with Wilcoxon signed rank test for before-aft er expression levels and 
Mann-Whitney U test for post-treatment expression levels as follows: *p<0.05, **p<0.01, ***p<0.001, NS: not significant.
Part 1 – Chapter 4
82
4.4.4 Treatment with elimination diet leads to normalization of the CXCL16-iNKT-CD1d 
axis in early-onset EoE patients
To analyze the response of the CXCL16-iNKT-CD1d axis to EoE treatment, we repeated mRNA 
measurements in biopsies that were obtained during follow-up endoscopies performed to 
monitor disease progression and therapeutic response. Follow-up biopsies were available from 
12 of 18 early-onset EoE patients after a median follow-up time of 10.1 months (range 1.9 – 24.8 
months). Based on the degree of tissue eosinophilia obtained from routine histopathological 
analysis, 7 out of 12 EoE patients had significantly improved with treatment, with median 
eosinophil counts of 8/high power field (hpf) (range 0–25) compared to the initial biopsies that 
showed a median of 100 eosinophils/hpf (range 37-120, p=0.02 by Wilcoxon signed rank test, 
Figure 4.3A). Conversely, in the 5 non-responding patients, tissue eosinophilia at follow-up 
remained high, ranging from 40-120 eosinophils/hpf (median 100/hpf, p=0.25). In line with tissue 
eosinophil counts and previously published data (Blanchard et al., 2007), mRNA expression 
levels of eotaxin-3 and periostin at follow-up had decreased significantly in responding 
patients, whereas this reduction was smaller and not significant in the non-responders (Figure 
4.3A). Patient and treatment details are summarized in Table 4.2. 
  We next turned our attention to the CXCL16-iNKT cell-CD1d axis in treated patients. We 
observed that, in the 7 responders, CXCL16 mRNA expression completely normalized to the 
expression levels encountered in age-matched control patients (1.2±0.1 vs. 1.3±0.3, p=0.88, 
Figure 4.3B). In contrast, CXCL16 expression remained significantly elevated in the 5 non-
responders (2.3±0.4) when compared to control patients (p=0.01) as well as responding EoE 
patients (p=0.03). CXCR6 and Vα24 TCR mRNA levels also decreased significantly in the 7 
responding patients (2.7-fold, p=0.02 and 3.3-fold, p=0.03 respectively) but not in the non-
responders (p=1.0 and p=0.63, Figure 4.3C). Likewise, response to treatment was associated 
with a 17-fold reduction in CD1d expression (p=0.01) compared to a 1.5-fold reduction in non-
responders (p=0.31, Figure 4.3D). No decrease, but rather an increase in CD1a expression  levels 
was observed upon successful treatment (2.0-fold increase, p=0.03), in this case showing that 
reduction of CD1d mRNA levels did not result from decreased myeloid cell infiltration (Figure 
4.3E). Lastly, we found that LTC4S mRNA levels only decreased following successful treatment 
(4.0-fold, p=0.03 compared to 1.3-fold, p=0.81 in non-responders, Figure 4.3F). Allergen 
avoidance therapy did not affect the levels of serum CXCL16 (Figure 4.3G), confirming that 
upregulation of CXCL16 represents a local mucosal event that is not broadcasted systemically. 
Together, these data show that involvement of the CXCL16-iNKT cell-CD1d axis can be 
modified by dietary interventions that aim to eliminate common allergens from the diet. 
4.4.5 EoE is potentially associated with use of antibiotics during the first year of life
Animal model experiments suggest that CXCL16 overexpression by epithelial cells can result 
from inadequate instruction from the commensal microbiota at an early age (Olszak et al., 
2012). We therefore hypothesized that antibiotic treatment during the first year of 
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life may be associated with the development of EoE, as has been previously suggested for 
pediatric IBD (Shaw et al., 2010) and asthma (Murk et al., 2011) and, very recently, also for EoE 
(Jensen et al., 2013). Unfortunately, our questionnaires at time of study enrollment did not 
directly address the extent of early-life antibiotic exposure or mode of delivery, but instead 
inquired into medication use during the first year of life, in particular the use of antacids, 
corticosteroids, and prokinetics. Data on the prescription of antibiotics was obtained 
through an open-ended question asking parents to list additional medications during the 
first year of life. Questionnaires of 451 patients (160 EoE) were analyzed. Antibiotics in the first 
year of life were reported in 29 patients, of whom 20 were subsequently diagnosed with EoE 
(p<0.001). Although it is very likely that underreporting affected the total number of cases, 
the difference between EoE patients and controls is unlikely the result of recall bias. This is 
because report of non-antibiotic drug-use during the first year of life did not differ between 
cohorts (33% of EoE patients vs. 41% of non-EoE controls, p=0.09) and questionnaires 
were filled out prior to diagnosis. Furthermore, a positive association (odds ratio 4.10, 95% 
confidence interval 1.36 – 12.35) between EoE and reported antibiotics use during the first 
year of life remained after adjustment for sex, age, prematurity, hospitalization in the first year 
of life, allergic comorbidities and non-antibiotic drug use in the first year of life (Table 4.3). 
Although statistical significance was reached for this association in our cohort, additional 
epidemiological studies designed to specifically address this question are needed to confirm 
a causative link between early-life antibiotic exposure and occurrence of EoE later in life.
4.5 Discussion
In the current study, we provide evidence that supports the involvement of CD1d-restricted iNKT 
cell pathways in the pathogenesis of pediatric EoE. There are several key elements associated 
with the findings contained here. First, our results provide a direct human corollary of previous 
observations in animal models that commensal microbes, in an age-dependent fashion, regulate 
iNKT cell accumulation in the colon and lung by altering expression of chemokine ligands that 
promote iNKT cell migration, such as CXCL16. Similar to this previous report, we found that all of 
the  factors associated with iNKT cells such as the associated TCR chain (Vα24), the antigen 
presenting molecule that regulates their activity (CD1d), and the chemokine ligand that 
determines their chemotaxis into tissues (CXCL16), are observed at significantly higher 
levels in the esophageal tissue of EoE patients compared to normal or inflammatory 
controls. Moreover, the highest levels were observed in children with early-onset EoE 
(<6 years) and the elements of the CXCL16-iNKT cell-CD1d pathway correlated with the 
presence of inflammatory mediators associated with EoE-specific inflammation (eotaxin, 
periostin), pointing towards a direct role in disease pathogenesis. Indeed, successful 
dietary therapy was associated with resolution of disease, together with a synchronous and
Table 4.2. Patient characteristics and treatment details of 12 early-onset EoE patients. PPI: proton pump inhibitor. 
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proportionate decrease in the levels of CXCL16, CD1d and Vα24, suggestive of a cause-and-
effect relationship. Given the observations in animal models, these findings in humans with 
EoE support the hypothesis that early-life events that affect CD1d-restricted T cell pathways 
at mucosal surfaces play an important role in the pathogenesis of EoE. Indeed, we detected 
an association between antibiotic use in the first year of life and the development of EoE, 
drawing additional and provocative similarities to the aforementioned animal studies. 
Together, these studies support the concept that a pathway involving environmentally induced 
changes in early life, in this case caused by antibiotic administration, cause perturbations in 
mucosal iNKT cell homeostasis in esophageal tissues and determines susceptibility to EoE. 
  Prior translational studies on the role of iNKT cells in human allergy have predominantly 
been performed in asthmatic patients, after it was shown that iNKT cells are required for the 
induction of experimental airway hyperreactivity in mice (Akbari et al., 2003; Brennan et al., 
2013; Lisbonne et al., 2003). Since efforts to demonstrate increased levels of iNKT cells in 
bronchoalveolar lavage fluid (BALF) of asthmatic patients have not yielded clear differences 
with control populations (Mutalithas et al., 2007; Thomas et al., 2006; Vijayanand et al., 2007), 
such a role has remained a matter of debate (Thomas et al., 2010; Umetsu and DeKruyff, 2010). 
These analyses of BALF have however been performed in adult patients with a longstanding 
history of asthma and therefore do not rule out a potential role for iNKT cells in the early phase 
of disease pathogenesis. This concept is further supported by recent experimental work that 
suggests that rather than being the main effector cell in advanced asthma, iNKT cells are critically 
involved in the allergic sensitization phase of disease. Specifically, Scanlon et al. showed that 
intratracheal exposure to bacterial lipid antigens resulted in rapid peribronchiolar infiltration of 
iNKT cells and formation of eosinophil-rich granulomas. Upon intratracheal co-administration 
of ovalbumin, a Th2 immune response was mounted against ovalbumin, including synthesis 
of anti-ovalbumin IgE. Allergic sensitization persisted until months after the initial exposure 
and, once established, was independent of iNKT cells (Scanlon et al., 2011). These observations 
thus point towards iNKT cells as a crucial instigating cell-type in allergic forms of inflammation 
and demonstrate that once allergic sensitization has occurred, cytokine production by iNKT 
cells is dispensable for disease pathogenesis. The latter finding likely explains the absence of a 
correlation between IL-13 and Vα24 expression in our cohort.  
  By studying pediatric EoE patients at the time of diagnosis, we were able to obtain 
affected mucosal tissues to directly correlate the involvement of iNKT cells and their 
mediators with disease phenotype. Like asthma, EoE is a chronic, immune/antigen-driven 
condition characterized by aberrant Th2 immune responses and allergic sensitization 
(Liacouras et al., 2011). Both food-derived and inhaled allergens have been implicated in its 
pathogenesis (Liacouras et al., 2011; Spergel, 2005; Spergel et al., 2012), which is reflected in 
high response rates upon initiation of an elemental or 6-food elimination diet (Gonsalves 
et al., 2012; Kagalwalla et al., 2006). As a corollary, increased esophageal eosinophilia is 
observed during the pollen season in pollen-sensitized patients (Fogg et al., 2003; Onbasi 
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et al., 2005). A likely role for iNKT cells in the process of allergic sensitization was suggested 
from studies that showed that food-allergen dependent, experimental murine EoE, could 
not be induced in CD1d-deficient mice (Rajavelu et al., 2012). Consistent with this, we have 
shown that individual components of the CXCL16-CD1d-iNKT axis are overexpressed in our 
entire pediatric EoE population, but increased expression was significantly more prominent 
in patients who developed the disease at a very young age. Epidemiological data from 
our cohort study further indicate that in patients diagnosed when <6 years of age, EoE is 
characterized by a higher fraction of food-allergic sensitization. In addition, local mRNA levels 
of LTC4S, the enzyme that generates the allergic mediator leukotriene C4, were significantly 
higher in children with early-onset EoE than in their older counterparts. As such, these data 
suggest that this early-onset disease phenotype is likely to depend more heavily on local 
sensitization to food-derived allergens. Our results are therefore supportive of an association 
between local accumulation of iNKT cells and allergic sensitization to food antigens in 
human EoE. Additional support for our concept was provided recently by Jyonouchi et al., 
who reported increased numbers of iNKT cells in esophageal biopsies of pediatric patients 
with active disease. Upon stimulation with milk-derived sphingolipids, iNKT cells from these 
EoE patients readily responded with increased IL-13 and IL-4, but not IFN-γ production, 
showing that iNKT cell-mediated responses to food-derived antigens can be responsible for 
Th2 skewing of immune responses (Jyonouchi et al., 2014). 
  Despite recent advances in our understanding of iNKT cell biology, the exact molecular 
mechanism that couples iNKT cell infiltration to allergic sensitization in human EoE patients 
remains to be further identified. iNKT cells are CD1d-restricted and can be activated in 
response to exogenous lipid antigens, including pollen and dust mite associated lipids (Agea 
et al., 2005; Wingender et al., 2011), as well as dietary antigens such as sphingomyelin derived 
from milk (Jyonouchi et al., 2011) or the allergen Ber e1 from Brazil nuts in the presence of a 
naturally-occurring lipid fraction (Mirotti et al., 2013). The study by Olszak et al. has furthermore 
implicated endogenous (self) antigens as a source of iNKT stimulation in a pathogenic 
environmental context and showed that microbes inhibit this auto-reactivity, at least in part, 
through dampening CXCL16 expression (Olszak et al., 2012). It is therefore of interest that we 
identified a relationship between early-life antibiotic use and EoE, suggesting that microbial 
reduction during early life may also confer risk for the development of EoE as previously 
demonstrated for asthma (Kummeling et al., 2007; Murk et al., 2011) and IBD (Shaw et al., 2010) 
in humans. Such antibiotic use may diminish the quantity and/or activity of microorganisms 
capable of regulating iNKT cells. Interestingly in this regard is evidence that Bacteroides 
fragilis encodes a biosynthetic pathway for the generation of glycosphingolipids capable of 
inhibiting colonic iNKT cells, suggesting that antibiotics which diminish this or similar types 
of organisms may predispose to iNKT cell-mediated diseases (55). Our longitudinal cohort 
study was not designed to specifically address the potential association between antibiotics 
use and onset of EoE, which has resulted in potential underreporting of early-life antibiotic 
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use and absence of data on the quantity or types of antibiotics prescribed. Although our data 
suggest that the association between early-life antibiotic exposure and development of EoE 
was not due to recall bias, we caution that additional epidemiological studies are needed to 
prove this important hypothesis. We propose that EoE is a suitable model disease for such 
studies, since an association with antibiotic exposure is less susceptible to reverse causation, 
which has hampered inference from pediatric asthmatic cohorts (Kummeling and Thijs, 
2008). Indeed, gastrointestinal symptoms are less likely to be treated with antibiotics than 
upper or lower airway infections, and symptomatology was not more pronounced in EoE 
patients compared to controls in our cohort. Supportive of our data is a recently published 
paper that has described an association of the same order of magnitude between EoE and 
antibiotic use during infancy as found in our study (Jensen et al., 2013). Large European 
studies have further pointed out that exposure to a wide variety of environmental micro-
organisms confers protection against both atopy and asthma (Ege et al., 2011), making it 
reasonable to surmise that similar mechanisms are operative in EoE. 
In summary, we have assessed how recent findings from experimental studies in mouse 
models translate to human allergic disease in the context of EoE. Based on our results, we 
propose the following model of EoE pathophysiology: 1. Insufficient immune imprinting 
by environmental microorganisms results in esophageal upregulation of CXCL16 and 
chemotaxis of iNKT cells into the esophagus, making the esophagus susceptible to triggers of 
iNKT cell activation; 2. Lipid antigens derived from food, aeroallergens, microorganisms, and/
or potentially self-antigens associated with the esophagus are inappropriately presented 
to iNKT cells by CD1d in a manner that stimulates their pathologic activation; 3. Activated 
iNKT cells serve as an early source of IL-4, IL-5, and IL-13, facilitating Th2-mediated allergic 
sensitization and responses that promote and sustain inflammation. Our observations 
further suggest that in an esophageal iNKT cell-dominant disease phenotype, as occurs 
early in life, allergic inflammation is driven primarily by food antigens. Conversely, in EoE 
that manifests at a later age, esophageal inflammation is potentially less dependent on 
iNKT cells based upon our findings. This model of disease pathophysiology suggests that 
pharmacological interference with CXCL16 and CD1d, especially at a young age and at onset 
of disease, is a potent target in the prevention and treatment of allergic diseases such as EoE 
and may further serve as diagnostic markers in determining disease etiology and therapeutic 
response.
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5.1 Abstract
Background: Eosinophilic esophagitis (EoE) is an allergic inflammatory disorder 
characterized by the accumulation of eosinophils in the esophagus. EoE often coexists with 
atopic dermatitis (AD), a chronic inflammatory skin disease. The impaired skin barrier in AD 
has been suggested as an entry point for allergic sensitization that triggers development of 
EoE.
Objective: To define the mechanisms whereby epicutaneous sensitization via a disrupted 
skin barrier induces development of EoE. 
Methods: To elicit experimental EoE, mice were epicutaneously sensitized with ovalbumin 
(OVA) followed by intranasal OVA challenge. Levels of esophageal mRNA for Th2 cytokines 
and IL-33 receptor Il1rl1 (St2) were measured by quantitative PCR. Esophageal eosinophil 
accumulation was assessed by flow cytometry and H&E staining. In vivo basophil depletion 
was achieved by using diphtheria toxin treatment of Mcpt8DTR mice and animals were 
repopulated with bone marrow basophils. mRNA analysis of esophageal biopsies from EoE 
patients was used to validate our findings in humans.
Results: Epicutaneous sensitization and intranasal challenge of wild-type (WT) mice 
resulted in an accumulation of eosinophils and upregulation of Th2 cytokines and St2 in the 
esophagus. Disruption of the IL-33-ST2 axis or depletion of basophils reduced these features. 
Expression of ST2 on basophils was required to accumulate in the esophagus and transfer 
experimental EoE. Expression of IL1RL1/ST2 mRNA was increased in esophageal biopsies 
from EoE patients. Topical OVA application on unstripped skin induced experimental EoE in 
filaggrin-deficient, flaky tail (ft/ft) mice, but not in WT controls or ft/ft.St2-/- mice.
Conclusion: Epicutaneous allergic sensitization promotes EoE and this is critically mediated 
via the IL-33-ST2-basophil axis.
Allergic skin sensitization and onset of EoE
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5.2 Introduction 
Eosinophilic esophagitis (EoE) is a chronic inflammatory allergic disorder characterized by 
the accumulation of eosinophils in the esophagus (Furuta and Katzka, 2015). EoE affects 1 
in 2,000 individuals in the U.S., and has been increasingly diagnosed in the past two decades 
(Mulder and Justinich, 2011). Patients with EoE can present in infancy with vomiting and 
failure to thrive. Older patients develop dysphagia, food impactions and esophageal strictures. 
The mechanism that mediates eosinophil accumulation in EoE is not fully understood. The 
observations that immune suppression or allergen avoidance ameliorate EoE symptoms 
indicate that EoE is an allergen-driven disease mediated by an abnormal immune response 
(Rothenberg, 2015). Several studies support a role of T-helper (Th)-2 cells that express the 
cytokines interleukin (IL)-4, IL-5, and IL-13 in eosinophil recruitment to tissue, as they regulate 
the differentiation of eosinophils from their precursors, and induce the production of eotaxin, 
a major chemoattractant of eosinophils (Rothenberg, 2015). However, modest effects of anti-
IL-5 or anti-IL-13 treatment in ameliorating the symptoms in the majority of EoE patients 
(Cianferoni and Spergel, 2014; Rothenberg et al., 2015; Stein et al., 2006) indicate that additional 
inflammatory mechanisms involved in the pathogenesis of EoE need to be elucidated. 
  Approximately 50% of EoE patients have coexisting atopic dermatitis (AD), a chronic 
pruritic inflammatory skin disease that affects 15-17% of children and 1-3% of adults in the 
U.S. (Blanchard et al., 2010; Leung, 2013). Patients with AD and EoE are typically characterized 
by development of allergen-specific Th2 cells, production of immunoglobulin E (IgE), and 
recruitment of eosinophils into inflamed tissue. The established observation that childhood 
AD can predispose to the progressive development of allergic diseases suggests AD as a 
potential risk factor for development of subsequent EoE. 
  An abnormal skin barrier is a hallmark of AD (Oyoshi et al., 2009a) and may provide an 
initial entry point for food allergens (Lack et al., 2003), potentially leading to development of 
EoE. Loss of function mutations in the Filaggrin gene (FLG) that encodes the epithelial barrier 
protein filaggrin are associated with increased risk for developing AD (Palmer et al., 2006; 
Weidinger et al., 2006) and EoE (Blanchard et al., 2010), further supporting the hypothesis 
that the skin may be a common route of sensitization in the pathogenesis of AD and EoE. 
  IL-33 is a member of the IL-1 family characterized as a Th2 promoting epithelial cytokine 
that activates an array of immune cells, including eosinophils, basophils, mast cells, group 2 
innate lymphoid cells (ILC2s), and Th2 cells through the receptor IL1RL1 (ST2) (Divekar and 
Kita, 2015; Molofsky et al., 2015; Schmitz et al., 2005; Siracusa et al., 2011). Levels of IL-33 are 
increased in the skin lesions and serum of patients with AD (Savinko et al., 2012; Tamagawa-
Mineoka et al., 2014) as well as in esophageal tissues from human EoE (Simon et al., 2015). 
Genetic variants in IL1RL1/ST2 or IL33 have been associated with AD (Shimizu et al., 2005) and 
EoE (Kottyan et al., 2014), suggesting a role of the IL-33-ST2 axis in the pathogenesis of these 
diseases. 
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  To understand the mechanisms of EoE, we have utilized a mouse model of AD-like 
allergic skin inflammation to demonstrate that epicutaneous sensitization with egg protein 
ovalbumin (OVA) on mechanically injured skin of wild-type (WT) mice, or topical sensitization 
with OVA on FLG-deficient skin of flaky tail (ft/ft) mice, followed by repeated intranasal 
administration of the same allergen results in development of EoE-like inflammation 
characterized by accumulation of eosinophils and upregulation of Th2 responses in the 
esophagus. We demonstrate that the IL-33-ST2 axis and basophils are critical for this process. 
We observed elevated IL1RL1/ST2 gene expression in esophageal biopsies from EoE patients, 
substantiating the importance of the IL-33-ST2 axis in EoE. Together, these data suggest 
that the IL-33-ST2-basophil axis contributes to the pathogenesis of EoE and could be a new 
therapeutic target for the treatment of EoE.
5.3 Methods 
5.3.1 Mice
BALB/c mice were purchased from Taconic. St2-/- mice (generated by Dr. Andrew McKenzie, 
Cambridge, United Kingdom) backcrossed onto the BALB/c background were a gift from Dr. 
Dale Umetsu (Boston Children’s Hospital, currently at Genentech). BALB/c ft/ft mice with the 
matted hair mutation removed were previously described (Oyoshi et al., 2015). BALB/c ft/ft 
mice were subsequently crossed onto BALB/c St2-/- background to generate ft/ft.St2-/- mice. 
Mcpt8DTR mice (Egawa et al., 2013) were backcrossed onto the BALB/c background. All mice 
were bred in the animal facility of BCH, and kept in a specific pathogen-free environment and 
fed an OVA-free diet. All procedures were performed in accordance with the Animal Care and 
Use Committee of Boston Children’s Hospital.  
5.3.2 Allergen sensitization
Epicutaneous sensitization of mice was performed as previously described (Nakajima et 
al., 2012; Spergel et al., 1998) with modification. The dorsal skin of anesthetized four to six-
week-old female mice was shaved and tape-stripped six times with Tegaderm (Westnet Inc.). 
Then 100 µg OVA (Grade V; Sigma) in 100 µl of normal saline, or placebo (100 µl of normal 
saline), was placed on a patch of sterile gauze (1x1 cm), which was secured to the dorsal skin 
with Tegaderm. Each mouse had a total of three one-day exposures to the patch separated 
by two-day intervals. Forty-eight hours after the last sensitization, mice were intranasally 
challenged with 3 mg OVA every other day for 5 days (see Figure  5.1A). The dorsal skin of 
ft/ft mice was shaved and rested for two days for recovery from any injury by shaving. Then 
OVA or saline was applied in a regimen involving two cycles of daily exposure to OVA for 5 
consecutive days prior to allergen challenge (Figure 5.4A). For some experiments, animals 
were treated intravenously with 40 µg of neutralizing anti-ST2 mAb or rat IgG2a isotype
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Figure 5.1. Epicutaneous sensitization predisposes to development of experimental EoE.  (A) Experimental 
plan. (B) Representative H&E stained sections of esophagus. Arrows indicate eosinophils. Magnification, 400X; 
inset, 800X. Scale bars: 100 µm. (C) Number of eosinophils per mm2. (D-F) Representative flow cytometry analysis 
(D), frequencies (E), and numbers (F) of eosinophils in the esophagus. (G) mRNA expression of Th2 cytokines, 
Ccl11/eotaxin-1, and Tslp as fold induction relative to saline controls. n = 5-7 per group in C and G. Percentages of 
eosinophils within live, CD45+lin- cells are shown in D. EC: epicutaneous. *P < .05, **P < .01 and ***P < .001. 
control (Biolegend). Mice were euthanized 24 hours aft er the last intranasal challenge to 
harvest tissues. For basophil depletion by diphtheria toxin (DT), Mcpt8DTR mice (Egawa et al., 
2013) were treated with 500 ng DT (List Biological Laboratory) intraperitoneally. 
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5.3.3 Bone marrow (BM) chimeras
BM chimeras were generated as described previously (Jin et al., 2009).
5.3.4 Adoptive transfer of basophils
Bone-marrow-derived basophils were grown in the presence of recombinant mouse IL-3 
(Peprotech) for 9 to 14 days as previously described (Siracusa et al., 2011). Basophils were 
FACS sorted and 3x105 cells were intraveneously injected into DT-treated Mcpt8DTR mice.
5.3.5 Histological analysis
Multiple 4 µm sections of mid-esophagus were stained with hematoxylin and eosin (H&E). 
Eosinophils were counted in a blinded fashion in 5-10 different randomly chosen high-power 
fields (HPFs) at a magnification of 400X. 
5.3.6 Flow cytometry
Esophageal tissue of mice was opened longitudinally, digested in 1 mg/ml collagenase 
(Worthington Biochemical) and 20 µg/ml DNase (Sigma) for 30 minutes, and mashed through 
70 µm nylon mesh filters as previously described (Noti et al., 2013). Single-cell suspensions 
were incubated with Fixable Viability Dye (eBioscience) for dead cell exclusion and stained 
with fluorochrome-conjugated mAbs for Siglec-F, IgE, c-kit, CD3, CD11c, CD19, CD45, CD49b, 
NKp46 (purchased from Biolegend, BD Biosciences, or eBioscience). Mouse eosinophils were 
identified as live, CD45+lin(CD3, CD19, CD11c, NKp46)-Siglec-F+ side-scatter (SSC)high cells. 
Mouse basophils were identified as live, CD45+lin-c-kit-CD49b+IgE+ cells. 
5.3.7 Quantitative PCR analysis
Total RNA was extracted from homogenized mid-esophageal tissue and quantitative real-
time PCR was performed as described previously (Oyoshi et al., 2011).
5.3.8 Serum antibody measurement
These assays were performed as described previously (Oyoshi et al., 2011). 
5.3.9 Gene expression analysis in esophageal biopsies of human subjects
All patients of this study are part of a longitudinal cohort study at Boston Children’s Hospital, 
which is approved by the Institutional Investigational Review Board. The subset of patients 
studied in this paper has been previously described (Lexmond et al., 2014) and includes pediatric 
patients between 2-17 years with either EoE (defined as ≥15 eosinophils per high-power field 
in at least one esophageal biopsy under proton pump inhibitor treatment) or normal tissue 
histology as determined by routine pathological examination. RNA was isolated from biopsies 
taken from the distal esophagus (defined as ~2 cm from the gastro-esophageal junction). RNA 
processed as previously described (Lexmond et al., 2014) and quantitative RT-PCR was performed 
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using Taqman gene expression assays for IL33 and IL1RL1 (Applied Biosystems). Expression 
values were normalized against the internal housekeeping gene GAPDH using the ΔΔCt method 
in duplex assays performed in duplicate. The history of AD was determined by self-report from a 
questionnaire filled out by patients and caregivers at the time of inclusion. 
5.3.10 Statistical analysis
A Mann-Whitney’s U test was used to compare the distribution of each outcome between 
two groups. Nonparametric one-way ANOVA was used to compare three or more groups. All 
analyses were performed using the Graphpad Prism version 5.0 (Graphpad Software). 
5.4 Results 
5.4.1 Epicutaneous sensitization predisposes to development of experimental EoE
Given the potential role of skin sensitization in EoE, we tested the hypothesis that 
epicutaneous exposure to allergen results in development of EoE-like allergic inflammation 
in the murine esophagus. To achieve epicutaneous sensitization, we utilized a mouse model 
of AD-like allergic skin inflammation elicited by repeated exposure to OVA on tape-stripped 
skin (Nakajima et al., 2012; Spergel et al., 1998). BALB/c WT mice were subjected to three 
cycles of epicutaneous sensitization with OVA or saline control. Intranasal challenge with 
OVA, which results in direct exposure of the esophagus to OVA, was started two days after the 
last cycle of sensitization (Figure 5.1A). Epicutaneous sensitization with OVA resulted in the 
generation of OVA-specific IgE and IgG1 antibodies (Figure 5.S1A-B), as previously reported 
(Nakajima et al., 2012; Spergel et al., 1998). Following intranasal challenge with OVA, WT mice 
epicutaneously sensitized with OVA exhibited higher eosinophil infiltration in the esophagus 
as compared to similarly challenged WT mice epicutaneously exposed to saline, as assessed 
by histology and quantified by enumeration of eosinophils (Figure 5.1B-C), consistent 
with a previous report (Akei et al., 2005). Flow cytometry analysis also demonstrated higher 
frequencies and numbers of eosinophils in the esophagus of OVA-sensitized mice compared 
to saline-exposed mice upon OVA challenge (Figure 5.1D-F). Levels of mRNA for Il4, Il5, Il13, 
Ccl11/Eotaxin-1, and thymic stromal lymphopoietin (Tslp) were higher in the esophagus of 
OVA-sensitized mice than those of saline-exposed controls following OVA challenge (Figure 
5.1G). Importantly, eosinophil accumulation in OVA-sensitized mice was specific to the 
esophagus since eosinophilia was not observed in the stomach or the jejunum of OVA-
sensitized mice or saline controls following OVA challenge (Figure 5.S2A-B). Consistent with 
previous reports of experimental EoE (Akei et al., 2005; Mishra et al., 2001; 2008; Niranjan et al., 
2013b), intranasal challenge of OVA-sensitized mice resulted in development of eosinophilia 
in the lung in addition to the esophageal symptomatic (Figure 5.S2C). These results suggest 
that epicutaneous allergen sensitization promotes development of EoE-like inflammation.  
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Figure 5.2. The IL-33-ST2 axis mediates development of experimental EoE elicited by epicutaneous 
sensitization. (A-C). Levels of Il33 mRNA in skin (A), IL-33 in serum (B), and Il33 and St2 mRNA in the esophagus of 
WT mice (C). (D) Representative H&E stained sections of esophagus of OVA-sensitized WT and St2-/- mice. Arrows 
indicate eosinophils. Magnification, 400X; inset, 800X. Scale bars: 100 µm. (E) Number of eosinophils per mm2. (F-H) 
Representative flow cytometry analysis (F), frequencies (G), and numbers (H) of eosinophils in the esophagus. (I-J) 
Flow cytometry analysis of frequencies (I) and numbers (J) of eosinophils in the esophagus of BM chimeras. (K) mRNA 
expression of Th2 cytokines, Ccl11/eotaxin-1, and Tslp. Fold induction relative to unsensitized (A) or saline (C,K) controls 
are shown. n = 5-9 per group in C, E, and K. EC: epicutaneous. *P < .05, **P < .01 and ***P < .001. ns, not significant. 
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5.4.2 The IL-33-ST2 axis mediates development of experimental EoE elicited by 
epicutaneous sensitization
The hallmark of AD is skin barrier dysfunction, which results in dry itchy skin (Oyoshi et al., 
2009a). IL-33 is upregulated in the skin of patients with AD by external triggers including 
scratching (Savinko et al., 2012; Tamagawa-Mineoka et al., 2014). We hypothesized that the 
impaired barrier in AD skin allows allergen entry as well as the release of IL-33 that initiates a 
cascade leading to development of EoE. We therefore tested whether tape stripping of mouse 
skin, a surrogate for scratching in human AD, results in elevated IL-33 expression. Levels 
of Il33 mRNA in both OVA- and saline-sensitized skin were higher than in unstripped skin 
(Figure 5.2A). Similarly, serum levels of IL-33 were increased in OVA-sensitized and control 
mice as compared to unstripped mice (Figure 5.2B). Importantly, we observed that levels 
of Il33 and St2 mRNA were increased in the esophagus of OVA-sensitized mice than saline-
exposed controls following OVA challenge (Figure 5.2C), demonstrating a dependence 
on allergen. These observations prompted us to test the role of IL-33 in development of 
experimental EoE. We examined the response of IL-33 receptor St2-/- mice to epicutaneous 
sensitization and intranasal challenge with OVA. In contrast to WT controls, OVA-sensitized 
St2-/- mice failed to develop EoE-like inflammation, as indicated by a decrease in esophageal 
eosinophil accumulation (Figure 5.2D-H). To determine the contribution of ST2 expression 
on non-hematopoietic cells versus hematopoietic cells in eosinophil accumulation in the 
esophagus, we generated reciprocal BM chimeras using WT and St2-/- mice (Fig. 2I,J). Lethally 
irradiated WT or St2-/- recipients reconstituted with WT BM showed comparable increases in 
esophageal eosinophil accumulation irrespective of the ST2 sufficiency of the recipients 
(Figure 5.2I-J). Conversely, esophageal eosinophil accumulation was comparable in WT or 
St2-/- recipients reconstituted with St2-/- BM and significantly lower as compared to those in 
WT or St2-/- recipients of WT BM (Figure 5.2I-J). These data suggest that ST2 expression on 
hematopoietic cells plays a key role in development of AD-associated experimental EoE. 
  OVA-sensitized St2-/- mice showed lower levels of cytokine mRNA in the esophagus upon 
OVA challenge (Figure 5.2K). This was not due to an impaired systemic cytokine response 
to OVA, given that OVA-specific antibody concentrations in St2-/- mice as well as Th2 and Th1 
cytokine secretion by St2-/- splenocytes in vitro stimulated with OVA were comparable to 
those in WT controls (Figure 5.S3), consistent with previous reports on Il33-/- mice (Morita et 
al., 2015). As an alternative approach to abrogating the IL-33-ST2 signaling, we intravenously 
treated WT mice with a monoclonal antibody (mAb) that neutralizes ST2 during epicutaneous 
sensitization with OVA (Figure 5.3A). Multiple systemic treatments of WT mice with anti-ST2 
mAb resulted in a decrease in eosinophil accumulation in the esophagus after OVA challenge 
(Figure 5.3B-F). Treatment with anti-ST2 mAb also limited levels of Il4, Il5, Il13, and Ccl11 
mRNA in the esophagus, but not Tslp (Figure 5.3G). Collectively, these data support our 
hypothesis that the IL-33-ST2 interactions are required for development of experimental EoE. 
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Figure 5.3. Blockade of the IL-33-ST2 responses attenuates development of experimental EoE. 
(A) Experimental plan. (B) Representative H&E stained sections of esophagus. Arrows indicate eosinophils. 
Magnification, 400X; inset, 800X. Scale bars: 100 µm. (C) Number of eosinophils per mm2. (D-F) Representative flow 
cytometry analysis (D), frequencies (E), and numbers (F) of eosinophils in the esophagus. (G) mRNA expression of 
Th2 cytokines, Ccl11/eotaxin-1, and Tslp as fold induction relative to saline controls treated with isotype control. n = 
5-6 per group in C and G. EC: epicutaneous. *P < .05, and **P < .01. ns, not significant.
5.4.3 FLG deficiency promotes IL-33-mediated esophageal eosinophil accumulation
Carriers of FLG mutations have an increased risk for multiple allergic disorders including EoE 
(Blanchard et al., 2010; Irvine et al., 2011). ft /ft  mice carry a 5303delA frame shift  mutation in 
the FLG gene (Fallon et al., 2009; Lane, 1972) and exhibit skin barrier dysfunction (Moniaga et 
al., 2010). To test whether FLG deficiency predisposes to development of EoE, ft /ft  mice were 
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topically sensitized with OVA or saline on unstripped skin over a 2-week period, then intranasally 
challenged with OVA (Figure 5.4A). ft /ft  mice topically sensitized with OVA developed more 
intense esophageal eosinophil accumulation as compared to ft /ft  mice topically exposed to saline 
or WT controls sensitized with OVA (Figure 5.4B-D). Eosinophil accumulation was minimal in WT 
mice topically sensitized with OVA or saline (Figure 5.4B-D), consistent with our previous reports 
that mechanical injury by tape stripping is a prerequisite for induction of allergic skin sensitization 
in WT mice (Oyoshi et al., 2015; 2009b). We next examined whether the IL-33-ST2 axis contributes 
to the increased susceptibility of ft /ft  mice to esophageal eosinophil accumulation. To this end, 
we bred the ft /ft  genotype onto the St2 null background and examined the responses to topical 
sensitization and challenge with OVA. ft /ft .St2-/- mice topically sensitized with OVA exhibited less 
esophageal eosinophil accumulation compared to OVA-sensitized ft /ft  controls (Figure 5.4E-
G). The results obtained in ft /ft  mice reinforce the concept that cutaneous sensitization via an 
impaired skin barrier predisposes to EoE and this is critically regulated via the IL-33-ST2 axis.  
Figure 5.4. FLG deficiency promotes IL-33-mediated esophageal eosinophil accumulation. (A) Experimental 
plan. Representative flow cytometry analysis (B), frequencies (C), and numbers (D) of eosinophils in the esophagus 
of WT or ft /ft  mice. Representative flow cytometry analysis (E), frequencies (F), and numbers (G) of eosinophils in the 
esophagus of ft /ft  or ft /ft .St2-/- mice. *P < .05, and **P < .01. ns, not significant.
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5.4.4 Basophils are required for development of experimental EoE
TSLP-induced basophil responses have been implicated in experimental EoE and in 
EoE patients (Noti et al., 2013), highlighting the role of basophils in the pathogenesis of 
EoE. We examined the role of basophils in mediating EoE-like inflammation elicited by 
epicutaneous allergen sensitization. Flow cytometry analysis revealed that OVA-sensitized 
WT mice exhibited higher accumulations of basophils in the esophagus compared 
to saline-exposed controls following OVA challenge (Figure 5.5A-C). To test whether 
basophils promote development of EoE-like inflammation, we used a genetic approach 
in which lineage-specific expression of the diphtheria toxin receptor gene allows selective 
basophil depletion by DT treatment (Egawa et al., 2013).  Mcpt8DTR mice were epicutaneously 
sensitized with OVA or saline then intranasally challenged with OVA while being treated 
with DT or PBS (Figure 5.5D). OVA-sensitized Mcpt8DTR mice treated with PBS exhibited 
higher eosinophil accumulation and upregulation of Th2 cytokines in the esophagus 
(Figure 5.5E-J) as compared to saline-exposed Mcpt8DTR controls. Interestingly, depletion 
of basophils in OVA-sensitized Mcpt8DTR mice decreased these features as compared to OVA-
sensitized Mcpt8DTR mice treated with PBS (Figure 5.5E-J). Mcpt8DTR mice treated with DT 
exhibited no signs of hypersensitivity to DT (data not shown). The decrease in esophageal 
eosinophilia in OVA-sensitized Mcpt8DTR mice treated with DT was likely due to depletion of 
basophils, but not mast cells, as injection of DT into Mcpt8DTR mice resulted in > 97% loss 
of basophils in the skin with no deleterious effects on mast cells (Figure 5.S4A) (Wada 
et al., 2010). Furthermore, OVA-sensitized mast cell-deficient KitW-sh/W-sh mice exhibited 
comparable levels of esophageal eosinophil accumulation to WT controls after OVA 
challenge (Figure 5.S4B-C), suggesting that mast cells unlikely account for development 
of esophageal eosinophilia in our model. This is consistent with a previous observation 
that development of esophageal eosinophilia is independent of mast cells (Niranjan et al., 
2013a) based on experiments in mast cell-deficient WWv mice. These results indicate that 
basophils are required for the pathogenesis of EoE-like inflammation.
5.4.5 Basophils mediate experimental EoE through the IL-33-ST2 interactions
IL-33 activates mouse and human basophils (Pecaric-Petkovic et al., 2009; Schneider et al., 
2009). Flow cytometry analysis revealed ST2 expression on basophils in the esophagus of 
OVA- and saline-sensitized mice (Figure 5.6A). Given that the IL-33-ST2 axis, basophils, and 
ST2 expression on hematopoietic cells play a key role in development of experimental EoE, 
we sought to test whether basophils promote experimental EoE in an IL-33-ST2 dependent 
manner. To this purpose, basophils were expanded from BM of WT and St2-/- mice in the 
presence of IL-3 in vitro, FACS sorted, then intraveneously injected into Mcpt8DTR mice while 
being sensitized with OVA and treated with DT (Figure 5.6B). Adoptive transfer of WT 
basophils restored esophageal eosinophil accumulation in basophil-depleted Mcpt8DTR 
recipients sensitized with OVA following OVA challenge (Figure 5.6C-G). In contrast, adoptive 
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Figure 5.5. Basophils are required for development of experimental EoE. Representative flow cytometry 
analysis (A), frequencies (B), and numbers (C) of basophils in the esophagus. (D) Experimental plan. (E) Representative 
H&E stained sections of esophagus. Arrows indicate eosinophils. Magnification, 400X; inset, 800X. Scale bars: 100 µm. 
(F) Number of eosinophils per mm2. Representative flow cytometry analysis (G), frequencies (H), and numbers (I) 
of eosinophils in the esophagus. (J) mRNA expression of Th2 cytokines, Ccl11/eotaxin-1, and Tslp as fold induction 
relative to saline-exposed Mcpt8DTR mice treated with PBS. n = 5 per group in F and J. EC: epicutaneous. Percentages 
of basophils within live, CD45+lin-c-kit- cells are shown in A. *P < .05, and ***P < .001.
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Figure 5.6. Basophils mediate experimental EoE through the IL-33-ST2 interactions. (A) Representative flow 
cytometry analysis of basophils in the esophagus for ST2 expression. (B) Experimental plan. (C) Representative H&E 
stained sections of esophagus. Arrows indicate eosinophils. Magnification, 400X; inset, 800X. Scale bars: 100 µm. (D) 
Number of eosinophils per mm2. Representative flow cytometry analysis (E), frequencies (F), and numbers (G) of 
eosinophils in the esophagus. Frequencies (H), and numbers (I) of basophils in the esophagus. n = 3 per group in C. 
EC: epicutaneous. *P < .05. ns, not significant.
Allergic skin sensitization and onset of EoE
105
Ch
ap
te
r 5
transfer of St2-/- basophils failed to elicit esophageal eosinophil accumulation in basophil-
depleted OVA-sensitized Mcpt8DTR recipients (Figure 5.6C-G). Adoptive transfer of WT 
basophils into basophil-depleted mice resulted in an increase in basophil accumulation in 
the esophagus (Figure 5.6H-I). In contrast, basophil-depleted mice reconstituted with St2-
/- basophils showed significantly lower numbers of esophageal basophils, comparable to 
minimal basophil influx in basophil-depleted mice without basophil reconstitution (Figure 
5.6H-I). These results suggest that failure of St2-/- basophils to restore esophageal eosinophil 
accumulation is likely due to an inability of St2-/- basophils to home to the esophagus, 
consistent with previous reports that IL-33-ST2 axis promotes migration of basophils (Pecaric-
Petkovic et al., 2009; Suzukawa et al., 2008). These results indicate that basophils are key 
cellular mediators of IL-33-ST2 mediated experimental EoE.  
Figure 5.7. EoE patients have elevated esophageal expression of IL1RL1/ST2 mRNA. Expression of IL33 (A) 
and IL1RL1/ST2 (B) in esophageal biopsies from normal controls and EoE patients. Expression of IL33 (C) and IL1RL1/
ST2 (D) in esophageal biopsies from normal controls and EoE patients with and without AD. A and C, B and D use the 
same data, respectively. ***P < .001. ns, not significant. 
5.4.6 EoE patients have elevated esophageal expression of IL1RL1/ST2 mRNA
Since the IL-33-ST2 axis critically contributes to the pathogenesis of experimental EoE in our 
model, we assessed the expression of IL33 and IL1RL1 (encoding ST2) in esophageal tissue 
biopsies obtained from pediatric patients (average age 8.0 years, ranging from 2-17) who were 
undergoing diagnostic endoscopy for suspected EoE. None of the patients had used systemic 
steroids in the six months prior to inclusion. Quantitative PCR analysis revealed that levels of 
IL33 mRNA were comparable in EoE patients and controls, regardless of AD history (Figure 
5.7A,C). However, expression of IL1RL1/ST2 was significantly increased in EoE patients (Figure 
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5.7B). EoE patients who reported a history of AD demonstrated a higher average expression of 
IL1RL1/ST2 compared to those who did not suffer from AD (Figure 5.7D). No differences in mRNA 
expression of IL1RL1/ST2 were detected in esophageal biopsies from control subjects with and 
without AD (Figure 5.7D). Fifteen patients in this cohort reported a history of AD and only three 
EoE patients reported rash in the past six months (data not shown). Peak esophageal eosinophil 
counts were significantly higher in EoE patients with AD compared to those without AD (Table 
5.1). There was a positive correlation between peak esophageal eosinophil counts and ST2 
mRNA levels (r=0.30, p=0.21)(Figure 5.S5). It is likely that significance of this positive correlation 
was not reached because of the rather small patient numbers. These data demonstrate that 
elevated IL1RL1/ST2 gene expression is associated with EoE in a pediatric cohort and further 
support the concept that the IL-33-ST2 axis contributes to the EoE pathogenesis.
Table 5.1. Characteristics of EoE patients. *Statistical significance of continuous variables was compared using a 
non-parametric Mann-Whitney U test. Dichotomous data was analyzed using Fisher’s exact test. 
None of the patients had used systemic steroids in the 6 months prior to inclusion.
Parameter EoE without AD EoE with AD p-value*
N 8 13 n/a
Age (median, range) 6.1 (3.8 – 13.9) 5.3 (2.2 – 17.7) 0.69
Male sex 7 (88%) 9 (69%) 0.61
Asthma 1 (13%) 3 (23%) 1.0
Seasonal allergy 5 (63%) 10 (77%) 0.63
Food allergy 3 (38%) 10 (77%) 0.16
Peak eosinophil count/hpf (median, range) 27.5 (15-100) 80 (25-150) 0.03
5.5 Discussion
In this study we demonstrate that allergic sensitization via a disrupted skin barrier promotes 
development of experimental EoE that is critically mediated by the IL-33-ST2 axis and 
basophils. The importance of the IL-33-ST2 axis in EoE was corroborated by our findings of 
elevated ST2 gene expression in human EoE. 
  The experimental murine EoE model used in our study shows several key features 
that parallel human EoE, validating our approach. Mice epicutaneously sensitized with 
OVA exhibited eosinophil accumulation and upregulation of Th2 cytokines and Tslp in the 
esophagus after intranasal OVA challenge, as shown in human EoE (Blanchard et al., 2011; 
Rothenberg et al., 2010). In addition, OVA-sensitized mice had an increase in esophageal 
accumulation of basophils, mast cells, and ILC2s (data not shown), which have been shown 
to be enriched in human EoE (Abonia et al., 2010; Doherty et al., 2015; Noti et al., 2013). Unlike 
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another model of EoE elicited by epicutaneous allergen sensitization with the vitamin D analog 
MC903 (Noti et al., 2013), the mouse models we have used had no change in eosinophilia in 
the stomach or in the jejunum, consistent with the observations that EoE patients exhibit 
eosinophilia limited to the esophagus within the gastrointestinal tract (Spergel et al., 2009). 
Intranasal administration of allergen resulted in development of lung eosinophilia in our model, 
consistent with previous models of EoE (Akei et al., 2005; Mishra et al., 2001; 2008; Niranjan et 
al., 2013b). This is in line with the observations that EoE is frequently associated with asthma 
(Greenhawt et al., 2013; Spergel et al., 2009) and that aeroallergens exacerbate EoE (Ram et al., 
2015), suggesting a link between EoE and respiratory allergy. Our model is physiologic in that it is 
adjuvant free and employs a portal of exposure (the skin) that is important for EoE development. 
Collectively, our results indicate that allergen sensitization via a disrupted skin barrier predisposes 
to development of allergic esophageal inflammation upon encountering the same allergen, 
supporting the hypothesis that impaired skin barrier in AD allows allergen sensitization that leads 
to development of EoE (Oyoshi, 2015; Oyoshi et al., 2014). 
  Mechanical skin injury caused by tape stripping induced IL-33 in mouse skin, consistent 
with previous reports in mice and humans (Dickel et al., 2010; Morita et al., 2015). The link 
between IL-33 upregulation and a disrupted skin barrier is also supported by elevated IL-33 
expression in ft/ft skin (Savinko et al., 2012). The mechanisms by which tape stripping induces 
IL-33 in skin and systemic circulation may include a release of IL-33 from the nucleus into the 
extracellular environment from necrotic cells during tissue damage (Molofsky et al., 2015). 
Levels of Il33 mRNA were upregulated in the esophagus of OVA-sensitized mice, consistent 
with previous findings in human EoE (Judd et al., 2016). A recent genome-wide association 
study has identified genetic variants at the IL33 locus (Kottyan et al., 2014), also associated 
with allergic sensitization (Bønnelykke et al., 2013; Hinds et al., 2013), accentuating the 
importance of IL-33 in both EoE and allergic sensitization. Indeed, we demonstrate that the 
IL-33-ST2 axis is critical in development of experimental EoE, as EoE features were attenuated 
in St2-/- mice or in WT mice treated with anti-ST2 antibodies. Comparable allergen-specific 
systemic responses in St2-/- mice and WT controls suggest that the IL-33-ST2 interactions 
in the esophagus underlie the decreased susceptibility of St2-/- mice to EoE. One possible 
explanation for the presence of local allergic inflammation in WT mice, but not in St2-/- mice, 
could be increased esophageal expression of IL-33 that promotes cytokine production by 
infiltrating basophils, Th2 cells, mast cells, and/or ILC2s via ST2. Increased local expression 
of TSLP could also amplify Th2 responses (Han et al., 2014; He et al., 2008; Oyoshi et al., 
2010; Ziegler, 2012). This is in line with the hypothesis that allergen sensitization followed by 
esophagus-specific responses may drive EoE (Oyoshi, 2015; Rothenberg, 2015). 
  Cutaneous allergen sensitization in ft/ft mice mimics skin exposure to environmental 
antigens in patients with AD (Oyoshi et al., 2009b; Scharschmidt et al., 2009). We demonstrate 
that allergen sensitization through an impaired skin barrier due to congenital FLG deficiency 
in ft/ft mice induces EoE features. The increased susceptibility of ft/ft mice to experimental EoE 
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is consistent with the association of FLG mutations with human EoE (Blanchard et al., 2010). 
We further verified the critical role of IL-33 in promoting EoE in ft/ft mice, as OVA-sensitized 
ft/ft.St2-/- mice showed an decrease in esophageal eosinophil accumulation, supporting our 
hypothesis that IL-33 produced by epithelial cells is an important cofactor in development of 
EoE by potentiating allergic inflammation to cutaneously introduced allergens. Expression of 
filaggrin is downregulated in esophageal tissues of EoE patients (Blanchard et al., 2010; Simon 
et al., 2015). Impaired esophageal barrier function in EoE may allow allergen penetration and 
exaggeration of esophageal inflammation. Analysis of differential contribution of barrier 
abnormalities in skin and in esophagus to the pathogenesis of EoE is an important future 
question to be addressed. 
  TSLP and basophils have been implicated in promoting Th2 responses and 
development of EoE (Giacomin et al., 2012; Kottyan et al., 2014; Noti et al., 2013; Rothenberg 
et al., 2010; Siracusa et al., 2011; Sleiman et al., 2014), however, the capacity of Tslpr-/- 
basophils in promoting EoE has not been directly examined. Experimental EoE in our 
model was attenuated in basophil-depleted mice, consistent with a previous report (Noti 
et al., 2013). Our findings that WT, but not St2-/-, basophils restored esophageal eosinophil 
accumulation in basophil-depleted mice indicate that basophils are the critical source of IL-
33-mediated EoE. These findings may also apply to human EoE because basophil responses 
and IL-33 levels are increased in patients with EoE (Noti et al., 2013; Simon et al., 2015). Our 
data suggest that ST2-mediated migration of basophils to the esophagus (Pecaric-Petkovic 
et al., 2009; Suzukawa et al., 2008) likely accounts for development of EoE, however, further 
mechanisms by which basophils promote EoE in this model remain elusive. IL-33 directly 
activates basophils via ST2 (Pecaric-Petkovic et al., 2009; Suzukawa et al., 2008). IL-33 also 
influences dendritic cells (DCs) and promotes allergic skin sensitization and Th2 response 
in mouse models of food allergy (Han et al., 2014; Tordesillas et al., 2014). Recent studies 
have suggested that DCs and basophils cooperate to promote Th2 responses (Han et al., 
2014; Leyva-Castillo et al., 2013; Tang et al., 2010). It is possible that IL-33 primes DCs for Th2 
responses and activation of local innate immune responses to secrete Th2 cytokines for 
further recruitment of basophils. ILC2s are enriched in skin lesions from patients with AD and 
EoE, and respond to stimulation with IL-33, resulting in secretion of Th2 cytokines (Doherty 
et al., 2015; Kim et al., 2013; Salimi et al., 2013). IL-33-primed basophils may also interact 
with ILC2s to promote Th2 responses (Kim et al., 2014; Motomura et al., 2014) and regulate 
eosinophil recruitment to the tissue (Nakashima et al., 2014). The contribution of ILC2s 
together with innate and adaptive immune pathways to development of EoE requires future 
investigations. Consistent with a previous report (Noti et al., 2013), esophageal eosinophilia 
was significantly decreased in OVA-sensitized Tslpr-/- mice (data not shown), suggesting that 
TSLP also plays a key role in our EoE model. We previously reported that TSLP is induced 
in skin by tape stripping (Oyoshi et al., 2010) and induce allergic skin inflammation (He et 
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al., 2008). Whether TSLP and IL-33 synergistically or differently regulate basophils and other 
immune cells in promoting EoE will be an important subject to be addressed in future.
  Levels of St2 gene expression were increased in the esophagus of mice and this was 
associated with eosinophil accumulation and Th2 responses. The importance of the IL-33-
ST2 axis in the pathogenesis of EoE was strongly corroborated by the increased expression of 
IL1RL1/ST2 gene in esophageal biopsies from EoE patients, but not in control biopsies. Peak 
median esophageal eosinophil counts were significantly higher in EoE patients with AD than 
in EoE patients without AD, potentially implying a more severe EoE phenotype may affect 
EoE patients with AD. The obvious trend towards elevated IL1RL1/ST2 gene expression in EoE 
patients with AD as compared to those in EoE patients without AD supports our concept of 
the IL-33-ST2 axis mediating the pathogenesis of AD-associated EoE, although the difference 
in mRNA levels did not reach statistical significance in the patient population analyzed in 
this study. The positive correlation of peak esophageal eosinophil counts with ST2 mRNA 
levels suggests that higher infiltration in the esophagus of EoE patients by ST2 expressing 
cells including eosinophils, basophils, mast cells, ILC2s, and Th2 cells may contribute to 
the increased ST2 expression at these sites. Future study with a larger patient cohort and 
clinically diagnosed atopic dermatitis rather than self-reported disease is needed to confirm 
the correlation between the disease severity and ST2 expression levels.  Levels of IL-33 mRNA 
were comparable in esophageal biopsies from control and EoE subjects unlike the previous 
report (Judd et al., 2016). The reason for the discrepancy is not clear. It could possibly reflect 
instabilities of cytokine mRNA during the sampling process and/or elevated IL-33 protein 
levels in EoE biopsies (Simon et al., 2015). 
  Taken together, we demonstrate that skin barrier dysfunction in AD caused by 
mechanical injury secondary to scratching or due to FLG deficiency plays a key role in 
allergen sensitization and promotes the progression to EoE. Our study endorses the 
paradigm that allergic skin sensitization and basophils play a key role in the pathogenesis 
of EoE and adds new insights into currently underinvestigated role of the IL-33-ST2 axis to 
the pathophysiology of EoE, leading to a better understanding of mechanisms whereby 
epicutaneous sensitization promotes EoE. Our findings are novel as we demonstrate the 
fundamental role of IL-33 in EoE by blocking IL-33 pathway with two independent models 
of experimental EoE as well as anti-ST2 neutralizing antibodies. We have directly proven 
impaired ability of St2-/- basophils to elicit esophageal eosinophil accumulation. Our data 
using filaggrin-deficient mice provide further experimental support for the epidemiologic 
findings that filaggrin deficiency predisposes to EoE. In conclusion, this work has important 
implications for the development of new therapeutic strategies since neutralization of IL-33 
and/or blockade of ST2 might be an effective target for EoE. 
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5.7 Supplemental data
Figure 5.S1. Allergen-specific systemic immune responses in epicutaneously sensitized mice. Serum levels 
of OVA-specific IgE (A) and IgG1 (B) in WT mice EC sensitized with OVA or saline. EC: epicutaneous. n = 7-10. **P < .01, 
***P < .001. 
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Figure 5.S2. Analysis of tissue eosinophilia in epicutaneously sensitized mice. Flow cytometry analysis of 
frequencies and numbers of eosinophils in the stomach (A), the jejunum (B), and the lung (C). EC: epicutaneous. ns, 
not significant.
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Figure 5.S3. Allergen-specific systemic immune responses in epicutaneously sensitized St2-/- mice. Serum 
levels of OVA-specific IgE (A) and IgG1 (B) in WT or St2-/- mice with OVA. (C) Cytokine production by splenocytes in vitro 
stimulated with OVA. n = 5-10 per group. EC: epicutaneous. ns, not significant.
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Figure 5.S4. Development of esophageal eosinophil accumulation is independent of mast cells. (A) 
Frequencies and numbers of mast cells and basophils in the skin of Mcpt8DTR mice 3 days aft er DT injection. Flow 
cytometry analysis of frequencies (B) and numbers (C) of eosinophils in the esophagus of OVA-sensitized KitW-sh/W-sh 
mice following OVA challenge.
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Figure 5.S5. Correlation analysis of peak esophageal eosinophil counts and IL1RL1/ST2 mRNA expression 
levels in esophageal biopsies from EoE patients.  Pearson’s r=0.30. p=0.21.
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6.1 Abstract
Mice reconstituted with a human immune system provide a tractable in vivo model to 
assess human immune cell function. To date, reconstitution of murine strains with human 
hematopoietic stem cells (HSCs) from patients with monogenic immune disorders have 
not been reported. One obstacle precluding the development of immune-disease specific 
“humanized” mice is that optimal adaptive immune responses in current strains have required 
implantation of autologous human thymic tissue. To address this issue, we developed a 
mouse strain that lacks murine major histocompatibility complex class II (MHCII) and instead 
expresses human MHCII DR1. These mice displayed improved adaptive immune responses 
when reconstituted with human HSCs including enhanced T cell reconstitution, delayed-
type hypersensitivity responses, and class-switch recombination. Following immune 
reconstitution of this novel strain with HSCs from a patient with immune dysregulation, 
polyendocrinopathy, enteropathy, X-linked (IPEX) syndrome, associated with aberrant FOXP3 
function, mice developed a lethal inflammatory disorder with multi-organ involvement and 
autoantibody production mimicking the pathology seen in affected humans. This humanized 
mouse model permits in vivo evaluation of immune responses associated with genetically 
altered HSCs, including primary immunodeficiencies, and should facilitate the study of 
human immune pathobiology and the development of targeted therapeutics.
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6.2 Introduction
Studies in mice have offered significant insight into the pathogenesis of human diseases; 
however, animal models have frequently failed to predict the efficacy and safety of novel 
therapeutics in humans (McKenzie et al., 1995; Seok et al., 2013; Suntharalingam et al., 
2006; Xu et al., 2014a). An experimental system allowing direct functional assessment of 
patient cells in vivo could serve as an invaluable intermediate step in the process of drug-
development that could increase safety while reducing overall cost of clinical trials. Over the 
past decade, advanced immunodeficient mouse models have been established to improve 
engraftment of human hematopoietic stem cells (HSCs) and leukocyte development 
facilitating in vivo mechanistic studies. Though several iterations of humanized mice have 
been described (Shultz et al., 2012) most strains combine null mutations in Prkdc or Rag 
genes with Il2rg-/- to impair de novo murine lymphocyte maturation and NK cell development 
respectively, while permitting xenogeneic thymopoiesis in the murine thymus (Melkus et al., 
2006). Transfer of human CD34+ HSCs in these mice leads to multi-lineage hematopoiesis 
with variable levels of reconstitution depending on the strain and age of recipient mice and 
the source of donor HSCs (Lepus et al., 2009; Traggiai et al., 2004). Despite robust lymphoid 
reconstitution in most models, adaptive immune responses remain incomplete in both the 
CD34+ HSC model as well as advanced models incorporating concurrently implanted human 
fetal thymic and liver tissue and autologous HSCs (BLT mice) (Ishikawa et al., 2005; Rajesh et 
al., 2010; Traggiai et al., 2004). This impediment has been postulated to result from inefficient 
CD4+ T cell selection on murine major histocompatibility complex class II (MHCII) in the 
mouse thymus (Baenziger et al., 2006). In support of this hypothesis, intravenous injection 
of human HSCs into adult NOD.Rag1-/-Il2rg-/- (NRG) mice expressing human MHCII leukocyte 
antigen (HLA)-DR4 improves CD4+ T cell development as well as B cell function (Danner et al., 
2011). One potential limitation of this model is that human CD4+ T cells can be restricted on 
either murine MHCII or HLA-DR4 molecules. 
  In this report, we developed a novel immunodeficient mouse strain lacking murine 
MHCII and instead express a human MHCII molecule to test whether adaptive immunity 
would be improved in this model. We show that these mice reconstituted with human HSCs 
exhibit adaptive immune responses and when reconstituted using HSCs from a patient 
with immune dysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX) syndrome, 
recapitulate many aspects of the patient’s disease. This humanized murine model has the 
potential to serve as a pre-clinical tool to screen therapeutic alternatives and ultimately 
facilitate precision medicine.
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6.3 Materials and methods
6.3.1 Human hematopoietic stem cell isolation and HLA typing 
Human CD34+ HSCs were obtained by positive selection using CD34 microbeads (Miltenyi 
Biotec, San Diego, CA) on healthy human cord blood. Screening for HLA-DRA*0101, HLA-
DRB*0101-matched donor samples was performed at the tissue typing laboratory of Brigham 
& Women’s Hospital using high resolution LABType SSO kits (One Lambda, Canoga Park, CA). 
The IPEX patient sample was obtained from a bone marrow aspirate with parental consent 
and approval from the IRB at Boston Children’s Hospital prior to allogeneic hematopoietic 
stem cell transplantation.
6.3.2 Human immune reconstitution 
One-day old pups were pre-conditioned using 150 rads of 137Cs source g-radiation. Pups were 
injected 5 hours later via the intrahepatic route with 3-5x104 human CD34+ HSCs in PBS.
6.3.3 Human immunophenotyping and flow cytometry
Human immunophenotyping on reconstituted mice was performed at 20 weeks of age. Cells 
were blocked in 10% rat serum then incubated with fluorochrome-conjugated antibodies for 
20’ at 4oC, washed in 2X FACS buffer, and then analyzed using a 3-laser BD FACS Canto II (BD 
Biosciences, San Jose, CA). 
6.3.4 Delayed-type hypersensitivity 
Mice were injected subcutaneously with 200 μL emulsion containing 250 μg ovalbumin (OVA) 
(Sigma-Aldrich, St. Louis, MO) and 100 μL complete Freund’s adjuvant (CFA) (Sigma-Aldrich) 
at the base of the tail. Seven days later, mice were challenged with 50 μL of 10 μgml-1 OVA 
injected into the left footpad. The right footpad was injected with 50 μL of phosphate-buffered 
saline (PBS) as a control. Footpad swelling was measured at 24 hours using a digital caliper. 
DTH was calculated as the difference in swelling between the left and the right footpad.
6.3.5 FOXP3 sequencing
A DNA fragment containing the C-terminal DNA binding domain of the FOXP3 
gene was PCR amplified using For: 5’-TAGTCCTGTCCCTGATTACCTGCCCC and Rev: 
5’-TGTGCTTGTGTGTGATTGTGTGATGAT primers, gel purified, and sequenced using a For: 
5’-GTCTGGGCTCATAGGCACAT sequencing primer. 
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6.3.5 Immunohistochemistry
Histopathology was carried out on formalin fixed paraffin embedded tissue sections stained 
with hematoxylin and eosin. Detection of human T cells was performed using an anti-human 
CD3 antibody (cat# A0452, Dako, Carpinteria, CA) while human macrophages were detected 
using anti-human CD68 (clone KP1, Dako). 
6.3.6 TCR CDR3 sequencing
Splenic human CD4+ T cells were enriched using negative selection (Miltenyi Biotec) and 
DNA isolated by ethanol precipitation following an overnight proteinase K digestion at 
56oC. Purified DNA was subjected to next generation sequencing of the CDR3 region using 
immunoSEQ (Adaptive Biotechnology, Seattle, WA) and analyzed with the immunoSEQ 
Analyzer software (Adaptive Biotechnology). 
6.3.7 Autoantibody detection
Detection of autoantibodies was performed on cryosections from lung and liver tissue of a 
non-reconstituted NSGAboDR1 mouse. Briefly, sections were warmed to room temperature 
(RT) for 5’ and fixed using pre-cooled acetone for 10’ at RT. Samples were washed 3X in PBS and 
blocked using goat serum for 30’ at RT followed by incubation with sera from individual mice 
reconstituted with either IPEX or control HSCs diluted in PBS containing 0.1% Triton X-100 
(PBST) overnight at 4oC. Sections were washed 3X for 5’ in PBST followed by an incubated 
with FITC-conjugated goat anti-human IgG (Santa Cruz Biotechnology, Dallas, Texas) for 60’ 
at RT, washed 3X for 5’ in PBST, overlaid with vectashield mounting medium containing DAPI 
(Vector Laboratories, Burlingame, CA) and detected by indirect immunofluorescence. 
6.3.8 Suppression assay
A leukocyte suspension was obtained from peripheral blood using Lympholyte (Cedarlane 
laboratories, Burlington, NC). The CD4+ T cells were enriched by negative selection (Miltenyi 
Biotec) following the manufacture’s protocol. The flow through was then subjected to CD25 
positive selection (Miltenyi Biotec) to isolate putative Treg cells. CD25-depleted allogeneic 
responder Tnaïve cells were labeled with 5 mM CFSE and 5x10
4 cells were co-cultured with or 
without an equal number of IPEX Treg or control Treg cells in the presence of 1 mg plate-bound 
aCD3 (clone: OKT3, eBiosceince) and 1 mg soluble aCD28 (clone: CD28.6, eBiosceince) in T cell 
media. After 4 days of culture, proliferation of Tnaïve cells was assessed by flow cytometry.
6.3.9 ELISAs 
Total immunoglobulins in sera of humanized mice were quantified using standard ELISA kits 
for human IgM (Bethyl Laboratories, Montgomery, TX) and human IgG (Bethyl Laboratories). 
Human IgE was measured using a capture antibody (clone: MHE-18, BioLegend) and detected 
using horseradish peroxidase-conjugated anti-human IgE (cat# A9667, Sigma-Aldrich).
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6.3.10 Statistical analysis
Statistical analysis was performed using Prism 6 (GraphPad Software, La Jolla, CA). 
6.3.11 Mice 
NOD.Cg-PrkdcscidH2-Ab1tm1Doi.Tg(HLA-DQA1,HLA-DQB1) mice were purchased from The 
Jackson Laboratory (Bar Harbor, Maine). Since these mice were hemizygous for the HLA 
transgene, inbreeding of this strain occasionally generated NOD.Cg-PrkdcscidH2-Ab1tm1Doi 
mice, which were then crossed with the NOD.Cg-PrkdcscidIl2rgtm1Wjl.Tg(HLA-DRA*0101,HLA-
DRB1*0101) strain, also purchased from The Jackson Laboratory. The resulting F1 offspring 
were inbred to generate NOD.Cg-PrkdcscidIl2rgtm1WjlH2-Ab1tm1Doi.Tg(HLA-DRA*0101,HLA-
DRB1*0101) (NSGAboDR1) mice. The H2-Ab1 mutant allele was maintained homozygous while 
the mutant Il2rg allele was maintained homozygous for females and hemizygous for males 
since it is X-linked. The HLA-DR1 transgene was maintained in a hemizygous state, allowing 
for some offspring to be negative for HLA-DR1 giving rise to NSGAbo mice used in our studies. 
The NSG mice were also purchased from The Jackson Laboratory. All mice were maintained 
in autoclaved cages with autoclaved food and water ad libitum in the specific-pathogen free 
facility at Boston Children’s Hospital. All animal experiments were approved and conducted 
according to the institutional guidelines at Boston Children’s hospital.
6.3.12 Antigen-specific immunoglobulin
Mice were immunized against OVA by injecting a 200 ml emulsion containing 250 mg OVA in 
100 ml and 100 ml CFA. After two weeks, mice administered a single immunization booster 
using a 200 ml emulsion containing 50 mg OVA in 100 ml and 100 ml incomplete Freund’s 
adjuvant. Fourteen days later, mice were bled and serum OVA-specific IgG determined by 
ELISA.
6.3.13. In vitro T cell stimulation and intracellular staining
Total splenocytes were plated at a concentration of 1x106 cells in RPMI 1640 (Life Technologies, 
Grand Island, NY) supplemented with 10% FBS, 2 mM L-glutamine (Life Technologies), 1 mM 
sodium pyruvate (Life Technologies), 100 mM non-essential amino acids (Life Technologies), 
10 mM HEPES (Life Technologies), 55 mM 2-mercaptoethanol (Life Technologies), and 100 U/
ml Penicillin/Streptomycin (Life Technologies) (hereafter referred to as T cell media). Cells 
were stimulated with stimulated with 20 ngml-1 phorbol myristate acetate (PMA) (Sigma-
Aldrich) and 1 ngml-1 ionomycin (Sigma-Aldrich) for 4 hours at 37oC in the presence of 10 
ngml-1 GolgiStop (BD Biosciences, San Jose, CA). Cells were collected and washed 2X with 
FACS buffer (PBS supplemented with 2% FBS and 0.1% NaN3). Cell surface staining for human 
TCRb (clone: IP26, BioLegend) was performed for 30’ at RT, washed 2X with FACS buffer, then 
fixed using BD Cytofix/Cytoperm (BD Biosciences) following the manufacture’s protocol. Cells 
were then stained using a cocktail of anti-human antibodies including IFNg (clone: 4S.B3, 
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BioLegend), TNF (clone: MAb11, BioLegend), IL17A (clone: BL168, BioLegend), and IL10 (clone: 
JES3-19F1, Biolegend) for 45’ at RT. Cells were washed 2X with FACS buffer and intracellular 
cytokine production detected using a 3-laser FACSCanto II (BD Biosciences) flow cytometer.
6.3.14 Quantitative real-time PCR
qPCR was performed with SYBR Green (Bio-Rad) using a CFX96 real-time PCR (Bio-Rad, 
Hercules, CA) machine on cDNA generated with the iScript cDNA kit (Bio-Rad) on 1 mg total 
RNA isolated from whole tissue homogenized in TRIzol (Life Technologies). 2 mM of each 
human target primer was used in the reaction and quantified by normalizing the cycle 
threshold (Ct) of the target gene to the Ct value of HPRT and the fold change was compared 
to a pooled human RNA control sample using the formula 2-  (Ct(target) - Ct (HPRT)).  Sequences for 
human targets are as follows: 
IFNg For: 5’-TCGGTAACTGACTTGAATGTCCA, Rev: 5’-TCGCTTCCCTGTTTTAGCTGC, 
TNF For: 5’-GAGGCCAAGCCCTGGTATG Rev: 5’-CGGGCCGATTGATCTCAGC,
IL10 For: 5’-GACTTTAAGGGTTACCTGGGTTG Rev: 5’-TCACATGCGCCTTGATGTCTG, 
IL12A For: 5’-ATGGCCCTGTGCCTTAGTAGT Rev: 5’-AGCTTTGCATTCATGGTCTTGA, 
IL17A For: 5’-TCCCACGAAATCCAGGATGC Rev: 5’-GGATGTTCAGGTTGACCATCAC, 
IL4 For: 5’-CGGCAACTTTGTCCACGGA Rev: 5’-TCTGTTACGGTCAACTCGGTG, 
IL2 For: 5’-AACTCCTGTCTTGCATTGCAC Rev: 5’-GCTCCAGTTGTAGCTGTGTTT, 
IL13 For: 5’-CCTCATGGCGCTTTTGTTGAC Rev: 5’-TCTGGTTCTGGGTGATGTTGA,
HPRT For: 5’-CCTGGCGTCGTGATTAGTGAT Rev: 5’-AGACGTTCAGTCCTGTCCATAA.
6.3.15 Autoantigen array
Antigens were spotted in triplicates onto SuperEpoxy2 slides (Arrayit, Sunnyvale, CA) with a 
robotic microarrayer (Genetix, Sunnyvale, CA) fitted with solid spotting pins. Nonspecific binding 
on microarrays was blocked with 1% bovine serum albumin, followed by incubation with serum 
samples from Control(DR1), IPEX(NSG) and IPEX(DR1) mice (1:100 dilution in blocking buffer). 
Microrrays were then washed and incubated with Cy3-conjugated goat antibody to human 
immunoglobulin G (Jackson ImmunoResearch Labs; 109-166-088) and Cy5-conjugated goat 
antibody to human immunoglobulin M (Jackson ImmunoResearch Labs; 109-176-129). Antigen 
reactivity was defined by binding to the replicates of that antigen on the microarray. Significant 
antibody response to autoantigens was determined by comparing raw reactivity observed in 
IPEX(NSG) and IPEX(DR1) to the cut-off value (mean + 2*SD) calculated in Control(DR1) group 
for all antigens; only values greater than the cut-off  were considered to be a significant antibody 
response to autoantigens in IPEX(NSG) and IPEX(DR1). Subsequently, antibody reactivity was 
normalized in IPEX(NSG) and IPEX(DR1) by taking a ratio of raw reactivity observed in IPEX(NSG) 
and IPEX(DR1) to maximum reactivity observed in IPEX(NSG) and IPEX(DR1). 
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6.3.16 Flow cytometry antibodies
mCD45 (clone: 30-F11, BioLegend), mEpCam (clone: G8.8, BioLegend) hCD45 (clone: HI30, 
BioLegend), CD3 (clone: OKT3, BioLegend), CD4 (clone:OKT4, BioLegend), CD8 (clone: 
RPA-T8, BioLegend), CD25 (clone: 3G10, Miltenyi Biotec), FOXP3 (clone: PCH101, eBioscience, 
San Diego, CA), CCR7 (clone: 150503, BD Pharmingen, San Jose, CA), CD45RA (clone: HI100, 
BD Pharmingen), CD127 (clone: A019D5, BioLegend), CD19 (clone: HIB19, BioLegend), CD38 
(clone: HB-7, BioLegend), CD27 (clone: O323, BioLegend), IgD (clone: IA6-2, BioLegend), CD14 
(clone: HCD14, BioLegend), HLA-DR (clone: L243, BioLegend), CD16 (clone:3G8, BioLegend), 
CD56 (clone: CMSSB, eBiosceince), CD11c (clone:3.9, BioLegend), CD123 (clone: 6H6, 
BioLegend), 7-AAD (BD Pharmingen), and CD107a (clone: H4A3, BD Pharmingen). 
6.3.17 NK cell cytotoxicity assay
Effector cells (PBMCs or splenocytes from immune replete NSGAboDR1 mice) were first 
stimulated with 6000 U/ml of human IL-2 for 24 hours in DMEM media (Cellgro, Manassas, 
VA) supplemented with 10% heat-inactivated fetal bovine serum (Life Technologies, Grand 
Island, NY) and 100 U/ml Penicillin/Streptomycin (Life Technologies). Lymphokine-activated 
killer cells were then co-cultured with 50,000 K562 target cells (ATCC, CCL-243) previously 
labeled with 5 mM CellTrace Violet (Life Technologies) at a ratio of 32:1 (E:T) at 37oC 5% CO2 in 
a 96-well plate. After 4 hours, cells were washed, stained, and quantified by flow cytometry.
6.4 Results 
6.4.1 NSG mice expressing human MHC Class II permit enhanced T cell development
To investigate whether human CD4+ T cells can be positively selected and also promote 
adaptive immune responses in mice that express human MHCII in the absence of murine 
MHCII, we generated NOD.PrkdcscidIl2rg-/-H2-Ab1-/- (NSGAbo) mice harboring a human HLA-
DR1*0101 transgene (NSGAboDR1) under the control of the murine MHCII promoter. We first 
confirmed cell surface expression of HLA-DR1 on murine thymic epithelium and splenic 
antigen presenting cells (APCs) (Figure 6.S1). Next, CD34+ cord blood human HSCs were 
obtained from a healthy HLA-DR1*0101 positive donor and injected intrahepatically into 
radiation-conditioned 1-day old NOD.PrkdcscidIl2rg-/- (NSG), NSGAbo, and NSGAboDR1 pups. 
Human leukocyte chimerism at 20 weeks was found to be equivalent among the three 
strains in peripheral blood, spleen, and bone marrow (Figure 6.1A). Immunophenotyping of 
human leukocytes isolated from recipient strains revealed a slight but statistically significant 
increase in the proportion of T cells and monocytes with a concomitant/relative decrease 
in the proportion of B cells in NSGAboDR1 mice compared to NSG and NSGAbo mice (Figure 
6.1B and Table 6.S1). There was a trend towards fewer CD4+ T cells in the thymus of NSGAbo 
mice suggesting a requirement for either murine or human class II expression for proper 
Autoimmunity in humanized mice
127
Ch
ap
te
r 6
development of human CD4+ T cells (Figure 6.1C). Further evaluation of the specific subtypes 
of CD4+ and CD8+ splenocytes in NSGAboDR1 mice demonstrated no significant difference 
in the proportion of naïve, effector, effector memory or central memory cells compared 
to the other strains (Table 6.S1). Most of the CD4+ and CD8+ T cells from NSGAboDR1 mice 
were CD45RA-CD45RO+ (data not shown). Interestingly, the relative frequencies of thymic 
regulatory T cells (Tregs) was slightly elevated in NSGAboDR1 mice and may reflect higher 
avidity between human T cell receptor (TCR) and HLA-DR1 (Figure 6.1C). T cells isolated 
from all reconstituted strains were equally adept in their ability to produce human cytokines 
in vitro following TCR-independent stimulation (Figure 6.S2). 
6.4.2 NSGAboDR1 mice develop delayed-type hypersensitivity
Although there was no obvious difference in thymic selection or the development of 
the CD4+ T compartment when HLA-DR1 was expressed, we hypothesized that the 
TCR repertoire might exhibit improved diversity that would improve T cell function. 
Development of a diverse population of antigen-specific T cells requires rearrangement 
of germline-encoded TCR gene segments (Alt et al., 1992) and is largely mediated by the 
complementarity determining region 3 (CDR3) within variable (V) gene segments of the 
TCRb (TRB) genes (Jung and Alt, 2004). To assess if human CD4+ T cell selection on HLA-DR1 
modulates T cell clonotype diversity, we profiled the CDR3 region of TRB on splenic CD4+ 
T cells in reconstituted mice using high throughput next-generation sequencing (Freeman 
et al., 2009). A high degree of combinatorial diversity in V gene segment usage was readily 
observed in splenic CD4+ T cells isolated from either NSGAboDR1 or NSG mice with the CDR3 
length following standard Gaussian distribution in both strains (Figure 6.1D-E).  A few T 
cell clonotypes were overrepresented in each of the reconstituted strains but the NSG mice 
exhibited a higher degree of clonality compared to NSGAboDR1 mice (Figure 6.1F). This 
diversity was achieved in the absence of exogenous interleukin-7 (IL7), similar to a previous 
report in mice reconstituted as neonates (Marodon et al., 2009). Although NSGAboDR1 CD4+ 
displayed a greater frequency of unique clonotype sequences in the periphery compared to 
NSG mice (Table 6.S2), the normalized TCR diversity index was similar between NSGAboDR1 
and NSG mice (Figure 6.1D). These data indicate that selection of human CD4+ T cells 
on HLA-DR1 does not alter TCR diversity relative to NSG mice but exhibits reduced T cell 
oligoclonality. Next, we assessed CD4+-dependent adaptive T cell responses in vivo. One 
of the hallmarks of cell-mediated immunity is the ability to mount a rapid response to a 
previously encountered antigen. Though delayed-type hypersensitivity (DTH) responses 
to recall antigens have been reported in BLT mice (Rajesh et al., 2010), recall challenge 
inflammation-associated swelling is minimal in humanized mouse models where there is
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Figure 6.1. Normal T cell development and function in NSGAboDR1 mice. (A) Human chimerism in blood, 
spleen, and bone marrow determined using human CD45 staining 20 weeks post-reconstitution from a single DR1 
allelically matched cord blood donor. n ≥ 6 per group pooled from three independent experiments. (B) Human 
immune cell populations as a percent of human leukocytes in spleens of reconstituted mice. (C) Representative flow 
cytometry dot plots of developing T cells (left) quantified (right) showing double positive (DP), CD4+, CD8+, double 
negative (DN) and CD4+CD25+FOXP3+ Tregs. n ≥ 5 per group from two independent experiments. (D) The CDR3 region 
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of the TCRb locus was profiled using next-generation ultrahigh-throughput sequencing. Pie segments displayed in 
different colors to highlight unique V-gene segments for NSG and NSGAboDR1 mice. TCRb repertoire Diversity was 
calculated using normalized Shannon’s entropy (P > 0.05). (E) Histogram of CDR3 nucleotide length in CD4+ T cells 
isolated from spleens of reconstituted NSG or NSGAboDR1 mice. (F) The relative frequency or “evenness” of the 
CD4+ TCRb repertoire was plotted for the top 100 clonotypes in two representative animals in each genotype with 
each circle depicting an individual clonotype. (G) Delayed-type hypersensitivity response in OVA-immunized mice 
displayed as the difference in swelling between OVA-injected left footpad (lfp) and PBS-injected right footpad (rfp). 
NSGAboDR1 (mismatched) refers to reconstitution using HSCs from a donor that was negative for the DRB1*01:01 
allele. Data are pooled from two independent experiments. Bars are the mean ± SEM. Statistical analysis performed 
using one-way ANOVA with Tukey’s multiple comparisons test (A), multiple t test corrected for multiple comparisons 
using Holm-Sidak method (C), non-linear regression (E), unpaired t test (F, G)  *P < 0.05, **P < 0.01, ***P < 0.001
absence of autologous human tissue graft or exogenous recombinant IL7 (Lepus et al., 2009; 
Unsinger et al., 2009). We compared DTH responses to ovalbumin (OVA) in NSGAbo, NSG, and 
NSGAboDR1 mice that were previously immunized subcutaneously against OVA. While we 
observed low degree of footpad swelling in NSG mice, similar to a previous report (Unsinger 
et al., 2009), NSGAboDR1 mice, when compared to NSG or NSGAbo mice, exhibited greater 
footpad swelling in response to the recall antigen following secondary challenge indicating 
improved immunological memory responses are present (Figure 6.1G). This improved recall 
response also occurred when NSGAboDR1 mice were reconstituted using donor HSCs that 
were not matched for the HLADR1*01:01 allele (Figure 6.2G). While these data indicate that 
CD4+ T cells have functional capacity, CD8+ T cells and NK cells from NSGAboDR1 mice also 
have functional properties at least in vitro, as evidenced by IFNg secretion (Figure 6.S3A) 
and target cell lysis respectively (Figure 6.S3B-C).
6.4.3 Human B cell maturation and class switch recombination occurs in NSGAboDR1 mice 
T cells also play a critical role in the humoral arm of adaptive immunity as rodents and humans 
lacking T cells exhibit profound defects in B cell maturation and antibody class switching 
(Luzzati and Jacobson, 1972; Mond et al., 1982). Previous data in humanized NSG mice show 
varying stages of human B cell development; however, progression to mature naïve B cells from 
immature transitional B cells remains poor with low levels of class switched antibodies (Biswas 
et al., 2011; Chang et al., 2012; Watanabe et al., 2009; Xu et al., 2014b). We analyzed the immature 
transitional splenic B cell population in reconstituted NSGAbo, NSG, and NSGAboDR1 mice by 
staining for CD45, CD19, CD24 and CD38. NSGAboDR1 mice had a significant decrease in the 
proportion of CD45+CD19+CD24hiCD38hi immature transitional B cells with a concomitant increase 
in CD45+CD19+CD24intCD38int mature naïve B cells (Figure 6.2A) (Cuss et al., 2006; Palanichamy et 
al., 2009).  Consistent with an increase in mature naïve B cells, serum IgG and IgE levels were also 
increased, indicating that immunoglobulin class switching was intact in NSGAboDR1 mice (Figure 
6.2B), as was previously seen in NRG mice expressing both murine MHCII and human HLA-DR4 
(DRAG mice) (Danner et al., 2011). Immunization against OVA led to the development of OVA-
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specific IgG in some but not all NSGAboDR1 mice (Figure 6.S4). Collectively, these data indicate 
that adaptive humoral immune responses are present when human CD4+ T cells are restricted by 
human HLA-DR1 in the absence of murine MHCII.
Figure 6.2. Increased B cell maturation and class switched immunoglobulins in reconstituted NSGAboDR1 
mice. (A) Representative flow cytometry dot plots of splenic B cells gated on CD45+CD19+ (left) and quantified (right) 
from three independent experiments with n ≥ 5 per group. (B) Serum immunoglobulin levels quantified by ELISA. 
Each data point represents an individual mouse from three independent experiments.  Solid bars are the mean ± 
SEM. Statistical analysis was performed using multiple t test corrected for multiple comparisons using Holm-Sidak 
method (A), Mann-Whitney test (B), *P < 0.05, **P < 0.01, ***P < 0.001 
6.4.4 Multi-organ inflammation and mortality in NSGAboDR1 mice reconstituted with 
IPEX CD34+ HSCs 
One inherent limitation of the BLT humanized mouse system is the requirement for an 
autologous setting comprising human thymus, liver, and HSCs from the same donor source, 
which prohibits assessment of immune dysfunction associated with patient-specific genetic 
abnormalities. The improved adaptive immune responses in humanized NSGAboDR1 mice 
led us to test whether immune reconstitution using HSCs isolated from a patient with a 
genetically defined immunological disorder would transfer manifestations of the human 
disease to recipient mice. Given that CD4+ T cell function is relatively intact in NSGAboDR1 
mice, we hypothesized that transplantation of HSCs from a patient in which CD4+ T cells, 
especially Tregs, are dysfunctional and directly involved in disease pathogenesis would 
permit assessment of the utility of this model system. We identified a 7-month old male 
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infant patient who presented with secretory watery non-bloody diarrhea, eczema, and 
enteropathy and found to have a nonsynonymous single-nucleotide polymorphism at 
position c.A1226C in the forkhead box protein 3 (FOXP3) gene (Figure 6.3A). This mutation 
resulted in a p.D409A amino acid change in the C terminal DNA binding domain, the same 
location previously reported in IPEX syndrome (Rao et al., 2007). IPEX syndrome is a rare, and 
often fatal, X-linked recessive disorder caused by loss-of-function mutations in FOXP3, the 
master transcriptional regulator of Tregs that is essential for establishment and maintenance 
of central tolerance (Bennett et al., 2001; Fontenot et al., 2003; Sakaguchi et al., 1985; Schubert 
et al., 2001). Patients with IPEX syndrome develop enteropathy, eczema, autoantibodies, and 
sometimes insulin-dependent diabetes mellitus (Gambineri et al., 2008). Mice harboring a 
loss-of-function mutation in Foxp3 (Foxp3sf) display a similar phenotype with multi-organ 
inflammation attributed to autoreactive CD4+ T cells (Blair et al., 1994; Mayer et al., 2014). 
Although FOXP3 expression was intact in CD4+CD25+ Tregs isolated from this patient (Figure 
6.3B), which has also been described for other FOXP3 mutations associated with IPEX 
syndrome (Kinnunen et al., 2013), suppression of allogeneic naïve T cell proliferation by the 
patient’s Tregs was profoundly impaired (Figure 6.3C).
Figure 6.3. Identification of a novel variant in FOXP3 associated with IPEX syndrome. (A) Sequence of the 
FOXP3 gene in the IPEX patient. (B) FOXP3 expression in Tregs (CD4+CD25hi) and Tnaïve (CD4+CD25-) from the IPEX patient 
and healthy control shown by flow cytometry (left) and histogram the mean fluorescence intensity (MFI) (right). (C) 
In vitro suppression assay using Tregs from a healthy control or IPEX patient and carboxyfluorescein succinimidyl ester 
(CFSE)-labeled allogeneic responder T cells.
 
  To test whether transfer of HSCs from this IPEX patient would cause a spontaneous IPEX-
like disease in NSGAboDR1 and NSG mice, bone marrow-derived CD34+ HSCs were purified 
and used to engraft 1-day-old NSG and NSGAboDR1 recipient mice, hereafter referred to as 
IPEX(NSG) and IPEX(DR1) respectively. In parallel, bone marrow-derived CD34+ HSCs from 
a healthy pediatric donor were injected into NSGAboDR1 mice as controls, referred to as 
Control(DR1) mice. Since the patient was not an allelic match with the DR1 allele expressed in 
the mice, we also selected mismatched bone marrow as a control to account for any potential 
pathology due to HLA mismatch. Mice were monitored for the development of clinical 
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Figure 6.4. NSGAboDR1 mice reconstituted with IPEX hematopoietic stem cells causes mortality and multi-
organ inflammation. (A) Longitudinal assessment of body weight change compared to weight at 10 weeks from 
two independent experiments. (B) Kaplan-Meier survival curve comparing reconstituted mice. The 18-week cutoff 
was selected based on 100% lethality in IPEX(DR1) mice by this time point in the first experimental cohort in order to 
compare variability across two independent experiments. Control(DR1) n=10, IPEX(NSG) n=10, IPEX(DR1) n=19. (C) 
Human chimerism in spleen of reconstituted mice assessed by flow cytometry pooled from two experiments. Open 
circles are individual mice. Bars are the mean ± SEM. (D) H&E stained sections from the lung, liver, small intestine 
(Sm. Int.), and colon of NSGAboDR1 mice reconstituted with control bone marrow CD34+ HSCs or IPEX CD34+ HSCs, 
NSG mice reconstituted with IPEX CD34+ HSCs, and Foxp3sf mice. Black arrowheads denote leukocyte infiltrate. Scale 
bars are 100 mm. Statistical analysis performed using one-way ANOVA with Tukey’s multiple comparisons test (A, C), 
curve comparison using Log-rank Mantel-Cox test (B). *P < 0.05, **P < 0.01 
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immune cell infiltration using (A) anti-hCD3 staining on lung, liver, small intestine, and colon tissue sections 
(top) quantified by counting the number of CD3+ cells/20X field for 3 mice per group (bottom). (B) Representative 
flow cytometry dot plots of splenic T cells gated on TCRb+ (left) with the frequency of CD4+/CD8+ T cells reported 
(right). Open circles are individual mice. (C) The absolute numbers of splenic T cells were quantified. Open circles 
are individual mice. All values are mean ± SEM. Statistical analysis performed using one-way ANOVA with Tukey’s 
multiple comparisons test (A), one-way ANOVA using Kruskal-Wallis multiple comparisons test (B, C). *P < 0.05, **P 
< 0.01, ***P < 0.001
manifestations characteristic of patients with IPEX syndrome and Foxp3sf mice. IPEX(DR1) 
mice exhibited significant weight loss and increased mortality by 18 weeks post-transfer 
which was rarely observed in IPEX(NSG) mice and never observed in Control(DR1) mice 
(Figure 6.4A-B). Similar to the absence of diabetes in this patient, IPEX(DR1) mice also did not 
exhibit signs or symptoms of insulitis. At necropsy, IPEX(NSG) and IPEX(DR1) mice exhibited 
splenomegaly (not shown) with increased human immune cells in the spleen compared to 
Control(DR1) mice (Figure 6.4C). Since IPEX patients, Foxp3sf mice, and mice with targeted 
depletion of FOXP3-expressing cells, develop multi-organ inflammation (Lahl et al., 2007), we 
analyzed organs known to be affected by Treg-deficiency. Similar to observations in Foxp3sf 
mice (Chen et al., 2005), inflammation was consistently observed by immunohistochemistry 
in the lung and liver of IPEX(DR1) mice with mild leukocyte infiltration also observed in the 
small intestine (Figure 6.4D). Given the inflammation detected in these organs, we screened 
whole tissue to quantify human inflammatory cytokines which were broadly elevated in both 
lung and liver tissue of IPEX(DR1) mice compared with IPEX(NSG) and Control(DR1) mice as 
anticipated (Figure 6.S5). This inflammatory infiltrate consisted of human CD3+ T cells, and 
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to a lesser extent human CD68+ macrophages, in the lung and liver tissue of IPEX(DR1) mice 
but not IPEX(NSG) mice or Control(DR1) mice (Figure 6.5A and 6.S6). We assessed the T cell 
compartment and found similar proportions of CD4+ and CD8+ T cells in the spleens of all 
three groups (Figure 6.5B). The absolute numbers of CD4+ and CD8+ T cells were increased 
in both IPEX(NSG) and IPEX(DR1) mice, with a normal CD4+/CD8+ ratio, reminiscent of the 
lymphoproliferation observed in Foxp3sf mice (Figure 6.5C) (Huter et al., 2008). We tested the 
function of IPEX human Tregs by isolating the CD4
+CD25+ fraction from several pooled spleens 
of IPEX(DR1) mice and found, analogous to the patient’s Treg suppression defects, that the 
ability to suppress autologous CD4+CD25- T cells was impaired (Figure 6.S7).
6.4.5 Engraftment of IPEX CD34+ HSCs leads to autoantibody production 
Defective Treg function in both Foxp3
sf mice and IPEX patients is also associated with 
hyperimmunoglobulinemia, loss of peripheral B-cell tolerance, and the development of 
autoantibodies (Aschermann et al., 2013; Bacchetta et al., 2006; Lampasona et al., 2013; 
López et al., 2011). Similar to observations in patients with IPEX syndrome and in Foxp3sf mice 
(Godfrey et al., 1991; Lampasona et al., 2013; López et al., 2011) serum IgG and IgE levels 
were elevated in both IPEX(NSG) and IPEX(DR1) mice compared to Control(DR1) mice (Figure 
6.6A). Patients with IPEX syndrome develop autoantibodies and our patient tested positive 
for several including antibodies against glutamic acid decarboxylase, thyroperoxidase, and 
nuclear antigens (Lampasona et al., 2013; Tsuda et al., 2010) We investigated whether human 
mouse-specific autoantibodies were produced in mice reconstituted with HSCs from the 
IPEX patient. Indirect immunofluorescence on cryosectioned lung and liver tissue revealed 
the presence of autoreactive IgG in serum from IPEX(DR1) mice that co-localized with DAPI 
stained nuclei and was not observed in sera from IPEX(NSG) or Control(DR1) mice (Figure 
6.6B). Using a more global approach, sera from Control(DR1) mice, IPEX(NSG) mice, and 
IPEX(DR1) mice were screened using an autoantigen microarray spotted with 500 murine 
lipid and peptide antigens. Broad IgM and IgG autoreactivity was detected in IPEX(DR1) mice, 
and to a lesser extent in IPEX(NSG) mice, with several autoantibodies commonly observed in 
human autoimmune diseases including gliadin, dsDNA, and collagen (Figure 6.6C and 6.S8-
9). While there was a clear correlation between autoantibody reactivity and the percentage of 
human B cells in IPEX(DR1) mice, this was not the case for IPEX(NSG) mice (Figure 6.6D). This 
suggests that the increased autoreactivity is likely attributed to T cell help provided by DR1-
restricted CD4+ T cells. It is noteworthy that the higher levels of autoantibodies also did not 
appear to correspond to early mortality in IPEX(DR1) mice suggesting that additional factors 
are likely dominant (Figure 6.6D).  
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Figure 6.6. Loss of B cell tolerance in IPEX mice. (A) Serum immunoglobulin levels quantified by ELISA from two 
independent experiments. (B) Autoantibody detection by indirect immunofluorescence on cryosections of frozen 
lung and liver tissue from a non-humanized NSGAboDR1 mouse. Frozen sections were incubated independently 
with sera from 4 individual reconstituted mice per group. FITC-conjugated anti-human IgG was used as a secondary 
antibody combined with DAPI to label nuclei. (a) denotes lung airway. Scale bars are 50 mm. (C) Heat map of 
antibody response to select murine antigens determined using an antigen microarray. Each column is the IgM and 
IgG serum reactivity from an individual mouse in each group with the averaged reactivity score for all antigens per 
group noted at the bottom. IgM P = 0.06, IgG P = 0.09  (D) The normalized cumulative autoreactive IgM and IgG 
antibody reactivity values for all 500 mouse antigens in arbitrary units (a.u.) were plotted against the % human B 
cells in each mouse (n=5). Solid line marks the best-fit linear regression for each cohort with the R2 value calculated 
using Pearson correlation coefficients. For each data point the % of human chimerism is shown in parenthesis and 
for IPEX(DR1) mice, the age in weeks when mice became moribund and were euthanized. Statistical analysis was 
performed using Mann-Whitney test (A) and nonlinear regression correlation using Pearson correlation coefficients 
(D). ***P < 0.001
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6.5 Discussion
The main goal of this study was to develop a humanized mouse strain that would support 
human adaptive immune function and enable in vivo modeling of a monogenic human 
immune-mediated disease using patient HSCs. Since CD4+ T cells are known to play critical roles 
in maintaining immune homeostasis, we reasoned that a setting in which human CD4+ T cells 
were selected on a human HLA class II molecule in the absence of murine MHCII might improve 
thymic positive selection and, consequently, adaptive immune responses in humanized mice. 
The NSGAboDR1 mice described in this study were an attractive strain to test this hypothesis 
especially given the frequency of the HLA-DR1 allele in the population (Mori et al., 1997).  
  The improved CD4+ T cell recall response in NSGAboDR1 mice may result from more 
effective interactions between DR1-restricted CD4+ T cells and HLA-DR1/peptide complexes 
presented by DR1+ APCs resulting from co-evolution of the human TCR and human MHCII 
molecules (Huseby et al., 2005; Kim et al., 2005) Although we observed a slight but significant 
increase in T cell frequency in NSGAboDR1 mice compared to NSG mice, we did not observe 
an increase in the frequency of CD4+ T cells, which is in contrast to the increase in CD4+ T cells 
reported in DRAG mice that also express a human class II molecule (Danner et al., 2011). This 
difference may result from expression of both human and murine class II in DRAG mice, which 
permits interspecies a/b MHCII pairing and enhanced positive selection. 
  Humoral immunity in humanized mice has generally been poor with B cells exhibiting 
an immature phenotype and yielding lower levels of serum immunoglobulins compared 
to humans (Brainard et al., 2009; Gorantla et al., 2007). In our studies, B cell maturation and 
antibody class switch recombination was increased in reconstituted NSGAboDR1 mice 
compared to NSG and NSGAbo mice. This increase is may be a result of improved cognate 
interactions between HLA-DR1 restricted CD4+ T cells and HLA-DR1+ B cells triggering cytokine 
secretion and antibody class switching (Oxenius et al., 1998). The fact that B cells in NSG mice 
exhibited a more immature phenotype and relatively lower serum IgG and IgE levels suggests 
that MHCII-restricted CD4+ T cells in NSG mice are less efficient at providing T cell help to B cells.
  The most significant finding of our study was that HSCs from a patient with IPEX 
syndrome caused immunodysregulation in NSGAboDR1 mice. To date, human HSCs with 
a causative mutation of a monogenic disease triggering a similar disease phenotype in 
humanized mice has not been reported. Interestingly the disease phenotype was not readily 
observed when these HSCs were transferred into the NSG strain despite NSG mice having 
increased T cell numbers, elevated serum immunoglobulins, and autoantibodies compared 
with control bone marrow HSCs. This is likely attributed to the enhanced adaptive immune 
responses seen in reconstituted NSGAboDR1 mice. Similar to the phenotype in our IPEX(DR1) 
mice, a recent report also demonstrated a role for human Tregs in immune homeostasis in 
humanized mice by showing that administration of antibodies blocking CTLA-4, a molecule 
critical for Treg suppressive function (Jain et al., 2010; Tai et al., 2012; Wing et al., 2008) also 
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caused weight loss, liver inflammation, and anti-nuclear antibodies (Vudattu et al., 2014). 
One possibility for the multi-organ inflammation is that the IPEX mice developed allogeneic 
graft vs. host disease (GVHD) since the IPEX donor was not matched for the DR1*01:01 allele; 
a previous report using NSGAbo mice expressing human DR4 injected with human PMBCs 
resulted in allogeneic GVHD (Covassin et al., 2011). However, human stem cell reconstitution 
in one-day old NSGAboDR1neonates gives rise to human T cells selected on murine (and 
likely human) antigens in the mouse thymus where autoreactive T cells are likely deleted. In 
this regard, using this method, we have never observed characteristic xeno-GVHD symptoms 
(weight loss or alopecia) following reconstitution even in NSG mice. Moreover, control HSCs 
that were negative for the DR1*01:01 allele did not result in systemic T cell inflammation 
following reconstitution in NSGAboDR1 mice.
In summary, genetic studies in mice have advanced our understanding of gene/protein 
function in health and disease giving rise to new therapeutic targets. Even so, disparities 
persist between validated therapeutics using rodent models and improved clinical 
outcomes necessitating the development of new model systems (McKenzie et al., 1995; 
Suntharalingam et al., 2006). Humanized mice provide the opportunity to study the 
function of human immune cells in an in vivo setting without risk to human subjects. The 
model described here exhibits enhanced adaptive immune function which circumvents the 
requirement of surgically implanted autologous thymic and liver tissue and enables use of 
HSCs from genetically defined patients (Vudattu et al., 2014; Zheng et al., 2013) These mice 
will likely be most useful for studies pertaining to T cell responses and immune-mediated 
diseases resulting from Treg dysfunction and/or aberrant effector CD4
+ T cell activation. One 
pre-clinical utility of this model would permit assessment of the efficacy and safety of novel 
genome editing or vector-based gene therapy strategies aimed at correcting monogenic 
immunodeficiencies; early trials using retroviral-based vectors had complications due to 
vector-mediated insertional activation of cellular oncogenes (Cuss et al., 2006; Gaj et al., 
2013; Howe et al., 2008). Overall, we propose that NSGAboDR1 mice, alone or in combination 
with additional HLA molecules and/or other human cytokines (Rongvaux et al., 2014) will 
further the utility and usefulness of humanized mice to study human immune responses in 
health and disease and the development of emerging immunotherapies.
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6.8 Supplemental data
Figure 6.S1. Expression of human HLA-DR1 in NSGAboDR1 mice. Representative flow cytometry dot plots 
demonstrating expression of human HLA-DR1 on murine splenic dendritic cells (CD11b+CD11c+) and macrophages 
(CD11b+F4/80+), and thymic epithelium (CD45-EpCAM+) from NSGAboDR1 mice compared to murine MHCII expression 
on splenic dendritic cells and macrophages from NSG control mice.
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Figure 6.S2. Human T cells in humanized mice are functional. Splenocytes from indicated mice and human 
peripheral blood mononuclear cells (PBMCs) were stimulated with PMA/Ionomycin for 4 hours. Representative flow 
cytometry dot plots for intracellular cytokine expression gated on TCRb+ cells (left) and quantified (right). All bars 
are mean ± SEM.
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Figure 6.S3. Human CD8+ and NK cells isolated from NSGAboDR1 mice are functional in vitro. (A) Activation of 
CD8+ T cells in PBMCs and from reconstituted NSGAboDR1 splenocytes was assessed following stimulation with PMA 
and ionomycin for 6 hours followed by intracellular staining for IFNg. (B) Lymphokine-activated PBMCs or splenocytes 
from reconstituted NSGAboDR1 mice were co-cultured with CellTrace Violet-labeled K562 target cells for 4 hours. 
Cytotoxic killing of K562 cells was determined by 7-AAD incorporation into CellTrace Violet+ cells with representative 
histograms shown (left) and quantified (right) (n=4) from two independent experiments. (C) Degranulation of human 
NK cells (CellTrace Violet– CD3-CD56+) following stimulation with K562 target cells was measured by cell surface 
expression of CD107a with a representative flow cytometry dot plot shown (left) and quantified (right). Statistical 
analysis was performed using one-way ANOVA with multiple comparisons and unpaired t-test respectively. **P < 
0.01, ***P < 0.0001
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Figure 6.S4. Development of OVA-specific IgG in NSGAboDR1 mice. Twelve-week-old NSGAboDR1 mice were 
bled prior to immunization and serum was stored frozen. Mice were immunized against OVA using an emulsion 
containing CFA as an adjuvant. A booster immunization containing OVA using incomplete Freund’s adjuvant was 
administered two weeks later with serum isolated after an additional two weeks.  Sera was screened for OVA-specific 
IgG using a standard ELISA and compared to pre-immunization OVA-specific IgG levels. Open circles represent 
individual animals. Values are the mean ± SEM. Statistical analysis was performed using paired t-test.
Figure 6.S5. IPEX(DR1) mice have increased pro-inflammatory human cytokines transcripts in lung and 
liver tissue. mRNA isolated from lung and liver tissue of reconstituted mice was reverse transcribed to make cDNA 
using oligo(dT) primers. Relative human cytokine transcript levels were determined by quantitative real-time PCR 
normalized to hypoxanthine phosphoribosyltransferase (HPRT) and compared to Control(DR1) mice using the ΔΔCt 
method to calculate fold change. n ≥ 4 per group shown as the mean ± SEM. Statistical analysis was performed using 
one-way ANOVA using Kruskal-Wallis multiple comparisons test *P < 0.05, **P < 0.01 
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Figure 6.S6. Infiltrating human macrophage in lung and liver of IPEX(DR1) mice. Immunohistochemical 
analysis detecting human macrophage using anti-hCD68 staining on lung and liver tissue sections counterstained 
with hematoxylin (top) and quantified by counting the number of CD68+ cells/20X field for 3 mice per group (bottom). 
Black arrowheads denote human CD68+ cells. Scale bars are 100 mm. Statistical analysis performed using one-way 
ANOVA with Tukey’s multiple comparisons test.
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Figure 6.S7. IPEX(DR1) Tregs fail to suppress naïve T cell proliferation. CD4+CD25+ Treg cells were isolated from 
spleens of Control(DR1) or IPEX(DR1) mice and cultured with 50k CFSE-labeled autologous CD4+CD25- responder 
T cells stimulated with 1 mgml-1 plate bound aCD3 and 1 mgml-1 soluble aCD28 antibodies for 72 hrs. Percent 
proliferation was determined by CFSE dilution using flow cytometry.
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Table S1. Splenic human leukocyte frequencies determined by flow cytometry. 
NSGAbo
 
NSG NSGAboDR1
T cells (% CD3+
 
of hCD45+) 2.0 (1.0) 12.6 (7.5) 23.8 (4.1)
* 
    CD4 (% CD4+
 
of CD3+) 7.9 (3.4) 63.1 (5.6) 44.9 (6.6) 
        Naive (CCR7+
 
CD45RA+) 3.4 (0.88) 10.5 (3.2) 7.2 (1.2) 
        Effector (CCR7
- 
CD45RA+) 8.6 (3.2) 15.8 (4.7) 13.9 (2.0) 
        Effector Memory (CCR7-
 
CD45RA-) 10.7 (6.0) 32.5 (5.1) 24.7 (3.3) 
        Central Memory (CCR7+
 
CD45RA-) 3.5 (1.3) 8.4 (2.4) 4.6 (1.0) 
        Treg (% CCR4+
 
CD127lo/-of T cells) 0.34 (0.20) 5.5 (2.1) 2.4 (0.43) 
    CD8 (% CD8+
 
of CD3+) 42.7 (12.9) 25.4 (4.4) 34.9 (5.8) 
        Naive (CCR7+
 
CD45RA+) 18.8 (6.8) 5.22 (2.2) 11.9 (3.5) 
        Effector (CCR7-
 
CD45RA+) 12.5 (3.9) 6.4 (1.6) 11.9 (1.3) 
        Effector Memory (CCR7- CD45RA-) 7.6 (2.8) 10 (2.2) 7.65 (2.1) 
        Central Memory (CCR7+
 
CD45RA-) 3.03 (0.94) 1.06 (0.37) 1.73 (0.47) 
B cells (% CD3-
 
CD19+
 
of hCD45+) 86.1 (2.8) 78.6 (7.5) 62.7 (4.5)*
 
    Immature (% CD24hiCD38hi
 
of B cells) 52.3 (3.5) 47.1 (9.3) 25.9 (3.9)*
 
    Mature Naïve (%CD24intCD38int
 
of B cells) 33.1 (3.2) 35.1 (6.1) 55.9 (3.6)*
 
Monocytes (% CD3-
 
CD19-
 
CD14+
 
of hCD45+) 0.80 (0.1) 1.5 (0.50) 8.6 (2.1)*
 
cDCs (% CD3-
 
CD19-
 
CD14-
 
HLADR+
 
CD11c+) 3.2 (0.74) 3.4 (1.2) 2.6 (2.2) 
myeloid DCs (% CD3-
 
CD19-
 
CD14-
 
HLADR+
 
CD123+CD11c+) 10.9 (4.8) 11.6 (5.9) 14.9 (2.9) 
NK cells (% CD3-
 
CD56+
 
of hCD45+) 1.69 (0.51) 2.72 (0.52) 2.32 (0.38) 
Numbers are the mean (± SEM) * P < 0.05 
Table S2. TCR repertoire. Sequence analysis of the TRB CDR3 region in splenic CD4+
 
T cells. 
Sample Total sequences Unique sequences (%) Diversity index 
NSG #1 487,721 846 (0.17) 0.24 
NSG #2 280,031 1369 (0.48) 0.14 
NSGAboDR1 #1 411,070 3538 (0.86) 0.18 
NSGAboDR1 #2 597,708 3874 (0.64) 0.16 
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Chapter 7 
FOXP3+ Tregs require WASP to restrain 
Th2-mediated food allergy
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7.1 Abstract
In addition to the infectious consequences of immunodeficiency, patients with Wiskott-
Aldrich syndrome (WAS) often suffer from poorly understood, exaggerated immune responses 
that can result in autoimmunity and elevated levels of serum IgE. Here we show that WAS 
patients and mice deficient in Wiskott-Aldrich syndrome protein (WASP) frequently develop 
IgE-mediated reactions to common food allergens. In Was-/- animals, this adjuvant-free IgE-
sensitization to chow antigens was most pronounced for wheat and soy, and occurred under 
specific pathogen free as well as germ-free housing conditions. Allergic responses to food 
allergens in WASP deficiency critically depended upon FOXP3+ Tregs, as conditional deletion of 
WASP in this immune compartment resulted in more severe Th2-type intestinal inflammation 
than observed in Was-/- counterparts. While WASP-deficient Tregs efficiently contained Th1 
and Th17-type effector differentiation in vivo, they failed to restrain Th2 effector responses 
that drive allergic intestinal inflammation. Loss of WASP was phenotypically associated with 
increased GATA3 expression by effector memory, but not naïve-like, FOXP3+ Tregs, which 
occurred independently of increased IL-4 signaling. Our results reveal a novel, Treg-specific 
role for WASP that is required for prevention of Th2 effector cell differentiation and allergic 
sensitization to dietary antigens. 
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7.2 Introduction
Type 2 immunity is involved in a variety of host-defense functions, ranging from protection 
against parasites and support of epithelial barrier integrity, to regulation of wound healing 
and control of metabolic homeostasis (Palm et al., 2012; Pulendran and Artis, 2012; Wynn, 
2015). Many of these functions are performed by cells of the innate immune system, including 
eosinophils, basophils and mast cells, which in turn are orchestrated by Th2 lymphocytes of 
the adaptive immune system through the production of type 2 cytokines such as IL-4, IL-5 
and IL-13. Th2 help can furthermore instruct B cells to produce immunoglobulin E (IgE), 
which arms mast cells and basophils with antigen-specific effector functions through binding 
to their high-affinity IgE receptor FcεRI on the cell surface. Despite the presence of multiple 
inhibitory pathways of type 2 immunity (Wynn, 2015), dysregulation within this system is 
increasingly common in Westernized societies and can result in the production of allergen-
specific IgE, type I hypersensitivity reactions, and allergic tissue inflammation (Palm et al., 
2012; Pulendran and Artis, 2012; Wynn, 2015). In order to better understand the recent surge 
in incidence as well as the pathogenesis of Th2-driven allergic diseases, the study of aberrant 
activation of Th2 effector responses is of critical importance.  
  As is true for Th1 responses, Th2-mediated immune reactions critically rely on the 
function of regulatory T cells (Tregs) for their containment. Functional defects in Foxp3, 
the lineage-defining transcription factor that identifies the best-characterized population 
of Tregs, results in the immune dysregulation, polyendocrinopathy, enteropathy, X-linked 
(IPEX) syndrome in human patients, and in the IPEX-related scurfy phenotype in mice 
(Ramsdell and Ziegler, 2014). In both species, the severe lymphoproliferation that ensues 
shows concomitant Th1 and Th2 effector responses, which may counter-regulate each 
other (Suscovich et al., 2012), and manifests clinically as a loss of tolerance-to-self and 
autoimmunity in combination with elevated IgE levels and food allergies (Akdis and Akdis, 
2009; Lin et al., 2005; Suscovich et al., 2012). Emerging data implicate functionally distinct 
subsets of CD4+FOXP3+ Tregs that exert differential control over Th1 and Th2 effector cell 
proliferation, which may be related to their anatomic location of origin. For instance, thymus-
derived Tregs were recently shown to specifically control Th1 immunity (Dhainaut et al., 
2015), whereas selective loss of peripherally-induced (i)Tregs resulted in uncontrolled Th2, 
but not Th1 or Th17-type inflammation (Josefowicz et al., 2012b). These findings fit within 
the broader paradigm that lineage-committed FOXP3+ Tregs are responsive to environmental 
cues and can assume tissue-specific phenotypes by co-opting other transcription factors 
such as GATA3 or T-bet (Josefowicz et al., 2012a; Li and Zheng, 2015; Yu et al., 2015). The 
mechanisms and consequences of this phenotypic variation and functional plasticity are 
only beginning to be understood. 
  In addition to the human IPEX syndrome, dysregulated Th2 responses, atopy and 
elevated IgE levels occur in a range of primary human immunodeficiencies, some of which 
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are phenocopied in the corresponding mouse models (Datta and Milner, 2011; Liston et al., 
2008; Ozcan et al., 2008; Sassi et al., 2014; Yong et al., 2012; Zhang et al., 2014). The variety 
of genes that are affected in these disorders - e.g. STAT3, DOCK8, PGM3 and multiple genes 
involved in TCR signaling such as LAT, ZAP70 or RAG - suggests that hyper IgE phenotypes can 
result from alterations in a number of distinct immunological pathways. In most of these 
cases, however, the underlying mechanisms of increased IgE production or the functional 
consequences of elevated serum IgE have not been studied in detail.  
  One well-known primary immunodeficiency with elevated serum IgE is Wiskott-Aldrich 
syndrome (WAS) (Datta and Milner, 2011; Ozcan et al., 2008). WAS is caused by mutations in 
the Wiskott-Aldrich syndrome (WAS) gene on the X-chromosome, which encodes the Wiskott-
Aldrich syndrome protein (WASP) with expression restricted to hematopoietic lineages. 
WASP is the founding member of a family of actin regulators, capable of transducing a variety 
of signals to mediate changes in the actin cytoskeleton, and has been implicated in a great 
variety of cellular functions in both lymphocytes and non-lymphocytes (Snapper and Rosen, 
1999; Thrasher and Burns, 2010). More than 100 unique loss-of-function mutations in WAS 
have been reported, giving rise to a clinically heterogeneous group of patients (Thrasher and 
Burns, 2010). The most severely affected males present early in life with thrombocytopenia, 
eczema, autoimmune sequelae and recurrent infections, which can be fatal in the absence of 
bone-marrow transplantation or gene therapy. In contrast, milder loss-of-function mutations 
have been identified in patients who suffer from an attenuated form of the disease termed 
X-linked thrombocytopenia (XLT), which has excellent long-term survival with medical 
management alone (Albert et al., 2011). Despite the long-known association between WAS 
mutations and atopy, the antigenic specificity of the expanded IgE pool and the consequences 
of elevated IgE on the prevalence of allergic disease are only beginning to be investigated in 
human patients (Tuano et al., 2014) and have not been addressed in WASP-deficient mice. 
  Here we show that patients with mutations in WAS demonstrate an increased frequency 
of sensitization to food allergens as measured by serum specific IgE and skin prick testing 
and increased prevalence of clinically relevant food allergy in childhood when compared to 
the general population. Similarly, Was-/- mice spontaneously develop IgE-mediated immune 
responses and intestinal mast cell expansion. Using conditional WASP-deficient mice, we 
identified that WASP deficiency limited to FOXP3+ Tregs results in a strongly Th2-skewed, 
allergic inflammation of the small intestine, which was exacerbated compared to complete 
Was-/- counterparts. Phenotypically, WASP-deficient Tregs displayed elevated levels of Th2 
transcription factor GATA3 in the effector-like, but not naïve subset of FOXP3+ Tregs, which 
occurred independently of IL-4. These findings demonstrate that WASP is required for FOXP3+ 
Tregs to exert selective control over Th2-type immune responses. 
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7.3 Methods
7.3.1 Patients
25 consecutive patients with Wiskott-Aldrich syndrome (WAS) or X-linked thrombocytopenia 
(XLT) followed by NHGRI on an active clinical protocol (NCT00006319), provided informed 
consent on an NIH IRB-approved research protocol designed to study atopy (NCT01164241). 
Prior to enrollment, a clinical diagnosis of WAS or XLT was confirmed by mutation analysis 
of the WAS gene and WASP protein expression as previously described (Wada et al., 2001). 
Comprehensive allergic histories, review of all available outside records pertaining to 
prior allergic or immunologic evaluation and therapeutic intervention, as well as physical 
examinations were performed at the Clinical Center of the National Institutes of Health 
(NIH). Total and allergen-specific serum IgE levels were quantified by ImmunoCAP (Uppsala, 
Sweden) from all patients (n = 25). Skin prick testing to a panel of common allergens was 
performed in patients with sufficient intact / non-inflamed skin (n = 14) and compared to 
standard clinical positive and negative controls. Because three individuals had previously 
undergone hematopoietic stem cell transplantation, data from sera and skin prick tests 
were excluded from analysis. Skin prick testing to morphine (10, 3, 1, 0.3, 0.1 mg/mL) was 
performed in individuals with WAS mutations (n = 13) and compared to control subjects (n 
= 15).
7.3.2 Animals
The generation of Was-/-, Was-/-Il4-/-, and Was-/-Rag2-/- mice has been previously described 
(Nguyen et al., 2007; Snapper et al., 1998) and Was-/- animals have since been made 
commercially available from The Jackson Laboratory (Bar Harbor, ME).  All mice used in 
this study were bred in house and maintained in accordance with institutional guidelines in 
specific pathogen-free conditions at the Boston Children’s Hospital. 129SvEv Was-/- animals 
were re-derived into germ-free conditions at Boston Children’s Hospital. The C57BL/6 mice 
harboring floxed Was alleles (Wasfl/fl females or Wasfl males) were generated and donated 
by Adrian Thrasher (University College London Institute of Child Health, London UK) as 
previously described (Recher et al., 2012). We backcrossed these mice for 10 generations 
onto the 129SvEv background in our facility. Itgax-Cre mice and Foxp3-Cre mice on the 
C57BL/6 background were obtained from Jackson laboratory and backcrossed for at least 
10 generations onto the 129SvEv background. Serum from WasflMb1-Cre and WaswtMb1-Cre 
animals was kindly provided by Drs. Stefano Volpi and Luigi Notarangelo at the Department 
of Immunology of Boston Children’s Hospital (Boston, USA). 
7.3.3 Chow and chow extracts
All mice were kept on irradiated Prolab® Isopro® RMH 3000 (LabDiet, St. Louis, MO) throughout 
their lives. Crude samples of the five main (%w/w) components (in order of abundance: 
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ground wheat, soybean meal, wheat middlings, ground yellow corn, and fish meal) were 
obtained directly from LabDiet. Protein extracts for in vitro studies were generated by 
soaking approximately 10 gram of homogenized chow pellets or meal component in 40 ml 
of phosphate buffered saline (PBS) in a 50 ml Falcon® tube, which was placed in a shaking 
incubator at 37 °C for 4 hours, and then spun at 5000 x g for 10 minutes. The supernatant 
containing solubilized food antigens was then ultra-centrifuged (100,000 x g) for 1 h and 
sterile-filtered using a 20-micron syringe filter (Corning, Tewksbury, MA). Protein concentration 
of extracts was quantified using a colorimetric protein assay (Bio-Rad, Hercules, CA). For 
allergen elimination experiments, mice were transferred to a clean cage containing a protein-
free, amino acid-based formula (Research Diets Inc, New Brunswick, NJ). An elemental chow 
extract was obtained from mortar-and-pestle-homogenized pellets as described for regular 
chow. 
7.3.4 ELISAs
Total and OVA-specific IgE and IgG1 ELISAs were performed as previously described (Platzer et 
al., 2015a) using the following reagents: capture antibodies: anti-mouse IgE (southern biotech 
1110-01) and anti-mouse IgG1 (southern biotech 1070-01); protein standards: mouse IgE and 
IgG1 κ isotype controls (BD Pharmingen), and mouse anti-ovalbumin IgE (MCA2259, AbD 
Serotec); detection reagents: horseradish peroxidase-conjugated anti-mouse IgE (southern 
biotech 1110-05) and IgG1 (southern biotech 1070-05), biotin-conjugated ovalbumin (US 
Biologicals), and streptavidin-conjugated horseradish peroxidase (BD Pharmingen).
  For food-specific Ig ELISAs, 96-well polystyrene plates (Costar assay plates, Corning) 
were coated overnight with 100 μl of food extract in PBS (100 μgml-1 protein concentration). 
Plates were subsequently washed 6 times with 300 μl of 0.05% tween in PBS (washing buffer) 
and blocked with 10% fetal calf serum (FCS) in PBS for a minimum of 2 h at room temperature. 
Serum dilutions ranging from 1:30 to 1:5000 were prepared in 2% FCS in PBS buffer and 
transferred to wells in a volume of 100 μl. Plates were incubated at room temperature for 3 
h and then washed again 6 times in washing buffer, after which anti-food Ig antibodies were 
detected with horseradish peroxidase-conjugated antibodies to IgE (1110-05), IgG1 (1070-05), 
IgG2a (1080-05), IgG2b (1090-05), IgG3 (1100-05), or IgA (1040-05, all from Southern Biotech) in 
1:1000 dilutions in 2% FCS in PBS for 1 h at room temperature. Following 6 additional washes, 
plates were developed in the dark for 3-10 minutes with 100 μl of tetramethylenbenzidine per 
well (KPL, Gaithersburg, MD). This reaction was stopped by the addition of 50 μl of 2M H2SO4 
prior to spectrophotometric analysis at 450nm (Perkin Elmer). To allow semi-quantitative 
comparison of reactivity against different food extracts, all five investigated extracts were 
coated in equivalent concentrations in adjacent wells on the same 96-well plate. For each 
sample, a sixth well was included that was coated with PBS alone and the OD of this blank 
well was subtracted from the OD of the extract-coated wells to correct for any non-specific 
binding and thus obtain the Ig reactivity against any of the five components. Cumulative 
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anti-food Ig titers were defined as the sum of the blanked OD values of all five investigated 
extracts. For some experiments, wells were coated with combined wheat and soy extracts, 
and 2-fold serial dilutions of a positive serum sample were used to quantify the anti-food 
IgG1 reactivity as arbitrary units/ml (U/ml). 
  Serum MCPT1, as well as IL-4, IL-13, IL-2, IL-17a and IFN-g ELISAs were performed using 
a commercially available kit (eBioscience) according to the manufacturer’s instructions. 
7.3.5 Flow cytometric analysis
To assess basophil-surface IgE loading, whole blood samples were collected in EDTA. 
Following lysis of erythrocytes in RBC lysis buffer (eBioscience), cell pellets were blocked 
with anti-mouse CD16/CD32 (clone 2.4G2, BD Pharmingen) and stained with anti-mouse 
CD45 (clone 30-F11), anti-mouse CD49b (clone DX5), anti-mouse FcεRIa (clone MAR-1) 
and anti-mouse IgE (clone RME-1, all from Biolegend). Basophils were identified within 
peripheral blood mononuclear cells as CD45MidCD49b+FcεRIa+IgE+, and IgE surface loading 
was determined from the mean fluorescence intensity of the anti-IgE stain. Immune profiling 
of MLN and PP lymphocytes was performed using the following fluorochrome-conjugated 
antibodies: antio-CD16/CD32 (clone 2.4G2, BD Pharmingen), anti-CD4 (clone GK1.5), anti-
Foxp3 (clone FJK-16s, eBioscience), anti-GATA3 (clone TWAJ, eBioscience), anti-CD44 (clone 
IM7), anti-CD62L (clone MEL-14), anti-ICOS (clone C398.4A), anti-T-bet (clone 4B10), anti-
RORgt (clone B2D, eBioscience) anti-neuropilin-1 (product number FAB556A, R&D systems) 
and Fixable Viability Dye eFluor® 450 (eBioscience). Transcription factors were stained using 
the Foxp3/Transcription Factor Staining kit (eBioscience). 
  PBMCs from patients were isolated and regulatory CD4+ T cells were stained as 
previously described (Milner et al., 2015) with Live/Dead Fixable Blue viability dye (Invitrogen, 
Carlsbad, CA), anti-CD3 Alexa Fluor (AF)700, anti-CD25 phycoerythrin (PE)-Cy7, anti-CD127 
AF647, anti-CD4 brilliant violet 605, anti-GATA3 AF488 (BD Biosciences, San Jose, CA), anti-
CD45RO Texas Red-PE (Beckman Coulter, Brea, CA), and anti-FOXP3 efluor 450 (eBioscience, 
San Diego, CA). 
7.3.6 Mast cell degranulation assays
Bone marrow-derived cells from WT BALB/c mice were differentiated to mast cells in vitro 
by culturing cells in RPMI 1640 medium (Gibco) supplemented with 10% FCS, 100 U/ml 
penicillin and 100 μgml-1 streptomycin, 2 mM L-glutamine, 50 μM β-mercaptoethanol, 10 
ngml-1 interleukin-3 and 20 ngml-1 stem cell factor (SCF) (henceforth referred to as mast cell 
medium). Experiments were performed using cultures that were at least 8 weeks old and 
had a purity of >90% as assessed by cell surface co-expression of mast cell markers c-kit 
(clone 2B8) and FceRIa (clone MAR-1, both from Biolegend) by flow cytometry. Prior to 
degranulation assay, mast cells were resuspended in 106/ml mast cell medium and loaded 
overnight with dilutions of mouse serum in concentrations as indicated per experiment. The 
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next day, cells were washed twice in medium, plated in a 96-well tissue culture plate (105 cells 
in 100 μl per well) and stained with viability dye. Cells were then challenged for 10 minutes 
with an antigen cocktail containing solubilized chow antigens (protein concentration 5 
μgml-1) or OVA (500 ngml-1), in combination with anti-mouse LAMP-1 antibody (clone 1D4B, 
Biolegend). Following two washes with cold flow cytometry buffer (0.01% NaN3 in PBS), cells 
were acquired on a FACSCanto II flow cytometer (BD Bioscience) and further analyzed using 
FlowJo software (Treestar).  
7.3.7 Histology and mast cell staining
Following euthanasia, intestinal sections were isolated and flushed with cold PBS. Three 
jejunal sections per animal were fixed in formalin for 24h and then transferred to 70% ethanol. 
Tissue samples were paraffin-embedded and sectioned by the Histology Core facility of Beth 
Israel Deaconess Medical Center (Boston, MA), and mast cell quantification was performed 
as described (Burton et al., 2012). In brief, slides were deparaffinized in sequential xylene 
baths and rehydrated in graded alcohol solutions. Chloroacetate esterase staining solution 
consisted of 0.04% naphtol AS-D chloroacetate (Sigma), 0.04% pararosaniline (Sigma), and 
0.04% sodium nitrite (Sigma) in PBS, and was used to stain slides for 30 minutes at room 
temperature. Slides were counterstained with modified Harris hematoxylin solution (Sigma) 
and mounted in Permount (Fisher). For statistical analysis, a blinded investigator counted 
mast cells in 4 randomly selected high-power fields. Images were captured using an Olympus 
DP70 microscope equipped with DP Controller software (Olympus corporation). 
7.3.8 Quantitative RT-PCR
Three jujunal tissue sections were pooled and stored in RNAlater (Qiagen). Following tissue 
disruption and homogenization, total RNA was extracted using an RNeasy Plus mini kit 
(Qiagen) and reverse transcribed using iScript Supermix (Bio-Rad). Mcpt1 gene expression 
was assessed with iQ SYBR Green Supermix (Bio-Rad) using the following primers: FOR 5’-
GAG GAC AGA TGT GGT GGG TTT-3’ and REV 5’-AGG AGT CAA CTC AGC TTT CTC TT-3’, and 
normalized against expression of housekeeping gene Hprt (FOR 5’-GTT GGA TAC AGG CCA 
GAC TTT GTT G-3’ and REV 5’-GAG GGT AGG CTG GCC TAT AGG CT-3’). Relative expression was 
determined using the 2-ΔΔCt method, in which the ΔCt of a WT sample was set as reference 
value.
7.3.9 In vivo allergen challenge
To assess the occurrence of oral anaphylaxis, mice were starved for 3 hours and then 
challenged with 12.5 mg soy protein in 300 μl PBS by gavage. Body temperature was registered 
with the use of implantable temperature transponders (IPTT-300, Biomedic Data Systems, 
Seaford, Del). Baseline temperature was defined as the average of three measurements 
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prior to challenge, and severity of anaphylaxis was assessed by calculating the ΔT from this 
average every 10 minutes after challenge. 
7.3.10 Ex vivo culture and stimulation of mesenteric lymphocytes
Following isolation of MLNs, single cell suspensions were purified using a MagniSort Mouse 
CD4+ T cell Enrichment Kit (eBioscience) according to the manufacturer’s protocol and 
resuspended and plated in RPMI 1640 medium (Gibco) supplemented with 10% FCS, 100 
U/ml penicillin, 100 μgml-1 streptomycin, 2 mM L-glutamine and 50 μM β-mercaptoethanol. 
Cytokine production was determined by ELISA in supernatants obtained in triplicates from 
200,000 cultured cells per well that were stimulated for 18-24h with anti-CD3/CD28 using 
Dynabeads® (Life Technologies). 
7.3.11 In vitro polarization
Naïve T cells were isolated from CD45.1 congenic C57BL/6 mice, stained using antibodies 
against anti-CD3 clone 145-2C11 (BioLegend), anti-CD4 cloneGK1.5 (Biolegend), anti-CD25 
clone PC61 (BioLegend), anti-CD44 cloneIM7 (BioLegend) and anti-CD62L clone MEL-14 and 
sorted based on CD3+CD4+CD25-CD44-CD62L+. 2.5x105 cells were plated in a 24-well plate 
in RPMI 1640 medium (Gibco) supplemented with 10% FCS, 100 U/ml penicillin, 100 μgml-1 
streptomycin, 2 mM L-glutamine, 50 μM β-mercaptoethanol, and stimulated with plate bound 
5 mgml-1 anti-CD3 clone 145-2C11 (BD Pharmingen) and 1 mgml-1 anti-CD28 clone 16-0281-
85 (BD Pharmingen) for 7 days in the presence of 20 ngml-1 of IL2 (Peprotech), 10 ngml-1 IL-12 
(R&D systems), and 10 mgml-1 anti-IL-4 clone 11B11 (BD Pharmingen) for Th1 polarization; 
20 ngml-1 of IL-2, 100 ngml-1 IL-4, 10 mgml-1 anti-IFNg clone XMG1.2 (BD Pharmingen), and 
10 mgml-1 anti-IL-12 clone C17.8 (BD Pharmingen) for Th2 polarization; 20 ngml-1 of IL-6 
(BioLegend), 2 ngml-1 of human TGFb (BioLegend), 10 mgml-1 anti-IFNg and 10 mgml-1 anti-
IL-4 for Th17 polarization.  
7.3.12 Treg suppression assay
Following in vitro Th polarization, responder cells were labeled with CFSE and 5x104 cells 
were co-cultured in a 1:1 ratio with sorted CD3+CD4+GFP+ Tregs isolated from Was+/+Foxp3Cre-
EGFP or Wasfl/flFoxp3Cre-EGFP mice plated in a 96-well round bottom plate in RPMI 1640 (Gibco) 
supplemented with 10% FCS, 100 U/ml penicillin, 100 μgml-1 streptomycin, 2 mM L-glutamine, 
50 μM β-mercaptoethanol and stimulated with aCD3/aCD28 Dynabeads® (Life Technologies) 
for 3 days. Responder cell proliferation was analyzed by staining with anti-CD45.1 clone A20 
(BioLegend) and assessing CFSE dilution using a 3-laser BD FACSCanto II (BD Biosciences) 
flow cytometer.
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7.3.13 In vitro Treg generation assay
CD3+CD4+CD25-GFP- naïve T cells were sorted from Was+/+Foxp3-Cre-EGFP and Wasfl/flFoxp3-
Cre-EGFP mice. 5x104 sorted cells were plated in a 96-well plate in RPMI 1640 medium 
(Gibco) supplemented with 10% FCS, 100 U/ml penicillin, 100 μgml-1 streptomycin, 2 mM 
L-glutamine, 50 μM β-mercaptoethanol, and stimulated with anti-CD3/anti-CD28 Dynabeads 
(Life Technologies) in the presence of 2 ngml-1 TFGβ (BioLegend) for 5 days. WT and Was-/- 
GFP+ iTregs were assessed for GATA3 expression using a 3-laser FACSCanto II (BD Biosciences).
7.3.14 Nanostring assay and hierarchical cluster analysis
Digital gene expression profiling was performed on isolated whole tissue jejunal RNA as 
previously described using a customized Nanostring® codeset consisting of 86 inflammatory 
targets and five housekeeping genes (Platzer et al., 2015a). 57 out of 86 investigated genes 
that were differentially expressed in any pair-wise 2-sided t-test comparison (p<0.05) were 
subjected to hierarchical cluster analysis based on absolute Pearson correlation value with 
pairwise average linkage using the GenePattern algorithm (http://genepattern.broadinstitute.
org).  
7.3.15 Statistical analysis
All results were analyzed and visualized using GraphPad Prism version 6.0c for Mac (GraphPad 
Software). Details pertaining the use of specific statistical tests are provided in the figure 
legends. A p-value of less than 0.05 was considered significant.
7.3.16 Study approval 
All patients provided informed consent prior to inclusion in the study. Clinical studies 
were performed under an NIH IRB-approved research protocol (NCT01164241). All animal 
experiments were performed in accordance with Institutional Animal Care and Use 
Committee-approved protocols number 13-06-2415R and 14-04-2677R (IACUC, Boston 
Children’s Hospital), and adhered to the National Research Council’s ‘Guide to the care and 
Use of Laboratory Animals’.
7.4 Results
7.4.1 Sensitization to food antigens and food allergy are enriched among patients with 
WAS mutations
We assessed the overall burden of clinical food allergy within a cohort of 25 patients with 
mutations in the WAS gene. Results from three patients were excluded from the analysis as 
they could not be tested prior to hematopoietic stem cell transplantation. A variety of WAS 
mutations were observed in this cohort (Figure 7.1A), which consisted of both patients with 
WAS (n=15) as well as XLT (n=10). Elevated IgE (normal range 0-90 IU/ml) was observed in 59% 
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Figure 7.1. Increased sensitization and prevalence of food allergy among patients with WAS mutations. (A) 
Schematic of WAS gene with mutations identified among cohort (n = 25). Bold indicates Wiskott-Aldrich syndrome 
(WAS) diagnosis; unbolded indicates X-linked thrombocytopenia (XLT); italicized indicates mutations associated with 
food allergy in childhood.  (B) Total serum IgE levels and food allergen specific IgE (sIgE) levels among cohort; limit 
of detection for sIgE was 0.1 IU/ml. Light grey fill indicates the normal range; boxes indicate median and interquartile 
ranges for four foods reported in NHANES (Ref 23). White circles indicate food allergic individuals. (C) Among patients 
with sera obtained prior to transplantation (n = 22), percent of WAS (n = 12) or XLT (n = 10) patients with positive 
serum IgE (sIgE) to foods (minimum cutoff 0.35 IU/mL) compared to the general population as reported in NHANES 
analysis (left panel). Prevalence of food allergy during childhood among all WAS (n = 15) and XLT (n = 10) patients 
compared to those reported in the general population (NHANES) and in patients with moderate to severe atopic 
dermatitis (AD) (right panel) (Refs 24 and 25). (D) Concordance of sIgE measurement to skin prick testing to foods 
(SPT) for individuals who underwent both modalities (n = 14) (left panel).  Results of SPT and sIgE testing among 
patients with persistent clinical food allergy (n = 4); two individuals with food allergy in childhood without current 
evidence of sensitization were excluded (right panel). (E) Percent positive wheal responses to SPT with morphine 
titration among patients with WAS mutations (n = 13) compared to sex-matched controls (n = 15), *p=0.03 by Fisher’s 
exact test. U/D – undefined; N/D – none detected; WH1 – WASP Homology domain 1; GBD – GTP-ase binding domain; 
PPP – Polyproline domain; VCA – verprolin homology, cofilin homology and acidic region domain. 
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of patients (13/22), and food allergen-specific IgE was detected in 33% (4/12) of WAS and 20% 
(2/10) of XLT patients (Figure 7.1B) (Salo et al., 2014). Compared to the general population, 
individuals with WAS mutations were more likely to demonstrate serum sensitization to 
peanut, milk, and egg (Figure 7.1C) (Salo et al., 2014). The prevalence of physician-diagnosed 
food allergy among WAS and XLT patients in childhood (20% and 30%, respectively) was also 
increased compared to rates reported among children in NHANES (6.5%) (McGowan and 
Keet, 2013) and approached levels reported among children with moderate-severe atopic 
dermatitis (37±13%) (Figure 7.1C) (Eigenmann et al., 1998), although none of the patients 
reported a history of anaphylaxis. Food sensitization was generally detected with greater 
sensitivity using serum IgE (sIgE) testing than by skin prick test (SPT, Figure 7.1D, left panel): 
peanut and egg white allergens failed to elicit positive SPT responses in two physician-
diagnosed food allergic patients who were found positive for sIgE against these two allergens 
(Figure 7.1D, right panel). One patient with a clinical history consistent with food allergy was 
negative both by SPT and by serum-specific IgE to all tested food antigens. Five additional 
patients who underwent sIgE testing could not have SPT performed and were not included 
in evaluating the sIgE/SPT concordance rates. Patients with mutations in WAS demonstrated 
dampened wheal responses to skin-challenge with morphine (Figure 7.1E), suggesting that 
WASP deficiency in mast cells may contribute to the high discordance of sIgE levels and SPT 
responses. Taken together, our data demonstrate a marked enrichment of clinically relevant 
food-antigen-specific IgE in patients with mutations in WAS.
7.4.2 Was-/- mice spontaneously develop IgE-mediated immune responses to food 
allergens
Following the observation that WAS patients frequently develop IgE antibodies against food 
antigens, we investigated the occurrence of IgE-mediated responses to allergens in chow 
in WASP-deficient mice. Was-/- females or hemizygous Was- males (henceforth both referred 
to as Was-/- mice) on BALB/c, C57BL/6, and 129SvEv backgrounds developed elevated levels 
of total serum IgE and IgG1 in comparison to background-matched wild-type (WT) controls 
(Figure 7.2A and 7.S1A,C). Serum IgE increased with age and correlated positively with the 
density of surface-bound IgE on circulating basophils, indicating that binding of IgE to its 
high-affinity receptor FceRI was unperturbed in Was-/- animals (Figure 7.S1A,B). We next 
developed ELISA-based assays to screen for antibodies against the five main components of 
mouse chow. Food-specific antibodies were not detected in WT mice while soy and wheat-
specific IgE and IgG1 were readily detected in the serum of Was-/- mice (Figure 7.2B). For all 
investigated food extracts, a strong positive correlation between ingredient-specific titers of 
IgE and IgG1 was observed (Figure 7.S1D). The observation that food-specific IgE could be 
detected in Was-/- mice on three different genetic backgrounds indicated that sensitization to 
ingested antigens did not result from colonic inflammation since, in contrast to Was-/- mice 
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on the colitis-prone 129SvEv background (Nguyen et al., 2007; Snapper et al., 1998), animals 
on the BALB/c and C57BL6 background are resistant to colitis (Figure 7.S1E,F). 
Figure 7.2. Spontaneous sensitization to food antigens and food allergy in Was-/- mice. (A) Comparative 
analysis of total serum IgE and IgG1 levels in 3-month old WT BALB/c (open circles, n=7) and Was-/- mice (gray circles, 
n=9) of mixed genders. (B) IgE and IgG1 reactivity against the five main (%w/w) chow components as determined by 
ELISA in 1:30 (IgE) or 1:1000 (IgG1) diluted serum samples. (C) Loading of WT bone-marrow-derived mast cells with 
serum of food allergic (FA Sens) or non-food allergic (FA Non-Sens) Was-/- mice compared to no-serum control (left 
panel). Appearance of surface LAMP-1 as a marker of mast cell degranulation after stimulation with antigen extracts 
from conventional chow (CCh), elemental chow (ECh) or PBS (-). (D) Intestinal mast cell expansion as determined by 
chloroacetate esterase staining of jejunal cross-sections (20X, with digital magnification to 50X shown in window) 
and quantification in WT (n=7) and Was-/- mice (n=8). (E) Serum levels of mast cell protease 1 (MCPT1) determined 
by ELISA. (F) Effect of 7-day treatment with elemental diet on serum MCPT1 in Was-/- mice (n=11). Spearman’s 
rank correlation between cumulative anti-food IgE titers of mice and response to allergen elimination defined as 
ΔMCPT1. (G) Effect of oral rechallenge with 12.5 mg soy protein extract on body temperature and serum MCPT1 
after 4h. Symbols represent individual mice and error bars depict SEM. N/D: not detectable; ** p<0.01; ***p<0.001; 
NS: not significant as determined by two-tailed Student’s t-test. Results in C are representative of 2 independent 
experiments. Equivalent results were obtained in a cohort of WT and Was-/- mice on the 129sv background. 
  To assess whether food-specific serum IgE from Was-/- mice was functional in mediating 
type I hypersensitivity reactions, bone marrow-derived WT mast cells were loaded with 
serum from Was-/- mice previously identified by ELISA to be sensitized to food antigens (FA 
Sens) or with serum from Was-/- mice of comparable IgE titer that had been found to not 
be sensitized to food (FA Non-Sens, Figure 7.2C). The appearance of lysosomal-associated 
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membrane protein 1 (LAMP-1) at the cell surface of mast cells is an established surrogate 
marker for antigen/IgE-mediated histamine release (Burton et al., 2014a; Föger et al., 2011), 
and we found that WT mast cells loaded with serum from food-sensitized Was-/- mice 
degranulated in response to stimulation with an antigen extract from conventional chow 
(CCh), but not in response to an extract from a protein-free, amino-acid-based elemental 
diet (ECh, Figure 7.2C). In contrast, mast cells loaded with serum from non-food-sensitized 
animals were not activated by either food extract, which further demonstrated that IgE-
dependent degranulation was antigen-specific and established that screening of antibody 
reactivity against the five main chow components is a reliable marker for the overall anti-
food IgE reactivity. 
  Expansion of intestinal mast cells is a common symptom in food allergic patients 
(Caffarelli et al., 1998; Hogan et al., 2012) and has been demonstrated to correlate with 
disease severity in experimental mouse models of food allergy (Brandt et al., 2003; Burton et 
al., 2012; Platzer et al., 2015a). In line with these findings, we observed expansion of the small 
intestinal mast cell pool in Was-/- mice as detected by chloroacetate staining on jejunal tissue 
sections (Figure 7.2D). In addition, mRNA expression levels of the mucosal mast cell marker 
Mcpt1 was elevated in Was-/- animals and positively correlated with the cumulative anti-food 
IgE titer (Figure 7.S1G). Since Was-/- mice cannot eliminate food antigens from their diet, we 
hypothesized that persistent oral allergen exposure would result in continuous IgE/FceRI-
mediated degranulation of intestinal mast cells. Indeed, Was-/- animals had elevated serum 
levels of the mast cell protease MCPT1 (Figure 7.2E), which is released from mucosal mast 
cells in response to IgE-mediated detection of food antigens (Brandt et al., 2003; Khodoun 
et al., 2011). Moreover, anti-food IgE titers positively correlated with serum MCPT1 levels 
(Figure 7.S1H). Consistent with a critical role for food antigens in mast cell activation, 
elimination of the dietary allergens via switching Was-/- mice from conventional chow to an 
elemental amino acids-based chow resulted in a decline in serum MCPT1 after 7 days, with 
the most pronounced therapeutic effect (defined as ΔMCPT1) observed in mice with the 
highest cumulative anti-food IgE titers (Figure 7.2F, right panel). Oral rechallenge with soy 
extract after more than a week of allergen elimination led to rapid activation of mucosal mast 
cells indicated by increased levels of serum MCPT1, but did not result in signs of anaphylactic 
shock as measured by a reduction in core body temperature (Figure 7.2G). Combined, these 
data demonstrate that Was-/- mice develop food-specific IgE, which effectively mediates 
mast-cell degranulation in vitro and in vivo. 
7.4.3 The microbial flora is dispensable for spontaneous oral sensitization to chow, but 
shapes the humoral anti-food response in Was-/- mice
Since commensal microbes play a dominant role in regulating IgE-mediated responses to 
food antigens (Cahenzli et al., 2013; Noval Rivas et al., 2013; Stefka et al., 2014), we assessed 
the contribution of the microbiome to the induction of food-specific IgE responses in Was-
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/- animals. When compared to specific pathogen free-housed (SPF) WT mice, both SPF and 
germ-free (GF) Was-/- mice showed elevated total IgE and IgG1 levels. Although total IgE was 
lower in GF Was-/- than in SPF Was-/- animals (Figure 7.3A), detailed food-specificity profiling 
of IgE and IgG1 revealed that sensitization to food occurred efficiently in mice housed under 
either condition (Figure 7.3B) with MCPT1 titers comparable between SPF and GF Was-/- mice 
(Figure 7.3C). Further comparative analysis of the isotype composition of the humoral anti-
food response in GF Was-/- and SPF Was-/- mice showed that anti-food IgG1 and IgG2b titers 
were elevated in the absence of microbes, whereas food-specific IgG3 and IgA levels were 
diminished (Figure 7.3D and Figure 7.S2). Since the chow used in SPF and GF setting differed 
only by one additional cycle of high-dose irradiation in the latter, it is reasonable to assume 
that all Was-/- animals were exposed to food of nearly identical antigenicity. Consequently, 
food-specific IgE responses in Was-/- mice do not require microbial modifications or co-
signals that could potentially confer allergenic properties to food antigens. Moreover, these 
results demonstrate that food allergy in Was-/- animals does not require alterations in the 
commensal flora that may possibly occur as a consequence of WASP deficiency. 
Figure 7.3. Commensals are dispensable for spontaneous sensitization to food in Was-/- mice but shape the 
isotype composition of the humoral anti-food response. (A) Comparison of total IgE and total IgG1 serum levels 
in 4-6-month old WT (open circles, n=5) or Was-/- (gray circles) on the 129SvEv background that were housed under 
either specific-pathogen-free (SPF, n=10) or germ-free (GF, n=14) conditions. (B) Food-specific IgE and IgG1 for the 
five main chow constituents in IgE (serum dilution 1:100) or IgG1 (1:5000) from SPF (n=8) and GF (n=7) Was-/- mice. (C) 
Comparison of serum MCPT1 levels. (D) Comparison of cumulative anti-food titers of IgE, IgG1, IgG2a (1:1000), IgG2b 
(1:1000), IgG3 (1:200), and IgA (1:5000) in SPF (n=8) and GF (n=7) Was-/- animals. Symbols represent individual mice 
and error bars depict SEM. *p<0.05; ** p<0.01; ***p<0.001; NS: not significant as determined by two-tailed Student’s 
t-test. Results are shown from sera obtained from mice from ≥3 independent cohorts. 
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Figure 7.4. WASP deficiency in Tregs is sufficient for the development of spontaneous food allergy and 
results in more severe disease. (A) Comparison of MCPT1 levels in mice with cell type-specific WASP deletions. 
Mice with conditional deletion of Wasfl/fl alleles in B cells (Wasfl/flMb1-Cre), CD11c+ dendritic cells (Wasfl/flItgax-Cre) 
or Tregs (Wasfl/flFoxp3-Cre) of ≥2 months of age, n≥5 per group. (B) Representative H&E (10X) and chloroacetate 
staining (20X) of intestinal cross-sections in Wasfl/flFoxp3-Cre or WaswtFoxp3-Cre littermates on C57BL/6 background. 
(C) Comparison of total and soy-specific IgE and IgG1 at 2 months in co-housed WT (open circles, n=9), Was-/-  (gray 
circles, n=12), and Wasfl/flFoxp3-Cre (black circles, n=9) mice of mixed genders on the C57Bl6 background. (D) 
Comparison of serum protein and jejunal mRNA expression levels of mucosal mast cell marker MCPT1. Symbols 
represent individual mice and error bars depict SEM. *p<0.05; ** p<0.01; ***p<0.001; NS: not significant as determined 
by two-tailed Student’s t-test (panel A) or one-way ANOVA with Tukey’s multiple comparisons test (panels C, D). BDL 
below detection limit. Data in panels C and D are representative of 2 independent cohorts. 
7.4.4 Conditional deletion of WASP in FOXP3+ regulatory T cells results in exacerbated 
Th2-type intestinal inflammation
WASP is expressed in all hematopoietic lineages, and its deficiency in dendritic cells, B 
cells, effector T cells or regulatory T cells (Tregs) has been described to have a variety of 
consequences for immune responses (Maillard et al., 2007; Nguyen et al., 2007; Thrasher and 
Burns, 2010; Westerberg et al., 2005). Unlike Was-/- mice, Was-/-Rag2-/- double knockout mice 
presented with serum MCPT1 levels comparable to WT or Rag2-/- animals (Figure 7.S3A), 
indicating that intestinal mast cell expansion and activation in WASP deficiency does not 
occur in the absence of an adaptive immune system. We next analyzed strains with conditional 
deletion of WASP in B cells (Wasfl/flMb1-Cre), CD11c+ dendritic cells (Wasfl/flItgax-Cre) or 
FOXP3+ Tregs (Wasfl/flFoxp3-Cre). Elevated serum MCPT1 was not found in animals harboring 
conditional deletions of WASP in B cells or dendritic cells, but was present in Wasfl/flFoxp3-
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Cre females or WasflFoxp3-Cre males (henceforth also referred to as Wasfl/flFoxp3-Cre mice) on 
both the C57BL/6 and 129SvEv backgrounds (Figure 7.4A). Histological analysis confirmed a 
profound expansion of mucosal mast cells in the small intestine of Wasfl/flFoxp3-Cre mice but 
not in their WaswtFoxp3-Cre littermates (Figure 7.4B). Mucosal mast cell infiltration occurred 
in the absence of gross histological changes and we observed no evidence of colitis in Wasfl/
flFoxp3-Cre mice on the C57BL/6 background (Figure 7.4B). 
Figure 7.5. WASP deficiency in Tregs results in Th2-type small intestinal inflammation. (A) Hierarchical 
cluster analysis of differentially expressed genes within a panel of 86 inflammatory targets in tissue sections 
obtained from jejunum of cohoused female mice. Row-normalized, log-transformed mRNA counts are shown from 
4 animals per group. (B) Bar graph representation and statistical analysis of mRNA expression of Il4, Ifng, and Il17a 
in jejunal sections as shown in panel A. Symbols represent individual mice and error bars depict SEM. ** p<0.01; NS: 
not significant as determined by one-way ANOVA with Tukey’s multiple comparisons test.
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  Following the observation that Treg-specific WASP deletion was sufficient for expansion of 
intestinal mast cells, we next asked whether WASP deficiency in other immune compartments 
contributed further to the pathogenesis of food allergic sensitization. Comparison of co-housed, 
age and sex-matched Wasfl/flFoxp3-Cre, Was-/- and WT animals revealed that Wasfl/flFoxp3-Cre mice 
developed higher levels of total and soy-specific IgE and IgG1 (Figure 7.4C), as well as higher 
serum MCPT1 levels and increased intestinal Mcpt1 mRNA expression (Figure 7.4D) than mice 
with complete deletion of WASP. More severe allergic intestinal inflammation was confirmed by 
digital mRNA expression profiling on jejunal tissue, which revealed a type 2 immune cluster that 
contained multiple mast-cell markers in addition to Mcpt1, including Mcpt2, Fcer1a, Fcer1b, and 
Cpa3, together with Th2-type cytokines Il4, Il13 and Il5 that were more prominently expressed in 
Wasfl/flFoxp3-Cre than Was-/- mice (Figure 7.5A and Figure 7.S3B). This analysis indicated that 
jejunal inflammation was Th2-specific since mRNA levels of Ifng, Il17a and Tnfa in the small 
intestine were equivalent to WT levels in both Was-/- and Wasfl/flFoxp3-Cre mice (Figure 7.5B and 
Figure 7.S3B). Taken together, these results demonstrate that conditional deletion of WASP in 
FOXP3+ Tregs resulted in increased development of IgE-mediated immune responses to food 
antigens and Th2-specific small intestinal tissue inflammation. 
7.4.5 WASP-deficient Tregs fail to selectively suppress Th2 effector responses in vivo 
Was-/- animals are known to have reduced FOXP3+ Treg numbers, and WASP-deficient Tregs 
exhibit aberrant proliferation and suppression in response to TCR stimulation in vitro 
(Humblet-Baron et al., 2007; Maillard et al., 2007; Marangoni et al., 2007). These abnormalities, 
which can be partly attributed to reduced levels of IL-2, have previously been associated 
with the occurrence of autoimmunity and colitis in Was-/- mice (Humblet-Baron et al., 2007; 
Maillard et al., 2007). The sequelae of Treg-conditional WASP deficiency on intestinal immune 
homeostasis, however, have thus far remained undefined. 
  In sharp contrast to Was-/- mice, both relative and absolute FOXP3+ Treg numbers in the 
MLNs and Peyer’s patches (PPs) of Wasfl/flFoxp3-Cre were equal to or higher than those of WT 
counterparts (Figure 7.6A and Figure 7.S4A). This increase in Treg numbers compared to 
Was-/- mice could have been due to higher levels of IL-2, since CD4+ T cells from the MLNs of 
Wasfl/flFoxp3-Cre mice were found to produce WT levels of IL-2 upon anti-CD3/CD28 stimulation 
(Figure 7.6B). We reasoned that a relative underrepresentation of peripherally-induced FOXP3+ 
Tregs (iTregs), which particularly control tolerance to foreign antigens (Josefowicz et al., 2012b), 
could potentially underlie the occurrence of IgE-mediated immune responses to food antigens. 
However, cell surface staining of neuropilin-1, the absence of which specifically defines iTregs 
(Weiss et al., 2012; Yadav et al., 2012), revealed that iTregs made up equivalent fractions of total 
FOXP3+ Tregs in WT, Was-/- and Wasfl/flFoxp3-Cre mice (Figure 7.S4B). Similarly, we found no 
differences in the activation-status of Tregs as Wasfl/flFoxp3-Cre and WT mice showed equal 
fractions of CD44hiCD62Llo effector-memory Tregs (Figure 7.S4C). 
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Figure 7.6. WASP-deficient Foxp3+ Tregs fail to suppress Th2 type lymphoproliferation in vivo. (A) Quantification 
by flow cytometry of Foxp3+ Tregs amongst CD4+ T cells obtained from mesenteric lymph nodes (MLNs) or Peyer’s patches 
(PP) of WT (open circles, n=5), Was-/- (gray circles, n=6) and Wasfl/flFoxp3-Cre (black circles, n=4) mice. (B) Production of 
IL2 by CD4+ mesenteric T lymphocytes stimulated with anti-CD3/CD28 ex vivo. Each dot represents the average cytokine 
production from triplicate cell suspensions from a single mouse. (C) Total CD4+ T cell numbers obtained from MLN and 
PP. (D) Gating strategy of GATA3+ICOS+ Th2-type effector cells within the parent gate of effector memory T cells from MLNs 
of representative samples, with quantification and statistical testing in the right panels. (E) Fraction of T-bet+ and RORgt+ 
effector memory T cells. (F) Production of IL-4, IL-13, IFN-g and IL-17a by CD4+ mesenteric T lymphocytes stimulated with 
anti-CD3/CD28 ex vivo. Each dot represents the average cytokine production from triplicate cell suspensions from a single 
mouse. (G) Serum levels of anti-soy specific IgE and IgG1, and MCPT1 in Was-/- mice on the 129SvEv background with 
either Il4+/+ (gray circles, n=10 or 15) or Il4-/- alleles (gray squares, n=8). (H) Anti-soy IgG2b titer as determined by ELISA in 
1:1000 serum dilution. Symbols represent individual mice and error bars depict SEM. *p<0.05; ** p<0.01; ***p<0.001; NS: 
not significant as determined by two-tailed Student’s t-test or one-way ANOVA with Tukey’s multiple comparisons test. 
In B and F, data were log-transformed prior to statistical testing. Data from 2 pooled experiments (panels C, G and H) or 
representative results from ≥2 independent experiments (panels A, B, D, E and F) are shown.
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  Despite these normal numerical and phenotypical characteristics of WASP-deficient 
FOXP3+ Tregs, we observed that both Was-/- and Wasfl/flFoxp3-Cre mice developed a mild 
CD4+ lymphoproliferation in MLNs (Figure 7.6C). Within this expanded CD4+ T cell pool 
in MLNs of Was-/- and Wasfl/flFoxp3-Cre mice, an increased fraction of cells displayed the 
CD44hiCD62Llo effector-memory T cell phenotype. Within this latter fraction, we observed an 
increase in Th2-skewed effector T cells as determined by their co-expression of ICOS and the 
Th2 transcription factor GATA3 (Nurieva et al., 2003; Tindemans et al., 2014) (Figure 7.6D 
and Figure 7.S4D). In sharp contrast, the fraction of Th1-skewed, T-bet+ effector T cells was 
decreased in Wasfl/flFoxp3-Cre mice, whereas the abundance of Th17-skewed, RORgt+ T cells 
was equivalent amongst all three genotypes (Figure 7.6E). This selective Th2 skew in the CD4 
effector compartment was corroborated further by analysis of cytokine production from CD4+ 
mesenteric lymphocytes cultured ex vivo, which showed significantly increased production 
of IL-4 and IL-13, whereas IFN-g and IL-17 production was similar to WT mice in both Was-/- 
and Wasfl/flFoxp3-Cre animals (Figure 7.6F). These results demonstrated that WASP-deficient 
Tregs are capable of normally regulating Th1 or Th17 differentiation, but fail to specifically 
contain Th2 effector responses in vivo.
  We then aimed to investigate whether WASP-deficient FOXP3+ Tregs were selective in 
their capacity to suppress Th1, Th2, or Th17 polarized effector cells in vitro. To do this, we first 
isolated congenically marked CD45.1+ naïve CD4+ T cells and polarized them into Th1, Th2, or 
Th17 effector subsets respectively (Figure 7.S5A). We confirmed the identity of the polarized 
cells by staining for Th-specific transcription factors T-bet, GATA3, and RORgt (Figure 7.S5B). 
We then CFSE-labeled these responder cells and co-cultured them with sorted EGFP+ Tregs 
from Was+/+Foxp3-Cre or Wasfl/flFoxp3-Cre mice (Figure 7.S5C) in the presence of aCD3/aCD28 
and examined CD45.1+ responder cell proliferation 72 hours later (Figure 7.S5D). Both WT and 
WASP-deficient FOXP3+ cells proved equally poor in their ability to suppress in vitro polarized 
effector cells (Figure 7.S5D) even though the WT Tregs were competent to suppress naïve T 
cells proliferation (Figure 7.S5E). With this set of experiments, we were therefore unable to 
demonstrate that the selective loss of Th2 suppression by WASP-deficient Tregs in vivo also 
occurs with co-cultured polarized cells in vitro. 
  We next assessed the pertinence of the Th2 cytokine IL-4 on the pathogenesis of food 
allergy in Was-/- mice, by analyzing the extent to which food allergic sensitization occurred 
in Was-/-Il4-/- animals. Anti-soy, as well as total IgE and IgG1 responses were completely 
abrogated in the absence of IL-4, and mucosal mast cell expansion and activation did not 
occur as assessed by serum MCPT1 levels (Figure 7.6G and Figure 7.S4E). Furthermore, 
anti-soy titers of the IL-4-independent IgG2b isotype were also significantly lower in Was-/-Il4-/- 
mice (Figure 7.6H), signifying a critical role for Th2-mediated inflammation in the induction 
of anti-food humoral immune responses in WASP-deficient mice. 
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Figure 7.7. WASP-deficient effector Tregs assume a Th2-like phenotype in mice and human patients. (A) 
Fraction of CD44hiCD62LloCD4+Foxp3+ Tregs that co-express GATA3 and ICOS in WT (open circles, n=4), Was-/- (gray 
circles, n=6) and Wasfl/flFoxp3-Cre (black circles, n=5) mice, with gating strategy in representative samples depicted 
on the right. (B) Intracellular GATA3 levels in CD44loCD62LhiCD4+Foxp3+ Tregs determined by flow cytometry. (C) 
GATA3+ICOS+ effector T cells in WT or Was-/- mice with either Il4+/+ (gray circles, n=4) or Il4-/- alleles (gray squares, n=3) 
and IL-4 production by CD4+ mesenteric lymphocytes stimulated with anti-CD3/CD28 ex vivo. Each dot represents 
the average cytokine production from triplicate cell suspensions from a single mouse. (D) Percentage of Foxp3+ 
Tregs co-expressing GATA3 and ICOS, T-bet, or RORgt in in WT or Was-/- mice with either Il4+/+ or Il4-/- alleles.  (E) 
Gating strategy and cumulative data of percent of total effector (CD45RO+) Tregs co-expressing GATA3 in isolated 
peripheral blood mononuclear cells (PBMCs) from XLT (n=10) and WAS (n=11) patients compared to age and sex 
matched controls (n=10) or WAS patients following hematopoietic stem cell transplantation (HSCT, n=3). Symbols 
represent individual mice or patients and error bars depict SEM. *p<0.05; ** p<0.01; ***p<0.001; NS: not significant 
as determined by one-way ANOVA with Tukey’s multiple comparisons test. Mouse experiments representative of 2 
independent experiments. Results in panel E are cumulative data from 1 experiment
Part 2 – Chapter 7
170
7.4.6 WASP-deficient effector Tregs assume a Th2-like phenotype
Recent data indicate a role for Th2-type-programmed Tregs in an experimental model of 
murine food allergy as well as human children (Noval Rivas et al., 2015). Similarly, a Th2-
promoting fraction of Tregs that depends on TCR signaling was identified in asthmatic mice 
and patients (Ulges et al., 2015). Since aberrant responses to TCR activation are a feature 
of WASP-deficient T cells (Matalon et al., 2013), we analyzed the extent to which WASP-
deficient Tregs display a Th2-like phenotype. In both Was-/- and Wasfl/flFoxp3-Cre mice, we 
observed increased fractions of GATA3+ICOS+ Tregs in MLNs compared to WT counterparts 
(Figure 7.7A and Figure 7.S6A). These cells were confined to the CD44hiCD62Llo effector-
like Treg subset as GATA3 expression in the naïve-like fraction of Tregs was equivalent to 
WT CD4+FOXP3+CD44loCD62Lhi Tregs (Figure 7.7B). Th2-type reprogrammed Tregs in the 
context of food allergy had previously been observed in a genetic model that relies on 
increased signaling through the IL-4 receptor (Noval Rivas et al., 2015). We therefore asked 
whether WASP-deficient CD44loCD62Lhi Tregs exhibit an increase GATA3 expression pattern 
in response to increased availability of IL-4 in a Th2-skewed inflammatory setting. However, 
analysis of Was-/-/Il4-/- animals revealed that while Th2 skewing of effector T cells and IL-4 
production from CD4+ mesenteric lymphocytes was abrogated (Figure 7.7C), an equivalent 
increase in the fractions of GATA3+ICOS+ memory-effector Tregs was found when compared to 
Was-/- IL-4 competent counterparts, while relative Treg numbers were similar between groups 
(Figure 7.7D and Figure 7.S6B). Additional analysis revealed that increased expression 
of transcription factors did not extend to T-bet or RORgt, as memory-effector Tregs co-
expressing these markers were found in similar frequencies amongst all genotypes (Figure 
7.7D). When naïve T cells were stimulated with anti-CD3/CD28 and TGFβ in vitro, we observed 
no difference in the induction of GATA3+ Tregs from WT or Wasfl/flFoxp3-Cre donor-derived 
cells (Figure 7.S6C), indicating that differentiation into the Treg lineage in the absence of 
WASP by itself is insufficient to cause increased GATA3+ expression. This suggests that the 
appearance of GATA3+ICOS+ Tregs depends on additional external signals in vivo. Combined, 
these data demonstrate that WASP-deficient effector memory Tregs, but not naïve-like Tregs, 
assume a Th2-like phenotype independently from increased IL-4 signaling. 
  Lastly, we looked whether GATA3+ Tregs are increased in patients with mutations in 
WAS. Individuals with either XLT or WAS displayed increased fractions of GATA3+ Tregs among 
the effector Tregs isolated from peripheral blood mononuclear cells (PBMCs, Figure 7.7E). 
Similarly, mean fluorescence intensity of GATA3 was higher in effector Tregs from WAS and 
XLT patients than in age-matched, male controls (Figure 7.S6D). Interestingly, we observed 
a correlation between severity of WAS mutation and GATA3-expression in Tregs, as the 
fraction of GATA3+ Tregs was significantly higher in WAS patients than in individuals with 
XLT. In agreement with our observations in mice, WAS patients also had a higher fraction 
of FOXP3- GATA3+ effector T cells (Th2 cells, Figure 7.S6E). Three WAS patients who had 
previously undergone hematopoietic stem cell transplantation (HSCT) showed a normal 
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GATA3+ effector Treg compartment, as well as Th2 effector cells among PBMCs (Figure 7.7E 
and Figure 7.S6E). These results indicate that loss of suppression of Th2 effector responses 
and assumption of a Th2-type phenotype of Tregs also occur in human WAS patients. 
7.5 Discussion
The Wiskott-Aldrich syndrome is an illustrative example of how investigating a monogenetic 
human disease can advance our understanding of immune pathways in health and disease 
(Liston et al., 2008; Thrasher and Burns, 2010). Data from Was-/- mice (Snapper et al., 1998) 
revealed that WASP-dependent functions are highly conserved between mouse and man 
and that many aspects of the human disease are faithfully mimicked in these animals. WASP 
is best characterized for its role as stimulator of ARP2/3-mediated actin polymerization, 
which enables a variety of downstream effector functions including tissue migration and 
filopodia stability. A vast body of literature has accumulated that addresses the molecular 
and immunological consequences of deficiency of WASP in not just T and B lymphocytes, 
but also iNKT cells, platelets, NK cells, mast cells, dendritic cells, monocytes and neutrophils 
(Massaad et al., 2013). Because many of these WASP-dependent functions have been defined 
in either patients and mice lacking WASP in all hematopoietic lineages, or in isolated cell 
systems ex vivo or in vitro, the systemic sequelae of cell-specific perturbations in WASP-
mediated signals has remained largely unknown (Massaad et al., 2013).
  Here we report an increased prevalence of allergic responses against common food 
antigens as a feature of WAS in humans. Although elevated levels of serum IgE and eczema 
are well-described characteristics of the disease, the burden of IgE-mediated allergic 
disorders among patients with WAS or XLT has remained largely uncharacterized. Our studies 
demonstrate that the elevated serum IgE pool in these patients is functional and has the 
capacity to mediate allergic reactions to common food antigens, which should prompt 
treating physicians to be vigilant for food allergy among these patients and to obtain a 
careful history of adverse events after food ingestion. 
  The connection between WASP deficiency and the occurrence of IgE-mediated reactions 
against foods was further corroborated by studies in Was-/- animals. WASP-deficient mice 
produce IgE and IgG1 antibodies with specificity for components of chow, most prominently 
soy and wheat, which are also two allergens commonly implicated in IgE-mediated food 
allergy in human patients (Sicherer and Sampson, 2010; Wang and Sampson, 2011). These 
responses were observed in Was-/- mice on three different genetic backgrounds, independent 
of colonic inflammation, and occurred similarly in mice that were housed under germ-free 
settings when compared to those colonized with an SPF-flora. As such, our findings suggest 
that mutations in Was predispose to allergic disease independently from microbe-derived 
signals or differences in strain-specific immune constitution.   
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  Using a loxP/Cre-based system permitting cell-specific deletion of WASP (Recher et al., 
2012), we demonstrated that FOXP3+ Tregs are critically dependent on WASP-mediated signals 
for their ability to maintain tolerance to ingested food antigens. These results indicate that 
WASP deficiency in other immune compartments such as antigen presenting cells, B cells, 
or effector CD4+ T cells is dispensable for the pathogenesis of food allergic responses in Was-
/- mice and, potentially, WAS patients. In fact, the absence of WASP in non-FOXP3+ immune 
cells is likely to have a net dampening effect on IgE sensitization to food antigens since both 
food-specific IgE titers and allergic intestinal tissue inflammation were significantly lower in 
Was-/- mice when compared with Wasfl/flFoxp3-Cre mice. In support of this conclusion, work by 
Morales-Tirado et al. previously identified a Th2-specific dysfunction of WASP-deficient CD4+ 
effector T cells, manifesting as a reduced production of IL-4 and compromised expulsion 
of N. Brasiliensis (Morales-Tirado et al., 2010). Indeed, following ex vivo TCR stimulation, we 
confirmed reduced production of IL-4 and IL-13 by CD4+ mesenteric lymphocytes obtained 
from Was-/- mice when compared to cells from Wasfl/flFoxp3-Cre mice. In human WAS patients, 
which are more likely to resemble Was-/- mice than Wasfl/flFoxp3-Cre animals, reduced effector 
function in Th2 lymphocytes may account for the observation that only 20-30% of WAS and 
XLT patients in our cohort suffer from clinically relevant food allergy. Notably, none of the food 
allergic patients suffered from anaphylaxis upon allergen exposure, which may be related to 
reduced mast-cell histamine secretion in response to IgE-mediated activation, as has been 
previously described for WASP-deficient mice (Pivniouk et al., 2003). Using morphine as an 
antigen/IgE-independent mast cell stimulus, we observed reduced wheal responses in WAS 
patients when compared to controls. Together with the high discordance between sIgE levels 
and SPT in patients with mutations in WAS, with several false-negative SPT results, these data 
suggest that mast cell dysfunction may contribute further to the moderate allergic phenotype 
in WAS patients, and in Was-/- mice when compared to Wasfl/flFoxp3-Cre animals. 
  Previous studies on Tregs in Was-/- mice have hypothesized that the immunopathology 
in these animals results in part from reduced numbers of FOXP3+ CD4+ lymphocytes in 
secondary lymphoid organs (Humblet-Baron et al., 2007; Maillard et al., 2007; Marangoni 
et al., 2007). However, we found that conditional deletion of WASP in Wasfl/flFoxp3-Cre 
mice did not lead to lower Treg numbers in PP’s or MLNs when compared to WT animals. 
These findings implicate functional abnormalities in WASP-deficient Tregs as the principal 
cause of immune dysregulation in Was-/- mice. Although these Treg abnormalities manifest 
in vivo as an inability to control Th2 effector cells, in vitro suppression assays showed that 
WASP-deficient Tregs were unable to suppress other effector cell subsets as well. The basis 
for this difference is not yet understood. In further support of a Treg-intrinsic role for WASP 
in controlling aberrant immune responses, we observed increased expression of the Th2 
transcription factor GATA3 in activated WASP-deficient Tregs from either Wasfl/flFoxp3-Cre or 
Was-/- hosts when compared to WT animals, and similarly in human patients with WAS in 
comparison with age and sex-matched controls.   
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  Although the molecular mechanism of Treg-specific dysfunction in the absence of 
WASP remains to be elucidated, emerging data suggest aberrant signaling downstream 
of TCR ligation as a possible candidate. Increased Th2 responses and elevated IgE also 
result from loss of function of the TCR-associated scaffold protein LAT (Aguado et al., 2002; 
Sommers et al., 2002). WASP is rapidly recruited to the TCR upon ligation (Barda-Saad 
et al., 2005), and is required for internalization of the TCR complex (Zhang et al., 1999). 
Since Tregs have been shown to require continuous TCR-dependent signaling for optimal 
suppressive function (Levine et al., 2014; Vahl et al., 2014), Alterations in downstream events 
following TCR-mediated activation in the absence of WASP may be related to the loss of Th2-
suppressive capacity. Moreover, deficiency of the TCR-associated phosphatase SHP-1 results 
in an increased population of GATA3+ Tregs and food allergy similar to our observations in 
patients and mice with WASP-deficiency (Noval Rivas et al., 2015). Together, these findings 
support a link between aberrant TCR signaling in WASP-deficient Tregs and unrestrained 
Th2 pathology in vivo. However, our studies also indicate that disruption of TCR-mediated 
signals in WASP-deficient effector T cells is not required for Th2-skewed immune responses 
to occur, as Wasfl/flFoxp3-Cre mice, which are sufficient for WASP in effector cells, showed 
increased numbers of GATA3+ effector T cells compared to Was-/- animals. Molecular profiling 
and immune phenotyping of WASP-deficient Tregs following TCR-mediated activation may 
further elucidate the mechanism that results in a Th2-skewed regulatory phenotype.
In summary, we identified an increased prevalence of IgE-mediated food allergy amongst a 
cohort of patients with mutations in WAS. Using Was-/- mice, we showed that IgE sensitization 
occurs both in the presence and absence of an intestinal flora and that the deficiency of WASP 
in FOXP3+ Tregs alone is sufficient to drive allergic intestinal inflammation. While capable of 
fully containing Th1 and Th17 effector responses in vivo, WASP-deficient Tregs exhibit a Th2-
like phenotype and fail to selectively restrain Th2 effector differentiation resulting in intestinal 
mast cell expansion and activation. Our findings demonstrate that in WAS, defective FOXP3+ 
Tregs promote Th2-type immune hyperactivation and allergic disease.
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7.8 Supplemental data 
Figure 7.S1. Age-dependency of IgE levels in Was-/- mice and absence of colonic inflammation in C57BL/6 
and BALB/c Was-/- animals. (A) Serum IgE levels in 129SvEv Was-/- animals between 8 and 24 weeks. (B) Bi-weekly 
assessment of surface IgE loading on blood basophils (CD45MidCD49b+) from WT (open circles, n=5) and Was-/- 
(gray circles, n=10) on the C57BL/6 background. (C) Total levels of serum IgG1 in C57BL/6 Was-/- mice. (D) Pearson 
correlation coefficients between anti-food IgE and IgG1 titers for the five main chow components in Balb/c Was-
/- mice. (E) H&E staining of colonic cross-sections from 6-12 month old WT and BALB/c Was-/- mice (20X) and (F) 
4-month old Was-/- mice on the C57BL/6 background (20X). (G) Relative gene expression of Mcpt1 in small intestinal 
(SI) tissue samples and correlation of Mcpt1 mRNA expression with anti-food IgE titer. (H) Pearson correlation 
coefficients (r) between food-specific IgE titers and baseline serum MCPT1. Symbols represent individual mice and 
error bars depict SEM. *p<0.05; ** p<0.01; ***p<0.001; NS: not significant as determined by two-tailed Student’s t-test 
or paired t-test for intraindividual analyses.
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Figure 7.S2. Detailed analysis of food-specific titers for the five main chow constituents. Contribution of 
individual component-specific immunoglobulins to the cumulative anti-food isotype titers of IgG2a, IgG2b, IgG3, 
and IgA in SPF (n=8) and GF-housed (n=7) Was-/- mice. Bars represent results from individual mice. 
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Figure 7.S3. Intestinal mast cell expansion in Was-/- mice requires adaptive immunity and Wasfl/flFoxp3-Cre 
mice develop Th2-type intestinal inflammation. (A) Comparison of serum MCPT1 in WT (open circles, n=5), Was-
/- (gray circles, n=8), Rag2-/- (open triangles, n=3) and Was-/-Rag2-/- (gray triangles, n=5) mice ≥ 2 months old on the 
129SvEv background. (B) Normalized absolute mRNA counts obtained from digital mRNA profiling of jejunal tissue 
for indicated genes. Symbols represent individual mice and error bars depict SEM. *p<0.05; ** p<0.01; ***p<0.001; 
NS: not significant as determined by two-tailed Student’s t-test (panel A) or one-way ANOVA with Tukey’s multiple 
comparisons test (panel B). 
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Figure 7.S4. WASP-deficient Foxp3+ Tregs fail to suppress Th2 type lymphoproliferation in vivo. (A) 
Quantification of Foxp3+ Tregs counts in MLNs and PPs of WT (n=5), Was-/- (n=6), and Wasfl/flFoxp3-Cre (n=4) 
animals. (B) Gating strategy and summary statistic of the fraction of iTregs, defined as Foxp3+ Neuropilin1-, within 
the total population of Tregs obtained from MLNs. (C) Summary statistic of the subpopulation of CD44HiCD62LLo 
effector memory Tregs within the total population of CD4+Foxp3+ lymphocytes. (D) Absolute numbers of Th2-type, 
GATA3+ICOS+ effector memory cells in MLNs and PPs. (E) Serum levels of total IgE and IgG1 in Was-/- mice on the 
129SvEv background with either Il4+/+ (n=10) or Il4-/- (n=8) alleles. Symbols represent individual mice and error bars 
depict SEM. *p<0.05; ** p<0.01; ***p<0.001; NS: not significant as determined by two-tailed Student’s t-test or one-
way ANOVA with Tukey’s multiple comparisons test. Representative results of 2 independent experiments. 
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Figure 7.S5. In vitro suppression of polarized Th cells. (A) Schematic of in vitro Th1, Th2, and Th17 polarization 
of WT naïve T cells and subsequent suppression assay using Was+/+Foxp3Cre-EGFP or Was-/- Foxp3Cre-EGFP. (B) Expression of 
Th-specific transcription factors following Th1/Th2/Th17 polarizing conditions. (C) Sorting of FOXP3-GFP+ cells from 
Was+/+Foxp3Cre-EGFP or Wasfl/flFoxp3Cre-EGFP mice. (D) Gating of CD45.1+ responder Th cells labeled with CFSE (left) with Th 
cell proliferation indicated by CFSE dilution in overlaid histograms (right). (E) Suppression of freshly isolated naïve 
CD4+ T cells by GFP+ WT Tregs isolated from Was+/+Foxp3Cre-EGFP mice. Data are representative of three independent 
experiments.
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Figure 7.S6. WASP-deficient effector Tregs assume a Th2-like phenotype. (A) Fraction of total CD4+Foxp3+ 
Tregs that co-express GATA3 and ICOS in WT, Was-/- and Wasfl/flFoxp3-Cre mice. (B) Fraction of Foxp3+ Tregs amongst 
CD4+ mesenteric lymphocytes and effector memory Tregs amongst total Foxp3+ Tregs in WT or Was-/- mice with 
either Il4+/+ or Il4-/- alleles on the 129sv background. (C) Comparison of TGFβ-mediated induction of GATA3+ Tregs 
from naïve CD3+CD4+CD25-GFP- T cells from WT or Wasfl/flFoxp3-Cre mice in vitro. Representative dot plots are shown 
with the percentage of GATA3+ iTregs depicted gated on CD3+CD4+GFP+ cells. (D) Mean fluorescent intensity (MFI) of 
GATA3 expression among total effector (CD45RO+) Tregs and (E) percent of GATA3+ effector T cells among XLT (n=10) 
and WAS (n=11) patients compared to age and sex matched controls (n=10) or WAS patients after hematopoietic 
stem cell transplantation (HSCT) (n=3). Dots represent cells from individual mice or patients and error bars depict 
SEM. *p<0.05; ** p<0.01; ***p<0.001; NS: not significant as determined by one-way ANOVA with Tukey’s multiple 
comparisons test. Panels A-C are representative of 2 independent experiments. Results in panels D and E are 
cumulative data from 1 experiment. 
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8.1 Abstract
Background: Food allergies are a rapidly growing health problem worldwide. Mechanisms 
underlying the natural development of this disease are poorly understood, in part, because 
spontaneous disease models have not been reported.
Objective: We sought to determine if sensitization to chow as spontaneously occurring 
in mice deficient for Wiskott-Aldrich syndrome (WAS) protein results in IgE-mediated food 
allergy. 
Methods: ImmunoCAP ISAC microarray was performed in serum of food allergic and WAS 
patients. Adjuvant-free sensitization to ovalbumin (OVA) was assessed following repetitive 
OVA gavage in WASP deficient (Was-/-) mice or in animals with a Treg-specific Was deletion 
(Wasfl/flFoxp3-Cre mice) and compared with an experimental model induced in wild-type 
mice by gastric gavage after intraperitoneal sensitization with OVA/alum.
Results: Polysensitization to multiple food antigens was found in food allergic and WAS 
patients. As seen in food allergic patients, low titers of OVA-specific IgE were found in the 
spontaneous Was-/- model. Anaphylaxis and allergic diarrhea occurred to a similar degree 
in both models. Adjuvant-free intestinal sensitization in Was-/- mice occurred independently 
of FcεRI but expansion of jejunal mast cells was less pronounced. Significant spontaneous 
sensitization and pronounced intestinal allergy was also observed in Wasfl/flFoxp3-Cre 
animals.
Conclusion: Was-/- and Wasfl/flFoxp3-Cre animals provide models for food allergy that address 
the current experimental gap in analyzing aberrant immune responses at the onset of food 
allergy. Wasfl/flFoxp3-Cre mice are a genetically parsimonious alternative to this model that 
allows the study of allergy without confounding influence of WASP deficiency in non-Treg 
immune compartments. 
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8.2 Introduction
Immunoglobulin E (IgE)-mediated food allergies are a rapidly growing health problem in 
industrialized societies. Although the determination of the exact prevalence is hampered 
by non-overlapping diagnostic definitions, estimates for US adults and children currently lie 
around 5% and 8% respectively (Sicherer and Sampson, 2014). In these patients, exposure 
to minute quantities of food allergens can trigger anaphylactic reactions, which range in 
severity from oral tingling and nausea to profuse diarrhea and anaphylactic shock (Longo et 
al., 2013). Allergic reactions to food can be fatal, and form a common reason for emergency 
room visits and hospitalization (Bock et al., 2007; Henson and Burks, 2012). Considerable 
research effort is therefore dedicated to understanding the origin of IgE-mediated food 
allergy (Sampson et al., 2014). 
  The pathogenesis of food allergic reactions consists of a sensitization phase, during 
which food-specific IgE antibodies are first produced, and an effector phase, in which IgE 
antibodies mediate activation of immune effector cells upon repeated exposure to food 
antigens. Allergic sensitization results from perturbations in the pathways that normally 
maintain a state of immune tolerance to innocuous food antigens. While the physiological 
outcome of food antigen presentation by dendritic cells is anergy of T cells and induction 
of FOXP3+ regulatory T cells (Tregs), sampling of intestinal allergens in food allergic patients 
instead results in Th2 effector responses. Allergen-specific Th2 cells respond to subsequent 
allergen encounters with production of Th2 type cytokines such as IL-4 and IL-13, and thereby 
can instruct allergen-specific B cells to undergo class-switching to IgE. Food-specific IgE 
circulates freely, until it binds to the high-affinity IgE receptor FcεRI that is expressed on the 
cell surface of mast cells and basophils. During the allergic effector phase, these IgE effector 
cells respond to antigen-mediated crosslinking of FcεRI by rapid secretion of pre-formed 
inflammatory mediators such as histamine and proteases, which are responsible for the 
local and systemic symptoms associated with allergic reactions. 
  Epidemiologic studies have identified numerous associations between genetic, 
microbial, environmental and nutritional factors and the development of food allergy, 
but experimental and mechanistic evidence to prove causality remains scarce. This gap in 
our understanding is, at least in part, attributable to the lack of animal models that mimic 
spontaneous sensitization to food as it occurs in humans (Van Gramberg et al., 2013). 
Wild-type mice have proven to be highly resistant to the dysregulation of IgE-mediated 
immune responses to food allergens, testifying to the robustness of the cellular regulatory 
mechanisms that normally mediate tolerance to ingested foreign antigens (Oyoshi et al., 
2014). Consequently, murine models of food allergy commonly rely on adjuvant-based 
strategies that either induce systemic production of antigen-specific IgE prior to first intestinal 
exposure, or, alternatively, disrupt the induction of oral tolerance by intestinal co-exposure 
to adjuvants such as cholera toxin or staphylococcal enterotoxin B (Berin and Mayer, 2009). 
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These models, which recapitulate the symptoms and treatment responses of human disease 
but not the underlying cause of disease, are considered ‘isomorphic’ (Oyoshi et al., 2014). 
A ‘homologous’ animal model of food allergy, in contrast, would not only capture the IgE 
effector phase of disease, but also faithfully mimic oral, spontaneous sensitization to food 
antigens (Oyoshi et al., 2014). Unfortunately, true homologous food allergy models do not 
exist at this time (Oyoshi et al., 2014), and while conventional adjuvant-based, isomorphic 
models have proven to be highly valuable tools to decipher the mechanisms of the symptoms 
of the mast cell-dependent IgE-effector phase, their use for understanding spontaneous 
disease onset remains contentious.
  Recently, we documented an increased prevalence of food allergy in human patients 
suffering from the primary immunodeficiency Wiskott-Aldrich syndrome (WAS). Similarly, 
mice that are deficient in the homologous murine Was gene (Was-/- females or hemizygous 
Was- males) were found to develop IgE antibodies against common food allergens such as 
wheat and soy that are ubiquitously present in mouse chow. Given this shared phenotype 
between human patients and the corresponding mouse model, we hypothesized that Was-
/- animals could potentially be developed as a novel experimental model to study allergic 
sensitization to intestinal allergens in a more homologous fashion. Here we show that Was-/- 
mice can be sensitized without a requirement for oral or systemic adjuvant against the model 
antigen OVA and that IgE-mediated effector responses are equivalent to those observed in 
a conventional food allergy model of disease. These data identify WASP-deficient mice as a 
novel model of experimental food allergy with a direct corollary to human disease. 
8.3 Materials and Methods
8.3.1 Patients
Serum from pediatric WAS patients was obtained from a bio repository maintained under 
IRB-approved protocol number P00000529 at Boston Children’s Hospital. Samples from 
age-matched food allergic and non-allergic control patients was available from a previously 
described longitudinal cohort study at Boston Children’s Hospital (Lexmond et al., 2013) that 
was approved by the Investigational Review Board of Boston Children’s Hospital (Harvard 
Medical School, Boston, MA, approval number: 07-11-0460). All patients or their legal 
guardians provided informed consent prior to donation of blood. 
8.3.2 Animals
The generation of Was-/- and Wasfl/flFoxp3-Cre mice has been previously described (Snapper 
et al., 1998) and Chapter 7. Was-/- and Was+/- or WT animals on both BALB/c and C57BL/6 
backgrounds were bred in house and kept under SPF conditions in compliance with 
institutional guidelines. Experiments were performed in littermate setting where possible 
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and comprised both sexes. Where additional mice were required to increase animal numbers, 
mice were cohoused prior to the start of the experiment. C57BL/6 Fcer1a-/- mice were crossed 
with Was-/- mice and then bred to give rise to cohorts of Was-/-Fcer1a-/- and Was-/-Fcer1a+/- 
littermates. All described experiments were approved by the Institutional Animal Care and 
Use Committee under protocol number 13-06-2415R (IACUC, Boston Children’s Hospital). 
8.3.3 ELISAs
IgE and IgG levels in human serum were detected by ELISA using anti-human IgE (clone: 
MHE-18, BioLegend) and anti-human IgG (Southern Biotech 2014-01) capture antibodies 
and horseradish peroxidase-conjugated anti-human IgE (Sigma-Aldrich A9667) or biotin-
conjugated anti-human IgG (eBioscience 13-4998-83) detection antibodies and quantified 
against serial dilutions of human IgE (NBS-C BioScience 0911-0-050) or human IgG (Southern 
Biotech 0150-01). Quantification of murine total, food antigen-specific and OVA-specific IgE 
and IgG1 has been previously described (Chapter 7 and (Platzer et al., 2015a). MCPT1, IL-13, 
IL-6 and TNF-α protein levels were quantified using Ready-Set-Go! ELISA sets (eBioscience) 
according to manufacturer’s instructions. 
8.3.4 ImmunoCAP ISAC microarray
Allergen-specific IgE and IgG4 in serum samples was detected using the ImmunoCAP® ISAC 112 
solid phase assay (Thermo Scientific, 81-1012-01) according to manufacturer’s instructions. 
For detection of IgG4, serum samples were diluted 1:50 with ImmunoCAP®-specific IgA/
IgG Sample Diluent and incubated for 2h at room temperature to ISAC 112 ImmunoCAP® 
microchips in a humidified chamber. After washing and drying, bound IgG4 was detected 
with fluorescently labeled anti-IgG4 as described by the manufacturer, and quantified as 
relative ISAC standard units between 0.1-12 ISU-G4 with Phadia Microarray Image Analysis 
(MIA®) and Xplain® software by ThermoFisher. 
8.3.5 In vivo food allergy models and allergen challenges 
The adjuvant-based model of OVA food allergy has been previously described (Brandt et al., 
2003). In brief, WT Balb/C mice were immunized with 50 μg of OVA (Sigma) in 100 μl aluminum 
hydroxide (Thermo Scientific) via a total of 3 intraperitoneal injections every 7 days. Adjuvant-
free sensitization to OVA in Was-/- mice was obtained by gavaging 5 mg of OVA in 200 μl PBS 
every 5th day for a total of 35 days as described in the main text. Following sensitization, 
mice were challenged by gavage with 50 mg OVA in 250 μl PBS. To assess anaphylaxis, body 
temperature was registered with the use of implantable temperature transponders (IPTT-
300, Biomedic Data Systems, Seaford, Del). Baseline temperature was defined as the average 
of three measurements prior to challenge, and severity of anaphylaxis was assessed by 
calculating the ΔT from this average every 10 minutes after challenge. 
Part 2 – Chapter 8
188
8.3.6 In vitro mast cell degranulation assays
Bone marrow-derived cells from WT or Was-/- mice on either the Balb/C or C57BL/6 
background were differentiated in vitro under influence of 10 ng/ml interleukin-3 and 20 ng/
ml stem cell factor (Peprotech) for 8-15 weeks in RPMI 1640 medium (Gibco) supplemented 
with 10% FCS, 100 U/ml penicillin and 100 μg/ml streptomycin, 2mM L-glutamine and 55 
μM  β-mercaptoethanol (mast cell medium). Purity of mast cell cultures was established 
using mast cell markers c-kit (clone 2B8) and FcεRI (clone MAR-1, both from Biolegend). For 
degranulation assays, cells were loaded for 16-24h with IgE using either diluted serum or 
100 ng/ml TNP-specific IgE, and then challenged with 500 ng/ml OVA or TNP-specific OVA in 
indicated doses. Degranulation was assessed by staining with anti-mouse LAMP-1 antibody 
(clone 1D4B, Biolegend) and viability dye (eBioscience). Cells were acquired on a FACSCanto 
II flow cytometer (BD Bioscience) and further analyzed using FlowJo software (Treestar). For 
some experiments, IgE-loaded mast cells were stimulated for 6h with 100 ng/ml TNP-specific 
OVA prior to collection of the supernatant for the assessment of cytokine production. 
8.3.7 Flow cytometric analysis of basophils
Whole blood samples were lytreated with RBC lysis buffer (eBioscience) and peripheral blood 
mononuclear cells were stained with an antibody cocktail containing: anti-mouse CD16/
CD32 (clone 2.4G2, BD Pharmingen), anti-mouse CD45 (clone 30-F11), anti-mouse CD49b 
(clone DX5), anti-mouse FceRIa (clone MAR-1) and anti-mouse IgE (clone RME-1, all from 
Biolegend). Basophils were identified as CD45MidCD49b+ and analyzed for IgE surface loading 
using the mean fluorescence intensity of the anti-IgE stain.
8.3.8 pERK WB and quantification
Bone-marrow derived mast cells were lysed in RIPA buffer containing protease inhibitor 
cocktail, 2mM PMSF, 1 mM  sodium orthovanadate and phosphotase inhibitor cocktail 
B (Santa Cruz Biotechnologies, Dallas, TX). Samples were run on 12%  SDS-PAGE gels, 
transferred to PVDF membranes (Pierce, Rockford, IL) and probed with following antibodies: 
anti-ERK1/2 and anti-phosphoERK1/2 (both reagents from Cell Signaling Technology, 
Danvers, MA) followed by peroxidase-conjugated goat anti-rabbit IgG. Peroxidase activity 
was detected with SuperSignal chemiluminescent substrate reagents (Pierce). Western blots 
were quantified with ImageJ (NIH). 
8.3.9 mRNA expression analysis
Intestinal Mcpt1 mRNA expression was determined as previously described (Chapter 7) 
using iQ SYBR Green Supermix (Bio-Rad) and the following primers: FOR 5’-GAG GAC AGA TGT 
GGT GGG TTT-3’ and REV 5’-AGG AGT CAA CTC AGC TTT CTC TT-3’, and normalized against 
expression of housekeeping gene Hprt (FOR 5’-GTT GGA TAC AGG CCA GAC TTT GTT G-3’ 
and REV 5’-GAG GGT AGG CTG GCC TAT AGG CT-3’). For mast cell assays, mRNA expression 
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was assessed by Nanostring® Mouse Immunology codeset (nCounter) according to the 
manufacturer’s protocol. 
8.3.10 Histology and mast cell staining
Mast cells were quantified using by chloroacetate esterase staining solution as previously 
described (Burton et al., 2012) and Chapter 7, and representative images were captured using 
an Olympus DP70 microscope equipped with DP Controller software (Olympus corporation). 
8.3.11 Statistical analysis
All results were analyzed and visualized using GraphPad Prism version 6.0c for Mac (GraphPad 
Software). Details pertaining the use of statistical tests are provided in the figure legends. 
8.4 Results
8.4.1 IgE and IgG4 antibodies against multiple foods are common in both food allergy 
and Wiskott-Aldrich syndrome
We have previously documented an increased prevalence of physician-diagnosed food allergy 
among patients suffering from WAS (Chapter 7). To further investigate the extent to which 
WAS-associated food allergy corresponds to common food allergic disease, we compared 
total IgE levels in serum samples from five pediatric WAS patients (aged 14 months to 7 years) 
with serum from age-matched patients who either suffered from food allergy (FA) or had no 
history of allergy (control). Pediatric FA and WAS patients demonstrated equivalent increases 
in total serum IgE levels when compared to control patients without allergic disease, whereas 
no differences were observed in serum total IgG levels between any of the groups (Figure 
8.1A). 
  Patients with food allergy are at increased risk of sensitization to other, unrelated food 
antigens (de Jong et al., 2011; Liu et al., 2010). To assess whether polysensitization is also 
a feature of WAS-associated food allergy, we performed an immunochip-based assay that 
allowed for high-throughput screening for IgE reactivity against 112 common allergens, 
49 of which represented food-derived epitopes from 19 unique foods. In three out of five 
patients with WAS, we observed IgE sensitization against food antigens, and two of these 
patients were found to be sensitized to at least two of the investigated foods. Similarly, four 
out of six FA patients were polysensitized to food antigens (Figure 8.1B). To further map the 
occurrence of anti-food antibody responses in FA and WAS patients, we also screened for the 
presence of allergen-specific IgG4, another Th2-dependent immunoglobulin that is thought 
to have a protective effect on the occurrence of food allergic reactions. IgG4 reactivity against 
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food allergens was common amongst all three diagnostic groups and across all investigated 
foods. Combined, these results demonstrate a high degree of overlap in total and food-
specific IgE and IgG4 sensitization profiles between FA and WAS patients. 
Figure 8.1. IgE and IgG4 antibodies against multiple foods are common in both food allergy and Wiskott-
Aldrich syndrome. (A) ELISAs for total serum immunoglobulin levels in pediatric WAS patients and age-matched 
controls without (control) or with food allergy (FA). (B) Antigen specificity profiling by ImmunoCAP® demonstrates 
the presence of IgE and IgG4 with specificity for common food allergens in WAS patients. Serum from 3 control, 6 FA, 
5 WAS patients was analyzed (3 WAS patients for IgG4). **p<0.01; ***p<0.001; NS: not significant as determined by 
ANOVA with Tukey’s multiple comparisons test on log-transformed data.
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Figure 8.2. Was-/- mice develop adjuvant-free IgE sensitization to orally administered OVA. (A-B) 
Experimental time course of adjuvant-based and adjuvant-free sensitization protocols. (C) Total IgE, OVA-specific 
IgE, and % OVA-specific IgE of total IgE before final challenge in OVA/alum sensitized (gray squares) WT mice and 
OVA-gavaged Was-/- (gray circles) or WT/ Was+/- littermates (open circles). (D) Mast cell degranulation following OVA 
stimulation. Wild-type cells were loaded with serum (diluted to contain 100 ng/ml OVA-specific IgE) from Was-/- or 
OVA/alum-sensitized WT. Representative of 2 experiments. (E) Degranulation assays in response to OVA after loading 
of WT mast cells with serum of similar total IgE levels from spontaneously sensitized Was-/- mice (dark gray bars) 
or OVA/alum-sensitized WT animals (light gray bars). The mean +SEM of biological triplicates is shown. Symbols 
represent individual mice. Error bars depict SEM. *p<0.05; ** p<0.01; ***p<0.001; NS: not significant as determined 
by ANOVA with Tukey’s multiple comparison test. Where data are displayed on a log-axis a log-transformation was 
performed prior to statistical analysis to meet normality assumptions.  
8.4.2 Was-/- mice develop OVA-specific IgE following oral antigen exposure without adjuvant 
Based on the presence of food antigen-specific IgE in the serum of Was-/- mice (hemizygous 
Was- males are also referred to as Was-/- throughout the manuscript), we hypothesized that 
allergic sensitization would occur in Was-/- animals following exposure to orally administered 
antigens in the absence of adjuvant. To be able to quantify and compare the efficiency of 
oral sensitization, we chose to study ovalbumin (OVA) as a model allergen, which is used 
in an established, isomorphic model of food allergy that relies on systemic sensitization by 
injection of OVA in aluminum hydroxide (Brandt et al., 2003) (Figure 8.2A). As predicted, 
after a sensitization phase of 8 oral gavages of 5 mg OVA in PBS (Figure 8.2B), OVA-specific 
IgE was detected in the serum of Was-/- mice, but not their Was+/- or WT littermates (Figure 
8.2C). However, absolute titers of OVA-specific IgE were significantly lower than those 
obtained following adjuvant-mediated sensitization. In addition, because Was-/- mice have 
an expanded IgE pool at baseline, an even greater difference existed in the fraction of OVA-
specific to total IgE between spontaneously sensitized Was-/- and OVA/alum-treated WT 
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animals (Figure 8.2C). To assess whether these disparate ratios of antigen-specific to total 
IgE levels affected the efficiency of antigen-mediated activation of the IgE-effector axis, we 
loaded bone marrow-derived mast cells with IgE in serum of mice from either model. When 
mast cells were loaded with equivalent concentrations of OVA-specific IgE, we observed 
denser surface IgE coating on cells loaded with serum from Was-/- mice (Figure 8.2D), which 
was expected given the greater concentration of serum IgE in Was-/- mice. However, the extent 
of OVA-induced degranulation was comparable between mast cells that were loaded with 
serum derived from either Was-/- mice or adjuvant-induced allergic WT mice (70% vs. 57% 
LAMP-1 positive cells respectively in a representative experiment, Figure 8.2D). When loading 
was alternatively corrected for the differences in total IgE concentrations, we also observed 
similar degrees of degranulation despite the approximately 20-fold lower concentration 
of OVA-specific IgE in Was-/- serum (Figure 8.2E). Very low titers of antigen-specific IgE are 
thus sufficient to mediate efficient activation of mast cells in vitro. Combined, our results 
demonstrate that Was-/- animals produce physiologically relevant levels of antigen-specific 
IgE after oral gavage of a foreign antigen in the absence of an adjuvant. 
8.4.3 IgE effector responses in Was-/- mice are intact 
A homologous model of food allergy needs to not only mimic spontaneous allergic 
sensitization, but should also faithfully recapitulate the IgE effector phase. Since anaphylaxis 
is a critical phenotype in food allergic individuals, we sought to determine if OVA-specific IgE 
antibodies in Was-/- mice would be associated with anaphylaxis in vivo. In line with results 
from other institutions (Berin and Mayer, 2009; Brandt et al., 2003), OVA/alum-sensitized WT 
mice in our facility were found to be resistant to oral anaphylaxis as assessed by a drop in 
body temperature upon repeated allergen challenge. Similarly, body temperature stayed 
constant in OVA-sensitized Was-/- mice after high-dose oral OVA challenge (Figure 8.3A). In 
contrast, allergic diarrhea, which has also been termed intestinal anaphylaxis (Brandt et al., 
2003) was readily observed in 79% of Was-/- and 60% of OVA/alum-sensitized animals 60 min 
after gavage, but not in Was+/- or WT controls, or in Was-/- mice challenged with an irrelevant 
antigen (Figure 8.3B). Oral OVA challenge in Was-/- mice and OVA/alum-sensitized WT 
animals furthermore resulted in equivalent increases in serum levels of MCPT1, a mast cell 
protease that is released from mucosal mast cells upon allergen-dependent crosslinking of 
surface-bound IgE and that can therefore be used as a marker for the severity of experimental 
food allergy (Brandt et al., 2003; Burton et al., 2012; Khodoun et al., 2011) (Figure 8.3C). In 
line with these results, expansion of mucosal mast cells in the small intestine as assessed 
by Mcpt1 mRNA levels was found to be similar between both spontaneously sensitized Was-
/- and OVA/alum WT mice (Figure 8.3D). These data thus corroborate our in vitro findings by 
demonstrating that oral allergen-dependent IgE effector responses in Was-/- mice occur with 
equivalent vigor as observed in a conventional adjuvant-based model of food allergy.  
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Figure 8.3. In vivo IgE effector responses are intact in Was-/- mice. (A) Oral anaphylaxis in OVA/alum sensitized 
(gray squares) WT mice and OVA-gavaged Was-/- (gray circles) or WT/ Was+/- controls (open circles). (B) Occurrence 
of allergic diarrhea after oral challenge with OVA or Bovine Serum Albumin (BSA) as an irrelevant antigen control. 
Significance assessed by Fisher’s exact test. Upper panels show WT or BSA-gavaged controls. (C) Levels of serum 
MCPT1 after oral challenge with OVA or BSA. (D) Comparison of small intestinal Mcpt1 mRNA expression levels. (E) 
Occurrence of anaphylaxis following systemic, but not oral OVA challenge in Was-/- mice. (F) Comparison of decrease 
in body temperature between OVA-gavaged Was-/- or WT/ Was+/- littermates and Kaplan-Meier survival curves. Symbols 
represent individual mice. Error bars depict SEM. *p<0.05; ** p<0.01; ***p<0.001; NS: not significant as determined by 
t-test or Mann-Whitney U test (Panels C, E and F), paired t-test or Wilcoxon matched-pair rank test for intra-individual 
analyses (Panels C), or ANOVA on log-transformed data with Tukey’s multiple comparison test (Panel D). 
  Despite their resistance to oral anaphylaxis, anaphylactic shock to food allergens in 
BALB/c mice can be studied using systemic allergen exposure. Whereas body temperature 
had remained stable in Was-/- mice following high-dose oral OVA challenge, we consistently 
observed a rapid temperature decrease characteristic of anaphylactic reactions in the same 
mice in response to systemic challenge with 500 μg OVA (Figure 8.3E). While Was+/- or WT 
controls subjected to the adjuvant-free sensitization protocol were protected from a drop in 
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body temperature upon systemic challenge, we observed systemic anaphylaxis in 19 out of 
20 Was-/- littermates, which was fatal in >50% of mice (Figure 8.3F).
 
8.4.4 Absence of WASP in mast cells permits IgE-mediated degranulation but abrogates 
inflammatory cytokine production 
The susceptibility of OVA-sensitized Was-/- mice to anaphylaxis was surprising because we 
had not observed any anaphylactic reactions among a cohort of 25 patients with WAS. 
Furthermore, a previous study had found decreased histamine release from mast cells in the 
absence of WASP and resistance of Was-/- mice to passive anaphylaxis (Pivniouk et al., 2003). 
To further investigate the consequences of WASP deficiency in mast cells, we generated 
bone marrow-derived mast cells from either WT or Was-/- donors on both the BALB/c and 
C57BL/6 background. All cultures differentiated normally under the influence of IL-3 and 
SCF and showed equal surface expression levels of cKit and the high-affinity IgE receptor 
FcεRI (Figure 8.4A). In contrast to previously published findings (Pivniouk et al., 2003), we 
found only a modest, non-significant decrease in the fraction of IgE-loaded mast cells that 
displayed degranulation upon challenge with a range of antigen concentrations in cells from 
mice of either genetic background (Figure 8.4B). Analysis of the downstream IgE/FcεRI-
signaling cascade, however, revealed a significant reduction in ERK1/2 phosphorylation 
in WASP-deficient mast cells (Figure 8.4C). Reduced ERK-signaling was associated with a 
striking decrease in the concentrations of pro-inflammatory cytokines that were found in 
the supernatant of mast cells 4h after IgE-mediated activation (Figure 8.4D). Because 
mRNA transcript levels of these cytokines were found to be comparable between WT and 
Was-/--derived mast cells, reduced cytokine production was likely the result of an inability 
to secrete pre-formed cytokines (Figure 8.4E), which has been previously shown to be true 
for WASP-deficient T effector cells (Morales-Tirado et al., 2010). These findings explain why 
Was-/- mice are susceptible to the sequelae of acute, IgE-mediated immune activation, but 
also demonstrate that WASP deficiency in mast cells may affect levels of mast-cell derived 
inflammatory cytokines in the intestine of Was-/- mice.  
8.4.5 Spontaneous allergic sensitization occurs in the absence of IgE-mediated signaling 
through FcεRI 
Recent studies in two different murine models of food allergy have demonstrated a role 
for IgE:FcεRI-mediated signals in expansion of mucosal mast cells and the pathogenesis of 
food allergy (Burton et al., 2014b; Chen et al., 2015). Following our observation that WASP 
deficiency in mast cells affects their ability to produce inflammatory cytokines in response 
to IgE-mediated activation, we asked whether IgE:FcεRI-mediated signaling in mast cells 
contributed to spontaneous oral sensitization to ingested allergens in Was-/- mice. To address 
this question, we generated Was-/-Fcer1a-/- and their Was-/-Fcer1a+/- littermates to study the 
induction of IgE responses against OVA. Genetic ablation of FcεRI was confirmed by measuring 
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Figure 8.4. WASP is dispensable for IgE-mediated mast cell degranulation but is required for cytokine 
production.   (A) Flow cytometric analysis of in parallel-cultured bone marrow-derived mast cells from WT or Was-
/- donors from either the C57BL/6 or BALB/c background, with cKit+FcεRI+ cells representing differentiated mast cells. 
(B) LAMP-1 degranulation assay measuring the response to different doses of antigen in TNP-specific IgE-loaded 
mast cells derived from bone marrow of either WT (open circles) or Was-/- mice (gray circles). (C) Time course of 
the appearance of phosphorylated ERK (pERK) in response to antigen-mediated IgE crosslinking in WT and Was-
/- mast cells, with total ERK shown as loading control and analysis of pixel intensity on the right. (D) Inflammatory 
cytokine concentration in supernatants of WT and Was-/- mast cells 6h after IgE-mediated antigen stimulus. (E) 
Normalized mRNA counts for Fcer1a, Il13, Il6 and Tnfa in IgE-loaded WT and Was-/- mouse-derived mast cells with or 
without stimulation with 100 ng TNP-OVA in vitro. Error bars depict SEM. ** p<0.01; ***p<0.001; NS: not significant as 
determined by student t-test. 
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surface IgE loading on basophils and was associated with only a slight and non-statistically 
significant reduction in the fraction of basophils amongst peripheral blood mononuclear 
cells (Figure 8.5A). Serum levels of total IgE (Figure 8.5B) and IgG1 with reactivity to soy and 
wheat antigens (Figure 8.5C) were equivalent between FcεRI-deficient and FcεRI-competent 
Was-/- mice. Similarly, oral sensitization with OVA following our established protocol of oral 
sensitization resulted in similar levels of OVA-specific IgE and IgG1 between groups (Figure 
8.5D). Surprisingly, we did not observe lower baseline levels of serum MCPT1 before or 
after sensitization in Was-/-Fcer1a-/- mice (Figure 8.5E), indicating that mucosal mast cell 
expansion in Was-/- animals occurs independently of IgE:FcεRI-mediated signals. This was 
in stark contrast with OVA/alum-sensitized WT mice, in which we confirmed the recently 
published result that mast cell expansion occurs to a lesser extent in challenged animals that 
are deficient in Fcer1a (Chen et al., 2015) (Figure 8.5E). 
  Early studies in Fcer1a-/- animals have clearly demonstrated that anaphylactic responses 
can occur in the absence of the high-affinity IgE receptor, which are then mediated primarily 
through IgG:FcγRIII activation on macrophages (Burton and Oettgen, 2011; Dombrowicz et 
al., 1997; Khodoun et al., 2011). Since we had observed efficient induction of IgG1 responses 
against OVA, we aimed to assess the susceptibility of Was-/-Fcer1a-/- mice to IgG-mediated 
anaphylaxis. Systemic OVA challenge of Was-/-Fcer1a-/- and Was-/-Fcer1a+/- littermates resulted 
in anaphylactic shock in mice of both groups, with similar survival curves in mice with and 
without expression of FceRI (Figure 8.5F). These results demonstrate that Was-/- mice are 
susceptible to IgG-mediated anaphylaxis upon systemic allergen challenge. 
8.4.6 Spontaneous oral sensitization to OVA in Wasfl/flFoxp3-Cre mediates more 
pronounced IgE effector responses compared to adjuvant-sensitized mice 
Using loxP-Cre-mediated conditional deletion of WASP in different lineages, we recently 
identified deficiency of WASP in FOXP3+ Tregs to be sufficient for WAS-associated food allergic 
responses to occur (Chapter 7). This genetic system allows the study of spontaneous oral 
sensitization without any confounding influences of WASP deficiency in other hematopoietic 
lineages such as mast cells. Similar to our findings in Was-/- mice on the BALB/c genetic 
background, we detected OVA-specific IgE in the serum of C57BL/6 Wasfl/flFoxp3-Cre mice 
following our protocol outlined in Figure 8.2A-B (Figure 8.6A). OVA-IgE titers were again found 
to be significantly lower than those observed in co-housed C57BL/6 WT mice subjected to 
repeated OVA challenge following OVA/alum-mediated systemic sensitization (Figure 8.6B). 
However, these low IgE titers effectively mediated mast cell degranulation in all 12 Wasfl/
flFoxp3-Cre mice in this cohort, as evidenced by significant increases in levels of serum MCPT1 
after high dose OVA challenge. Post-challenge MCPT1 levels were significantly higher than 
observed in OVA/alum-treated mice, which correlated to a much greater expansion of the 
small intestinal mast cell pool in Wasfl/flFoxp3-Cre mice that was apparent from elevated pre-
challenge serum levels of MCPT1 (Figure 8.6B), increased mRNA expression of Mcpt1 in the 
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jejunum (Figure 8.6C) and higher numbers of small intestinal mast cells upon chloroacetate 
esterase staining of histological sections (Figure 8.6D). Combined, these results indicate that 
Wasfl/flFoxp3-Cre mice can be used to study adjuvant-free induction of IgE against lumenal 
antigens and intestinal mast cell effector responses in the normally Th2-resistant C57BL/6 
genetic background. 
Figure 8.6. Spontaneous oral sensitization to OVA occurs in Wasfl/flFoxp3-Cre mice. (A) Adjuvant-free induction 
of OVA-specific IgE in Wasfl/flFoxp3-Cre (black circles) compared with C57Bl6 WT controls (open circles) and OVA/
alum-sensitized C57Bl6 WT mice (dark squares). (B) Serum MCPT1 levels in response to oral challenge with 50 mg 
OVA after oral sensitization protocol. (C) Small intestinal mRNA levels of Mcpt1 and (D) chloroacetate staining for 
jejunal mast cells. Symbols represent individual mice. Error bars show SEM. *p<0.05; ** p<0.01; ***p<0.001; NS: not 
significant as determined by ANOVA with Tukey’s multiple comparison on log-transformed data (Panel A and C) or 
paired t-test for intraindividual analyses (Panel B). 
8.5 Discussion
In the present work, we have characterized mice deficient in WASP as a novel experimental 
model of food allergy. Was-/- animals demonstrate spontaneous, i.e. adjuvant-free, generation 
of IgE antibodies against oral antigens and these antibodies effectively mediate the antigen-
dependent responses in IgE effector cells that underlie the typical symptoms of allergic 
disease. As such, our model recapitulates both the sensitization and effector phases of food 
allergy, and could thereby prove to be a valuable addition to the experimental arsenal of 
allergists and immunologists. 
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  The degree to which Was-/- mice can be considered a homologous animal model of 
food allergy is dependent on several factors. First, we need to interrogate whether food 
allergy in human WAS patients resembles the more common food allergies that arise in 
the general population outside the context of this rare immunodeficiency. In this study, we 
have performed a direct comparison of serum obtained from either WAS or age-matched 
FA patients. Both diseases were associated with equivalent increases in serum IgE, and 
screening of IgE and IgG4 reactivity against food allergens showed highly comparable profiles 
between children from either diagnostic category. Importantly, patients with mutations 
in WAS frequently demonstrated IgE reactivity against the 8 allergens that are responsible 
for the large majority of clinically relevant food allergies in the US (Sicherer and Sampson, 
2010; Wang and Sampson, 2011). Similarly, we have shown that the strongest food-specific 
IgE responses in Was-/- mice are mounted against soy and wheat (Chapter 7), which also 
rank among these 8 major human food allergens (Sicherer and Sampson, 2010; Wang and 
Sampson, 2011). These observations indicate that the mechanisms that drive the allergenicity 
of these particular food antigens are not only operative in both WAS and FA patients, but also 
in Was-/- mice. 
  A second argument in favor of significant overlap between common food allergy and 
the food allergic responses associated with WASP deficiency is the critical involvement 
of FOXP3+ Tregs in disease pathogenesis. Several observations in the literature imply that 
dysfunction of Tregs accounts for the failure in oral tolerance as observed in food allergic 
patients (Akdis and Akdis, 2014a; Noval Rivas et al., 2015). We show here that WASP deficiency 
confined to FOXP3+ Tregs is sufficient for intestinal mast cell expansion and oral sensitization 
to OVA to occur. We previously documented that WASP deficiency in FOXP3+ Treg results in a 
selective loss of their Th2-suppressive capacity in vivo and is associated with their increased 
expression of the Th2-associated transcription factor GATA3. Such Th2-like GATA3+FOXP3+ 
Tregs have been observed in the blood of children with FA and were found to be pathogenic 
in a murine model of food allergy that depends on augmented signaling through the IL-4 
receptor (Noval Rivas et al., 2015). Increased prevalence of this subset of Tregs is thus another 
shared feature between WAS-associated and common food allergy. 
  Another potential advantage of the experimental model presented here is that it allows 
the study of allergen-dependent responses in the context of a polysensitized host. Screening 
of human patient sera identified IgE reactivity to multiple unrelated food antigens in children 
with food allergy as well as WAS patients, which is in line with the epidemiological observation 
that patients commonly suffer from multiple allergies (de Jong et al., 2011; Liu et al., 2010; 
Sicherer and Sampson, 2014). By selectively inducing IgE against a single model antigen, this 
pathophysiological aspect of human food allergy is commonly lost in isomorphic, adjuvant-
based experimental models. Indeed, we observed that the fraction of OVA-specific IgE was 
as high as 80% of total IgE in food allergic mice following systemic sensitization with OVA/
alum. In stark contrast, spontaneous oral sensitization in Was-/- mice only induced OVA-
Part 2 – Chapter 8
200
specific IgE titers that constituted on average <10%, and in a number of mice even <1% of 
total IgE. In vitro mast cell degranulation assays and in vivo antigen challenge clearly showed 
that these disparate fractions of antigen-specific to total IgE do not affect the efficiency with 
which antigen-specific IgE mediates mast cell activation in response to OVA. Since low titers 
of allergen-specific IgE can sometimes be found in severely food allergic patients (Sampson 
et al., 2014; Steckelbroeck et al., 2008), this aspect of human food allergic disease may be 
more faithfully reflected in Was-/- mice than in conventional experimental models.
  WASP is expressed in all hematopoietic lineages and is functionally linked to a great 
variety of immune effector functions (Massaad et al., 2013; Thrasher and Burns, 2010). The 
immunological consequences associated with a complete absence of WASP could therefore 
be used as an argument against homology of the model. Our studies on the effects of 
WASP deficiency in mast cells directly illustrate this principle. Although we observed that 
IgE-mediated degranulation was relatively unperturbed, we found an almost complete 
abrogation in the production of pro-inflammatory cytokines from IgE-activated Was-/- mast 
cells, as has been previously described for mast cells deficient in either WASP or the WASP-
interacting protein (WIP) (Kettner et al., 2004; Pivniouk et al., 2003). Was-/- mice are thus 
susceptible to intestinal and systemic anaphylaxis, but reduced cytokine production from 
WASP-deficient mast cells is likely to limit intestinal allergic inflammation. In support of this 
conclusion, we previously found that food allergy is exacerbated in Wasfl/flFoxp3-Cre animals 
when compared to Was-/- mice (Chapter 7). Furthermore, we showed here that Was-/-Fcer1a-/- 
and Was-/-Fcer1a+/- littermates are equally susceptible to OVA sensitization and mucosal mast 
cell expansion, which was not the case for WT mice deficient in FcεRI. As such, it is possible 
that the pro-inflammatory function of FcεRI-signaling in mast cells in other models of food 
allergy (Burton et al., 2014b; Chen et al., 2015) is dependent on WASP. Since Wasfl/flFoxp3-
Cre mice can be efficiently sensitized to OVA and will develop robust intestinal mast cell 
responses, such potentially confounding influences from panhematopoietic WASP deficiency 
can be circumvented in this genetic system. 
  Finally, it is worth pointing out that spontaneous oral sensitization to OVA in Wasfl/
flFoxp3-Cre was associated with robust expansion of mucosal mast cell in mice on the 
normally Th2-resistant C57BL/6 background (Lee et al., 2013; Van Gramberg et al., 2013). 
Indeed, the OVA/alum model is typically used in conjunction with BALB/c mice. We have here 
demonstrated that although OVA-IgE can be readily induced in C57BL/6 mice following OVA/
alum sensitization, these animals proved to be resistant to the mucosal mast cell expansion 
in the intestine that is associated with repeated oral allergen challenge. Lack of robust models 
of food allergy in C57BL/6 mice means that a large part of currently available genetic tools 
are beyond the easy reach of the experimental allergist, since back-crossing strains to BALB/c 
background is time-intensive and can thus be prohibitively costly. Examples of tools that 
are generally more widely available in C57BL/6 animals are congenic markers, transgenic 
TCRs and a great variety of fluorescence reporter systems (The Jackson Laboratory, Bar 
Was-/- mice as a model of food allergy
201
Ch
ap
te
r 8
Harbor, ME). Furthermore, the International Mouse Phenotyping Consortium, which aims to 
generate a null mouse for every gene in the mouse genome, works exclusively with mice on 
the C57BL/6 background (Skarnes et al., 2011). Availability of an adjuvant-free experimental 
model of oral sensitization in C57BL/6 mice would thus open up a plethora of research tools 
to address novel hypotheses on the pathogenesis of food allergic reactions. 
In summary, we have identified Was-/- mice as a genetic model of food allergy. In contrast to 
commonly available, isomorphic, adjuvant-based experimental strategies, the oral sensitization 
phase was faithfully recapitulated in addition to IgE-mediated type I hypersensitivity responses 
upon allergen exposure. Sensitization to food antigens occurred in both Was-/- mice as well as 
WAS patients, and was directed against allergens most relevant to common food allergy. In 
addition, polysensitization was a common feature in both mice and patients, and aberrant 
IgE immune responses were shown to be critically dependent on FOXP3+ Tregs. Combined, 
these features all support the conclusion that Was-/- mice may serve as a more homologous 
animal model of human food allergy, which could likely continue to reveal new insights in to 
the etiology of human food allergy and inspire new therapeutic approaches.
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WAS-associated food allergy: 
synthesis, discussion and future directions
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9.1 Introduction
Despite renewed attention for beneficial roles of IgE-mediated immune responses to 
allergens (Marichal et al., 2013; Palm et al., 2012; Profet, 1991), it is clear that allergic reactions 
to innocuous food antigens have highly detrimental effects on the host. In chapters 6, 7 and 
8, we have discussed the critical involvement of FOXP3+ CD4+ T cells (Tregs) in regulating the 
synthesis of IgE. IPEX patients lacking functional Tregs due to mutation of the FOXP3 gene 
develop elevated levels of IgE (Bennett and Ochs, 2001), whereas other antibody isotypes 
(IgM, IgA and IgG) are generally normal (Gambineri et al., 2003). Similarly, we observed 
increased IgE in a novel humanized mouse model reconstituted with hematopoietic stem 
cells of an IPEX patient (Figure 6.6A, page 135). Treg control over production of IgE is 
preserved across species, as mice with the Foxp3sf mutation also develop greatly increased 
levels of serum IgE before succumbing to the sequelae of autoimmunity around 21-days of 
age (Figure 9.1A and (Lin et al., 2005)). Besides dysregulated IgE production, the absence of 
Tregs in mice also leads to significant expansion of intestinal mast cells (Figure 9.1B-D), which 
is commonly observed in patients suffering from food allergy (Caffarelli et al., 1998; Hogan 
et al., 2012). Since proliferation of mucosal mast cells depends critically on T cell help rather 
than IgE (Gurish et al., 2004), the intestinal mastocytosis encountered in the context of Treg 
deficiency signifies aberrant Th2-mediated immune activation (Figure 9.1E). As discussed in 
the introduction of Chapter 7, loss of functional Tregs also results in pronounced Th1 and Th17 
responses (Figure 9.1F), demonstrating that the immune sequelae observed in IPEX patients 
and Foxp3sf mice are the combined effects of aberrant Th1, Th2 and Th17 immune activation. 
  In Chapter 7, we described that patients with the Wiskott-Aldrich syndrome (WAS) 
suffer from IgE-mediated food allergy (Figure 7.1, page 159). Mechanistically, these food 
allergic responses in the context of WAS could be pinpointed to the selective failure of WASP-
deficient FOXP3+ Tregs to restrain Th2-mediated immune activation. Conditional deletion of 
Was in murine FOXP3+ Tregs was sufficient for IgE-mediated responses against common food 
allergens. In fact, compared to Was-/- mice, Wasfl/flFoxp3-Cre animals developed significantly 
higher levels of serum IgE and exhibited more pronounced expansion of intestinal mast cells. 
In Chapters 7 and 8, reduced effector function of Was-/- mast cells is offered as a potential 
explanation for the different susceptibility in allergic disease between these two models 
(Figure 7.4, page 164). However, the question whether WASP deficiency in lineages other 
than mast cells affects food allergic responses in Was-/- mice and WAS patients remains to be 
exhaustively discussed. Since the allergic immune response involves cooperation of many 
cell types from both the innate as well as adaptive immune arms, analysis of the role of WASP 
in any of these cellular compartments is required for a thorough understanding of the food 
allergy that occurs in patients with WAS. Because many of the features of WAS-associated 
food allergy are shared with common food allergic patients (Chapter 8), appreciation of 
any pro- and anti-allergic factors mediated by WASP deficiency could shed new light on the 
Food allergy in WAS: a synthesis
205
Ch
ap
te
r 9
general pathogenesis of IgE-mediated responses to food. Lastly, comparative analysis of 
Was-/- and Wasfl/flFoxp3-Cre mice will help better define WASP-deficient animals as a novel 
experimental model of food allergy (Chapter 8). The aim of this chapter is therefore to 
provide a comprehensive overview of factors that may help explain the more severe food 
allergy observed in Wasfl/flFoxp3-Cre mice in comparison to Was-/- and WT animals. 
Figure 9.1. Foxp3sf mice develop hyper IgE responses and expansion of intestinal mast cells. Levels of total 
serum IgE (A) and MCPT1 (B) in Foxp3sf/wt females and their Foxp3sf  and Foxp3wt offspring. (C) Chloroacetate esterase 
staining on jejunal sections in Foxp3sf and Foxp3wt littermates, and corresponding mRNA expression levels of Mcpt1 
(D). Flow cytometry plots of GATA3+ICOS+ Th2-type effector cells within the parent gate of CD44hiCD62LloCD4+ effector 
memory T cells from MLNs of representative samples. (F) mRNA expression levels in small intestinal sections as 
assessed by quantitative RT-PCR. Dots represent individual mice and error bars depict SEM. *p<0.05; ** p<0.01; 
***p<0.001; NS: not significant as determined by student t-test. 
9.2 Cellular functions of WASP 
Structural integrity and modulation of the actin cytoskeleton allows eukaryotic cells not 
merely to maintain polarization and orientation in the context of a multicellular host, but 
also to undergo division, migration, locomotion, and cell-cell interactions. Despite this 
plethora of actin-dependent functions, all external signals that can induce cytoskeletal 
rearrangements converge on the activation of only three members of the evolutionarily 
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highly conserved Rho protein family: Cdc42, Rac and Rho. To account for the great variety in 
effector responses, these activated proteins can interact with a large number of proteins from 
the WASP family, which serve to activate the Arp2/3 complex to initiate the polymerization 
of actin filaments (Alberts et al., 2008). WASP itself was the first protein to be identified as 
a nucleation-promoting factor (NPFs), but several other closely related family members 
such as neural-WASP (N-WASP) and WAVE1-3 have since been discovered (Massaad et al., 
2013). As intermediary factors between Cdc42 and Arp2/3, WASP family proteins thus play 
a critical role in translating external signals into changes of the actin cytoskeleton. Under 
normal conditions, WASP is auto-inhibited through its binding to the WASP Interacting 
Protein (WIP). Upon cellular signaling, however, the WIP/WASP complex can be recruited to 
the cell surface, where Cdc42 and PIP2 bind to WASP to liberate its VCA domain from the auto-
inhibited state. The VCA domain, in turn, activates the Arp2/3 complex and hence initiates 
actin polymerization. Auto-inhibition and intracellular delivery by WIP warrant the highly 
controlled and localized effect of WASP, allowing cytoskeletal rearrangements in a polarized 
fashion. Once phosphorylated, WASP is rapidly ubiquitinated and degraded, which further 
limits WASP activity to the site of the external stimulus (Massaad et al., 2013; Matalon et al., 
2013; Thrasher and Burns, 2010). Of all other WASP-family members, N-WASP shares the 
greatest levels of homology with WASP (around 50%), including the VCA domain. While WASP 
is exclusively expressed in hematopoietic lineages, the expression of N-WASP is ubiquitous, 
which is reflected in the fact that genetic deletion of N-WASP is embryonically lethal 
(Westerberg et al., 2012). In the remainder of this chapter, we will review the consequences of 
WASP-deficiency on the function of immune compartments involved in the allergic response. 
9.3 Antigen Presenting Cells 
In contrast to B cells, which can be activated by intact antigens in the absence of other 
immune cells, T cells can only recognize their cognate antigen in the context of MHC proteins 
on the surface of antigen presenting cells (APCs). Consequently, effective T cell immunity 
relies on the presence and function of a broad surveillance network of mononuclear 
phagocytes that continuously sample and process the antigenic environment. Because the 
mechanisms underlying the uptake of antigens do not necessarily discriminate between 
antigens of pathogenic origin versus those that are derived from innocuous sources such as 
food and commensals, APCs provide T cells with additional signals to ensure the appropriate 
downstream immune response. These signals consist of interactions between various cell-
surface receptors and ligands, and also include the cytokine milieu in which the APC-T cell 
interaction takes place. The efficient crosstalk between APC and T cell is facilitated by the 
formation of a temporary immune synapse, a highly dynamic mechanical structure at the 
interface between the antigen-specific TCR and peptide-loaded MHC molecule. The integrity 
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of the immune synapse is strongly dependent on rearrangements in the actin cytoskeleton, 
which follow from a sequence of events that is initiated upon primary signaling through the 
TCR and includes the recruitment of nucleation-promoting factors, including WASP, to the 
immune synapse (Barda-Saad et al., 2005; Matalon et al., 2013). In the absence of WASP on 
the T cell side, the function of the immune synapse is severely impaired, and Was-/- T cells 
show aberrant antigen-specific interaction with APCs (Matalon et al., 2013). Similarly, APCs 
critically rely on actin cytoskeletal rearrangements for normal intercellular interactions, as 
well as for carrying out other functions such as cytokinesis and cell migration (Moulding et al., 
2013). The paradigm of APCs functioning as gatekeepers of T cell activation and downstream 
immune responses raises the question how deficiency of WASP in mononuclear phagocytes 
contributes to the immunopathology observed in WAS patients and mice deficient in WASP. 
  As in other hematopoietic lineages, WASP actively regulates the actin cytoskeleton 
in mononuclear phagocytes (Massaad et al., 2013; Thrasher and Burns, 2010). Its absence 
results in aberrant podosome formation and chemotaxis of APCs, which has been observed 
independently in human monocytes (Badolato et al., 1998), macrophages (Linder et 
al., 1999), and dendritic cells (Burns et al., 2001) from patients with WAS. In contrast to T 
and B lymphocytes, the survival advantage of WASP-competent cells over WASP-deficient 
counterparts is less pronounced for the myeloid compartment, with the exception of 
marginal zone macrophages (Westerberg et al., 2008). However, a non-redundant role for 
WASP in the function of APCs can be distinguished on at least four different levels: 
 1   Phagocytosis and antigen uptake. Human macrophages that are deficient in WASP show 
a reduced ability to form the phagocytic cup that is required for the efficient uptake of 
particles such as bacteria (Tsuboi and Meerloo, 2007). This defect is associated with 
aberrant presentation of particulate antigens, as Was-/- dendritic cells induced lower 
levels of D011.10 T cell proliferation than WT dendritic cells following co-culture with 
ovalbumin-expressing bacteria (Westerberg et al., 2003). Conversely, no difference in 
DO11.10 T cell activation was observed between WASP-deficient and WASP-competent 
dendritic cells when soluble ovalbumin was used as the antigenic stimulus, suggesting 
that aberrant antigen uptake and presentation in the absence of WASP is limited to 
particulate antigens (Westerberg et al., 2003). A recent paper points out another difference 
in antigen handling between WASP-competent and WASP-deficient dendritic cells: in the 
absence of WASP, APCs show increased propensity for cross-presentation of exogenous 
antigen. Cross-presentation refers to the process in which non-self antigens taken up by 
APCs are presented on MHC class I rather than class II molecules, consequently leading to 
CD8+ instead of CD4+ T cell responses (Baptista et al., 2016). 
 2   Tissue homing and migration. The podosomes that are deficient in the context of 
WAS are actin-dependent membrane protrusions that allow cells to attach to and 
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move through the extracellular matrix. In addition, the absence of WASP leads to 
aberrant integrin assembly, which affects the ability of mononuclear phagocytes and 
granulocytes to interact with ICAM-1 on endothelial cells during cell extravasation 
from the circulation (Moulding et al., 2013). Consequently, Was-/- dendritic cells exhibit 
defective homing to draining lymph nodes (Snapper et al., 2005), which persists 
after their adoptive transfer into WT hosts and thus represents a cell-intrinsic defect 
(Bouma et al., 2007). It has been hypothesized that delayed migration of dendritic 
cells after antigen uptake results in ectopic maturation that hence could contribute 
to pathogenesis of eczematous skin lesions in WAS patients (Moulding et al., 2013; 
Thrasher and Burns, 2010), although this remains to be demonstrated in vivo.  
 3   Immune synapse formation and T cell activation. As delineated above, the point of 
contact between T cells and APCs gives rise to an immune synapse, which depends 
on structural rearrangements in the actin cytoskeleton and provides a platform 
for sustained signaling through the T cell receptor. The role of WASP and the 
cytoskeleton in immune synapse function have predominantly been studied on 
the T cell side of this interface (Barda-Saad et al., 2005; Matalon et al., 2013; Sims 
et al., 2007). However, normal immune synapse integrity also requires cytoskeletal 
rearrangements in dendritic cells (Al-Alwan et al., 2001). Priming of WASP-competent 
CD4+ and CD8+ T cells by WASP-deficient dendritic cells is reduced (Bouma et al., 
2007; Pulecio et al., 2008), which was later demonstrated to be due to defects in the 
formation of the immune synapse (Bouma et al., 2011; Malinova et al., 2015). WT T 
cells interacting with Was-/- dendritic cells showed reduced polarization of the T cell 
receptor, LFA-1, talin and f-actin to the immune synapse, and this was associated with 
lower levels of localized tyrosine phosphorylation, indicative of aberrant signaling 
through the TCR (Bouma et al., 2011). These abnormalities are exacerbated further 
by defects in integrin function, as actin-mediated localization of ICAM-1 and MHCII 
to the IS, which promotes the stability of the immune synapse, was recently shown 
to be WASP dependent (Malinova et al., 2015). In addition to an overall reduced 
proliferation, T cells interacting with Was-/- dendritic cells secrete lower levels of IL2 
and undergo Th17 skewing at the expense of Th1 and Th2 lineages, as evidenced by 
elevated production of IL-17 and lower levels of IFNγ and IL-4 in dendritic cell and T 
cell co-cultures (Malinova et al., 2015). In a similar assay, reduced induction of Tregs 
has been observed from Was-/- compared to WT dendritic cells (Nguyen et al., 2012). 
 4   Interpretation of environmental stimuli. In addition to the mechanical aspects 
associated with a loss of WASP-dependent functions in APCs, absence of WASP 
could interfere with intracellular processes that endow mononuclear phagocytes 
with their capacities for immune surveillance. As an example of this principle, 
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Prete and colleagues have demonstrated that Was-/- plasmacytoid dendritic cells 
are hyperresponsive to TLR9 signaling (Prete et al., 2013). The TLR9 pathway is 
activated by fragments of bacterial DNA and results in the rapid generation of pro-
inflammatory cytokines such as type 1 interferons and IL-12 from endosomes. This 
heightened state of activation in plasmacytoid dendritic cells was associated with 
the occurrence of autoimmunity and colitis in Was-/- mice. Mechanistically, this 
study thus reveals a role for WASP-dependent actin cytoskeleton rearrangement 
in the intracellular trafficking and compartmentalization of pathogen-associated 
molecular patterns in APCs (Prete et al., 2013). 
Oral tolerance to food antigens largely depends on the CD103+ subset of dendritic cells in the 
lamina propria, which capture intestinal antigens and preferentially induce Treg responses 
through the production of TGFβ and retinoic acid (Berin and Sampson, 2013). This process 
appears to be confined to the mesenteric lymph nodes, implicating that oral tolerance 
requires the migration of CD103+ dendritic cells from the lamina propria to these secondary 
lymphoid organs in the intestine. Indeed, surgical removal of MLNs prior to antigen exposure 
or genetic deletion of the chemokine receptor CCR7 on dendritic cells both abrogate oral 
tolerance (Worbs et al., 2006). Consequently, it can be hypothesized that migratory defects 
in WASP-deficient dendritic cells could result in diminished delivery of food antigens to the 
MLNs in Was-/- mice, which in turn could contribute to food allergic sensitization. In support 
of this theory, lower fractions of CD11c+CD11b+CD103+ dendritic cells amongst total dendritic 
cells have been described in the MLN and lamina propria of Was-/-Rag2-/- compared to Rag2-/- 
mice (Nguyen et al., 2012). In Chapter 7, we have described the generation of Wasfl/flItgax-Cre 
mice, which express cre-recombinase in association with the dendritic cell-specific CD11c 
promoter. These mice were found to have serum MCPT1, IgE and IgG1 levels equivalent to 
Waswt/wtItgax-Cre littermates (Figure 7.4A and results not shown), demonstrating that WASP 
deficiency confined to CD11c+ dendritic cells – and thus including the highly migratory, 
tolerogenic subset of CD11c+CD103+ dendritic cells – is insufficient to initiate the cascade 
of food allergic sensitization. However, in addition to a potentially causative role in the 
pathogenesis of WAS-associated food allergy, we should also consider the possibility that 
WASP-deficiency in the APC compartment contributes to the differential susceptibility to 
food allergy between Was-/- and Wasfl/flFoxp3-Cre mice. As is apparent from the foregoing 
discussion, it is conceivable that WASP-deficient dendritic cells have a diminished uptake 
of (particulate) antigens from the intestinal lumen, which could dampen the CD4+ T cell 
activation in an already sensitized host. Moreover, increased cross-presentation of food 
antigens via MHC I rather than MHC II in the absence of WASP may further reduce CD4+ effector 
T cell responses. In addition, decreased migratory capacity of APCs might reduce the chance 
of their successful interaction with T cells in the lamina propria. It is furthermore likely that the 
food antigen-specific effector T cells that interact with Was -/- APCs may be hampered in their 
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activation due to failing structural support of immune synapse stability from the dendritic cell 
side, leading to diminished signaling through the T cell receptor. Interestingly, Malinova and 
colleagues have demonstrated in vitro that T cells interacting with WASP-deficient dendritic 
cells preferentially differentiate away from the Th2 lineage and instead assume a Th17 
phenotype (Malinova et al., 2015). As such, the absence of WASP from dendritic cells in Was-
/- but not in Wasfl/flFoxp3-Cre animals may operate as an opposing force to the uncontrolled 
Th2 immune activation that occurs in the context of WASP-deficient FOXP3+ Tregs. In line with 
this hypothesis is the observation that the Th2 signature of the inflammatory infiltrate that 
typifies WASP deficiency-associated colitis in mice on the 129SvEv background (Nguyen et 
al., 2007) is absent in colonic inflammation that follows after transfer of WT naïve T cells into 
Was-/-Rag2-/- hosts (Nguyen et al., 2012). 
In conclusion, it is conceivable that loss of WASP-dependent functions from APCs in Was-
/- mice contribute to a dampened food allergic phenotype. Formal test of this hypothesis 
could be attained by generating Wasfl/flFoxp3-Cre Itgax-Cre double knock-out mice, which 
would allow for the estimation of the effect size in the absence of confounding influence 
from WASP-deficiency in non-Tregs, non-CD11c+ dendritic cells. 
9.4 B cells
Similar to the absence of WASP in antigen presenting cells, we must consider WASP deficiency 
in B cells as a possible explanation for the difference in susceptibility to food allergy between 
Was-/- and Wasfl/flFoxp3-Cre mice. The B cell compartment can be envisioned as a rather distal 
checkpoint in food allergic sensitization, only initiating and maintaining the synthesis of 
food-specific IgE and IgG1 when several conditions are met. Since a growing body of evidence 
suggests that B cell homeostasis is affected in WAS patients and WASP-deficient animals 
(Massaad et al., 2013; Thrasher and Burns, 2010), lower serum levels of food-specific IgE and 
IgG1 in Was-/- mice could potentially be caused by a loss of WASP-dependent functions in B 
cells. For the benefit of the current discussion, we will highlight the following B-cell-intrinsic 
roles for WASP:
 1   Development, differentiation, and survival. Convincing evidence for a role of WASP in 
B cell homeostasis came from experiments that used heterozygous Was+/- mice, or 
WT and Was-/- mixed-bone-marrow-chimeric, B-cell-deficient μMT animals. In these 
settings, WASP-competent B cells exhibit a survival advantage over Was-/- counterparts 
(Meyer-Bahlburg et al., 2008; Westerberg et al., 2008). This advantage starts to be 
evident at the late transitional B cell stage, and becomes particularly striking in the 
marginal zone B cell populations (Meyer-Bahlburg et al., 2008; Westerberg et al., 2008), 
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resulting in a significantly reduced number of marginal zone B cells in both Was-/- mice 
and patients with WAS (Westerberg et al., 2005). With the generation of Wasfl/flMb1-Cre 
mice, it has become possible to study the effect of the selective loss of WASP from the 
B cell lineage. These animals demonstrate unperturbed early B cell development in 
the bone-marrow, but have a reduced number of total B lymphocytes in the spleen 
and an altered distribution of B cell subsets compared to WT counterparts: both Was-
/- and Wasfl/flMb1-Cre mice are characterized by reduced marginal zone and follicular 
B cells, whereas a relative increase is seen in plasma cells and germinal center B cells 
(Recher et al., 2012). These data are indicative of a cell-intrinsic role for WASP in the 
peripheral homeostasis of B-lymphocytes. 
 2   Mobility and chemotaxis. Analogous to T lymphocytes and mononuclear 
phagocytes, loss of WASP in B cells results in altered cell morphology and reduced 
cell surface protrusions (Westerberg et al., 2001). Aberrant rearrangement of the 
actin cytoskeleton likely underlies the observation that Was-/- B cells show impaired 
migration towards B cell-tropic chemokines such as CXCL13 and CXCL12 in vitro, 
because expression levels of the respective chemokine receptors CXCR5 and CXCR4 
on B lymphocytes was found to be unaltered (Westerberg et al., 2005). This study 
has also documented the changes in splenic architecture following immunization 
with sheep red blood cell antigen and found that germinal centers in the spleens 
of Was-/- hosts were more resistant to expansion than in WT counterparts, which 
could not be overcome by transfer of WT T cells prior to immunization (Westerberg 
et al., 2005). These results suggest that WASP-deficient B cells are less efficient at 
mediating a humoral immune response against a foreign antigen. It is currently 
unclear to which extent alterations in migratory capacity contribute to the observed 
alterations in distribution of splenic subpopulations of B cells that are observed in 
Was-/- and Wasfl/flMb1-Cre mice. 
 3   Activation and isotype switching. Whether WASP is required for the activation of B 
and T lymphocytes was the subject of the first investigations in Was-/- mice. Whereas 
a significant reduction was observed in Was-/- T cell proliferation following anti-
CD3ε stimulation, stimulation of the B cell receptor (BCR) with anti-IgM antibody 
resulted in efficient proliferation despite the absence of WASP protein (Snapper 
et al., 1998). Follow-up studies found that WASP-deficient B cells are actually 
hyperresponsive to BCR signaling, as evidenced by prolonged Ca2+ flux following 
anti-IgM treatment, which is likely related to a delayed internalization of the BCR 
(Becker-Herman et al., 2011). In vitro, Was-/- B cells furthermore exhibit an increased 
propensity to undergo class switching to IgG1 after combined stimulation with anti-
CD40 antibodies (simulating T cell help) and IL4, or to IgG2b following stimulation 
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with LPS (Westerberg et al., 2005).4 The heightened response to BCR ligation in 
the absence of WASP has been hypothesized to mediate a loss of peripheral B cell 
tolerance and thereby contribute to WAS-associated autoimmunity. Irradiated μMT 
animals receiving mixed Was-/-/μMT bone-marrow spontaneously develop increased 
numbers of germinal center B cells (defined as B220+PNA+FAS+) in the spleen and 
IgG autoantibodies in serum, before succumbing to an SLE-like glomerulonephritis. 
Anti-CD4 treatment of these chimeric mice significantly ameliorated autoimmune 
pathology, and abrogated spontaneous germinal center formation and production 
of IgG2b and IgG2c (the C57BL/6 equivalent of IgG2a), although increased levels of 
IgG3 autoantibodies could still be detected in this setting (Becker-Herman et al., 
2011). Aberrant BCR signaling alone is insufficient to explain these results, as loss of 
TLR-mediated signaling through genetic deletion of the TLR adapter protein MyD88 
completely halted autoimmune responses and GC formation, including synthesis 
of IgG3 autoantibodies (Becker-Herman et al., 2011). These results were later 
confirmed in Wasfl/flMb1-Cre mice, which spontaneously develop germinal centers 
and have elevated serum levels of IgM and IgG with reactivity against a broad 
variety of self-antigens (Recher et al., 2012). Combined, these data demonstrate 
that autoimmune humoral immune responses can be initiated and driven by 
WASP-deficient B cells in the presence of a WASP-competent T cell compartment. 
 4   Variation of the BCR repertoire. A follow-up paper to the study by Becker-Herman et 
al. has recently shed more light on the role of WASP in B cell homeostasis (Kolhatkar 
et al., 2015). By employing the Nur77-GFP reporter system, which provides a 
fluorescent read-out of strength of TCR or BCR signaling (Zikherman et al., 2012), 
this study provided further confirmation of the increased sensitivity to BCR signaling 
in Was-/- B cells, and went on to demonstrate that combined hyperresponsiveness to 
BCR and TLR signaling results in alterations in the naïve B cell repertoire. The merit 
of this work lies in showing that these changes are due to an increase in antigen-
mediated, positive selection amongst B cells at the transitional stage, rather than 
from a failure of negative selection in the bone-marrow. Auto-reactive B cells can be 
found in healthy mice and humans, and evidence suggests that the selection of these 
clones is an active process depending on BCR-signaling in response to splenic self-
antigens, CD40-mediated T cell help and B cell activating factor (BAFF) (Kolhatkar 
et al., 2015; Zikherman et al., 2012; Gaudin et al., 2004). The benefit of maintaining 
potentially self-reactive B cell clones in the naive B cell repertoire has been thought 
to stem from an increased chance of reactivity against invading pathogens (Male 
et al., 2006) or to contribute to the pool of natural immunoglobulins to serve 
4   LPS functions as a polyclonal stimulator of B cells, and challenge of naïve mature B lymphocytes with LPS in the 
presence of IL4 is sufficient to induce class-switching to IgG1 and IgE in vitro (Kracker and Radbruch, 2004).
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    homeostatic functions such as clearance of apoptotic cells (Gaudin et al., 2004; 
Kolhatkar et al., 2015). In WASP deficiency, this positive selection of splenic B cells is 
altered, resulting in an enrichment for low-affinity, self-reactive BCRs (Kolhatkar et 
al., 2015). Importantly, skewing of BCR repertoire and increased auto-reactivity has 
recently been observed by several groups after sequencing naïve B cells from WAS 
patients (Castiello et al., 2014; O’Connell et al., 2014; Simon et al., 2014), implicating 
that altered selection in Was-/- mice may also be operative in WAS patients. 
 5   Regulatory function. The study of regulatory subsets amongst T cells has been at 
the forefront of adaptive immunity research for the last two decades. However, it 
is becoming clear that a subset of B cells (analogously termed Bregs) also exhibits 
immunoregulatory functions, including the production of IL10. Bregs may originate 
from several B cell subpopulations, but appear to be largely controlled by T cell 
help, as there is no induction of IL10-producing B cells in absence of CD40 or ICAM-1 
(Mauri and Bosma, 2012). Importantly, Bregs may support the development of Tregs 
by acting as an additional source of IL10, as evidenced by reduced numbers of Tregs 
in μMT mice (Mauri and Bosma, 2012). Parasites can induce Bregs, and consequent 
recruitment of Tregs may contribute to the modulating effects on allergy by 
ova of Schistosoma mansoni (Khan et al., 2015; Amu et al., 2010). Gerben Bouma 
and colleagues have recently interrogated the role of regulatory B cells in WASP-
deficient mice (Bouma et al., 2014). Both Was-/- and Wasfl/flMb1-Cre animals showed 
lower frequencies of Bregs in the spleen at baseline. In a model of Th17-mediated 
experimental arthritis that relies on immunization with BSA in complete Freund’s 
adjuvant followed by intra-articular injection of BSA, Was-/- mice were found more 
susceptible to disease when compared to WT mice, and adoptive transfer of WT 
Bregs ameliorated inflammation and increased Treg numbers in the inflammatory 
infiltrate. However, Wasfl/flMb1-Cre mice showed equivalent susceptibility to arthritis 
to WT mice, demonstrating that Breg-dysfunction is unlikely to account for the 
increased autoimmunity in WAS.  
Taken together, these results demonstrate that WASP-dependent processes form a critical 
part in many aspects of B cell biology. 
Since Wasfl/flFoxp3-Cre mice showed significantly higher titers of total and food-specific IgE 
and IgG1, we asked whether WASP deficiency in B cells would account for restrained allergic 
responses in Was-/- animals. As delineated above, murine WASP-deficient B cells have an altered 
BCR repertoire, exhibit increased proliferation in germinal centers (GCs) and spontaneously 
secrete higher levels of IgM (Recher et al., 2012). In support of normalization of the B cell 
compartment in Wasfl/flFoxp3-Cre mice, we observed complete abrogation of the hyper-IgM 
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phenotype that is seen in Was-/- mice (Figure 9.2A). These alterations in the peripheral B cell 
pool were likely to be of consequence for food allergic sensitization, as significantly higher 
serum titers of anti-soy and anti-wheat IgM in Wasfl/flFoxp3-Cre mice are indicative of a higher 
fraction of naïve B cells with specificity for food antigens (Figure 9.2B). We then screened 
serum of WAS patients for total and food-specific IgM. In line with previously published data 
(Thrasher and Burns, 2010), and in contrast with WASP-deficient mice, we observed reduced 
levels of total IgM in WAS patients compared to those with or without food allergy (Figure 
9.2C). Anti-soy and anti-wheat IgM titers were similarly decreased in WAS patients compared 
to those with food allergy (Figure 9.2D), strongly resembling the data obtained in Was-/- and 
Wasfl/flFoxp3-Cre mice. These data demonstrate that the naïve B cell repertoire in healthy 
mice and humans contains lymphocytes with BCRs that exhibit specificity for soy and 
wheat, and suggest that WASP deficiency affects the number of food-specific B cells. Lower 
levels of IgM with reactivity against food in Was-/- mice did not result from the recruitment of 
food-specific clonotypes from the naïve to the antigen-experienced, class-switched B cell 
repertoire, because Wasfl/flFoxp3-Cre mice and food allergic children show normal levels of 
food-specific IgM. In light of recently published data (Kolhatkar et al., 2015), it seems likely 
that the skewing of the B cell repertoire that results from enhanced positive selection of 
transitional WASP-deficient B cells negatively affects the number of food-specific B-cells that 
are available for food antigen-specific activation. This smaller pool of naïve (IgM+) soy- and 
wheat-specific B cells might contribute to lower levels of food-specific IgE and IgG1 (derived 
from class-switched, antigen-experienced B cells) observed in Was-/- mice in comparison to 
Wasfl/flFoxp3-Cre animals. 
Differential activation requirements of WASP-deficient and WASP-competent B cells may 
underlie further differences in humoral immunity between Was-/- and Wasfl/flFoxp3-Cre mice. 
Data from Wasfl/flMb1-Cre mice showed that the spontaneous germinal center formation 
observed in Was-/- animals occurs as a result of WASP-deficiency in the B cell compartment 
(Recher et al., 2012). Germinal centers contain antigen-specific B cells that are undergoing 
active proliferation leading to clonal expansion. Somatic hypermutation results in differential 
antigen affinity amongst the progeny of the founder B cells, and through competition for 
limited T cell help, this process results in affinity maturation of the antibody response. 
Furthermore, T cell-mediated help and cytokine production instructs class switching in 
proliferating B cells prior to their differentiation into plasma cell or memory B cell precursors, 
as well as their migration away from the germinal center (Male et al., 2006). Initial antigen 
exposure of naïve B cells occurs via CD11c+ dendritic cells, which enhance their survival 
by providing soluble B cell activating factor (BAFF) and APRIL, and the cumulative signals 
received from dendritic cells and T cells at this stage shape the fate of the descendants of 
a particular B cell many generations later (Goodnow et al., 2010). Interestingly, elevated 
serum levels of BAFF in WASP deficiency have recently been reported by several independent
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Figure 9.2. WASp deficiency in B cells affects food-specific IgM levels in mice and humans. (A) Total and (B) 
soy and wheat-specific levels of serum IgM in WT (open circles), Was-/- (gray circles) and Wasfl/flFoxp3-Cre (black 
circles) mice. (C) Total and (D) soy and wheat-specific levels of serum IgM levels in in pediatric WAS patients and 
age-matched controls without (control) or with food allergy (FA). Dots represent individual mice or patients and error 
bars depict SEM. *p<0.05; ** p<0.01; ***p<0.001; NS: not significant as determined by one-way ANOVA with Tukey’s 
multiple comparisons test. 
groups (Castiello et al., 2014; Crestani et al., 2015; Kolhatkar et al., 2015) and elevated 
BAFF may therefore drive increased B cell recruitment and survival, although murine data 
suggest that WASP-deficiency reduces responsiveness to BAFF signaling (Bouma et al., 2014). 
Commitment to germinal center proliferation instead of differentiation into extrafollicular 
plasma cells or recirculating memory B cell depends on the migration of B cells towards 
follicular dendritic cells, a process that is dependent in part on CXCL13-CXCR5 interaction 
(Goodnow et al., 2010). Notably, migration in response to dendritic-cell-derived CXCL13 was 
shown to be aberrant in Was-/- B cells (Westerberg et al., 2005), which would be predicted to 
result in less efficient germinal center formation in WASP deficiency. Increased expression of 
transcription factor Bcl6 underlies further differentiation into germinal center B cells, whereas 
expression of Blimp1 and IRF4 promotes a plasma cell fate. This reciprocal engagement of 
transcription factors is dependent on strength of BCR and CD40 ligation, as well as TLR signals, 
with increased signal strength all promoting expression of IRF4 instead of BCL6 (Goodnow et 
al., 2010). These findings can link alterations in responsiveness to BCR and TLR stimuli in WASP-
deficient B cells (Becker-Herman et al., 2011; Kolhatkar et al., 2015) to a different germinal center 
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to plasma cell ratio in Was-/- mice, although this paradigm would predict increased signaling to 
skew the ratio in favor of plasma cells instead of germinal center B cells. 
  Since germinal centers contribute critically to affinity maturation of B cells, dysfunction 
in the germinal center response could result in antibodies with reduced antigen affinity. In 
Chapter 8, we used the in vitro degranulation of bone-marrow derived mast cells following 
soluble OVA challenge as a readout for the affinity and functionality of OVA-specific IgE that 
was spontaneously induced in Was-/- hosts in comparison with antibodies obtained from 
OVA/Alum immunized WT mice (Figure 8.2D-E, page 191). Here, we observed no differences 
in the capacity of antigen-specific IgE to mediate mast cell degranulation, suggesting that 
affinity maturation is not significantly altered in the absence of WASP and that Was-/- mice 
can make high-quality antibodies. 
  To further study the role of aberrant germinal center responses in the context of food 
allergic sensitization, we compared the B cell compartment in intestinal lymphoid organs 
of Was-/- and Wasfl/flFoxp3-Cre animals. Although reduced total B cell counts have been 
described in the spleens of Was-/- and Wasfl/flMb1-Cre mice (Recher et al., 2012), we found that 
MLNs from both Was-/- and Wasfl/flFoxp3-Cre mice contained increased numbers of B cells. In 
Peyer’s patches, significantly fewer B cells were encountered in Was-/- than Wasfl/flFoxp3-Cre 
mice (Figure 9.3A). Within PPs and MLNs, we measured an increase in both absolute and 
relative numbers of germinal center B cells, which was significantly greater in the PPs of Wasfl/
flFoxp3-Cre mice compared to WT and Was-/- mice (Figure 9.3B-C). These results suggest that 
WASP-deficiency in B cells may contribute to their altered distribution throughout the GALT 
and clearly indicate that aberrant germinal center responses also occur in a WASP-competent 
B cell compartment in the presence of WASP-deficient Tregs. 
  Failing regulatory mechanisms in the T cell lineage can also result in increased germinal 
center responses, as evidenced by increased germinal center B cells in PPs (but not spleen or 
MLNs) of mice deficient in iTregs via deletion of the intronic Foxp3 enhancer CNS1 (Josefowicz 
et al., 2012b). We found that scurfy mice deficient in all Foxp3 regulatory cells have profound 
spontaneous GC formation, including in the MLNs, with significantly higher frequencies of 
germinal center B cells (~15%) compared to Was-/- and Wasfl/flFoxp3-Cre mice (up to 5% of 
B220+ B cells) (Figure 9.3D). This represents a pathogenic process, as B cells have been shown 
to critically contribute to autoimmune disease in scurfy mice (Aschermann et al., 2013) and 
were found to be dysregulated in humanized mice reconstituted with hematopoietic stem 
cells from an IPEX patient (Chapter 6). A number of studies have identified mechanisms 
that allow Tregs to directly suppress B cell functions. Contact-dependent killing of antigen 
presenting B cells by cognate CD4+CD25+ T cells has been observed (Zhao et al., 2006), and 
in vitro data suggest that this function is defective in WASP-deficient Tregs due to a reduced 
ability to secrete granzyme B (Adriani et al., 2011), although to which extent this contributes 
to spontaneous germinal center formation in WASP-deficient mice has not been investigated. 
The very question how Tregs regulate GC responses resulted in the identification of a 
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subpopulation of FOXP3+ Tregs that co-express transcription factor Bcl6, the lineage-defining 
master regulator of both follicular helper T cell (Crotty, 2014) and germinal center B cell 
differentiation (Linterman et al., 2011) (Chung et al., 2011) (Wollenberg et al., 2011) (Sage et al., 
2012). These follicular regulatory T cells (TFR) cells express CXCR5, allowing CXCL13-mediated 
chemotaxis to germinal centers, and exert control over germinal center B cell responses, 
as Cxcr5-/- or Bcl6-/- Tregs are unable to restrain aberrant germinal center formation (Chung 
et al., 2011). Suppression occurs through inhibition of affinity maturation and plasma cell 
differentiation (Chung et al., 2011) as well as through controlling follicular helper T (TFH) cells 
activation (Linterman et al., 2011). Dysregulation of TFH or TFR responses form an attractive 
hypothesis to explain aberrant antibody responses in food allergic Was-/- mice, but to date no 
study has characterized the TFH or TFR compartment in the context of WASP deficiency. 
Figure 9.3. Deletion of WASP in Foxp3+ Tregs results in B-cell lymphoproliferation and aberrant germinal 
center responses. (A) Quantification of absolute B220+ cell numbers in MLNs and PPs of WT (open circles), Was-
/- (gray circles) and Wasfl/flFoxp3-Cre (black circles) mice. (B) Absolute numbers and relative proportion of germinal 
center (GC) B cells, with gating strategy shown in representative samples in (C). (D) GC B cells in MLNs of scurfy mice 
compared to their littermate controls. Dots represent individual mice and error bars depict SEM. *p<0.05; ** p<0.01; 
***p<0.001; NS: not significant as determined by one-way ANOVA with Tukey’s multiple comparisons test. 
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Figure 9.4 Follicular helper T cells are increased in Was-/- but not in Wasfl/flFoxp3-Cre mice. (A) Fraction of 
follicular helper T (TFH) cells amongst CD4
+ lymphocytes in WT (open circles) and Was-/- (gray circles) mice on the 
BALB/c background in MLN and Peyer’s patches (PP), with gating strategy depicted in (B). (C) Quantification of 
TFH cells in MLNs and PPs of WT (open circles), Was
-/- (gray circles) and Wasfl/flFoxp3-Cre (black circles) mice on the 
C57BL/6 background. (D) Surface expression of TFH markers CXCR5 and PD-1 on CD4+Foxp3+ regulatory T cells in 
WT, Was-/- and Wasfl/flFoxp3-Cre animals as determined by flow cytometry. Dots represent individual mice and error 
bars depict SEM. *p<0.05; ** p<0.01; ***p<0.001; NS: not significant as determined by one-way ANOVA with Tukey’s 
multiple comparisons test.
  Using food allergic Was-/- mice on the BALB/c background (described in Chapter 
7, Figure 7.2, page 161), we found increased fractions of TFH cells in PPs (defined as 
ICOS+CXCR5+, (Sage et al., 2012)) when compared to WT controls (Figure 9.4A-B). Increased 
TFH cells in PPs correlated with increased levels of germinal center B cells in this anatomical 
location, whereas both TFH and germinal center B cells in MLNs were not elevated in the Was
-
/- mice in this experiment (Figure 9.4C). To assess the association between increased TFH cell 
differentiation in WASP deficiency and spontaneously occurring food allergic sensitization, 
we repeated the analysis in WT, Was-/- and Wasfl/flFoxp3-Cre on the C57BL/6 background. 
In line with increased germinal center B cells (Figure 9.3B), we observed a consistent 
increase in the fraction of CXCR5+ TFH in both MLNs and PPs of Was
-/- animals (Figure 9.4D). 
However, increased TFH cells were not observed in Was
fl/flFoxp3-Cre mice, despite an even 
greater expanded germinal center B cell compartment in these mice (Figure 9.3B and 9.4D). 
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These results demonstrate that TFH differentiation is indeed aberrant in Was
-/- animals, but 
also show that an increased TFH compartment is dispensable for aberrant germinal center 
formation and allergic sensitization. 
  Pronounced TFH differentiation in Was
-/- but not Wasfl/flFoxp3-Cre mice could indicate 
that T cell-intrinsic loss of WASP might result in upregulation of TFH markers such as 
CXCR5. If this were true, then WASP-deficient Tregs would be expected to assume a TFR 
phenotype. However, although we indeed observed increased expression of TFR surface 
markers CXCR5 and PD-1 on WASP-deficient Tregs in Was-/- mice, this did not extend to 
Tregs with conditional deletion of WASP (Figure 9.4E). These data suggest that enhanced 
differentiation down the TFH pathway is not driven by T cell-specific loss of WASP, but 
instead is a consequence of the systemic loss of WASP. One mechanism through which 
deficiency of WASP can be hypothesized to contribute to TFH development is reduced 
production of IL-2 by  WASP-deficient T cells (Figure 7.6B, page 167). IL2-signaling 
in CD4+ T cells prevents Bcl6 expression via activation of STAT5 (Johnston et al., 2012) 
and local levels of IL2 thereby affect TFH differentiation. Of note, FOXP3+ Treg-mediated 
suppression of IL2 production was recently shown to result in enhanced germinal center 
formation and improved anti-influenza antibody responses (León et al., 2014), illustrating 
that physiological Treg function may also enhance development of germinal centers. 
  Are dysregulated germinal center responses at all required for the production of 
food-specific IgE? Research into the origin of IgE-secreting B cells has long been obscured 
by the difficulty in detecting these rare populations of B cells. However, over the last few 
years, several IgE-reporter systems have become available, and both M1 prime GFP knock-
in mice as well as Verigem IgE reporter animals have clearly revealed IgE+ germinal centers 
following parasitic infection (Talay et al., 2012; Yang et al., 2012). However, studies in MHCII-
deficient mice and T cell-deficient mice have also identified ‘natural IgE’ that does not 
require secondary lymphoid structures or germinal center formation (McCoy et al., 2006). In 
addition, non-mutated, germinal-center independent B cells can mediate early IgE responses 
following immunization prior to germinal-center-derived production of IgE (Wu and Zarrin, 
2014). One consideration of particular interest to the discussion of the origin of antigen-
specific IgE in the context of WASP deficiency comes from observations in the related primary 
immunodeficiency that results from mutation in the gene dedicator of cytokinesis 8 (DOCK8). 
DOCK8 and WASP both interact with Cdc42 to mediate changes in the actin cytoskeleton, 
and it has been suggested that the two proteins participate in the same signaling pathway 
(Ham et al., 2013; Notarangelo, 2013). DOCK8 patients frequently develop severe allergies, 
and the humoral immune response is characterized by low levels of serum IgM, normal IgG 
and greatly elevated IgE, thus strongly resembling patients with WAS (Zhang et al., 2009) 
(cf. Figure 7.1A, page 159). In strong contrast to mice deficient in WASP, Dock8-/- mice do 
not develop germinal centers, potentially due to failure of B cells to form an immunological 
synapse (Randall et al., 2009), which would indicate a germinal center-independent origin 
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of antibodies. However, Dock8-/- mice do not develop a hyper IgE phenotype (Notarangelo, 
2013), so it would be required to study integrity of germinal center formation in humans in 
order to answer this question. Complicating matters further is the observation that mice 
deficient in Cdc42 (Burbage et al., 2015) or WASP-interacting protein (WIP) (Keppler et al., 
2015) also fail to generate germinal center responses and are characterized by low serum 
levels of IgM and IgG. Since WIP interacts with both N-WASP as well as WASP, it is possible 
that N-WASP can compensate for loss of WASP to explain these seemingly paradoxical 
observations (Westerberg et al., 2012). Deficiency of WIP results in normal Ig levels in the only 
reported human patient (Lanzi et al., 2012). 
  Very recent evidence on the regulation of germinal center responses suggests that loss 
of FAS activity in B cells (underlying the genetic disease autoimmune lymphoproliferative 
syndrome) results in a population of unconventional germinal center B cells that underwent 
somatic hypermutation despite loss of antigen reactivity and continue to become plasma 
cells that preferentially secrete IgE and autoantibodies (Butt et al., 2015). The synthesis of 
FASligand (FASl) from WASP-deficient T cells is reduced (Nikolov et al., 2010). However, FAS/
FASl interactions do not contribute to the direct killing of B cells by CD4+CD25+ Tregs (Zhao et 
al., 2006), so although FAS-mediated dysregulation would provide an attractive hypothesis 
for aberrant B cell responses in Was-/- mice, it would not explain the increase in GC B cells 
in Wasfl/flFoxp3-Cre mice. Generation of WASP-deficient IgE reporter mice would certainly 
provide additional insight in the question of the origin of food-specific IgE in Was-/- mice. 
9.5 Effector T cells
Of all immune cells involved in food allergy, WASP-dependent functions have been most 
extensively characterized for T lymphocytes and the reader is referred to the following two 
papers for a comprehensive overview (Cotta-de-Almeida et al., 2015; Matalon et al., 2013). 
Analogous to the previous discussion on B cells, WASP-dependent functions in T cells can be 
broadly divided over the following, partly overlapping, domains. 
 1   Development and survival. In Was+/- heterozygous mice, around 65% of splenic CD4+ 
and CD8+ T cells express WASP. For thymic populations of double-negative (CD4-
CD8-) or double positive (CD4+CD8+) developing T cells, these frequencies were 
closer to 50%, suggesting that WASP-deficiency is associated with reduced survival 
in the periphery (Westerberg et al., 2008). This may be due to the fact that WASP-
deficient T cells appear to be more susceptible to apoptosis (Cotta-de-Almeida et 
al., 2015; Rengan et al., 2000), although reduced apoptosis of T cells following TCR-
restimulation has also been reported (Nikolov et al., 2010). In humans, secondary 
mutations in WAS that lead to protein re-expression is observed in up to 11% of 
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patients, and in most cases this somatic mosaicism is restricted to T cells (Cotta-de-
Almeida et al., 2015). These revertant T cells show a diversified TCR repertoire and, 
in line with Was+/- mice, also have a selective advantage in vitro and in vivo, although 
autoimmunity and immunodeficiency continued to exist (Trifari et al., 2010). 
 2   Mobility and chemotaxis. Like in other hematopoietic lineages, motility defects 
have been observed in WASP-deficient T cells and it is likely that aberrant 
migration contributes to immunodeficiency, although this remains to be formally 
demonstrated (Cotta-de-Almeida et al., 2015) (Haddad et al., 2001). In Transwell 
plates, Was-/- T lymphocytes exhibit reduced CCR7-mediated migration towards 
CCL19, which may have accounted for the reduced homing of CD4+ T cells to PPs in 
comparison to WT T cells (Snapper et al., 2005). Homing defects were not observed 
in MLNs and spleen, and since WASP integrates multiple chemotactic signals (Cotta-
de-Almeida et al., 2015), the consequences of WASP deficiency likely depend on the 
broad immunological context. It is unknown whether defects in CXCR5-mediated 
chemotaxis as observed in Was-/- B cells (Westerberg et al., 2005) also extend to T 
cells, which would be relevant given the increased fractions of TFH and germinal 
center B cells in Was-/- (Figure 9.4). 
 3   Immune synapse formation and activation. It has long been known that WASP-
deficient T cells show aberrant activation in response to ligation of the TCR with 
anti-CD3 antibodies (Gallego et al., 1997; Snapper et al., 1998). In Chapter 7, we 
discussed that WASP is rapidly recruited to the TCR upon ligation (Barda-Saad et al., 
2005), and is required for internalization of the TCR complex (Zhang et al., 1999). As we 
mentioned above in our discussion on APCs, WASP is indispensable for the formation 
of the immune synapse, where it acts reciprocally with PKCtheta to maintain immune 
synapse stability (Badour et al., 2003; Sims et al., 2007). The failure to maintain 
effective immune synapses between T cells and APCs has also been demonstrated 
in human WAS patients and was associated with reduced Ca2+ signaling and aberrant 
signal integration in WASP-deficient T cells (Calvez et al., 2011). 
 4   Th differentiation, effector function and cytokine production. In addition to aberrant 
activation of antigen-specific CD4+ or CD8+ T cells, it has become clear that absence 
of WASP also affects the differentiation of Th subsets. Skewed Th differentiation 
is of obvious pertinence to our current discussion, since a dysregulated Th1/Th2 
balance has been hypothesized to underlie the atopic features of WAS patients 
(Cotta-de-Almeida et al., 2015; Massaad et al., 2013). A frequently cited study found 
that CD4+ T cells from WAS patients exhibited a reduced induction of TBX21 (the gene 
encoding the Th1 transcription factor T-bet) following stimulation of TCR and CD28, 
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whereas GATA3 mRNA levels were similar to those in T cells from healthy donors. 
This was reflected in significantly reduced production of IFN-γ, IL-2 and TNF-α, but 
not IL-4 or IL-5, following TCR stimulation in vitro (Trifari et al., 2006). Mechanistically, 
diminished Th1 differentiation was associated with reduced translocation of NFAT to 
the nucleus (Trifari et al., 2006), which had also been found to underlie diminished 
Il2 gene expression in Was-/- mice (Cianferoni et al., 2005). Similarly, CD8+ cytotoxic 
T lymphocytes from WAS patients secrete lower levels of IFN-γ, IL-2 and TNF-α (De 
Meester et al., 2010). However, reduced Th1 immunity in WASP deficiency has been 
challenged by Deborah Fowell and colleagues (Morales-Tirado et al., 2010), who 
observed that transfer of Was-/- CD4+ T cells to Rag-/- mice resulted in protection against 
Leishmania major, which depends on IFN-γ production by Th1 cells, but not against 
the Th2-inducing Nippostrongylus brasiliensis. Although WASP-deficient CD4+ T cells 
were found to produce lower levels of IL-4, it is hard to compare the outcomes of these 
two parasite studies as the N brasiliensis model was carried out in TCR Cα-deficient 
and not Rag-/- mice (Morales-Tirado et al., 2010). Further adding to the complex role 
of WASP in Th differentiation is the recognition of WASP-mediated epigenetic effects 
(Taylor et al., 2010). In primary Th1-differentiating cells, WASP could be found in the 
nucleus where it was recruited to the proximal promoter locus of TBX21 (encoding 
T-bet) as well as IFNG and STAT1. In contrast, no binding was observed to the core 
promoters of either GATA3 or RORc (encoding RORgt) Interestingly, these authors also 
identified WASP binding to exons 9 and 12 of FOXP3, although the significance of this 
remains to be determined (Taylor et al., 2010).
 5   TCR repertoire variation. Similar to recent observations in B-lymphocytes, WAS 
patients show alterations in TCR repertoire compared to age-matched healthy 
subjects (O’Connell et al., 2014; Wada et al., 2005; Wu et al., 2015). Multiple 
mechanisms may contribute to this, including the accumulation of expanded T cell 
clones with specificity for self or persistent infectious agents - or for that matter, 
allergens – as well as abnormal thymic generation of a diversified naïve T cell pool 
(Cotta-de-Almeida et al., 2015). Analysis of the TCR-repertoire in Was-/- mice could 
help differentiate these two non-mutually exclusive origins of TCR-skewing, but in 
contrast to B cells (Kolhatkar et al., 2015), this has not yet been published. 
As we argued in Chapter 7, it is likely that the loss of WASP in non-regulatory T cells 
contributes to the differential disease activity observed between Was-/- and Wasfl/flFoxp3-Cre 
mice. Following ex vivo stimulation, we found significantly lower IL-4 production by CD4+ T 
cells isolated from MLNs of Was-/- mice when compared to Wasfl/flFoxp3-Cre animals (Figure 
7.6F, page 167). Since we also observed both a relative and absolute decrease in GATA3+ T 
cells (Figure 7.6D, page 167 and Figure 7.S4D, page 178), this reduced IL-4 production 
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appears to result from diminished Th2 differentiation rather than secretory defects in 
individual Th2 cells. T cell activation defects due to aberrant formation of immune synapses 
with food-antigen presenting mononuclear phagocytes provide an additional explanation 
for a dampened food allergic response in Was-/- mice. Lastly, alterations in the TCR repertoire 
may affect the availability of food antigen-specific T cells in the same way as we hypothesized 
to occur for B cells, which could reduce the likelihood of antigen-specific proliferation upon 
encountering food antigens.  
9.6 Regulatory T cells
Throughout this chapter, we have considered the WASP-deficient FOXP3+ Treg compartment 
as the one constant determinant between Wasfl/flFoxp3-Cre and Was-/- mice. However, we 
must also consider differences in FOXP3+ Tregs themselves as potentially contributing to 
disparate degrees of food allergy in Wasfl/flFoxp3-Cre and Was-/- mice. In Chapter 7 we found 
equivalent or even increased absolute and relative fractions of FOXP3+ Tregs in Wasfl/flFoxp3-
Cre compared to WT animals, whereas Tregs were significantly reduced in Was-/- mice (Figure 
7.6A, page 167). In addition, earlier in this chapter we observed that Was-/- but not Wasfl/
flFoxp3-Cre Tregs expressed increased levels of the TFH markers CXCR5 and PD-1 (Figure 
9.4E). Although we identified that Th2 skewing in WASP-deficient Tregs occurred to the same 
extent in mice of either genotype (Figure 7.7A, page 169), it is possible that differences in 
Treg numbers or phenotype contribute to differential food allergic disease. 
 Our currently available data are insufficient to explain alterations in the FOXP3+ Treg 
compartment between Was-/- and Wasfl/flFoxp3-Cre mice. However, based on the foregoing 
discussion of WASP deficiency in other hematopoietic lineages, we can envision a number of 
potential mechanisms:
 1   TCR-signal-mediated changes in Treg development and repertoire. As discussed in 
Chapter 6, TCR signaling is a critical determinant during T cell development in the 
thymus. Rather than being deleted through negative selection, T cells that express 
a TCR with low-affinity for self-antigens will undergo epigenetic changes associated 
with a regulatory phenotype, including the expression of FOXP3 (Li and Zheng, 
2015; Ohkura et al., 2013). Very recently, a role for the conserved region CNS3 of the 
FOXP3 gene has been identified as an epigenetic switch for Treg commitment in 
response to suboptimal TCR signals, with CNS3-deficient Tregs showing a skewed 
TCR repertoire that has higher affinity for self peptides (Feng et al., 2015). Given the 
abovementioned role of WASP in integrating TCR signals, it can be anticipated that 
the timing of loss of WASP (i.e. before or after Treg lineage commitment and Foxp3 
Part 2 – Chapter 9
224
transcription) will have marked effects on the specificity and regulatory function of 
Tregs that leave the thymus.  
 2   Altered Treg maintenance or induction by Was-/- dendritic cells. Earlier in this chapter, 
we discussed the potential contribution of Was-/- mononuclear phagocytes on 
spontaneously occurring food allergy in the context of WASP deficiency. BrdU 
and Annexin staining following transfer of WT Tregs into Rag2-/- or Was-/-Rag2-/- 
mice revealed equivalent rates of apoptosis, but reduced proliferation of FOXP3+ 
T cells, indicating aberrant Treg maintenance by Was-/- innate immune cells 
(Nguyen et al., 2012). Was-/-Rag2-/- mice showed reduced numbers of tolerogenic, 
CD11c+CD11b+CD103+ dendritic cells (Nguyen et al., 2012), which form the subset 
of intestinal APCs that migrate to the MLNs to induce Tregs. In this process, the 
vitamin A metabolite retinoic acid has been identified as a critical cofactor that acts 
together with TGF-β and IL-2 to promote Treg differentiation from naïve T cells at 
mucosal sites (Coombes et al., 2007; Josefowicz et al., 2012a; Zheng et al., 2010). 
As depicted in the heatmap data in Figure 7.5A (page 165), we observed striking 
differences between genotypes in the expression of the vitamin A metabolizing 
enzymes RALDH1 (Aldh1a1) and RALDH2 (Aldh1a2) (Figure 9.5A). Although 
expression of Aldh1a2 is restricted to tolerogenic CD103+ dendritic cells (Hall et al., 
2011b), we found no differences in transcription of Itgax (CD11c) or Itgae (CD103) in 
intestinal tissue, which suggests an equal abundance of CD103 positive dendritic 
cells in the lamina propria of WT, Was-/- and Wasfl/flFoxp3-Cre mice (Figure 9.5B). 
Expression of Aldh1a1 and Aldh1a2 was even more reduced in Wasfl/flFoxp3-Cre than 
Was-/- mice, demonstrating that WASP deficiency in dendritic cells is dispensable 
for downregulation of these enzymes. Given that Aldh1a1 and Aldh1a2 associated 
with mast cell markers in our hierarchical cluster analysis (Figure 7.5A, page 165), 
we asked whether their reduced expression was a consequence of Th2-mediated 
inflammation. By comparing Was-/- mice with WT animals that were sensitized with 
OVA/alum, we observed that despite equivalent degrees of type 2 inflammation as 
assessed by expression of Mcpt1 (Figure 8.3D, page 193), lower levels of Aldh1a1 
expression were only seen in Was-/- mice (Figure 9.5C). Moreover, in WASP-deficient 
mice, a negative correlation between expression of Mcpt1 and Aldh1a1 was observed, 
whereas in food allergic WT mice this correlation was inverted (Figure 9.5D). 
Combined, these results identify the downregulation of RALDH enzymes in tolerogenic 
dendritic cells as a feature of Was-/- FOXP3+ Tregs rather than of WASP deficiency in 
dendritic cells themselves. Reduced expression of Aldh1a1 and Aldh1a2 was not seen 
in Foxp3sf mice (Figure 9.1F, page 205), which illustrates that downregulation of 
RALDH enzymes in Was-/- and Wasfl/flFoxp3-Cre mice does not result from a functional 
deficiency of Tregs. In addition, it should be noted that retinoic acid is required for 
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normal Ca2+ signaling and NFAT translocation following TCR-mediated activation of 
T cells (Hall et al., 2011b; 2011a). As discussed in the previous section, both these 
mechanisms are already defective Was-/- T cells, thus adding an additional layer of 
complexity to the interplay between retinoic acid metabolism and failing immune 
homeostasis. The role of RALDH-positive dendritic cells in WAS-associated allergy 
deserves further study. 
Figure 9.5 WASP deficiency in Foxp3+ Tregs is associated with reduced mRNA expression of RALDH enzymes. 
(A) mRNA expression levels of Aldh1a1 and Aldh1a2 in jejunum of WT (open circles), Was-/- (gray circles) or Wasfl/
flFoxp3-Cre (black circles) C57BL/6 mice. (B) mRNA expression levels of Itgax and Itgae in jejunum of WT, Was-/- or 
Wasfl/flFoxp3-Cre mice. (C) Aldh1a1 mRNA expression in jejunum of OVA/alum sensitized (gray squares) WT mice and 
OVA-gavaged Was-/- (gray circles) or WT/ Was+/- littermates (open circles) on the BALB/c background. (D) Differential 
Pearson correlation between intestinal expression of Aldh1a1 and Mcpt1 in OVA-gavaged Was-/- (gray circles) and OVA/
alum sensitized WT BALB/c mice (gray squares). Dots represent individual mice and error bars depict SEM. * p<0.05; 
** p<0.01; ***p<0.001; NS: not significant as determined by one-way ANOVA with Tukey’s multiple comparisons test.
 3   Altered induction from microbes. Over the last few years, the composition of the 
microflora has been increasingly recognized as a critical determinant of Treg 
repertoire and numbers (Atarashi et al., 2013; Geuking et al., 2011; Lathrop et al., 
2011). Consequently, any differences in microbial colonization between Was-/- and 
Wasfl/flFoxp3-Cre mice can potentially result in differences peripheral Treg induction. 
Similarly, RALDH levels are lower in germ-free or MyD88-deficient mice (Hall et al., 
2011b), suggesting that differential expression of Aldh1a1 and Aldh1a2 could be 
the result of alterations in the microflora. The composition of the microflora will be 
discussed in a later section in this chapter. 
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 4   Reduced induction from regulatory B cells. As previously discussed in this chapter, 
regulatory B cells are a recently identified subset of IL-10 producing cells capable of 
recruiting Tregs. Considering that Bregs are decreased in Was-/- mice and that this 
reduction is due to a B cell-intrinsic defect (Bouma et al., 2014), it is likely that Breg 
cells occur in normal frequencies in Wasfl/flFoxp3-Cre mice and may thus contribute 
to increased Treg numbers in these mice. 
 5   Alterations in baseline IL-2 levels. As discussed in the previous section, the failure to 
maintain immune synapse stability (Sims et al., 2007) and aberrant NFAT signaling 
following TCR-mediated activation (Cianferoni et al., 2005) are associated with 
reduced IL-2 production from WASP-deficient T cells (Figure 7.6B, page 167). IL-2 
is critical for the formation of Tregs, both during thymic development as well as for 
their peripheral induction (Josefowicz et al., 2012a; Li and Zheng, 2015). As described 
in Chapter 7, the relative IL-2 deficiency in Was-/- mice has been hypothesized to 
contribute to Treg dysfunction, because exogenous IL-2 increased suppressive 
function of WASP-deficient Tregs in vitro (Humblet-Baron et al., 2007; Maillard et 
al., 2007). Although we have clearly demonstrated that a correction of defective 
IL-2 production in Wasfl/flFoxp3-Cre mice (Figure 7.6B, page 167) is insufficient to 
resolve immune dysregulation in vivo (Chapter 7), it is conceivable that lower levels 
of IL-2 in Was-/- animals result in reduced thymic and peripheral Treg differentiation. 
Indeed, STAT5 overexpression is associated with increased numbers of FOXP3+ Tregs 
(Burchill et al., 2008). Along the same line of argumentation, and as also discussed 
in the B cell paragraph of this chapter, it is becoming clear that STAT5-mediated 
IL-2 signaling through IL-2Rα (CD25) negatively affects Tfh differentiation through 
inhibition of Bcl6 transcription (Ballesteros-Tato et al., 2012; Johnston et al., 2012; 
Nurieva et al., 2012). Reduced IL-2 levels in Was-/- but not Wasfl/flFoxp3-Cre mice could 
thus be envisioned to skew the differentiation of T cells away from Treg and Th1 
and towards TFH in Was
-/-, which would explain both the increased fractions of Tfh as 
well as reduced Tregs in these animals compared to Wasfl/flFoxp3-Cre mice. Similarly, 
differential IL-2 levels could be expected to cause an upregulation of Tfh markers 
CXCR5 and PD-1 in WASP-deficient Tregs in Was-/- but not Wasfl/flFoxp3-Cre mice 
(Figure 9.4E, page 218). Combined, our results thus support a model in which 
WASP-deficient Tregs are affected in number and phenotype by differential levels of 
extrinsic IL-2 in vivo. Adding further significance to differential baseline levels of IL-2, 
Hondowicz et al. recently showed that IL-2 is required for the formation of allergen-
specific Th2 cells in lung tissue (Hondowicz et al., 2015). Since these cells were 
recruited from the CXCR5- population of T cells, the increased fraction of CXCR5+ 
T cells as well as lower concentrations of IL-2 could both contribute to dampened 
allergic disease in Was-/- compared to Wasfl/flFoxp3-Cre mice. 
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Although it is likely that a combination of these proposed mechanisms underlie differences 
in the Treg compartment between Was-/- and Wasfl/flFoxp3-Cre mice, it is clear that none of 
these are causative of food allergic sensitization. In fact, one important conclusion from the 
work presented in Chapter 7 is that immune dysregulation occurs in Wasfl/flFoxp3-Cre mice 
despite normal Treg numbers (Figure 7.6A, page 167), activation status (CD44hiCD62Llo, 
Figure 7.6D, page 167) and site of induction (Neuropilin-1, Figure 7.S4B, page 178). 
Furthermore, WT levels of immunoregulatory proteins CTLA4, GITR, and CD103 expression 
have been previously observed on the surface of Was-/- Tregs (Maillard et al., 2007; Marangoni 
et al., 2007). The only difference that we observed between WT and Was-/- Tregs – obtained 
from either Was-/- or Wasfl/flFoxp3-Cre mice – were the increased levels of Th2 transcription 
factor GATA3 in Tregs with an effector-like, CD44hiCD62Llo, phenotype. GATA3+ Tregs were 
recently found to promote food allergy in both humans and mice (Noval Rivas et al., 2015). 
However, the mechanism of how WASP deficiency results in enhanced expression of GATA3 
remains undefined. In the discussion of Chapter 7, we have started speculating on this 
question, and in the following section, that argument will be expanded. 
Immune dysfunction in WAS patients constitutes features of both immunodeficiency 
(i.e. increased susceptibility to opportunistic infections and malignancies) and immune 
dysregulation (i.e. increased autoimmunity and allergy). Intuitively, this amounts to a 
paradoxical condition, because it implies simultaneous hypo- and hyper-activation of the 
immune system. Yet the combination of immunodeficiency and immune dysregulation 
can also be found in a wide variety of primary T cell immunodeficiencies other than WAS 
(Notarangelo, 2013), suggesting that both features can be consequences of a single 
pathogenic mechanism. This notion is supported by genetic mouse models of T cell-
mediated immunodeficiencies, where a range of different mutations that affect T cell effector 
function concurrently result in autoimmunity and dysregulated IgE and IgG1 responses (see 
for example Table 2 in (Liston et al., 2008)). A recurring feature amongst many of the genetic 
defects in these different mouse models is that they directly affect TCR signaling. For example, 
as mentioned in Chapter 7, mutations in the TCR-associated scaffold protein LAT result in 
reduced Ca2+ signaling and IL-2 production upon TCR ligation of isolated T cells in vitro, but also 
lead to profound Th2-skewed lymphoproliferation and hyper IgE responses in these animals in 
vivo (Aguado et al., 2002; Sommers et al., 2002). Similarly, mice with compound heterozygous 
mutations in the TCR-dependent tyrosine kinase ZAP70 demonstrate reduced Ca2+ signaling 
and aberrant immune responses to Bordetella pertussis, while also developing elevated serum 
IgE/IgG1 and autoantibodies (Siggs et al., 2007). These mouse models show that mutations 
that interfere with TCR signaling can result in the same combination of immunodeficiency and 
Th2-type immune dysregulation that is observed in WASP-deficient mice.
  How to link aberrant TCR signals to the development of Th2 effector responses? It is 
becoming clear that the strength of the TCR:pMHC interaction is a determinant for subsequent 
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Th differentiation (Datta and Milner, 2011). This concept was founded on the observations 
from the laboratories of Kim Bottomly and Anne O’Garra that Th2 differentiation results from 
low-affinity TCR stimulation, whereas higher affinity interactions are more likely to give rise to 
Th1 cells (Datta and Milner, 2011; Hosken et al., 1995; Leitenberg et al., 1998). Recently, it was 
corroborated further using intra-vital microscopy that allowed for quantification of T cell–
dendritic cell interaction times and synapse size, which were shown to exert greater influence 
on the outcome of T cells than presence of Th1 or Th2 skewing cytokines or adjuvants (van 
Panhuys et al., 2014). Furthermore, weak TCR signaling is also hypothesized to underlie early 
cell-fate decisions that differentiate between a Th1 and Tfh response (Tubo and Jenkins, 
2014). In this scheme, shorter p:MHCII dwell times (i.e. lower signal quality) specifically 
promote Tfh over Th1 differentiation via preferential expression of Bcl-6 instead of Blimp-1 
(Tubo and Jenkins, 2014; Tubo et al., 2013). An attractive feature of this theory is that it helps 
explain the Th2 skew that is observed in immunodeficiencies characterized as ‘leaky SCID’, 
of which the Omenn syndrome is a well-known example. Like SCID, Omenn syndrome can 
be caused by mutations in the RAG enzymes that mediate VDJ recombination in developing 
T cells. In strong contrast to the former, T cell development is not completely abrogated 
(hence the leakiness). However, the T cells that do form in Omenn syndrome patients 
display a severely restricted TCR repertoire. The lack of high-affinity interactions with pMHCII 
molecules on APCs causes a selective Th2 skew (Milner et al., 2010). In mice, a restricted TCR 
repertoire results in eosinophilia and Th2-type inflammation (Milner et al., 2007), and Omenn 
patients have elevated IgE and increased levels of serum IL-4 (Ozcan et al., 2008). 
  Given the involvement of WASP in TCR-mediated signaling and T cell activation (Matalon 
et al., 2013) and our results that show increased Th2 and Tfh differentiation in Was-/- mice 
(Chapter 7 and Figure 9.4), it is tempting to speculate that absence of WASP from T cells 
affects TCR:pMHCII interactions in a way that promotes Th2 and Tfh development over Th1 
differentiation. Indeed, aberrant TCR signaling in itself has been hypothesized to underlie 
the immune dysregulation, Th2 skewing and atopic features observed in WAS patients (Datta 
and Milner, 2011). Furthermore, the recently demonstrated skewing of the TCR repertoire in 
patients with WAS (O’Connell et al., 2014; Wada et al., 2005; Wu et al., 2015) can be envisioned 
to contribute further to a reduced quality of TCR:pMHCII interactions via an Omenn-like 
mechanism. However, by identifying increased allergic disease in Wasfl/flFoxp3-Cre mice 
compared to Was-/- animals, we have shown that WAS deficiency in naïve effector T cells is 
dispensable for aberrant Th2 skewing. Atopy in the context of WAS is not due to aberrant 
priming of T cells, but results instead from a selective loss of Th2 suppressive capability 
in WASP-deficient Tregs. Nevertheless, it is very well possible that the abovementioned 
mechanisms that link aberrant TCR:pMHCII interactions to a Th2-like differentiation are also 
operative in WASP-deficient FOXP3+ T cells to give rise to a Th2-skewed population of Tregs 
which preferentially co-express GATA3.  
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  In addition to the here suggested effect on transcription factor expression, emerging 
evidence demonstrates that TCR-signaling is also required for normal Treg function. In model 
systems that allow for the abrogation of TCR-expression after T cells have started expressing 
FOXP3 (and thus have committed to the Treg lineage), continuous TCR activation was found 
indispensable for the prevention of autoimmunity (Levine et al., 2014; Vahl et al., 2014). Very 
recently, the role of the TCR on Tregs was illuminated further by intravital microscopy studies, 
which identified that in vivo, pSTAT5+ Tregs cluster together with IL-2 producing self-reactive 
CD4+ T cells. Deletion of the TCR on Tregs abrogated their migration to these self-reactive T 
cells, which was associated with rapid-onset autoimmunity (Liu et al., 2015). These results 
strongly suggest that antigen-specific activation of Tregs via their TCR serves as an important 
chemotaxis signal, and misinterpretation of this signal in the absence of WASP may be what 
underlies lymphoproliferation and allergic responses in Was-/- and Wasfl/flFoxp3-Cre mice. It is 
furthermore conceivable that a failure of WASP-deficient Tregs to migrate in response to TCR-
mediated signals is exacerbated further by the negative effect of loss of WASP on cell motility. 
Intravital studies in Wasfl/flFoxp3-Cre mice would be required to further test this hypothesis, 
and to delineate the mechanism that renders WASP-deficient Tregs pathogenic. 
9.7 IgE Effector cells 
Loss of WASP-dependent functions from IgE effector cells would be the most straightforward 
explanation for the alleviated food allergic phenotype observed in Was-/- mice when 
compared to Wasfl/flFoxp3-Cre animals. If WASP-deficiency cripples the acute hypersensitivity 
response, this would translate directly in a reduction of histamine-mediated allergic 
symptoms. In Chapter 7, we described that anaphylaxis to food antigens had never occurred 
in a cohort of 25 individuals with mutations in WAS, and showed that these patients have 
reduced IgE-dependent and IgE-independent cutaneous mast cell responses (Figure 7.1D-
E, page 159). This was in line with murine data, because mice deficient in WASP (Pivniouk 
et al., 2003) or WASP interacting protein (Kettner et al., 2003) were found to be protected 
against IgE-mediated anaphylaxis following passive immunization with hapten-specific IgE. 
However, in Chapter 8 we demonstrated that Was-/- mice on the BALB/c background were 
susceptible to allergic diarrhea (Figure 8.3B, page 193) and systemic anaphylaxis (Figure 
8.3E-F) following OVA challenge. These immune responses were mediated at least in part 
by IgE, as oral challenge with OVA resulted in the rapid increase in serum MCPT1, which is a 
selective biomarker of IgE-dependent degranulation of mucosal mast cells ((Khodoun et al., 
2011) and Chapter 8). How to reconcile these discrepant findings? First of all, the study by 
Pivniouk and colleagues used Was-/- mice on a C57BL/6-129SvEv mixed genetic background, 
but 129SvEv as WT controls. As delineated in detail in Chapter 7, C57BL/6 are notoriously 
resistant to Th2-mediated immunity, including allergic responses, and incomplete back-
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crossing may therefore have contributed to the observed differential susceptibility to 
anaphylaxis. A second, not mutually exclusive explanation could be that the elevated levels 
of endogenous IgE in Was-/- mice block FcεRI binding sites for exogenous NP-specific IgE, 
resulting in reduced mast cell sensitization before antigen challenge the next day. Following 
our protocol of repeated oral sensitizations (Figure 8.2B, page 191), OVA-specific IgE 
becomes part of the endogenous IgE pool and has sufficient time to saturate the surface IgE 
receptors of mast cells. Using in vitro culture of bone-marrow derived mast cells from Was-/- 
and WT mice of both the BALB/c and C57BL/6 genetic background, we further confirmed that 
IgE-mediated degranulation was almost completely intact in the absence of WASP (Figure 
8.4B, page 195). Despite normal acute degranulation, Was-/- mast cells significantly differed 
from WT counterparts in their ability to release inflammatory cytokines in response to IgE-
mediated signals (Figure 8.4D), demonstrating that WASP-deficiency does alter mast cell 
function. In addition to signaling events downstream of IgE:FcεRI, WASP is also implicated 
in the response to ligation of KIT with stem cell factor (Mani et al., 2009), which explains why 
WASP-competent mast cells show a selective advantage in culture over Was-/- counterparts 
and may affect homeostasis of intestinal mast cells after initial expansion. 
  It is tempting to ascribe the reduced allergic inflammation in Was-/- mice to altered IgE-
mediated cytokine production from WASP-deficient mast cells, but it is currently not clear 
to which extent mast-cell-derived cytokines contribute to intestinal allergy. We showed 
in Chapter 8 that the expansion of mucosal mast cells in WASP-deficient mice occurs 
independently of IgE:FcεRI signaling, because Was-/-Fcer1a-/- and Was-/-Fcer1a+/- littermates 
were equally susceptible to OVA sensitization and mucosal mast cell expansion (Figure 8.5, 
page 196). This is in line with results from experiments in IgE-deficient mice, which show 
reduced, but nevertheless still pronounced expansion of mucosal mast cells and elevated 
serum MCPT1 following infection with T. Spiralis. (Gurish et al., 2004). In contrast, the absence 
of T cells in nu/nu mice completely abrogates mucosal mast cell expansion in T. Spiralis-
infected mice (Ruitenberg and Elgersma, 1976), suggesting that T-cell-derived mediators 
are likely the most critical determinant of mucosal mast cell expansion (Burton et al., 2012; 
Chu et al., 2014; Reber et al., 2012). Recently it was shown that mast-cell derived IL-9 acts 
to significantly promote mucosal (MCPT1+) mast cells expansion in response to IL-33 (Chen 
et al., 2015; Forbes et al., 2008).  Il9 transcripts were below the level of detection in Was-/- as 
well as WT-derived cultured mast cells, irrespective of IgE-mediated stimulation (results not 
shown). Although this likely reflects the failure of these cultured cells to adopt a mucosal 
phenotype in vitro, the fact that we did not observe considerable increases in the abundance 
of Il9 or Il33 mRNA in jejunal sections of Was-/- and Wasfl/flFoxp3-Cre, and that these genes 
furthermore did not associate with mast cell markers in our hierarchical cluster analysis 
(Figure 7.5A, page 165) argues against significant involvement of mast-cell-derived IL-9 
in mucosal mast cell expansion in the context of WASP-deficiency. Conversely, we found 
that mast cell expansion could be completely abrogated by the absence of lymphocytes in 
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Was-/-Rag2-/-, or through deletion of IL-4 in Was-/-Il4-/- mice (Figure 7.S3A, page 177 and Figure 
7.6G, page 167 respectively). Reduced IL-4 production from WASP-deficient T cells (Figure 
7.6F) may therefore be quantitatively more important on limiting mast cell expansion than 
mast-cell intrinsic defects in cytokine production.  
Basophils comprise the other arm of IgE-mediated effector responses. Given their low 
abundance in blood in combination with a mast-cell-like phenotype, basophils have long 
been considered a more or less redundant immune population (Karasuyama et al., 2011). 
Not surprisingly, data regarding the role of WASP in basophil function are limited to one study 
on one human WAS patient whose basophils showed normal histamine release following 
IgE-dependent (anti-IgE) and IgE-independent (calcium ionophore A23187) stimulation 
(Marone et al., 1986). Scientific interest in basophils has greatly increased in recent years and 
with the availability of new genetic tools, the role of basophils in relation to other immune 
populations and IgE-mediated diseases is now becoming more crystallized (Karasuyama 
et al., 2011; 2009; Siracusa et al., 2013; Voehringer, 2013). Although basophils express FcεRI, 
several reports indicate that basophils are completely dispensable for acute, IgE-mediated 
hypersensitivity responses, which are mediated by mast cells (Sawaguchi et al., 2012; 
Tsujimura et al., 2008). In contrast, basophils were shown to contribute critically to IgG-
mediated anaphylaxis and basophil depletion before challenge rescued mice from death 
(Tsujimura et al., 2008). Furthermore, in an IgE-dependent fashion, basophils contribute 
to chronic, late phase allergic inflammation independent from involvement of mast cells 
and T cells (Mukai et al., 2005). Data from Mcpt8-Cre mice allowing constitutive deletion of 
basophils confirmed a reduced severity of chronic allergic responses and recall responses 
following secondary challenge with Nippostrongylus brasiliensis, but found that basophils 
are dispensable during a primary parasite infection and for the induction of IgE and IgG1 
responses against allergens (Ohnmacht et al., 2010). Work on the role of basophils in 
intestinal immunity and food allergy has come from a number of papers from the group of 
David Artis, who identified that epithelial cell-derived TSLP promotes a subpopulation of IL-3 
independent basophils particularly capable of supporting Th2 cells during allergic responses 
(Siracusa et al., 2011). Translation of this finding to human allergic disease was provided by 
patients with EoE, in whom polymorphisms in the TSLP are associated with increased risk 
(Noti et al., 2013; Rothenberg et al., 2010) (and see Chapters 1, 2, 3 and 5). Surprisingly, 
TSLP was dispensable for mediating the increased basophil numbers that were observed in 
mice treated with antibiotics. Rather, basophil expansion appeared to be regulated directly 
by IgE, because no increase in basophils was seen following antibiotic treatment of Rag-/-, Il4-
/- or Igh7-/- (IgE-deficient) mice and exogenous IgE expanded basophils in Rag-/- hosts (Hill et al., 
2012). However, a role for TSLP was identified in a model of food allergic sensitization initiated 
via allergen exposure to atopic dermatitis-like skin lesions. In this model, TSLP-expanded 
basophils contributed to mast cell expansion in the intestine, as evidenced by reduced Mcpt1 
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and Mcpt2 expression in Tslpr-/- mice or after DTR-mediated basophil depletion, although mRNA 
expression of basophil-specific Mcpt8 was not assessed (Noti et al., 2014). In Chapter 5 we have 
seen that this mechanism is also operative in murine EoE following epicutaneous sensitization. 
Combined these results suggest that basophils contribute to intestinal allergic responses, and 
the consequences of WASP-deficiency in these cells therefore deserve further study. 
Blood basophils (gated as CD45midCD49b+, see Figure 8.5A, page 196) made up a significantly 
greater fraction of peripheral blood mononuclear cells (PBMCs) in Was-/- than in WT or Wasfl/
flFoxp3-Cre animals (Figure 9.6A). In line with our earlier results (Figure 7.S1B, page 175), 
significantly different levels of serum IgE between these groups (Figure 7.4C, page 164) 
were reflected in the degree of IgE loading on the basophil cell surface, which was strongest 
in Wasfl/flFoxp3-Cre mice (Figure 9.6B). To assess whether the increased proportion of blood 
basophils in Was-/- animals resulted from a basophil-intrinsic effect of WASP deficiency, we 
determined absolute basophil numbers in blood of Was-/-Rag2-/- and Rag2-/- mice. Since 
RAG2 deficiency extends to both T and B cells, no IgE loading was detected on the surface 
of basophils (Figure 9.6C). In the absence of adaptive immunity, WASP-deficient basophils 
were reduced compared to WT basophils (Figure 9.6D), suggesting that loss of WASP is 
associated with reduced rather than increased basophil survival. Comparison of Was-/-Rag2-/- 
and Rag2-/- mice also allowed for analysis of in vivo expression levels of FcεRI in the absence 
of confounding influence of different levels of IgE. Here we observed a slight reduction in 
FcεRI expression on the surface of WASP-deficient basophils Figure 9.6E), although the 
biological relevance of this difference is unlikely to be large. 
  Based on abovementioned data on the regulation of basophils by IgE (Hill et al., 2012), 
we could have expected that uncontrolled Th2 responses in Wasfl/flFoxp3-Cre mice would 
be associated with a larger effect on blood basophil numbers. However, study of Was-/-Il4-/- 
animals further confirmed that increased serum IgE and Th2-mediated intestinal inflammation 
in WASP deficiency did not affect total basophil numbers (Figure 9.6F). However, these 
results do not rule out the possibility that loss of WASP-dependent functions from basophils 
contributes to differential intestinal inflammation between Was-/- and Wasfl/flFoxp3-Cre mice. 
In the gene expression data presented in Figure 7.5A (page 165), we observed increased 
expression of basophil-specific Mcpt8 in jejunum from Wasfl/flFoxp3-Cre, but not Was-/- mice 
(Figure 9.6G), which implicates that WASP-competent, but not WASP-deficient basophils 
contribute to the immune infiltrate in allergic intestinal inflammation. We therefore assessed 
basophil responses following antigen challenge in WT and Was-/- hosts. In OVA/alum-
sensitized BALB/c animals (following the sensitization scheme depicted in Figure 8.2A, 
page 191), OVA challenge by gavage is associated with the rapid disappearance of basophils 
from the systemic circulation, followed by almost complete repletion in the following 24 
hours (Figure 9.6H). The kinetics of this response are apparently similar to the increase in 
serum MCPT1 that signifies the IgE-mediated activation of mucosal mast cells (Figure 9.6H). 
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Using Was-/- mice that were sensitized to OVA using the adjuvant-free protocol depicted 
in Figure 8.2B (page 191), we observed that antigen-specific basophil responses were 
intact in the absence of WASP (Figure 9.6I). In combination with our data in Chapter 8 
that in the absence of WASP, IgG-mediated anaphylaxis, which has been described to be 
basophil-dependent (Tsujimura et al., 2008) is intact (Figure 8.5F, page 196), these results 
indicate that allergen-specific activation of basophils occurs relatively unperturbed in Was-
/- hosts. However, aberrant migration of granulocytes has been reported in WASP deficiency 
(Snapper et al., 2005), and reduced migration of WASP-deficient basophils to sites of allergic 
inflammation could therefore provide a potential explanation for absence of Mcpt8 mRNA 
expression that is not ruled out by our current set of data. 
Mast cells and basophils are increasingly recognized as important regulators of inflammatory 
responses rather than mere IgE effector cells in the context of allergic responses and anti-parasite 
immunity (Galli and Tsai, 2012; Karasuyama et al., 2011; Voehringer, 2013). Further research will 
likely lead to identification of novel regulatory functions. If some of these functions are found to 
be dependent on WASP, then additional roles for IgE effector cells in modifying disease severity in 
WASP-deficient mice may be uncovered. Combined deletion of WASP from Tregs and mast cells 
or basophils could provide a first step towards identification of such roles. 
9.8 Microflora
Research has begun to illuminate the many ways in which commensal microbes shape 
intestinal immune responses (Belkaid and Hand, 2014; Honda and Littman, 2012; Hooper 
et al., 2012). Each of these interactions bear the potential to become confounding variables 
in experiments that do not account for baseline differences in microbial populations (Eberl, 
2015; Macpherson and McCoy, 2015; Moon et al., 2015; Ivanov et al., 2009). Colonization status 
therefore deserves to be considered as a factor that may contribute to differential disease 
between Was-/- and Wasfl/flFoxp3-Cre mice. 
  The study of the microbiome in the context of primary immunodeficiencies is still in its 
infancy. For WAS patients, the only currently available data pertain to bacteria and fungi on 
the skin, which were studied in relation to patients with atopic dermatitis as well as two other 
PIDs associated with eczematous skin disease: autosomal dominant hyper IgE syndrome and 
DOCK8 deficiency (Oh et al., 2013). In all three immunodeficiencies, a reduction in diversity of 
the cutaneous microbiome was observed, but this could have been a function of eczematous 
inflammation, as diversity was also reduced in AD patients compared to healthy controls. 
However, PID patients also demonstrated increased ecological permissiveness, manifesting 
as colonization with species that were not found on the skin of AD or healthy patients. These 
data thus link immune dysfunction to dysbiosis in human skin (Oh et al., 2013). For WASP-
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deficient mice, the importance of the microflora was demonstrated by showing that Was-
/- animals on the 129SvEv background do not develop colitis in the absence of Helicobacter 
species (Nguyen et al., 2013), but so far no microbial sequencing data has been published. 
Importantly, the great majority of experiments that make up the currently available WAS 
literature have not been performed in littermate-controlled or cohoused setting; in many 
instances, control mice were obtained directly from repository laboratories rather than bred 
and maintained in tandem with Was-/- animals at the research institutes.  
  In Chapter 7, we demonstrated that food-allergic sensitization in Was-/- mice occurs 
in the absence of a commensal flora (Figure 7.3, page 163). In sharp contrast to colonic 
inflammation (Nguyen et al., 2013), we can therefore conclude that WAS-associated food 
allergy is not caused by a pathogenic host-microbe interaction. Our finding, however, does 
not rule out a modulatory effect from intestinal bacteria on disease pathogenesis. Indeed, 
we observed that the humoral immune response to food antigens is shaped by commensals, 
since SPF-housed mice developed higher food-specific IgA, and lower IgG1, than GF-
housed counterparts (Figure 7.3E). These observations fit within the emerging paradigm 
that microbial colonization status is an extremely important determinant in shaping host 
IgE immune responses (Berni Canani et al., 2015). GF WT mice have previously been shown 
to have elevated levels of polyclonal, natural IgE (McCoy et al., 2006) and were found to be 
more susceptible to oral adjuvant-induced sensitization to peanuts (Cahenzli et al., 2013). 
Using recolonization experiments with increasingly complex microfloras, these authors 
demonstrated the existence of a critical complexity threshold above which the spontaneous 
hyper IgE phenotype of WT GF mice could be reversed (Cahenzli et al., 2013). Furthermore, 
species of Clostridia have been described to promote tolerance in cholera-toxin-mediated 
IgE sensitization to food (Stefka et al., 2014). 
  To assess whether differential disease activity between WT, Was-/- and Wasfl/flFoxp3-Cre mice 
was associated with alterations in the microflora, we performed 16S rRNA gene sequencing on 
stool samples obtained from six-week-old animals that had been co-housed for three weeks after 
weaning. Following isolation of genomic DNA (Mobio PowerMag DNA Isolation Kit), bacterial 16S 
V4 rDNA regions were enriched and barcoded through amplification with fusion primers, then 
concentrated with solid-phase reversible immobilization, and finally quantified by electrophoresis 
(Agilent 2100 Bioanalyzer). 16S rDNA was analyzed with MiSeq® reagent cartridges. 
  First, we considered the amount of microbial variation within samples obtained from 
different genotypes (alpha diversity). At a sequencing depth of 150 000 sequences, alpha 
diversity for individual mice ranged from 519 to 966 operational taxonomic units (OTUs), and 
in many samples, richness continued to increase even in the last increment in sequencing 
depth. However, the variation between mice belonging to the same genotype was greater 
than that observed between genotypes, and ANOVA analysis at different sequencing depths 
revealed no significant differences in alpha diversity between WT, Was-/- and Wasfl/flFoxp3-Cre 
mice (Figure 9.7A). As a control, we also measured alpha diversity in Was-/- mice that had 
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been treated with oral antibiotics. Broad-spectrum antibiotics supplemented to the drinking 
water resulted in a 4-fold reduction in alpha diversity in fecal pellets, demonstrating that our 
methods reliably detected biological variation.  
  Alpha diversity addresses the fraction of unique OTUs, but does not consider the origin 
of these OTUs in relation to taxonomic classification. We next assessed how the OTUs in fecal 
samples were distributed over different bacterial phyla. In mice from all three genotypes, 
Bacteroidetes species made up over 50% of OTUs, followed by Firmicutes and Proteobacteria, 
which is typical for the murine as well as human intestine (Cho and Blaser, 2012; Honda and 
Littman, 2012). Among the 9 most abundant phyla, we observed no significant differences in 
distribution between groups, with the exception Cyanobacteria, which were lower in Was-/- than 
in Wasfl/flFoxp3-Cre mice (Figure 9.7B). At the two subsequent taxonomic levels, we found that the 
top 9 most abundant classes and orders respectively did not differ significantly between mice of 
either genotype (ANOVA p>0.05). However, at the level of bacterial families, we started observing 
differences in the distribution between the most abundant taxons, with relatively increased 
abundances of both Prevotellaceae and Bacteroidaceae in Wasfl/flFoxp3-Cre mice in comparison 
with co-housed WT and Was-/- counterparts (Figure 9.7C). It is noteworthy that expansion of 
Prevotellaceae has been described as a pathogenic factor that results in reduced IL-18 signaling, 
inflammasome dysfunction, and increased susceptibility to DSS colitis (Elinav et al., 2011). As is 
apparent from Figure 7.5A (page 165), reduced Il18 expression clustered strongly with increased 
mast cell markers and Th2-type cytokines in Wasfl/flFoxp3-Cre mice, which suggests that dysbiosis 
could be an upstream determinant of food allergic disease in these animals. Irrespective of these 
interesting speculations, our combined results indicate that the composition of the microbiome 
is significantly different between mice with different genotypes. 
To be able to consider the whole composition of the microbiome rather than merely the 
most abundant members at each taxonomic level, we calculated Weighted UniFrac 
dissimilarity scores that allow for graphical analysis of complex relationships between 
samples using a two-dimensional Prinicipal Coordinate Analysis (PCoA). Furthermore, to 
allow identification of significant alterations at the level of the whole microbiome we utilized 
the Adonis permutation test, which estimates the likelihood of the encountered distribution 
by comparing it to randomly generated permutations. Using these approaches, we first 
asked whether the microbiome differed between mice with (Was-/- and Wasfl/flFoxp3-Cre 
mice) and without (WT) spontaneously occurring food allergy. Principal component analysis 
based on 238 taxa that demonstrated significant differences in abundance across at least 
one of the groups revealed that food allergic status separated samples into distinct clusters, 
which suggests that disease status is associated with alterations in the microflora (Figure 
9.7D). To visualize these findings in more detail, we generated a circular heatmap image 
that plots the relative abundance of an OTU, expressed as coloric representation of the 
Z-score obtained from the distribution of that particular OTU amongst all three genotypes, 
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Figure 9.7 Spontaneously occurring food allergy in WASP deficiency is associated with a distinct microbiota 
signature. Results of 16S rDNA sequencing with MiSeq®. (A) Alpha diversity defined as number of unique operational 
taxonomic units (OUTs) for different number of sequences read in fecal pellets obtained from WT (open circles), 
Was-/- (gray circles) or Wasfl/flFoxp3-Cre (black circles) mice. Antibiotic-treated Was-/- mice (gray squares) serve as an 
internal control. (B) Relative fractions of the 9 bacterial phyla present in highest abundance, with results of ANOVA 
test indicated for every phylum analyzed. For Cyanobacteria, subanalysis between genotypes is shown. (C) Relative 
abundance of the 9 most abundant bacterial families. Each bar represents an individual sample. ANOVA results 
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and taxonomic classification are denoted for every family in the color legend. (D) Principal coordinate analysis 
(PCoA) depicting the average weighted UniFrac distance between samples with (Was-/- and Wasfl/flFoxp3-Cre) and 
without (WT) food allergy. (E) Circular hierarchical cluster dendrogram depicting the relative abundance (Z-score) 
of 38 taxa belonging to 33 families between samples with (inner ring) and without (outer ring) food allergy, with the 
color legend showing the phylum to which the particular family belongs. Dots represent individual mice and error 
bars depict SEM. *p<0.05; ** p<0.01; ***p<0.001; NS: not significant as determined by one-way ANOVA with Tukey’s 
multiple comparis
as a hierarchical cluster based on the average linkage (Figure 9.7E, cf. hierarchical cluster 
diagram in Figure 7.5A, page 165). For data reduction, only the most significantly different 
OTU for each bacterial family (n=33) is shown, except for 5 families in which different 
OTUs demonstrated opposite directions of change and an example of each was selected. 
Combined, these results show that food allergy associated with WASP-deficiency in mice 
is associated with a microbiota signature that differs from co-housed WT control mice. 
  We next asked whether differences in the microbiome were associated with the 
differential disease activity observed in Was-/- and Wasfl/flFoxp3-Cre mice. Significant 
differences in abundance were observed for 295 taxa, and the PCoA based on the Weighted 
UniFrac distance between samples clearly separated both genotypes except for one Was-/- 
outlier (Adonis p=0.003, Figure 9.8A), demonstrating that Was-/- and Wasfl/flFoxp3-Cre mice 
had a distinct microbial signature. The 12 taxa for which the difference in abundance between 
the two groups reached the highest statistical significance are listed in the table in Figure 
9.8B. Except for the Ruminococcaceae (OTU number 441494), all these OTUs belonged to 
members of the order Bacteroidales. Strikingly, for 11 out of 12 species (p=0.003) that 
differed most significantly between species, the greater abundance was observed in Wasfl/
flFoxp3-Cre and not in Was-/- mice (Figure 9.8C). Finally, we assessed whether any of these 
differences correlated with differential disease activity in Was-/- and Wasfl/flFoxp3-Cre mice. 
Having identified serum MCPT1 as a non-invasive biomarker of intestinal mast cell expansion 
and activation (Chapter 7 and 8), we performed correlation analysis between serum MCPT1 
levels obtained at the time of stool collection and the 12 OTUs in Figure 9.8B. Not surprisingly 
given the strong difference in serum MCPT1 between Was-/- and Wasfl/flFoxp3-Cre mice (Figure 
7.4B, page 164), we observed statistically significant correlations between MCPT1 and all 
12 relative OTU abundances. However, if an altered abundance of a particular OTU was truly 
related to disease activity, we reasoned that a significant correlation should also uphold in 
a within-genotype analysis. Such a relationship was found for OTU 270391, belonging to a 
species of the Rikanellaceae family not further named than 97otu41102 (see Figure 9.8B): 
its relative abundance correlated positively and significantly with serum levels of MCPT1 in 
two independent analyses of Wasfl/flFoxp3-Cre as well as Was-/- animals, thus strengthening a 
true association between the abundance of this species with intestinal disease severity and 
Th2-immune skewing (Chapter 7). Importantly, the species 97otu41102 does not depend on 
increased intestinal mast cells, because it was also found in the microflora of a subset of WT 
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animals that do not have elevated serum MCPT1 (Figure 9.8E). These results suggest that 
97otu41102 may play a pro-allergic role in a genetically susceptible host and illustrate how 
alterations in the microflora could contribute to differential disease activity between Was-/- 
and Wasfl/flFoxp3-Cre animals. 
Figure 9.8 Differential disease activity between Was-/- and Wasfl/flFoxp3-Cre mice is associated with differences 
in the intestinal microbiota. (A) PCoA depicting the average weighted UniFrac distance between samples obtained 
from Was-/- and Wasfl/flFoxp3-Cre mice. (B) Table listing the 12 taxa that were differed most significantly in relative 
abundance between Was-/- and Wasfl/flFoxp3-Cre mice, with distribution of and relative abundance depicted in (C). 
(D) Pearson correlation analyses between the relative abundance of OTU 270391 and concurrently obtained serum 
MCPT1 levels in all food allergic (left), Wasfl/flFoxp3-Cre mice (middle) and Was-/- (right) mice. (E) Relative abundance 
of OTU 270391 in WT mice in relation to Was-/- and Wasfl/flFoxp3-Cre animals. Dots represent individual mice and error 
bars depict SEM. ** p<0.01; ***p<0.001; NS: not significant as determined by one-way ANOVA with Tukey’s multiple 
comparisons test.
9.9 Other cell types
In this chapter, we have reviewed how WASP deficiency in a range of cellular immune 
compartments could affect the propensity for spontaneous food allergy in Was-/- mice. 
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Although spanning the breadth of the allergic response from allergic sensitization 
(microbiome, APCs) to the function of IgE effector cells, we have limited our discussion to cell 
types on which we have generated experimental data during the studies presented in this 
thesis. However, our current understanding of the pathogenesis of food allergic responses 
remains incomplete, and other immune cells that have hitherto not been discussed in this 
chapter are likely to play a modulatory role in WASP-deficiency associated food allergy. Three 
examples are: 
 1   Invariant chain natural killer T (iNKT) cells. iNKT cells have been implicated in the 
pathogenesis of allergic asthma and may act as an important link between microbial 
signals and immune homeostasis (Olszak et al., 2012). Indeed, in Chapter 4 of this 
thesis, we have uncovered a role for iNKT cells in the pathogenesis of eosinophilic 
esophagitis in pediatric patients. In Was-/- mice and WAS patients, iNKT cells in liver 
and spleen are significantly decreased compared to healthy controls (Astrakhan et 
al., 2009) and have a functional impairment in their production of IL-4 and IFN-γ 
(Locci et al., 2009). Although not directly tested, it seems likely that Wasfl/flFoxp3-
Cre animals have normal development of iNKT cells, and differential involvement 
of iNKT cells should be considered in explaining the difference in allergic responses 
between Was-/- and Wasfl/flFoxp3-Cre animals. 
 2   Innate lymphoid cells. Innate lymphoid cells have recently been recognized as 
important contributors to mucosal immune responses. Although devoid of antigen-
specific TCRs, innate lymphocytes type 2 (ILC2s) express GATA3 and are capable 
of producing Th2-type cytokines in response to epithelial cell-derived alarmins 
such as IL-25 and IL-33 (Spits et al., 2013). Through expression of MHCII, ILC2s may 
further promote type-2 mucosal immune responses by priming of Th2 lymphocytes 
(Gasteiger and Rudensky, 2014; Oliphant et al., 2014). To date, no studies have 
been published on the effects of WASP deficiency on the function of ILCs, although 
this is a line of investigation that is actively pursued in our laboratory (personal 
communication Amlan Biswas, PhD and Scott Snapper, MD PhD).  
 3   Eosinophils. Eosinophilic infiltration is an important component of type-2 mucosal 
immunity, as extensively discussed in Part 1 of this thesis. Our mRNA expression 
data (Figure 7.5A, page 165) demonstrated increased intestinal expression of Il5 
mRNA. Since IL-5 serves as a major chemotactic factor for eosinophils, an altered 
contribution of eosinophils might play a role in food allergic responses in Was-
/- mice. However, no published data currently exist on the consequences of WASP 
deficiency on the function of eosinophils. 
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9.10 Food allergy in Was-/- and Wasfl/flFoxp3-Cre mice follows different natural 
courses
Up to this point, our discussion of the differential disease susceptibility between Was-/- and 
Wasfl/flFoxp3-Cre mice has focused on the question how cell type-specific features of WASP 
deficiency may confer a pro- or anti-food allergic effect (summarized in Table 9.1). At the level 
of the organism, the severity of food allergy reflects the balance between all of these effects 
that are simultaneously operative. Given the large number of factors that are potentially 
involved, stochastic variation within this equation can easily be envisioned to result in 
considerable heterogeneity, even amongst genetically identical littermates. Furthermore, it 
is likely that this balance is dynamic, with individual variables gaining or losing biological 
significance in the course of disease. Such a notion is supported by human data showing that 
food allergies to certain allergens (e.g. milk, soy and wheat) are frequently outgrown during 
the first years of life (Longo et al., 2013; Sicherer and Sampson, 2014). Therefore, the study 
of severity of allergy over time in Was-/- and Wasfl/flFoxp3-Cre mice may provide an additional 
dimension to our current discussion.
  Figure 9.9A demonstrates the serum MCPT1 levels in a cohort of WT, Was-/- and Wasfl/
flFoxp3-Cre mice that was longitudinally followed to an age of 5 months. Whereas MCPT1 
levels stayed consistently elevated in Wasfl/flFoxp3-Cre animals between 2 and 5 months 
of age, there was a significant decline over time in Was-/- mice. Food allergy in these latter 
animals may thus be susceptible to spontaneous resolution as is commonly seen in pediatric 
patients. These differences in the natural course of disease are further proof for a dampened 
allergic phenotype in Was-/- compared to Wasfl/flFoxp3-Cre animals. 
9.11 Results from heterozygous Wasfl/wtFoxp3-Cre mice shed further light on 
WAS-associated food allergic disease
Obligate female carriers of a defective WAS gene do not suffer from any hematological 
abnormalities or immunodeficiency. In humans, this has been attributed to non-random 
inactivation of the X chromosome in hematopoietic (CD34+) stem cells, which therefore only 
give rise to WASP-competent hematopoietic lineages (Wengler et al., 1995). Indeed, if the 
genetic mechanism responsible for such non-random inactivation fails, features of WAS can 
be observed in a female patient (Parolini et al., 1998). In mice, the selective advantage of WASP 
becomes apparent only after the CD34+ stem cell phase and has been demonstrated to affect 
different hematopoietic cells to a different degree (Westerberg et al., 2008). FOXP3+ Tregs 
are amongst the cellular subsets for which this selective advantage is strongest, with >90% 
of Tregs in Was+/- heterozygotes being WASP competent (Westerberg et al., 2008). Given the 
critical role of WASP-deficient Tregs in the pathogenesis of allergic disease, it is therefore not 
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surprising that heterozygous Was+/- females are protected from the spontaneous expansion of 
intestinal mast cells (Figures 7.2, page 161 and 8.3, page 193, and Figure 9.9B). However, 
whether this is true for heterozygous Waswt/flFoxp3-Cre mice has not been examined. In this 
genetic system, expression of WASP from T cells is only lost after transcription of Foxp3 is 
initiated. Because WASP confers its selective advantage during the transition from the CD4-
CD8- double negative to CD4+CD8+ double positive stage in the thymus (Cotta-de-Almeida 
et al., 2007; Westerberg et al., 2008), it seems likely that a higher fraction of Tregs in Waswt/
flFoxp3-Cre animals are WASP-deficient. 
  Female mice possessing only one Wasfl allele in combination with the Foxp3-Cre 
transgene develop increased serum MCPT1 levels (Figure 9.9D). Although average values 
are significantly lower than those observed in homozygous females or hemizygous males, 
serum MCPT1 is consistently elevated over WT controls (Figure 9.9D) and intestinal mast 
cell numbers are increased (Figure 9.9E). Interestingly, this is only observed in heterozygotes 
born from Wasfl/flFoxp3-Cre mothers (termed Waswt/flFoxp3-Cre mice, see Figure 9.9C). 
Genetically indistinguishable Wasfl/wtFoxp3-Cre mice that inherited the Wasfl allele from the 
father do not develop elevated MCPT1 levels (Figure 9.9D).
Figure 9.9 Differential disease susceptibility Was-/- and Wasfl/flFoxp3-Cre becomes more apparent over time 
and affects immune homeostasis in heterozygous mice. (A) Serum levels of MCPT1 at 2 months and 5 months 
in WT (open circles), Was-/- (gray circles) or Wasfl/flFoxp3-Cre (black circles) C57BL/6 mice. (B) Serum MCPT1 in Was+/+ 
(WT), Was+/- and Was-/- mice on the BALC/c background. (C) Breeding strategy to generate Waswt/flFoxp3-Cre and Wasfl/
wtFoxp3-Cre heterozygous animals. (D) Serum MCPT1 levels in Waswt/flFoxp3-Cre and Wasfl/wtFoxp3-Cre heterozygous 
animals in comparison with WT and Wasfl/flFoxp3-Cre mice. (E) Representative chloroacetate esterase staining on 
jejunal sections from a Waswt/flFoxp3-Cre heterozygous female. Dots represent individual mice and error bars depict 
SEM. * p<0.05; ** p<0.01; ***p<0.001; NS: not significant as determined by (paired) t-test (A) or one-way ANOVA with 
Tukey’s multiple comparisons test (B and D).
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  Additional animal studies are required to solidify these findings and illuminate the 
factors responsible for this difference between Waswt/flFoxp3-Cre and Wasfl/wtFoxp3-Cre mice, 
starting with quantification of the ratios of WASP-competent vs. WASP-deficient Tregs. 
However, it is tempting to draw the following preliminary conclusions from the already 
available data:   
 1   WASP-deficient FOXP3+ Tregs can cause allergic disease in the presence of WT 
counterparts. These data favor a pathogenic, pro-inflammatory role for WASP-
deficient Tregs in the pathogenesis of WAS-associated allergy, which is critically 
different from the elevated IgE and mast cell expansion that occurs in the absence 
of any Tregs in IPEX patients or scurfy mice. Such a ‘gain-of-pathogenic-function’ 
hypothesis could also help explain the isolated loss of Th2 suppression while 
suppression of Th1 and Th17 responses in Was-/- mice remain unperturbed. 
 2   The genetic susceptibility to food allergy caused by loss of WASP in FOXP3+ Tregs is 
influenced by maternal factors. Effects of genetic imprinting notwithstanding, the 
fact that Waswt/flFoxp3-Cre and Wasfl/wtFoxp3-Cre mice are genetically similar yet 
develop different allergic phenotypes suggests that pups born to a food allergic 
mother have a higher chance of becoming food allergic themselves. Attractive 
targets for further exploration are maternal factors such as composition of breast 
milk (e.g. IgA, IgG or cytokine content) or the intestinal microbiome, which could be 
pinpointed further by additional cross-foster experiments. Although this conclusion 
increases the complexity of the mechanism of immune dysregulation that results 
from loss of WASP in Tregs, it also emphasizes the translational value of a model of 
WASP-deficiency in Tregs in study of allergic disease.  
9.12 Concluding remarks
This chapter provides a synthesis of the pathogenesis of food allergy in the context of WASP 
deficiency. Building on the large body of existing WAS literature, it reviews the experimental 
evidence described in the research papers that make up the previous three chapters of 
this thesis, and provides an additional nine figures of data not incorporated in another 
chapter. The overarching goal of the discussion presented here has been to explain why 
spontaneously occurring food allergies are more pronounced in Wasfl/flFoxp3-Cre than Was-
/- mice. As delineated in the introduction of this chapter, this question is relevant for the 
following three reasons: 
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 1   Analysis of the role of WASP in all of the cellular compartments involved in the 
pathogenesis of allergic disease is required for a thorough understanding of the 
food allergy that occurs in patients with WAS. We have found that WAS-associated 
food allergy hinges on dysfunction of the FOXP3+ Treg compartment and that the 
most severe allergy is seen in mice that only lack WASP in this particular cell type 
(Chapter 7). Human WAS patients, however, are WASP deficient in all hematopoietic 
lineages, and thereby more closely resemble Was-/- mice than the more allergic 
Wasfl/flFoxp3-Cre animals. Understanding the factors that confer partial protection 
against fulminant allergic responses could aid in identifying patients at risk for 
allergy and thereby result in improved clinical management of patients with WAS. 
Appreciation of the interplay between pro- and anti-allergic effects of individual cell 
types will further help gauge the immune status of individuals that have undergone 
treatment with gene-corrected autologous hematopoietic stem cells that results in 
mixed chimerism (Hacein-Bey-Abina et al., 2015; Mukherjee and Thrasher, 2013), 
or in patients with (lineage-specific) chimerism following hematopoietic stem cell 
transplantation (Moratto et al., 2011). Additionally, secondary mutations leading 
to chimeric re-expression of WASP (Trifari et al., 2010) may also affect the allergic 
balance. 
 2   Many of the features of WAS-associated food allergy are shared with common food 
allergic patients and improved understanding of its mechanisms could therefore shed 
new light on the general pathogenesis of IgE-mediated responses to food. In stark 
contrast to WAS, which has an incidence of <1 in 100 000 births (Puck and Candotti, 
2006), food allergy currently affects 4-8 out of a 100 children in Westernized 
societies (Longo et al., 2013; Sicherer and Sampson, 2014). A fundamental question 
underlying the research presented in this thesis is therefore to which extent the 
mechanistic insight into the pathogenesis of WAS-associated food allergy can be 
extrapolated to common food allergies. In Chapter 7 we demonstrated that WAS 
patients are susceptible to similar food allergies as those observed in the general 
population. Furthermore, increased levels of GATA3+ FOXP3+ Tregs were recently 
described in pediatric cow’s milk allergic patients (Noval Rivas et al., 2015). Although 
their mechanistic origin may differ, our identification of GATA3+ FOXP3+ Tregs in 
WASP-deficient mice and patients could indicate a final common pathway of 
disease pathogenesis that is shared between patients with food allergies and WAS-
associated food allergic disease. 
 3   In depth analysis of the differences between Was-/- and Wasfl/flFoxp3-Cre mice helps 
to better define WASP-deficient animals as an experimental model of food allergy. 
In Chapters 7 and 8, we have defined Was-/- animals as the first spontaneous 
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mouse model of food allergy with a direct human equivalent. Was-/- and Wasfl/
flFoxp3-Cre mice develop IgE antibodies against allergens that are responsible for 
IgE-mediated allergies in children (e.g. wheat and soy), whereas epidemiologically 
less allergenic foods such as corn were also better tolerated in mice. These findings 
implicate considerable translational potential of this novel model in determining 
what renders particular foods allergenic. In addition, many recent high-impact trials 
published on pediatric food allergy deal with questions regarding the timing of 
introduction of allergens as well as the effect of allergen avoidance on established 
allergies (Perkin et al., 2016; Toit et al., 2015; 2016). Although highly instructive 
from a preventative health perspective, unraveling the underlying mechanism of 
failed oral tolerance to allergens requires experimentally controlled settings and 
laboratory animals. In answering these questions, it is pertinent that the disease 
models used do not rely on an adjuvant-induced break of oral tolerance, but instead 
faithfully mimic the kinetics and route of sensitization as occurs in humans. The 
data presented in Figure 9.9A suggest that Was-/- mice can outgrow their food 
allergies, which provides further proof of a more humanized system. As suggested 
throughout this chapter as well as in the discussion of Chapter 8, crossing Wasfl/
flFoxp3-Cre or Was-/- mice with strains deficient in other immunological targets (e.g. 
basophil-deficient Mcpt8-/-, B cell-deficient μMT mice or mice genetically deficient 
in any of the cytokines or chemokines) or a range of reporter animals holds great 
promise for further illuminating the pathophysiology of food allergic disease. Lastly, 
advances in humanized mouse models such as presented in Chapter 6 could very 
likely increase the human relevance of these experiments even further. 
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The experiments described in the chapters of this thesis pertain to type 2 inflammatory 
immune responses within the gastrointestinal tract. When directed against innocuous 
antigens present in the lumen of the intestine, these immune reactions can result in a 
variety of symptoms in the host that give rise to the clinical phenotype of food allergic and 
eosinophilic gastrointestinal diseases. The aim of this work has been to enhance our 
insight into the immunological mechanisms that are responsible for the induction 
(i.e. the origin) of Th2-mediated inflammation. In light of this overarching theme, we 
describe two lines of investigation with their own specific aims that divide the thesis into a 
first and second part. Although working towards the same unifying goal, the two approaches 
have different starting points within the from-bench-to-bedside-and-back paradigm of 
translational medicine. In Part 1, we focus primarily on the pediatric patient that suffers 
from an established case of type 2 intestinal inflammation. By studying tissue biopsies 
of affected intestine, we aim to better diagnose these children and to characterize 
patient subsets that differ according to their immunological inflammatory profile. 
Within the inflammatory profiles of these patients, we look for clues that could 
help elucidate the pathogenesis of aberrant type 2 immunity in the intestinal tract. 
The work described in Part 2, in contrast, originated at the lab bench, where we assessed 
whether a mouse model based on a rare human primary immunodeficiency could be 
used to study the spontaneous induction of food allergic responses in the intestinal 
tract. Following their characterization as a bona fide model of food allergy, we use these 
animals to test how different types of immune cells contribute to the origin of 
aberrant type 2 inflammation. By subsequently investigating whether our findings in the 
mouse also apply to human patients suffering from the same immunological disorder, we 
have attempted to translate our observations from the bench back to the bedside.   
Chapter 1 provides a general introduction of Th2-mediated intestinal inflammation and 
gives an outline of the aims and most important results of the thesis. It can be read as a 
stand-alone summary of the work and afterwards the reader will have sufficient information 
to successfully navigate between the individual parts and chapters. Instead of providing a 
comprehensive summary of the research findings, the focus of chapter 1 is to illustrate 
the cohesion between the different papers in this thesis. To avoid redundancy, the 
summary that is presented in this final chapter will follow the more conventional, chapter-
by-chapter-style discussion and highlight the key research findings of each paper as to serve 
as an additional navigational aid for the interested reader.
Eosinophilic esophagitis results from a type 2 inflammatory process of the upper 
gastrointestinal tract. In the absence of systemic biomarkers that accurately predict the 
presence or absence of disease, proper patient characterization relies on quantification 
(i.e. a manual count by a pathologist) of eosinophils in tissue biopsies obtained via upper 
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gastrointestinal endoscopy. Since multiple conditions are associated with esophageal 
eosinophilia, this diagnostic approach suffers from poor specificity. The aim of the work 
described in Chapter 2 is to test whether mRNA expression data obtained via high-
throughput gene expression analysis could aid in establishing a diagnosis of 
eosinophilic esophagitis (EoE) in children with inflammation of the esophagus. 
To this end, we have studied gene expression data from 196 pediatric patients that were 
enrolled in a cohort study at Boston Children’s Hospital. Study biopsies were obtained from 
these children at time of inclusion and they were subsequently followed for a minimum 
of two years, which allowed for confirmation of the original clinical-histopathological 
diagnosis. Using a mathematical model that takes into account the expression of a 
combination of 10 EoE-specific genes, we were able to identify EoE patients from 
children with gastroesophageal reflux disease (GERD) or normal controls with up to 
94% sensitivity. These findings led us to conclude that mRNA profiling of esophageal 
tissue is an accurate diagnostic strategy for detecting EoE that could help stratify 
these patients at time of their first diagnostic endoscopy.  
In Chapter 3, we have used gene expression data from esophageal tissue of EoE and control 
patients to assess whether mRNA expression of the enzyme leukotriene C4 synthase 
(LTC4S) could serve as an EoE-specific marker. Leukotrienes are inflammatory mediators 
that contribute to type 2 inflammatory response in tissue and leukotriene receptor antagonists 
have a firm place in the maintenance treatment of asthma. Although we did identify an overall, 
statistically significant increase in expression of LTC4S in the esophagus of EoE patients 
versus controls, this difference was mainly caused by a subgroup of approximately 30% 
of EoE patients with LTC4S mRNA expression levels >2 standard deviations above the 
mean. Further characterization of this subpopulation revealed that children belonging to 
this subgroup had equivalent degrees of gastrointestinal symptoms and tissue eosinophilia, 
as well as a similar appearance of the esophagus at endoscopy as the 70% of EoE patients 
with normal LTC4S expression levels. However, serum IgE levels and co-occurrence of 
food allergies were higher in the LTC4SHigh patient population. This heterogeneity at 
the tissue level within the EoE patient population thus appears to be directly related to the 
epidemiological observation that IgE sensitization to food antigens occurs in only a subset 
of EoE patients. It is likely that the identification of such subpopulations may not only have 
relevance for our understanding of the pathogenesis of EoE, but also for the optimal medical 
management of patients because different subpopulations may show different responses to 
any given therapeutic modality. 
What determines whether children develop an intestinal type 2 inflammatory process such 
as EoE? Over the last decade, advances in high-throughput sequencing of species-specific 
16s ribosomal RNA have implicated the composition of our commensal microbial floras 
Chapter 10
290
(the microbiome) at mucosal surfaces as a critical determinant in health and disease. One 
mechanism through which signals from bacteria can affect immune responses in the host 
has been uncovered following the observation that germ-free mice showed an increased 
susceptibility to experimental asthma and colitis. The absence of commensal microbes in 
lung and colon resulted in mucosal upregulation of CXCL16 and chemotaxis of invariant 
chain natural killer T cells (iNKT cells), conferring an increased susceptibility to mucosal 
inflammation. For Chapter 4, we have studied our EoE patient cohort for evidence of 
involvement of the CXCL16-iNKT cell axis to determine whether a similar mechanism 
could be operative in human patients with immune-mediated intestinal diseases. 
We observed that CXCL16 gene expression was upregulated in children with EoE when 
compared to those with normal tissue histology or reflux esophagitis. Similarly, we found 
increased gene expression of Vα24 (comprising the invariant TCR) and Vα24-to-CD3ε 
ratio, as well as CD1d in EoE patients. Involvement of the CXCL16-iNKT-CD1d axis was 
especially pronounced in our youngest patients (<6 years of age) and an increased 
CXCL16-iNKT cell signature was associated with a more pronounced food allergic 
phenotype, as implicated by increased prevalence of a positive food allergen test (48% vs. 
25%, p=0.008) and elevated levels of LTC4S, our previously identified (Chapter 3) marker 
for the food allergic subset of EoE patients. In these early-onset EoE patients, treatment 
with elimination diet resulted in normalization of the CXCL16-iNKT-CD1d axis, 
demonstrating that iNKT cell involvement in EoE is amenable to dietary interventions that 
aim to eliminate common food allergens. Furthermore, using logistic regression analysis 
on clinical patient data, we found a positive association between antibiotics use in 
the first year of life and the occurrence of EoE. Combined, our results led us to propose 
a model for the pathophysiology of (early-onset) EoE that starts with insufficient 
immune imprinting by environmental microorganisms (1) resulting in upregulation of 
CXCL16 and chemotaxis of iNKT cells into the esophagus (2). Increased numbers of iNKT 
cells can become pathologically activated via CD1d-associated lipid antigens derived from 
food, aeroallergens, microorganisms, and/or potentially self-antigens associated with the 
esophagus (3). Activated iNKT cells, subsequently, act as an early source of IL-4, IL-5, and IL-
13, which can facilitate Th2-mediated allergic sensitization and induction of IgE responses 
that further promote and sustain inflammation (4). This model would help explain how 
environmental factors (in this case changes in signals derived from commensal 
bacteria) can predispose to type 2 intestinal inflammation and allergic sensitization 
to food antigens. 
The model presented at the end of Chapter 4 proposes a mechanism by which type 2 
intestinal inflammation and allergic sensitization to food antigens may originate locally, 
within the predisposed esophagus. Chapter 5 describes the work that originated in the lab 
of dr. Michiko Oyoshi at the Division of Immunology at Boston Children’s Hospital, who asked 
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whether allergic sensitization via the skin could affect eosinophilic inflammation in 
the esophagus. This hypothesis followed from evidence that demonstrates that sensitization 
to allergens can result from exposure to environmental antigen through an impaired skin 
barrier. From a pathophysiological point of view, cutaneous allergic sensitization is an 
attractive mechanism because it helps explain two important clinical phenomena: 1. why 
severe allergic reactions have been described following a first time ingestion of a food antigen 
(e.g. peanut), and 2. why atopic dermatitis is typically the earliest (<1 year of age) symptom 
within the atopic march. Chapter 5 demonstrates that epicutaneous sensitization to 
ovalbumin promotes eosinophilia and increased expression of type 2 cytokines in 
the esophagus of mice that are subsequently challenged with intranasal ovalbumin. 
Animals with mutations in the gene encoding for the keratin-associated skin protein filaggrin, 
which in humans can give rise to severe forms of eczema, were particularly susceptible to 
skin-mediated allergic sensitization and accumulation of eosinophils in the esophagus. 
Mechanistically, accumulation of eosinophils in the esophagus could be abrogated by 
disruption of IL-33-mediated signals, and was dependent on basophils, as basophil-
deficient mice were less susceptible to esophageal eosinophilia. The observation that 
pediatric EoE patients have increased expression of the IL-33 receptor (ST2) in the 
esophagus suggests that the IL-33/ST2 axis is also operative in human patients and that 
blockade of the IL-33 pathway might prove a novel therapeutic target in treatment of EoE. 
The experimental strategy employed in Chapter 5 follows an investigator-controlled 
temporal organization of immunological events. At the age of 4-6 weeks, mice are 
epicutaneously sensitized over the course of 7 days, followed by a series of three intranasal 
allergen challenges at day 9, 11 and 13 (Figure 5.1, page 95). Similarly, a commonly used 
model of food allergy that we encounter in Chapter 8 (Figure 8.2, page 191) relies on 3 
intraperitoneal sensitization of adjuvant-coupled allergen at day 0, 7 and 14 followed by 
repetitive oral challenge from day 21 to 39. The mechanistic advances of the results from 
these investigations notwithstanding, it is clear that the study of factors that affect disease 
pathogenesis could be hampered by such temporal restrictions and the assumptions that 
these models require. Ideally, we would study the onset of disease in the absence of any bias 
that may be related to the timing of experimental interventions. In Part 2 of this thesis, we 
investigate strategies to promote homology of animal models in the study of type 2 
intestinal inflammation.  
As delineated in the introductory chapter of this thesis, one possible approach to increasing 
the translational value of experiments in murine models is to make use of mice that have 
been reconstituted with human immune cells. Most easily, this can be achieved by isolation 
of peripheral blood mononuclear cells from a human donor followed by transfer of these cells 
to a murine immunodeficient recipient. However, human T cells in the isolate will recognize 
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the antigenic environment in the murine host as non-self, resulting in severe and lethal 
graft-versus-host disease that has the potential to confound the study of any downstream 
immune response of interest. This problem could be bypassed by reconstituting human 
adaptive immune cells from hematopoietic stem cells within the murine recipient, which will 
result in generation of T cells that have been educated against murine MHCII molecules and 
that will therefore be less prone to give rise to autoimmunity. Unfortunately, reconstitution 
of T lymphocytes in this setting has typically been poor, perhaps because of the stringency 
of positive selection in the thymus. Chapter 6 described the work that was led by our close 
collaborator dr. Jeremy Goettel, who hypothesized that improved reconstitution of 
human T cells could be obtained if these cells are educated against human instead 
of murine MHC class II molecules. This was achieved following a transgenic approach 
in which MHCII-deficient mice were made to express the human HLA-DR1*0101 transgene 
(NSGAboDR1) under the control of the murine MHCII promoter. Although there were no gross 
differences between the number of lymphocytes reconstituted in this novel system compared 
with the murine MHCII or MHCII-/- controls, NSGAboDR1 animals displayed improved 
delayed type hypersensitivity reactions, a richer TCR repertoire, and improved 
B cell maturation and class switch recombination. Furthermore, when mice were 
reconstituted with hematopoietic stem cells from an IPEX patient (an immune disorder 
caused by an absence of FOXP3+ Tregs that results in severe autoimmunity), NSGAboDR1 but 
not murine MHCII or MHCII-/- controls succumbed to lethal autoimmune responses 
and auto-antibody production, illustrating that the pathophysiology of the disease was to 
a large extent phenocopied in this novel system. 
IPEX patients (and their murine scurfy equivalent) are deficient in FOXP3+ Tregs and, 
consequently, suffer from unrestrained immune activation directed against foreign or self-
antigens. In addition to proliferation of Th1 and Th17 cells, the ensuing immune responses also 
contain a Th2 component, which gives rise to increased levels of serum IgE and allergic tissue 
inflammation. Besides the IPEX syndrome, dysregulated Th2 responses, atopy and elevated 
IgE levels occur in a variety of primary human immunodeficiencies. In Chapters 7-9, we have 
investigated patients and mice deficient in the Wiskott-Aldrich syndrome protein (WASP) as 
an example of one such disorder, with the overarching hypothesis that unraveling the 
pathogenesis of Th2 immunity in the setting of a rare genetic immunodeficiency 
might shed light on the origin of type 2 intestinal inflammation. Although it has long 
been known that patients with Wiskott-Aldrich syndrome (WAS) spontaneously develop 
increased IgE levels, the question to which degree this is associated with an increased burden 
of food allergies has never been systematically studied. In Chapter 7, we demonstrate that 
patients with mutations in WAS are at increased risk of developing clinically relevant 
food allergy. Similarly, we observed IgE with specificity against chow antigens in the 
serum of Was-/- mice, and these animals developed expansion of mast cells in the 
Summary and conclusions
293
Ch
ap
te
r 1
0
small intestine. By using a Cre-lox recombination system that allowed for cell-specific 
knock-out of WASP, we found that deletion of WASP confined to FOXP3+ Tregs was not 
only sufficient for the allergic sensitization and intestinal mast cell expansion, but 
that this allergic phenotype was even aggravated when compared to complete Was-
/- mice. In strong contrast to IPEX syndrome, where immune proliferation is a mix of Th1, Th2 
and Th17 responses, we observed in vivo that loss of WASP from FOXP3+ Tregs only 
interferes with their ability to restrain Th2-mediated immune responses, whereas 
Th1 or Th17 suppression remains intact in the absence of WASP. Mechanistically, we 
believe that this might be related to the fact that WASP-deficient FOXP3+ Tregs in mice 
and human patients assume a Th2-like phenotype which includes the increased 
expression of Th2-type transcription factors ICOS and GATA3 that occurred in the 
absence of IL4 signaling in Was-/-/Il4-/- animals and therefore appears to be a cell-intrinsic 
feature resulting from loss of WASP rather than a circumstantial finding that occurs in the 
setting of food allergy. 
The study of food allergy in mice is hampered by a lack of models that faithfully recapitulate 
the process of spontaneous allergic sensitization as it occurs in human patients. Commonly 
used isomorphic murine models of food allergy rely on sensitization via co-administration of 
adjuvant together with a model allergen, and are therefore primarily suitable for the study 
of allergic responses in an already sensitized host. However, the study of the pathogenesis 
of allergic sensitization itself requires a homologous experimental model, i.e. one that 
mimics both induction and effector phases of human food allergies. Having identified 
spontaneously occurring IgE responses to chow antigens in Was-/- mice, we hypothesized 
that these animals might serve as a novel experimental model of food allergy that 
would bypass the need for sensitization via adjuvant. Indeed, in Chapter 8 we showed 
that following ingestion of ovalbumin, WASP-deficient mice develop OVA-specific 
IgE antibodies. In comparison with an established, adjuvant-based model of food allergy, 
spontaneously induced OVA-IgE in Was-/- animals was equally effective in mediating 
mast cell degranulation following OVA exposure in vitro, demonstrating that the 
process of affinity maturation in WASP-deficient hosts is of sufficient quality to result in 
high affinity IgE antibodies with specificity for the model antigen. Following in vivo oral 
challenge, spontaneously sensitized Was-/- mice developed allergic diarrhea to a 
comparable degree as adjuvant-sensitized experimental animals, demonstrating 
that allergic effector responses are also recapitulated in this novel experimental model. 
By generating WASP-deficient mice that were also deficient in the high-affinity IgE receptor 
FcεRI, we observed that the process of spontaneous allergic sensitization in these 
animals does not require IgE-FcεRI mediated signals. We conclude that Was-/- mice 
are a useful adjunct to the experimental arsenal for mechanistic studies into the 
pathogenesis of food allergy. 
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Chapter 9, the final part of this thesis, was written as both a synthesis of the data presented in 
Chapters 6, 7 and 8, as well as a platform to incorporate additional findings and experiments 
that had not yet been described in the previous manuscripts. The section is built around the 
observation from Chapter 7 that Was-/- and Wasfl/flFoxp3-Cre mice display a significantly 
different susceptibility to food allergic disease, with the latter genotype being more 
severely affected. Following arguments from both a thorough review of existing WAS literature 
and additional experimental data, we systematically investigate how the absence of 
WASP from a variety of immune compartments could potentially contribute to this 
differential disease susceptibility. We suggest that loss of WASP from antigen presenting cells 
will affect their ability of 1. phagocytosis and antigen uptake, 2. tissue homing and migration, 3. 
immune synapse formation and T cell activation and 4. interpretation of environmental stimuli 
resulting in both pro and anti allergic effects on disease pathogenesis. We furthermore show 
that WASP-deficiency in the B cell compartment results in lower levels of food-specific 
IgM in mice and human patients and argue that this could reduce the overall humoral anti-
food response. Data from other groups that have used B-cell specific WASP-deficient animals 
(Wasfl/flMb1-Cre) have demonstrated a reduced number of total B lymphocytes in the spleen 
and an altered distribution of B cell subsets compared to WT counterparts, demonstrating a 
role of WASP in the development, differentiation and survival of B cells. In addition, we have 
reviewed evidence for WASP-dependent functions in mobility and chemotaxis, activation 
and isotype switching, variation of the BCR repertoire and function of regulatory B cells. 
Generation of WASP-deficient IgE reporter mice is suggested as a worthwhile endeavor to 
shed additional insight in the question of the origin of food-specific IgE in Was-/- mice. Data 
from our own experiments suggest that WASP-deficiency in B cells may contribute to 
their altered distribution throughout the GALT and indicate that aberrant germinal 
center responses also occur in a WASP-competent B cell compartment in the presence 
of WASP-deficient Tregs. Furthermore, we have identified aberrant follicular helper T cell 
(TFH) responses in Was
-/- animals, but go on to show that an increased TFH compartment is 
dispensable for aberrant germinal center formation and allergic sensitization. Based 
on recently published experiments, we hypothesize that low levels of circulating IL-2 in 
systemic Was deficiency underlie increased TFH differentiation, and this may be related to 
a decrease the formation of tissue resident Th2 cells. 
  In chapter 7, we argued that WASP deficiency in effector T cells is an important 
determinant in the differential disease susceptibility between Was-/- and Wasfl/flFoxp3-Cre 
mice because Th2 cells produce reduced levels of IL-4 in the absence of WASP. Indeed, 
following ex vivo stimulation, we found significantly lower IL-4 production by CD4+ T 
cells isolated from MLNs of Was-/- mice when compared to Wasfl/flFoxp3-Cre animals, 
although this appeared to result from diminished Th2 differentiation rather than secretory 
defects in individual Th2 cells. Reduced T cell activation due to aberrant formation of immune 
synapses with food-antigen presenting mononuclear phagocytes provides an additional 
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explanation for a dampened food allergic response in Was-/- mice. In addition, alterations in 
the TCR repertoire may affect the availability of food antigen-specific T cells in the same way 
as we hypothesized to occur for B cells, which could reduce the likelihood of antigen-specific 
proliferation upon encountering food antigens.  
  In comparing the allergic phenotype of Was-/- and Wasfl/flFoxp3-Cre mice, we have assumed 
FOXP3+ Tregs to be the one constant determinant between the animals. However, in Chapter 
9 we also provide a number of arguments against this assumption. First, constitutional versus 
conditional WASP deletion from Tregs may affect the thymic selection process. Second, 
WASP-deficient dendritic cells may alter peripheral Treg maintenance, for which we 
found evidence in the expression levels of vitamin A metabolizing enzymes RALDH1 
(Aldh1a1) and RALDH2 (Aldh1a2) that play an important role in the function of tolerogenic 
CD103+ dendritic cells. Third, differences in composition of the microflora between Was-/- and 
Wasfl/flFoxp3-Cre mice could potentially underlie differences in the degree of Treg induction. 
Fourth, alterations in the Breg compartment may result in altered recruitment of Tregs, and, 
lastly, alterations in baseline IL-2 levels may affect Treg homeostasis between the strains 
as a fifth argument against an equal Treg compartment between the two strains. These 
arguments are consecutively discussed in Chapter 10, in combination with a more elaborate 
discussion of the hypothesis put forth in the discussion of Chapter 7 in which aberrant TCR 
signaling in the absence of WASP is linked to a Th2-type differentiation. A plan for follow-up 
studies is suggested to substantiate these hypotheses. 
  The difference in WASP status of IgE effector cells (i.e. mast cells and basophils) is another 
factor that could contribute to the differential disease susceptibility between Was-/- and Wasfl/
flFoxp3-Cre mice that is examined in Chapter 9. For mast cells, the effect of loss of WASP was 
already examined in Chapter 8, where we identified reduced production of Th2 cytokines IL-4 
and IL-13 following IgE-mediated cell activation. With regards to basophils, we found that 
in the absence of adaptive immunity in Rag2-/- mice, WASP-deficient basophils were 
reduced compared to WT basophils, which suggests that loss of WASP is associated 
with reduced basophil survival. This could be related to the finding that basophil-specific 
expression of Mcpt8 was found to be higher in the intestine of Wasfl/flFoxp3-Cre mice than 
in Was-/- counterparts. However, following oral antigen challenge, we observed rapid 
depletion of basophils from the systemic circulation, and, in combination with the 
susceptibility of Was-/- to IgG-mediated anaphylaxis as observed in Chapter 8, we believe 
that allergen-specific activation of basophils occurs relatively unperturbed in Was-/- hosts. 
Lastly, we have interrogated whether changes in the microflora could account for the 
difference in disease severity between Was-/- and Wasfl/flFoxp3-Cre mice. Using high 
throughput genetic sequencing strategies, we assessed the relative abundance of species-
specific 16s ribosomal RNA sequences in stool samples of co-housed WT, Was-/- and Wasfl/
flFoxp3-Cre mice at the age of 6 weeks. We observed that a the family level, the composition 
of the microbiome is significantly different between mice with different genotypes, 
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with relatively increased abundances of both Prevotellaceae and Bacteroidaceae in Wasfl/
flFoxp3-Cre mice in comparison with co-housed WT and Was-/- counterparts. Overall, food 
allergy associated with WASP-deficiency in mice was associated with a microbiota 
signature that differs from co-housed WT control mice. For one OTU belonging to 
a member of the Rikanellaceae family, we found that its relative abundance correlated 
positively and significantly with serum levels of MCPT1 in two independent analyses of Wasfl/
flFoxp3-Cre as well as Was-/- animals, allowing speculation about a disease-promoting 
role for this bacterium. These findings thus illustrate how alterations in the microflora could 
also contribute to differential disease activity between Was-/- and Wasfl/flFoxp3-Cre animals. 
  Two important findings remained that are not directly related to loss of WASP from a 
single immune compartment, but are nevertheless discussed in Chapter 9. First, prospective 
follow-up of cohorts of Was-/- and Wasfl/flFoxp3-Cre mice revealed that whereas MCPT1 levels 
stayed consistently elevated in Wasfl/flFoxp3-Cre animals between 2 and 5 months of age, 
there was a significant decline over time in levels of this serum marker in Was-/- mice. Food 
allergy in these latter animals may thus be susceptible to spontaneous resolution as is 
commonly seen in pediatric patients. Second, we made the curious observation that 
heterozygous females with one Wasfl and one Waswt allele in combination with the 
Foxp3-Cre transgene develop increased serum MCPT1 levels, but only when the Wasfl 
gene was inherited from a Wasfl/flFoxp3-Cre mother and not when it was obtained 
from a WasflFoxp3-Cre father. The tentative conclusions that can be drawn from this result 
is, first, that WASP-deficient FOXP3+ Tregs can cause allergic disease in the presence of 
WT counterparts and may therefore play a pro-inflammatory role in disease pathogenesis. 
Second, the genetic susceptibility to food allergy that results from loss of WASP 
in FOXP3+ Tregs is influenced by non-genetic maternal factors, and in heterozygous 
females, these factors (e.g. composition of breast milk or the maternal microbiome) can make 
the difference between overt type 2 intestinal inflammation and intestinal homeostasis. It is 
obvious that these conclusions greatly increase the complexity of the mechanism of 
intestinal type 2 inflammation that results from loss of WASP in Tregs, but they also 
emphasize the translational value of a model of WASP-deficiency in Tregs in study of 
allergic disease.     
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Chapter 11 
Nederlandse samenvatting 
(Dutch summary)
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Het werk dat beschreven staat in dit proefschrift is gericht op het ontrafelen van de 
pathogenese van type 2 ontstekingsprocessen in het maag-darmkanaal. Type 2 inflammatie 
is een evolutionair oude tak van ons immuunsysteem die naast een beschermende functie 
tegen parasieten ook een cruciaal onderdeel vormt van verschillende homeostatische 
processen zoals het behoud van de integriteit van de epitheelcelbarrière, thermoregulatie, 
en controle van wondgenezing en stofwisseling (Palm et al., 2012; Pulendran en Artis, 2012; 
Wynn, 2015). Deze functies worden verricht door een samenspel van leukocyten uit zowel 
het aangeboren (aspecifieke) en verworven (adaptieve) afweersysteem, waarbij een centrale 
organiserende rol gespeeld wordt door type 2 helper T (Th2) cellen. Middels de productie van 
cytokines zoals IL-4, IL-5 en IL-13 sturen deze lymfocyten op antigeen-specifieke wijze type 2 
ontsteking in de darmmucosa aan. Hieronder valt ook de hulp aan B cellen bij hun productie 
van immuunglobuline E (IgE), een antistof die zich via de IgE receptor (FcεRI) kan binden 
op het oppervlak van mestcellen en basofiele granulocyten. Via IgE:FcεRI interacties kunnen 
deze IgE effector cellen bij een volgend antigeencontact reageren met snelle productie van 
ontstekingsmediatoren zoals histamine en proteasen (Burton en Oettgen, 2011; Gould and 
Sutton, 2008; Kraft en Kinet, 2007). Het vrijkomen van deze eiwitten leidt tot symptomen van 
een allergische reactie zoals lokale vasodilatatie, oedeem en jeuk. Bij ernstige systemische 
effecten spreken we van een IgE-gemedieerde anafylactische shock, gekenmerkt door 
luchtwegoedeem en ernstige hypotensie, hetgeen in een tijdsbestek van minuten tot een 
levensbedreigende situatie kan leiden in allergische patiënten. 
  Gezien de hevigheid en het potentiele gevaar van zulke immuunreacties is het niet 
verwonderlijk dat er meerdere mechanismen zijn ontstaan die type 2 immuniteit onder 
fysiologische omstandigheden in toom houden (Wynn, 2015). Onder onze moderne 
leefomstandigheden blijken dergelijke mechanismen echter steeds vaker tekort te schieten, 
waardoor allergische ziekten die gekenmerkt worden door aberrante type 2 inflammatie 
zijn gestegen in prevalentie. Een belangrijk voorbeeld is de vrij recente stijging in het aantal 
patiënten dat lijdt aan voedselallergie, maar deze trend werd in de vorige decaden reeds 
voorafgegaan door een toename in incidentie van astma, eczeem en hooikoorts. De oorzaak 
van dit falen ligt verscholen in gen-omgevingsinteracties en wordt tot op heden onvolledig 
begrepen. Het overkoepelend doel van dit proefschrift is om bij te dragen aan ons begrip 
van de pathofysiologie van type 2 inflammatie in het maag-darmkanaal, waarbij we 
twee onafhankelijke onderzoeksstrategieën hebben gevolgd die zijn beschreven in Deel 1 
en Deel 2. In Deel 1 proberen we om tot nieuw inzicht te komen in de pathogenese van 
allergische darmontsteking middels de studie van een cohort van patiënten die lijden 
aan eosinofiele oesofagitis, een type 2 ontstekingsproces van de slokdarm. Met behulp van 
een combinatie van klinische parameters en genexpressiedata in slokdarmbiopten tonen we 
aan dat er aanzienlijke immunologische heterogeniteit bestaat binnen deze patiëntengroep. 
In Deel 2 benaderen we het probleem van aberrante type 2 inflammatie via het ontwikkelen 
van een nieuw muismodel dat spontaan voedselallergie ontwikkelt en waarmee 
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derhalve de bijdrage van verschillende immunologische cellulaire componenten kan 
worden onderzocht. In beide delen hebben we voortdurend gestreefd naar translationele 
waarde van de experimenten. Multifactoriële, immuun-gemedieerde ziekten in darmmucosa 
zijn gedefinieerd in patiënten, maar worden veelal bestudeerd in muizen. Daar waar gebruik 
gemaakt wordt van muismodellen hebben we ook gekeken naar de mate van overlap met de 
menselijke situatie en deze vergelijkingen vormen een belangrijk onderdeel van het werk in 
dit proefschrift (Deel 1, Hoofdstuk 5; Deel 2, Hoofdstuk 6-9). 
11.1 Introductie Deel 1: Eosinofiele oesofagitis
Eosinofiele oesofagitis (EoE) maakt onderdeel uit van de eosinofiele gastro-intestinale 
syndromen, die gekenmerkt worden door infiltratie van eosinofiele granulocyten 
(eosinofielen) in de maag-darm mucosa. De pathogenese bestaat uit een complex samenspel 
van genetische predispositie, allergeen blootstelling en Th2-gemedieerde immuunactivatie. 
De huidige prevalentie ligt rond 0.5-1/1000 personen in Westerse samenlevingen en de 
totale incidentie neemt toe in Amerika, Australië en Europese landen (Dellon, 2014; Furuta 
en Katzka, 2015). De ziekte manifesteert zich veelal op de kinderleeftijd met symptomen die 
kunnen variëren van failure-to-thrive en voedingsproblemen in zuigelingen en peuters, tot 
buikpijn, spugen, dysfagie en passageproblemen en voedselimpactie in oudere kinderen en 
volwassenen (Assa’ad et al., 2007; Brown-Whitehorn en Liacouras, 2007; Straumann et al., 
2012). Aangezien de differentiaal diagnose van deze symptomen breed is komt diagnostische 
delay regelmatig voor (Hruz et al., 2011; Schoepfer et al., 2011). De gouden standaard voor 
een diagnose van EoE is histopathologische evaluatie van slokdarmbiopten, verkregen uit 
endoscopische onderzoek, waarin tenminste 15 eosinofielen per HPF aanwezig moeten 
zijn. Deze bevinding is op zichzelf echter verre van pathognomonisch en diagnostische 
onzekerheid kan de start van therapie in de praktijk nog verder vertragen (Liacouras et al., 
2011; Straumann, 2009). Behandeling geschiedt met ingestie van steroïdenpreparaten of met 
een voedingsinterventie die gericht is op het verwijderen van veelvoorkomende allergenen 
uit het dieet (Arias en Lucendo, 2014; Arias et al., 2014; Gonsalves et al., 2012; Lucendo et 
al., 2013). EoE is echter een chronische ziekte, die na staken van de behandeling terugkeert 
en op termijn leiden tot weefselveranderingen die kunnen resulteren in strictuurvorming en 
slokdarmvernauwing. De aandoening is geassocieerd met een verminderde kwaliteit van 
leven met persisterend symptomen 15 jaar na eerste presentatie (DeBrosse et al., 2011). 
  Immunologisch gezien bestaat EoE uit een Th2-gemedieerd, allergeenafhankelijk 
ontstekingsproces van de slokdarm. Comorbiditeit met andere allergische ziekten is hoog en 
varieert van 42-93% bij kinderen en 28-86% van de volwassen patiënten populatie (Liacouras 
et al., 2005; 2014; Roy-Ghanta et al., 2008; Spergel et al., 2005). Een groot deel van patiënten 
heeft voedingsantigeen-specifiek IgE, maar ondanks de duidelijk associatie tussen EoE en 
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een atopische constitutie worden in 50% van de gevallen normale IgE waarden gevonden, 
waaruit volgt dat eosinofiele ontsteking grotendeels onafhankelijk lijkt te zijn van IgE 
sensibilisatie (Simon et al., 2016). Dit verklaart ook waarom de resultaten van behandeling 
met het monoklonale anti-IgE antilichaam omalizumab teleurstellend zijn gebleken in zowel 
kinderen als volwassenen met EoE (Clayton et al., 2014; Rocha et al., 2011). Een alternatieve 
hypothese stelt dat de antigen-specificiteit van de ziekte met name gemedieerd wordt door 
antilichamen van de IgG4 klasse, dat eveneens in hogere waarden gevonden worden in EoE 
patiënten vergeleken met een controlegroep (Clayton et al., 2014). Net als IgE is IgG4 een 
IL-4-afhankelijk (dus type 2) antilichaam (Aalberse et al., 2016), en mogelijk bestaat er in vivo 
competitie tussen antigeen-specifieke IgE en IgG4 moleculen voor binding van een beperkte 
hoeveelheid allergeen. Dit fenomeen wordt in verband gebracht met het ontstaan van orale 
tolerantie bij immuuntherapie (Akdis en Akdis, 2014b), en het is in dit opzicht noemenswaardig 
dat er meerdere gevallen zijn beschreven waarin patiënten EoE ontwikkelden na het starten 
van desensibilisatie protocollen middels orale immuuntherapie (Lucendo et al., 2014). 
  Onafhankelijk van serologisch onderzoek in de individuele patiënt blijkt het Th2 
karakter van EoE verder uit genexpressiedata in de aangedane slokdarm (Blanchard et 
al., 2006a; 2006b; Furuta et al., 2007; Noti et al., 2013), uit de dominante rol van IL-13 in 
de pathogenese van de aandoening in experimenteel onderzoek (Blanchard et al., 2010; 
Davis en Rothenberg, 2016), en uit infiltratie van de slokdarm met mestcellen en basofiele 
granulocyten naast eosinofielen (Abonia et al., 2010; Noti et al., 2013). Volledig inzicht in 
het samenspel tussen allergische ziekten en een atopische constitutie enerzijds en de 
evolutie van de pathofysiologie van EoE anderzijds behoeft nog uitgebreid aanvullend 
onderzoek. In Hoofdstuk 5 wordt een van de factoren in dit samenspel verder onderzocht en 
demonstreren we dat allergische sensibilisatie door een beschadigde huid zoals die gezien 
wordt bij atopische dermatitis het ontstaan van EoE beïnvloedt via IL-33 en basofielen. Deze 
bevinding koppelt EoE aan eczeem op jonge leeftijd en suggereert dat EoE, net als astma en 
hooikoorts, een station zou kunnen zijn in wat wel de atopische mars genoemd wordt. 
11.2 Rationale en onderzoeksvragen behorend bij Deel 1 
In tegenstelling tot astma kan EoE alleen gediagnosticeerd worden middels de 
microscopische beoordeling van weefselbiopten na afname via gastroscopie. Dankzij deze 
diagnostische eis zijn er de laatste jaren op verschillende plekken in Noord-Amerika grote 
cohorten gevormd waarin klinische patiëntkenmerken gecombineerd kunnen worden met 
histologische en genexpressie data in de aangedane slokdarm teneinde beter inzicht te 
krijgen in het pathofysiologisch substraat van de ziekte (Dellon et al., 2012; 2013; Blanchard 
et al., 2011; Wen et al., 2015; 2013). Het patiëntencohort van het Boston Children’s Hospital 
dat we beschrijven in de Hoofdstukken 2, 3, 4 en 5 van dit proefschrift is hier een voorbeeld 
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van. Dit translationele onderzoeksproject is gericht op een drietal doelen: (1) de noodzaak 
voor herhaaldelijk endoscopisch onderzoek bij patiënten verminderen middels identificatie 
van minder invasieve biomarkers; (2) een beter begrip van de pathogenese van EoE en (3) de 
diagnostische waarde vergroten van oesofagiale biopten.
  In werk dat niet in dit proefschrift is geïncludeerd hebben we met betrekking tot het 
eerste onderzoeksdoel gekeken of een oplosbare vorm van de IgE oppervlakte receptor FcεRI 
gebruikt kan worden om EoE patiënten te identificeren (Lexmond et al., 2011). Daarnaast 
hebben we onderzocht of waarden van leukotrieën E4 in urine (Hoofdstuk 3) of de oplosbare 
IL-33 receptor in serum (hoofdstuk 5) onderscheid maken tussen kinderen met en zonder 
EoE. Andere groepen hebben gekeken naar combinaties van cytokines in bloed (Blanchard 
et al., 2011) of hebben getracht de diagnose te stellen op grond van materiaal verkregen via 
een doorgeslikte capsule aan een sonde (Furuta et al., 2013). Ondanks deze pogingen is er tot 
op heden geen klinisch alternatief voor gastroscopie in de diagnose van EoE. 
  Slokdarmbiopten van patiënten vormen een waardevolle bron bij het ontrafelen 
van de pathogenese van EoE. In 2006 werd voor het eerst beschreven dat EoE gepaard 
gaat met een ziekte-specifiek transcriptoom, wat wil zeggen dat er zich bij EoE patiënten 
in de oesophagus veranderingen voordoen in de mRNA expressie van verschillende 
(inflammatoire) genen (Blanchard et al., 2006b). In Hoofdstuk 2 demonstreren we dat een 
rekenkundig model gebaseerd op de expressie van een tiental van dit soort genen in staat 
is om met een sensitiviteit tot 94% patiënten met EoE te onderscheiden van kinderen met 
gastro-oesofageale refluxziekte of die met normale slokdarmhistologie. De hoge sensitiviteit 
van dit model is te verklaren door het feit dat het gebruik maakt van genen die tot expressie 
gebracht worden in de context van eosinofiele inflammatie en die derhalve gezien kunnen 
worden als passend bij een ‘final common pathway’. In het oorspronkelijke transcriptoom 
onderzoek werd reeds gevonden dat de meest karakteristieke veranderingen (verhoogde 
expressie van eotaxin-3 en periostin) optreden bij EoE patiënten ongeacht IgE sensibilisatie 
tegen voedselallergenen (Blanchard et al., 2006a; 2007). Zoals we hiervoor reeds bespraken 
is EoE echter een heterogene ziekte wat betreft klinische presentatie, leeftijd van ontstaan, 
en relatie tot het al dan niet bestaan van andere allergische ziekten. Derhalve vroegen we 
ons af of het EoE transcriptoom niet ook subtielere verschillen behelst die samenhangen met 
verschillende uitingsvormen van de aandoening. Deze hypothese vormt het uitgangspunt van 
Hoofdstuk 3, waar we een subpopulatie (ongeveer 30%) van EoE patiënten definiëren die 
gekenmerkt wordt door verhoogde mRNA expressie van het enzym leukotrieën C4 synthase 
(LTC4S) dat uit arachidonzuur leukotrieën C4 genereert, een ontstekingsfactor betrokken 
bij allergische weefselresponsen. EoE patiënten met lokaal verhoogde LTC4S transcriptie 
hadden vaker IgE-gemedieerde voedselallergieën en vormden daarmee dus een subgroep 
die op grond van zowel functionele als klinische eigenschappen kan worden gedefinieerd. 
Noemenswaardig is dat klinische trials met de leukotrieën receptor antagonist montelukast 
in EoE patiënten gemengde resultaten hebben gerapporteerd. Hoewel een aantal patiënten 
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verbetering vertoonde was de werkzaamheid in de totale patiëntengroep onvoldoende. Een 
aantrekkelijke hypothese die voortkomt uit de resultaten beschreven in Hoofdstuk 3 is dat 
alleen patiënten met verhoogde LTC4S expressie baat zullen hebben van medicamenteuze 
interventie in het leukotrieën metabolisme. 
  Naast dit werk gericht op het verbeteren van het diagnostisch proces bij EoE 
hebben we in Hoofdstuk 4 en 5 de biopten van ons EoE patiëntencohort gebruikt voor 
pathofysiologisch-georiënteerde vraagstellingen. Zoals het geval is voor andere allergische 
ziekten is de incidentie van EoE snel stijgende in Westerse samenlevingen, wat betekent dat 
omgevingsfactoren een doorslaggevende rol spelen bij het ontstaan van deze aandoening 
(Davis en Rothenberg, 2016; Furuta en Katzka, 2015). Een belangrijke factor die de laatste tien 
jaar veel wetenschappelijke aandacht heeft gekregen is de samenstelling van onze microflora 
– het geheel van micro-organismen op en in ons lichaam – waarbij moleculaire signalen van 
bacteriën een grote invloed blijken te hebben op de homeostase van onderdelen van het 
immuunsysteem in de mucosa (zie ook Hoofdstuk 7 en 9). Een type leukocyt waarvoor 
zo’n verband in sterke mate is aangetoond is de invariant chain natural killer T (iNKT) cel, die 
in verhoogde aantallen voorkomt in de darm en longen van muizen die opgroeien zonder 
bacteriële flora (zogenaamde germ-free muizen) en deze dieren daarmee gevoelig maakt 
voor colitis en allergisch astma (Olszak et al., 2012). In Hoofdstuk 4 beschrijven we dat iNKT 
cellen voorkomen in de slokdarm van patiënten met EoE. Hun betrokkenheid bleek het 
grootst in kinderen die op jonge leeftijd EoE ontwikkelden (voor hun zesde levensjaar) en 
bij wie we eveneens aanwijzingen vonden voor IgE-sensibilisatie tegen voedselallergenen 
en verhoogde LTC4S expressie. Verwijdering van allergenen uit het dieet van onze patiënten 
ging gepaard met normaliseren van de iNKT-cel as. We vonden verder dat EoE is geassocieerd 
met het gebruik van antibiotica op jonge leeftijd, wat inmiddels ook door andere groepen is 
gesuggereerd (Jensen et al., 2013; Radano et al., 2014), en in combinatie met het vaststellen 
van een ziekte-specifiek microbioom (Harris et al., 2015) kunnen deze bevindingen in de 
toekomst mogelijk leiden tot preventieve strategieën. 
  Als ook eerder al benadrukt moet EoE beschouwd worden als een complexe, 
multifactoriële aandoening, en een verstoorde bacteriële kolonisatie en iNKT cel homeostase 
alleen is niet voldoende om alle aspecten van de ziekte te verklaren. Zo wordt polymorfisme 
in de genen TSLP of IL33 in verhoogde mate gevonden bij EoE patiënten (Kottyan et al., 2014; 
Rothenberg et al., 2010; Sherrill et al., 2010; Spergel, 2010) en komt de ziekte vaak voor in de 
context van andere allergische aandoeningen. In Hoofdstuk 5 beschrijven we dat allergische 
sensibilisatie via de huid van muizen met dermatitis gevolgd door intranasale allergeen 
blootstelling leidt tot eosinofiele ontsteking van de slokdarm via verhoogde expressie van 
IL-33 en TSLP. Hierbij is een kritieke rol weggelegd voor basofiele granulocyten, want muizen 
zonder basofielen vertoonden minder eosinofielen in de oesophagus na allergeen stimulatie. 
Daarnaast vonden we in de slokdarm van kinderen met EoE verhoogde expressie van de 
IL-33 receptor. De bevindingen in dit hoofdstuk ondersteunen de theorie dat atopische 
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dermatitis (allergisch eczeem), vaak de eerste uiting van atopie in de atopische mars, direct 
kan bijdragen aan de manifestatie van allergische ziekten in het latere leven. 
11.3 Introductie Deel 2: proefdiermodellen in de studie van type 2 inflammatie 
van het maag-darmkanaal
Hoofdstuk 5 maakt gebruik van een experimentele strategie die erop gericht is om allergische 
sensibilisatie in muizen te bewerkstelligen via allergeen blootstelling door een mechanisch 
beschadigde huid. In dit protocol werden dieren op de leeftijd van 4-6 weken gedurende 7 
dagen blootgesteld aan allergeen-bevattende pleisters, gevolgd door intranasale allergeen 
toediening op dagen 9, 11 en 13. Een vergelijkbaar protocol dat we zullen tegenkomen in 
Hoofdstuk 8 is gebaseerd op de allergische sensibilisatie van proefdieren via intraperitoneale 
injectie met aan adjuvans gekoppeld allergeen op dag 0, 7 en 14 en daaropvolgende 
intragastrische provocaties van dag 21 tot 39. Hoewel dergelijke strategieën ons inzicht in 
de pathofysiologie van allergische ziekten ruimschoots vergroot hebben moeten we ons 
ook bewust zijn van de beperkingen die deze modellen met zich meebrengen en van de 
aannames die verscholen liggen in de timing van de immunologische interventies. Immers, 
het proces van allergische sensibilisatie zelf bevindt zich in deze experimenten volledig 
onder controle van de onderzoeker en is gebaseerd op relatief onfysiologische prikkels 
zoals het mechanisch beschadigen van de geschoren huid met plakband, of injectie met 
aan aluminium hydroxide gekoppeld ovalbumine. Deze experimenten gaan hiermee in hun 
opzet voorbij aan het feit dat de kritieke invloed van omgevingsfactoren op atopie heel goed 
zou kunnen liggen in het verhogen van de gevoeligheid voor IgE sensibilisatie. Om te komen 
tot mechanistisch inzicht in de vraag hoe omgevingsfactoren bijdragen aan de verhoogde 
incidentie van allergische ziekten zouden we juist het proces van allergische sensibilisatie 
zelf moeten bestuderen. Een ideaal experiment om een causaal verband aan te tonen dient 
de mate van sensibilisatie te vergelijken binnen twee groepen muizen die alleen van elkaar 
verschillen in de blootstelling aan de ene onderzochte omgevingsfactor. Natuurlijk zijn zulke 
studies alleen uitvoerbaar als allergische sensibilisatie daadwerkelijk optreedt in proefdieren 
op een wijze die min of meer overeenkomt met de pathofysiologie van de aandoening in 
patiënten. Voor de studie van voedselallergie zit hier een probleem. Wild-type muizen zijn 
zeer resistent voor aberrante IgE reacties tegen voedselantigenen dankzij het principe van 
orale tolerantie, waarmee het samenspel van immuun mechanismen bedoeld wordt dat 
ongewilde responsen tegen (onschadelijke) antigenen in het lumen van de darm dient te 
voorkomen. De robuustheid van orale tolerantie zorgt ervoor dat de inductie van type 2 
inflammatie onder normale omstandigheden alleen bestudeerd kan worden in muizen na 
het uitvoeren van immunologische manipulatie met adjuvans, waarvan hierboven al een 
voorbeeld werd geschetst, of – zo mogelijk nog minder fysiologisch – na passieve immunisatie 
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met allergeen specifieke IgE antilichamen. Zulke diermodellen, die de effector fase van 
de ziekte benaderen maar niet de totstandkoming ervan, worden ‘isomorf’ genoemd en 
staan daarmee in tegenstelling tot ‘homologe’ modellen, die zowel effector als inductiefase 
weergeven op een manier die overeenkomt met de bij mensen voorkomende aandoening 
(Oyoshi et al., 2014). In Deel 2 van dit proefschrift richten we ons op strategieën om de 
homologie van diermodellen van type 2 inflammatie te vergroten.  
11.4 Rationale en onderzoeksvragen behorend bij Deel 2 
Een van de mogelijke strategieën om de translationele waarde van dierexperimenten 
te vergroten is om gebruik te maken van muizen met (componenten van) een menselijk 
immuunsysteem (zogenaamde gehumaniseerde muizen, zie Hoofdstuk 1). Dit kan op 
vrij eenvoudige wijze worden bewerkstelligd door geïsoleerde leukocyten uit bloed van 
patiënten of vrijwilligers te transplanteren naar muizen die zelf niet beschikken over een 
adaptief immuunsysteem en derhalve geen afweerrespons kunnen opwekken tegen de 
lichaamsvreemde, menselijke immuuncellen. De omgekeerde respons, dat wil zeggen het 
herkennen van de muis als ‘lichaamsvreemd’ door de getransplanteerde lymfocyten, is 
echter wel intact, en de ernstige graft-versus-host reacties die het gevolg zijn leggen grote 
beperkingen op aan de conclusies die uit dergelijke studies kunnen worden getrokken. Dit 
graft-versus-host probleem kan worden voorkomen door in dezelfde immunodeficiënte 
muizen immuun reconstitutie te laten plaatsvinden uit menselijke hemopoietische (CD34-
positieve) stamcellen. De T-lymfocyten die zich op deze manier ontwikkelen ondergaan hun 
negatieve selectie immers via interacties met muizen MHC klasse II in plaats van menselijk 
MHC II, waardoor het risico op auto-immuniteit sterk wordt teruggebracht. Helaas is de 
opbrengst van T cellen in dit systeem laag en blijven adaptieve immuunreacties zwak 
(Baenziger et al., 2006). Reconstitutie van lymfocyten kan weliswaar worden verbeterd door 
transplantatie van foetaal beenmerg, lever en thymus weefsel samen met CD34-positieve 
hemopoietische stamcellen, maar dit gaat gepaard met hoge kosten en ethische bezwaren 
en maakt het tevens onmogelijk om patiëntmateriaal te bestuderen (Shultz et al., 2012). In 
Hoofdstuk 6 testen we de hypothese dat adaptieve immuniteit in gehumaniseerde muizen 
kan worden verbeterd door stamcelreconstitutie te laten plaatsvinden in immunodeficiënte 
muizen die in plaats van muizen MHC II een menselijk MHC II allel (DR1) tot expressie 
brengen. We demonstreren dat deze strategie leidt tot een groter T cel receptor repertoire 
en betere B cel rijping, met daarbij sterkere adaptieve immuunreacties en hogere antistof 
concentraties (inclusief IgE) in bloed. Transplantatie van stamcellen verkregen van een 
donor met het immune dysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX) 
syndroom, gekenmerkt door afwezigheid van FOXP3+ regulatore T cellen door mutatie van 
transcriptiefactor FOXP3, resulteerde in dodelijke auto-immuniteit in DR1+ muizen maar niet 
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in muizen zonder menselijk DR1. Hoofdstuk 6 vormt hiermee de eerste beschrijving van een 
menselijke immuunpathologie die op deze manier wordt gekopieerd in een gehumaniseerd 
muismodel.  
Naast ernstige auto-immuniteit leiden patiënten met het IPEX syndroom aan voedselallergieën, 
eczeem en verhoogd serum IgE (Akdis en Akdis, 2009; Lin et al., 2005; Suscovich et al., 2012). 
Deze symptomen zijn het gevolg van de ontregelde Th2 immuun activatie die optreedt in 
afwezigheid van FOXP3+ regulatore T (Treg) cellen. Verhoogd serum IgE en atopie wordt 
verder gezien in een aantal primaire immuundeficiënties. Een welbekend voorbeeld van een 
dergelijke aandoening met hoog serum IgE is het syndroom van Wiskott-Aldrich (WAS), wat 
veroorzaakt wordt door een mutatie van het gelijknamige gen WAS op het X-chromosoom. 
Het Wiskott-Aldrich syndroom eiwit (WASP) wordt in alle hemopoietische cellen tot expressie 
gebracht en is een regulator van het actine cytoskelet die ervoor zorgt dat een groot aantal 
externe stimuli gepaard kan gaan met morfologische en functionele veranderingen in de 
cel (Snapper en Rosen, 1999; Thrasher en Burns, 2010). Inmiddels zijn meer dan 100 unieke 
‘loss-of-function’ mutaties in WAS beschreven waardoor sprake is van een klinisch zeer 
heterogene patiëntengroep. Jongens met de meest ernstige mutaties presenteren zich in het 
eerste levensjaar met ernstig eczeem, trombocytopenie, auto-immuniteit en recidiverende 
infecties, die levensbedreigend kunnen verlopen tenzij patiënten stamceltransplantatie of 
gentherapie ondergaan. Andere WAS mutaties leiden tot X-linked trombocytopenie (XLT), 
een klinisch syndroom dat veel milder verloopt en ook zonder stamceltransplantatie een 
uitstekende prognose kent (Albert et al., 2011). Hoewel de relatie tussen mutaties in WAS en 
verhoogd serum IgE al in 1968 voor het eerst werd beschreven is het sindsdien onduidelijk 
gebleven wat in deze patiënten aanleiding geeft tot verhoogde productie van IgE. Daarnaast 
is de antigeenspecificiteit van IgE onbekend, en weten we niet wat de consequenties zijn 
van het verhoogde serum IgE op het bestaan van allergische aandoeningen in patiënten 
met WAS mutaties. WASP is een evolutionair geconserveerd eiwit en ook in muizen wordt 
op het X-chromosoom een ortholoog van het menselijk WAS gen gevonden (genaamd 
Was). Sinds 1998 bestaan WASP-deficiënte (Was-/-) muizen, waarin een groot aantal van de 
immunologische karakteristieken van Wiskott-Aldrich syndroom tot uiting komen (Snapper 
et al., 1998). Net als voor WAS patiënten geldt ook voor deze muizen dat er geen systematische 
studie is verricht naar het voorkomen en het mechanisme van aberrante IgE responsen. 
In Hoofdstukken 7, 8 en 9 bestuderen we IgE-gemedieerde immuun responsen in WASP-
deficiënte patiënten en muizen. De overkoepelende hypothese bij deze experimenten is dat 
verhoogd serum IgE specificiteit zou kunnen hebben voor voedselantigenen en dat Was-/- 
muizen in dat geval gebruikt zouden kunnen worden als een nieuw, mogelijk meer homoloog 
proefdiermodel voor de studie van voedselallergie. 
  In Hoofdstuk 7 beschrijven we dat voedselallergie voorkomt bij 20% van patiënten 
met mutaties in WAS, een significant hogere prevalentie dan in de algehele bevolking. Was-/- 
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muizen hebben net als WAS patiënten verhoogde waarden van serum IgE. Deze IgE antistoffen 
tonen specificiteit voor voedselantigenen die voorkomen in het dieet van de proefdieren, 
waaronder tarwe en soja. Aangezien tarwe en soja belangrijke voedselallergenen zijn bij 
patiënten met voedselallergie vormt deze bevinding een belangrijk argument voor homologie 
van het model. In Hoofdstuk 8 wordt onze hypothese uitgewerkt en worden Was-/- muizen 
verder gekarakteriseerd als proefdiermodel voor voedselallergie door ze te vergelijken met 
een bestaand en veelgebruikt model dat gebaseerd is op sensibilisatie via intraperitoneale 
injectie van ovalbumine (OVA) in combinatie met adjuvans. In Was-/- dieren leidt orale 
blootstelling aan OVA tot OVA-specifieke IgE productie, en kan de inductie van voedsel-
specifiek IgE dus bestudeerd worden zonder immuunmanipulatie met adjuvans. Aangezien 
een homoloog model naast de inductiefase ook de effectorfase van IgE-gemedieerde 
voedselallergie moet omvatten, bestuderen we tevens het optreden van allergisch diarree na 
provocatie met OVA in spontaan gesensibiliseerde Was-/- muizen. Dit werd gezien in ongeveer 
70% van de dieren, hetgeen overeen kwam met muizen uit het adjuvans-gemedieerde model. 
Na intraperitoneale injectie met een lage dosis OVA trad in Was-/- muizen een anafylactische 
reactie op gekenmerkt door een snelle daling van de lichaamstemperatuur, die in >50% van 
de proefdieren een dodelijke afloop kende binnen een uur na provocatie. 
  Nadat we WASP-deficiënte muizen hadden geïdentificeerd als nieuw proefdiermodel 
voor de studie van voedselallergie waren we erop gericht om de pathogenese van deze 
spontane type 2 inflammatie in het maag-darm kanaal te verhelderen. Zoals in Hoofdstuk 
7 wordt beschreven treden spontane IgE reacties tegen voedselallergenen ook op in Was-
/- muizen gehouden onder germ-free condities, hoewel de humorale immuunrespons 
in muizen mét en zonder darmflora wel van elkaar verschilde in de verhouding tussen 
immuunglobuline isotypes. Met behulp van genetische strategieën die het mogelijk maken 
om te komen tot cel-type-specifieke deletie van WASP tonen we aan dat verlies van WASP 
uit FOXP3+ Tregs voldoende is voor het spontaan ontstaan van voedselallergie en type 2 
intestinale inflammatie. Waar Th1 en Th17 responsen niet versterkt voorkomen in Was-
/- muizen blijken WASP-deficiënte Tregs niet in staat om Th2 proliferatie en activatie te 
onderdrukken. Dit gaat gepaard met verhoogde expressie van Th2 transcriptiefactor GATA3 
in Tregs, zowel in muizen als in patiënten met mutaties in WAS. De mate van GATA3 expressie 
in Tregs hangt in patiënten af van de ernst van de WAS mutatie. GATA3 waarden waren lager 
in patiënten met XLT dan in die met ergere loss-of-functie mutaties, wat suggestief is voor 
een dosis-respons relatie. De bevinding van een Th2 fenotype van FOXP3+ Tregs past binnen 
een recente studie waarbij dergelijke Tregs ook gevonden worden in jonge kinderen met 
koemelkallergie buiten de context van WASP deficiëntie (Noval Rivas et al., 2015). Dit vormt 
een extra argument voor relevante overlap tussen WAS-geassocieerde en veelvoorkomende 
voedselallergie en pleit daarmee voor homologie van het proefdiermodel. 
  Zoals weergegeven in Figuur 7.4 (pagina 164) resulteert FOXP3+ Treg-specifieke deletie 
van WASP in een versterkt allergisch fenotype met ernstigere type 2 inflammatie in het maag-
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darm kanaal ten opzichte van Was-/- muizen. Deze observatie vormt het uitgangspunt voor 
Hoofdstuk 9, dat geschreven is met als doel een synthese van de data uit Hoofdstukken 6, 
7 en 8 te presenteren met een inkadering in de bestaande WAS literatuur. De overkoepelende 
hypothese hierbij is dat verschillen in het allergisch fenotype tussen Was-/- muizen en 
muizen met FOXP3+ Treg-specifieke deletie van WASP het gevolg zijn van WASP-afhankelijke 
functies in immuuncompartimenten anders dan FOXP3+ Tregs (Tabel 9.1, pagina 241). Drie 
argumenten rechtvaardigen een nadere analyse van deze verschillen: 1. De analyse van de 
rol van WASP in verschillende immuuncompartimenten kan bijdragen aan een beter begrip 
van voedselallergie in WAS patiënten, in wie WASP ontbreekt in alle hemopoietische lijnen; 
2. Groter inzicht in de pathofysiologie van WAS-geassocieerde voedselallergie is relevant 
voor onze kennis over IgE-gemedieerde reacties tegen voedselantigenen in het algemeen; 
en 3. Beter begrip van de verschillen tussen beide muizen leidt tot een beter gedefinieerd 
proefdiermodel voor de studie van voedselallergie in de toekomst. In Hoofdstuk 9 
demonstreren we dat WASP-gemedieerde functies in antigeen presenterende cellen, B 
cellen, effector T cellen, regulatore T cellen en IgE effector cellen allemaal een vermoedelijke 
pro- of antiallergische rol spelen in de pathofysiologie van spontane voedselallergie. Verder 
demonstreren we in Hoofdstuk 9 preliminaire resultaten waaruit blijkt dat het microbioom 
en maternale factoren een invloed hebben op WAS-geassocieerde voedselallergie en dat 
WASP-deficiënte Tregs ziekte kunnen veroorzaken in muizen waar WASP ontbreekt in slechts 
de helft van de Tregs. Het hoofdstuk sluit af met samenvattende conclusies en suggesties 
voor verder onderzoek. 
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If these are the first words you read in this work, please be advised that a critical introduction 
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5  Umberto Eco. How to write a thesis. MIT Press 2015. Translated from the Italian, Come si fa una tesi di laurea: le 
materie umanistische 1977/2012. 
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Ouahed, pediatrician extraordinaire and – if possible – an even better friend. Thanks for the 
numerous drinks and stories we shared over these past years. It really has been great! Oliver 
Burton, thanks for your patience and your everlasting willingness to help out, to troubleshoot 
and to show me the ropes. You have taught me many things that nobody in our division was 
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postdoc at Cornell bodes well for our ambition to continue the Holland-Boston axis. I look 
forward to it! 
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had not gotten along as well as we have? Or that you have single-handedly taught me 50% 
of the methods that I have used throughout these pages? Or that hardly a day has gone by in 
which we did not talk for at least an hour? Maybe it suffices to say that you are by far the most 
generous person that I have ever met and that I have cherished each and every one of the 
16 oz. cans that we enjoyed to fuel our scientific and philosophical musings. I am extremely 
happy that you are now starting your own lab at Vanderbilt and I hope that our collaboration 
and friendship will flourish until deep into our retirement. Thank you for everything; I am 
honored that you are here today as my paranimf. 
I am very grateful to the crew at the Beatrix Children’s Hospital in Groningen, in particular 
prof. dr. Henkjan Verkade, prof. dr. Eduard Verhagen, prof. dr. Eric Duiverman, and dr. Bart 
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pediatrics. Thank you for your friendship and the trust you have had in me.  
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Joep Grootjans and Sarah Derks, what a great time and place to have met you, may the 
good times continue both in Amsterdam and Rotterdam. My loyal friends back home, who 
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every time I set foot in the homeland, in particular Rob, Boris, Huub, Jan, Ka, René, Tom, and 
Wouter, as well as Sander, Bart, Frank, Harold, Joost, Michiel, and Thijs. Thank you all for our 
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never want to see a different doctor again. Anne, I like to think that our healthy dose of sibling 
rivalry has bettered us both. Let our mutual paranimfism be the crown on that relationship! My 
parents Géke and Theo, it was around the time that you asked me if it had not, slowly, started 
to become time that I would come pick up my belongings from your attic – stored up there 
in cardboard boxes ever since my departure for Australia four years earlier – that I broke the 
news that ‘actually’, I was thinking about leaving to the US ‘for a couple of years’. A much heard 
question in those early days was whether this was not too harsh or cruel on my parents, to 
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it not say everything about the way you raised us that without consulting either of you I could 
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University who showed that epigenetic modifications occur in rats that receive a lot of parental 
love and warmth after birth, and that these DNA changes protect the rats against stress and 
disease later in life. However, I have decided that I will just leave it at the following conclusion: 
it will be very hard to live up to the example you have set. Thank you. 
And now I have a family of my own. Muß es sein? Es muß sein. Sandy my love, we met on day 1 
of this endeavor and now you are here on day 2346, in a front-row seat and with our daughter 
waiting in the next room. Of all the discoveries in Boston, you were the greatest. Thank you 
for choosing me.
6  Leo Tolstoy. Anna Karenina. Translated from Russian by Constance Garnett. Barnes & Noble Classics, New York 
2003. 
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